,Start Date,Start Price,End Date,End Price,Weekly Returns,Bin Label,News,Basics
0,2023-01-08,180.35000610351562,2023-01-15,192.0,0.06459658165909699,U5+,[],"{""assetTurnoverTTM"": 0.7299, ""bookValue"": 19123, ""cashRatio"": 0.6510257972780825, ""currentRatio"": 2.7282, ""ebitPerShare"": 3.8821, ""eps"": 3.5995, ""ev"": 66874.5, ""fcfMargin"": 0.3088, ""fcfPerShareTTM"": 11.8987, ""grossMargin"": 0.6227, ""inventoryTurnoverTTM"": 4.5322, ""netDebtToTotalCapital"": -0.1056, ""netDebtToTotalEquity"": -0.1115, ""netMargin"": 0.2882, ""operatingMargin"": 0.3108, ""pb"": 3.6086, ""peTTM"": 8.2524, ""pfcfTTM"": 15.0636, ""pretaxMargin"": 0.3255, ""psTTM"": 3.5823, ""quickRatio"": 2.3553, ""receivablesTurnoverTTM"": 8.4487, ""roaTTM"": 0.3168, ""roeTTM"": 0.4634, ""roicTTM"": 0.4403, ""rotcTTM"": 0.496, ""salesPerShare"": 12.4914, ""sgaToSale"": 0.3773, ""totalDebtToEquity"": 0.0561, ""totalDebtToTotalAsset"": 0.0415, ""totalDebtToTotalCapital"": 0.0531, ""totalRatio"": 3.8393, ""period"": ""2022-12-31""}"
1,2023-01-15,192.0,2023-01-22,193.97999572753906,0.010312477747599358,U2,[],"{""assetTurnoverTTM"": 0.7299, ""bookValue"": 19123, ""cashRatio"": 0.6510257972780825, ""currentRatio"": 2.7282, ""ebitPerShare"": 3.8821, ""eps"": 3.5995, ""ev"": 66874.5, ""fcfMargin"": 0.3088, ""fcfPerShareTTM"": 11.8987, ""grossMargin"": 0.6227, ""inventoryTurnoverTTM"": 4.5322, ""netDebtToTotalCapital"": -0.1056, ""netDebtToTotalEquity"": -0.1115, ""netMargin"": 0.2882, ""operatingMargin"": 0.3108, ""pb"": 3.6086, ""peTTM"": 8.2524, ""pfcfTTM"": 15.0636, ""pretaxMargin"": 0.3255, ""psTTM"": 3.5823, ""quickRatio"": 2.3553, ""receivablesTurnoverTTM"": 8.4487, ""roaTTM"": 0.3168, ""roeTTM"": 0.4634, ""roicTTM"": 0.4403, ""rotcTTM"": 0.496, ""salesPerShare"": 12.4914, ""sgaToSale"": 0.3773, ""totalDebtToEquity"": 0.0561, ""totalDebtToTotalAsset"": 0.0415, ""totalDebtToTotalCapital"": 0.0531, ""totalRatio"": 3.8393, ""period"": ""2022-12-31""}"
2,2023-01-22,193.97999572753906,2023-01-29,189.35000610351562,-0.02386838708114336,D3,[],{}
3,2023-01-29,189.35000610351562,2023-02-05,173.25,-0.08502775592578504,D5+,"[{""date"": ""2023-01-29"", ""headline"": ""Moderna Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-29"", ""headline"": ""Tracking Baillie Gifford's 13F Portfolio - Q4 2022 Update"", ""summary"": ""Baillie Gifford\u00e2\u0080\u0099s 13F portfolio value decreased from ~$96.99B to ~$95.96B this quarter. Click here for a detailed analysis.""}, {""date"": ""2023-01-30"", ""headline"": ""Moderna Scores A Win In RSV \u2014 But Its Shares Don't Reflect That"", ""summary"": ""The Food and Drug Administration granted Moderna's experimental RSV vaccine an expedited review, but Moderna stock dipped Monday.""}, {""date"": ""2023-01-30"", ""headline"": ""Fact Check-Vaccine work before SARS-CoV-2 had a name does not prove pandemic was planned"", ""summary"": ""U.S. biotech company Moderna Inc announced its collaboration with the National Institutes of Health (NIH) to develop an mRNA vaccine against the novel coronavirus in January 2020, before the virus was officially named SARS-CoV-2 in February 2020. Users online are circulating...""}, {""date"": ""2023-01-30"", ""headline"": ""Moderna\u2019s RSV vaccine gets Breakthrough Therapy status"", ""summary"": ""MARKET PULSE Moderna Inc. (MRNA) said Monday that the Food and Drug Administration granted the company\u2019s experimental respiratory syncytial virus vaccine a Breakthrough Therapy Designation. Moderna said it plans to apply for approval in the first half of this year.""}, {""date"": ""2023-01-30"", ""headline"": ""Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced mRNA-1345, an investigational mRNA vaccine candidate for respiratory syncytial virus (RSV), has been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration (FDA) for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) in adults aged 60 years or older.""}, {""date"": ""2023-01-30"", ""headline"": ""The Zacks Analyst Blog Highlights Pfizer/BioNTech, Moderna and Novavax"", ""summary"": ""Pfizer/BioNTech, Moderna and Novavax are included in this Analyst Blog.""}, {""date"": ""2023-01-30"", ""headline"": ""Moderna put volume heavy and directionally bearish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Moderna (MRNA) and TELA Bio (TELA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Moderna Gets FDA Breakthrough Designation for RSV Vaccine Candidate >MRNA"", ""summary"": ""By Colin Kellaher Moderna Inc. on Monday said the U.S. Food and Drug Administration granted breakthrough-therapy designation to its mRNA-1345 investigational...""}, {""date"": ""2023-01-30"", ""headline"": ""Moderna wins FDA`s breakthrough status for RSV vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-30"", ""headline"": ""Moderna granted Breakthrough Therapy Designation for mRNA-1345"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""TOP NEWS: GSK profit grows as aims for first-ever approved RSV vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""This Discount Growth Stock Is a Once-in-a-Decade Buying Opportunity Right Now"", ""summary"": ""The bad news is Moderna's vaccine may not be able to replicate these levels in a post-pandemic environment.  The good news is the vaccine still could lead to significant blockbuster revenue -- and that will support the development of Moderna's late-stage pipeline.  As a result, Moderna could launch other potential blockbusters over the next few years.""}, {""date"": ""2023-01-31"", ""headline"": ""Moderna\u2019s stock is down as Pfizer lowers revenue estimates for its COVID vaccine for 2023"", ""summary"": ""Moderna Inc.\u2019s  (MRNA)  shares were down 2.8% in trading on Tuesday.  Pfizer Inc.  (PFE)  which makes a competing COVID-19 vaccine to Moderna\u2019s Spikevax, on Tuesday put out guidance for 2023, saying it expects a total of $13.5 billion in sales of its COVID shot for the year.  Moderna\u2019s COVID vaccine is expected to bring in $18.1 billion in sales for 2022 and $7.3 billion in 2023, according to the FactSet consensus.""}, {""date"": ""2023-01-31"", ""headline"": ""Moderna Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slid 2.66% to $176.06 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-01-31"", ""headline"": ""The end of the Covid health emergency won't slow FDA clearance of shots and treatments"", ""summary"": ""The FDA has used separate emergency powers to authorize the Pfizer, Moderna, Johnson & Johnson and Novavax vaccines.""}, {""date"": ""2023-01-31"", ""headline"": ""Moderna (MRNA) RSV Jab For Older Adults Gets FDA Breakthrough Tag"", ""summary"": ""Moderna (MRNA) announces that the FDA granted Breakthrough Therapy Designation to its respiratory syncytial virus (RSV) vaccine candidate, mRNA-1345 for the prevention of respiratory disease in older adults.""}, {""date"": ""2023-01-31"", ""headline"": ""Moderna`s stock is down as Pfizer lowers revenue estimates for its COVID vaccine for 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Top 5 4th Quarter Trades of REIK & CO., LLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-01-31"", ""headline"": ""Is Moderna (MRNA) a High Growth Stock?"", ""summary"": ""Baron Funds, an investment management company, released its \u201cBaron Health Care Fund\u201d fourth quarter 2022 investor letter. A copy of the same can be downloaded here. In the fourth quarter, the fund increased by 9.08% (Institutional Shares) compared to an 11.54% gain for the Russell 3000 Health Care Index and a 7.56% gain for the S&P [\u2026]""}, {""date"": ""2023-02-01"", ""headline"": ""U.K. pharma lobby urges govt. to halt plans to raise revenue recovery rates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-01"", ""headline"": ""Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Moderna (MRNA) closed at $174.30, marking a -1% move from the previous day.""}, {""date"": ""2023-02-01"", ""headline"": ""The 7 Most Undervalued Nasdaq Stocks to Buy in February 2023"", ""summary"": ""Thanks to the wild events of 2022, discerning investors enjoy plenty of bargains, particularly in the arena of the most undervalued Nasdaq stocks. Given the exchange\u2019s bias toward technology players (including biotech), wagering in this space carries the advantage of relevance. Even if circumstances look shoddy right now, at some point, these enterprises have a shot at upside eventually. Now, a word of caution is in order following the utterances of the last few words above. With the most underv""}, {""date"": ""2023-02-01"", ""headline"": ""Moderna Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. shed 1.00% to $174.30 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-01"", ""headline"": ""Novavax refuses to refund $700M for COVID shots never delivered, NY Times says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-01"", ""headline"": ""1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell"", ""summary"": ""Novavax (NASDAQ: NVAX) has offered investors just such a ride over the past few years.  Initial gains came as investors bet on Novavax's chances of bringing a coronavirus vaccine to market; declines occurred after the vaccine entered the market later than rival products did.  Now, as we start a new year, you might be wondering what to do about Novavax.""}, {""date"": ""2023-02-01"", ""headline"": ""Novavax, JNJ dispute pre-payments for canceled COVID shots sought for world`s poor"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-01"", ""headline"": ""Novavax, JNJ dispute pre-payments for cancelled COVID shots sought for world`s poor"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-02"", ""headline"": ""Notable Friday Option Activity: MRNA, SPLK, SOND"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-02"", ""headline"": ""COVID is 'pretty much out of the models' for pharma companies: Wells Fargo analyst"", ""summary"": ""Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.""}, {""date"": ""2023-02-02"", ""headline"": ""The 7 Most Undervalued Biotech Stocks to Buy in February 2023"", ""summary"": ""You don\u2019t have to be particularly astute to recognize the importance of the most undervalued biotech stocks to buy. Fundamentally, the enterprises that undergird these names operate on the cutting edge of medical science. At the same time, the established players tend to be pricey. By picking up underappreciated names, it\u2019s possible to secure significant upside down the line. However, anytime a discussion about the most undervalued biotech stocks to buy materializes, a question comes up: how doe""}, {""date"": ""2023-02-02"", ""headline"": ""Pharma earnings: COVID \u2018is highly uncertain for this year,\u2019 analyst says"", ""summary"": ""Wells Fargo Managing Director Mohit Bansal joins Yahoo Finance Live to discuss pharmaceutical earnings amid COVID uncertainty, the impact of diabetic weight loss drugs on the market, and the outlook for drugmakers.""}, {""date"": ""2023-02-02"", ""headline"": ""Moderna Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. rose 1.18% to $176.35 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-02"", ""headline"": ""Moderna to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 23, 2023"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live conference call and webcast at 8:00 a.m.""}, {""date"": ""2023-02-02"", ""headline"": ""MRNA March 24th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-03"", ""headline"": ""Pfizer Is Moving Beyond Covid. Why Its Stock Is a Buy."", ""summary"": ""With its packed pipeline, growing R&D spending, and potential deals and share buybacks, there's more to the drugmaker than the market realizes.""}, {""date"": ""2023-02-03"", ""headline"": ""3 No-Brainer Growth Stocks to Buy in 2023"", ""summary"": ""In last-year's difficult market, growth stocks were among the first to suffer.  Why should we be confident about growth stocks?  Moderna (NASDAQ: MRNA) went from zero product revenue prior to the pandemic to about $18 billion annually over the past two years.""}, {""date"": ""2023-02-03"", ""headline"": ""Why Personalis Shares Are Trading Higher Today"", ""summary"": ""Personalis Inc (NASDAQ: PSNL) and Moderna Inc (NASDAQ: MRNA) have signed a new agreement to continue using the Personalis NeXT Platform as part of upcoming clinical studies of mRNA-4157/V940, an investigational personalized cancer vaccine, jointly developed by Moderna and Merck & Co Inc (NYSE: MRK). The platform, also utilized in the vaccine candidate's Phase 2b study, will be used to sequence genomic information from a patient's tumor sample to identify the unique genetic mutations that are mos""}, {""date"": ""2023-02-03"", ""headline"": ""China's CanSino confident its mRNA COVID vaccine as good as Moderna, Pfizer shots"", ""summary"": ""CanSino Biologics Chief Executive Yu Xuefeng said on Friday he was confident his company's experimental COVID-19 vaccine using messenger RNA (mRNA) technology was as good as shots from Moderna and Pfizer-BioNTech.""}, {""date"": ""2023-02-03"", ""headline"": ""UPDATE 1-China's CanSino confident its mRNA COVID vaccine as good as Moderna, Pfizer shots"", ""summary"": ""CanSino Biologics Chief Executive Yu Xuefeng said on Friday he was  confident his company's experimental COVID-19 vaccine using messenger RNA (mRNA) technology was as good as shots from Moderna and Pfizer-BioNTech.  As the COVID-19 pandemic evolves in China after the country abandoned its zero-COVID policy in December, domestic companies like CanSino are racing to develop mRNA COVID vaccines.  The country - which experienced a wave of infections across its 1.4 billion population after the sudden relaxation of COVID restrictions - has so far declined to use mRNA vaccines from abroad, and has yet to approve a domestic one that uses the technology.""}, {""date"": ""2023-02-03"", ""headline"": ""Moderna Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slid 1.76% to $173.25 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-03"", ""headline"": ""Pfizer: The Covid Reset Makes Sense"", ""summary"": ""Assuming an upward rerating, PFE could hit our price target of\u00c2\u00a0$55.79, suggesting 27.40% upside potential from current levels. Click here to read our analysis.""}, {""date"": ""2023-02-03"", ""headline"": ""Personalis and Moderna Sign New Agreement to Leverage NeXT Platform\u2122 in Personalized mRNA Cancer Vaccine Clinical Trials"", ""summary"": ""FREMONT, Calif., February 03, 2023--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced the companies have signed a new agreement to continue using the Personalis NeXT Platform\u00ae as part of upcoming clinical studies evaluating mRNA-4157/V940, an investigational personalized cancer vaccine, jointly developed by Moderna and Merck, kn""}, {""date"": ""2023-02-03"", ""headline"": ""Is Moderna Stock a Buy Now?"", ""summary"": ""The past three years have been fascinating for Moderna (NASDAQ: MRNA) and its shareholders.  Moderna's shares are up by an impressive 731% since early 2020, although its coronavirus-related sales will start falling this year.  At this point, it's fair to ask if Moderna can march on and continue delivering market-beating returns, or if the company won't be worth an investment in a post-pandemic world.""}, {""date"": ""2023-02-03"", ""headline"": ""Personalis Stock Jumps on Cancer-Vaccine Agreement with Moderna"", ""summary"": ""By Sabela Ojea Personalis Inc. on Friday jumped after it said it signed a new agreement with Moderna Inc. to develop the biotechnology company's cancer...""}, {""date"": ""2023-02-03"", ""headline"": ""Regeneron\u2019s Earnings Beat Forecasts, With No Sales of Covid-19 Treatment"", ""summary"": ""The pharmaceuticals company's total revenue dropped by 31% to $3.41 billion but beat the FactSet consensus of $3.13 billion.""}, {""date"": ""2023-02-03"", ""headline"": ""Personalis, Moderna announce new agreement to leverage NeXT Platform"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-03"", ""headline"": ""Top 5 4th Quarter Trades of Lipe & Dalton"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-04"", ""headline"": ""The Clock Is Ticking For Seres Therapeutics: I'm Not Afraid"", ""summary"": ""April 26 is FDA decision day for SER-109, the Seres microbiome treatment for recurrent C. difficile infection. See why MCRB stock is a Buy.""}, {""date"": ""2023-02-04"", ""headline"": ""The Clock Is Ticking For Seres Therapeutics: I`m Not Afraid"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-04"", ""headline"": ""Cancer vaccines are already a reality\u2014but your doctor might not tell you about them unless you ask"", ""summary"": ""\u201cPatients need to advocate for themselves.\""""}, {""date"": ""2023-02-04"", ""headline"": ""U.S. plans to stop buying Covid shots for the public this fall. Here's what that means for you"", ""summary"": ""Under the Affordable Care Act, most Americans would still get their Covid shots for free once the vaccine program goes commercial.""}, {""date"": ""2023-02-04"", ""headline"": ""Danaher said to be interested in acquiring contract manufacturer Catalent"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
4,2023-02-05,173.25,2023-02-12,169.27999877929688,-0.022914869960768414,D3,"[{""date"": ""2023-02-04"", ""headline"": ""The Clock Is Ticking For Seres Therapeutics: I'm Not Afraid"", ""summary"": ""April 26 is FDA decision day for SER-109, the Seres microbiome treatment for recurrent C. difficile infection. See why MCRB stock is a Buy.""}, {""date"": ""2023-02-04"", ""headline"": ""The Clock Is Ticking For Seres Therapeutics: I`m Not Afraid"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-05"", ""headline"": ""Personalis extends winning streak as Needham upgrades"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-06"", ""headline"": ""Moderna Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-06"", ""headline"": ""Moderna Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 1.72% to $170.27 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-02-06"", ""headline"": ""Drug companies face COVID cliff in 2023 as sales set to plummet"", ""summary"": ""Pharmaceutical companies that made billions from the pandemic  over the past two years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend  their windfalls wisely.  Western drugmakers including Pfizer Inc, BioNTech SE, Moderna Inc, Gilead Sciences Inc, AstraZeneca Plc and Merck & Co are estimated to have brought in about $100 billion in revenue from COVID vaccines and treatments in 2022.  Company and analyst estimates suggest those sales could fall by nearly two-thirds this year due to built up product inventories around the world including in the countries that pay the most.""}, {""date"": ""2023-02-06"", ""headline"": ""FOCUS-Drug companies face COVID cliff in 2023 as sales set to plummet"", ""summary"": ""Pharmaceutical companies that made billions from the pandemic  over the past two years selling vaccines and treatments are now up against a steep COVID cliff and investor pressure to spend  their windfalls wisely.  Western drugmakers including Pfizer Inc, BioNTech SE , Moderna Inc, Gilead Sciences Inc, AstraZeneca Plc and Merck & Co are estimated to have brought in about $100 billion in revenue from COVID vaccines and treatments in 2022.  Company and analyst estimates suggest those sales could fall by nearly two-thirds this year due to built up product inventories around the world including in the countries that pay the most.""}, {""date"": ""2023-02-06"", ""headline"": ""Catalent stock rockets 21% premarket on report of takeover interest from Danaher"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-06"", ""headline"": ""Personalis upgraded to Buy at Needham on cost reductions, biopharma potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-06"", ""headline"": ""Catalent Stock Surges on Report of Danaher Interest. M&A May Be Back."", ""summary"": ""After two major healthcare and life sciences deals at the end of 2022, M&A in the industry could be about to rebound.""}, {""date"": ""2023-02-07"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-07"", ""headline"": ""Moderna (MRNA) Gains But Lags Market: What You Should Know"", ""summary"": ""Moderna (MRNA) closed the most recent trading day at $171.06, moving +0.46% from the previous trading session.""}, {""date"": ""2023-02-07"", ""headline"": ""Moderna: Likely To See Continued Downward Pressure (Technical Analysis)"", ""summary"": ""Moderna specializes in developing innovative medicines and therapies using messenger RNA technology. Click here to read my analysis of MRNA stock.""}, {""date"": ""2023-02-07"", ""headline"": ""Catalent Reports Mixed Q2 Earnings, Expands Manufacturing Contract With Moderna"", ""summary"": ""Catalent Inc (NYSE: CTLT) reported Q2 FY23 sales of $1.15 billion, which decreased 6% Y/Y as reported, or 2% in constant currency, slightly beating the consensus of $1.12 billion. Adjusted EPS of $0.67, compared to $0.90 last year, missed the consensus of $0.69. Adjusted EBITDA was $283 million, or a margin of 25%, compared to $310 million a year ago. Biologics segment sales decreased by 7% to $580 million on a constant currency basis. Pharma and Consumer Health segment sales increased by 3% to""}, {""date"": ""2023-02-08"", ""headline"": ""Pandemic Profits In Healthcare"", ""summary"": ""Pfizer and Moderna profited by developing vaccines at a breakneck pace, but should investors add them to their portfolios in 2023? Check out more here.""}, {""date"": ""2023-02-08"", ""headline"": ""Sana Biotechnology: Time And Cash Burn Are The Enemies"", ""summary"": ""SANA was launched to pioneer a particular aspect of DNA-based therapies. This is new and revolutionary. Read why the therapy will likely to take time to mature.""}, {""date"": ""2023-02-08"", ""headline"": ""Model N price target raised to $52 from $45 at Truist"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-08"", ""headline"": ""Catalent price target raised to $82 from $75 at Baird"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-09"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-09"", ""headline"": ""Cramer's lightning round: EMCOR Group is my kind of stock"", ""summary"": ""\""Mad Money\"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.""}, {""date"": ""2023-02-09"", ""headline"": ""The Covid emergency in the U.S. ends May 11. HHS officials say here's what to expect"", ""summary"": ""HHS officials in a call with reporters laid out what the public can expect when the emergency ends. ""}, {""date"": ""2023-02-09"", ""headline"": ""Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Zacks.com users have recently been watching Moderna (MRNA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""2023-02-09"", ""headline"": ""See Which Of The Latest 13F Filers Holds Moderna"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-10"", ""headline"": ""Why Catalent Stock Was on Fire This Week"", ""summary"": ""Healthcare stocks were quite a mixed bag over the past few trading sessions, but one standout rising above the pack was contract drug manufacturer Catalent (NYSE: CTLT).  For its second quarter of fiscal 2023, Catalent's revenue was $1.15 billion, representing a 6% drop from the same period of the previous fiscal year.  The company's non-GAAP (adjusted) net income also fell, sliding to $122 million ($0.67 per share) from the year-ago profit of $163 million.""}, {""date"": ""2023-02-10"", ""headline"": ""Fact Check-Moderna CEO did not say company made 100,000 COVID-19 vaccine doses before the pandemic started"", ""summary"": ""At Davos 2023, Moderna CEO Stephane Bancel spoke about how quickly the company was able to scale up vaccine production at the start of the COVID-19 pandemic, not that Moderna had made 100,000 COVID vaccine doses before the pandemic began, as some are claiming online.""}, {""date"": ""2023-02-10"", ""headline"": ""Moderna Stock Getting Closer To Key Technical Benchmark"", ""summary"": ""A Relative Strength Rating upgrade for Moderna shows improving technical performance. Will it continue?""}, {""date"": ""2023-02-10"", ""headline"": ""25 Biggest Massachusetts Companies and Stocks"", ""summary"": ""In this article, we will be taking a look at the 25 biggest Massachusetts companies and stocks. To skip our detailed analysis, you can go directly to see the 5 biggest Massachusetts companies and stocks. If all U.S. states were countries, Massachusetts would be 32nd largest economy in the world based on a 2021 GDP [\u2026]""}, {""date"": ""2023-02-10"", ""headline"": ""Is Novavax Stock a Buy With the New Normal for COVID?"", ""summary"": ""My view was that the company had a big opportunity with an alternative to the messenger RNA (mRNA) vaccines from Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA).  Novavax's shares skyrocketed.  Is Novavax stock a buy in the new circumstances?""}, {""date"": ""2023-02-10"", ""headline"": ""Betting On Biotech"", ""summary"": ""Active investors can navigate the boom or bust biotech sector with the help of strategies like C-suite buying, cash to value and cash flow.""}, {""date"": ""2023-02-10"", ""headline"": ""Medicare mulls rebates in 2025 for drug prices rising faster than inflation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-10"", ""headline"": ""UPDATE: Hunt disappointed UK loses new AstraZeneca factory to Ireland"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-10"", ""headline"": ""Stocks with earnings at risk from UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Top 5 4th Quarter Trades of Gruss & Co., LLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Top 5 4th Quarter Trades of Theleme Partners LLP"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
5,2023-02-12,169.27999877929688,2023-02-19,166.60000610351562,-0.015831714881303638,D2,"[{""date"": ""2023-02-12"", ""headline"": ""6 Ways To Beat Inflation With `AIR` Factors - 2023 YTD Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Top 5 4th Quarter Trades of Gruss & Co., LLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-12"", ""headline"": ""Top 5 4th Quarter Trades of Theleme Partners LLP"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-13"", ""headline"": ""Stephen Mandel`s Lone Pine exits Meta, PayPal in Q4, takes stakes in AMD, Salesforce"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-13"", ""headline"": ""Moderna Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. advanced 1.30% to $171.48 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-13"", ""headline"": ""6 Ways To Beat Inflation With 'AIR' Factors - 2023 YTD Update"", ""summary"": ""Aswath Damodaran is an investing and finance authority on markets & valuation, among many other things.""}, {""date"": ""2023-02-14"", ""headline"": ""Autolus: Investment Case Further Entrenched With Latest Interim FELIX Data"", ""summary"": ""Autolus Therapeutics is a great speculative biotech play to look into. Read how positive interim results from phase 1b/2 FELIX study could make AUTL a Buy.""}, {""date"": ""2023-02-14"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""Moderna CEO to face Senate hearing over pricing for COVID shot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""Top 5 4th Quarter Trades of STARR INTERNATIONAL CO INC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-14"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. rose 2.41% to $175.62 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-14"", ""headline"": ""Lone Pine exited PayPal, initiated AMD position during Q4"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""GSK hails positive phase III trial results for RSV vaccine candidate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""Moderna CEO to testify in senate on proposed vaccine price hike"", ""summary"": ""Senator Bernie Sanders said on Wednesday Moderna Inc's chief executive officer St\u00e9phane Bancel will testify next month in front of the senate on the drugmaker's plans to raise the price of its coronavirus vaccine.""}, {""date"": ""2023-02-15"", ""headline"": ""Moderna promises free COVID-19 vaccines after U.S. public health emergency ends"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit"", ""summary"": ""The U.S. government should face a patent lawsuit over COVID-19 vaccines, not vaccine maker Moderna Inc, the Department of Justice told a Delaware federal court on Tuesday.""}, {""date"": ""2023-02-15"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. inched 0.95% higher to $177.28 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-02-15"", ""headline"": ""Moderna promises to keep COVID vaccine free"", ""summary"": ""Moderna Inc. said Wednesday it will keep its COVID-19 vaccines available and free for all people in the U.S. after the public-health emergency ends. The news...""}, {""date"": ""2023-02-15"", ""headline"": ""Moderna CEO St\u00e9phane Bancel will testify before Senate next month on Covid vaccine price hike"", ""summary"": ""Sen. Bernie Sanders, in a letter to the CEO, slammed a proposed price hike as \""outrageous\"" given that the vaccine was developed using taxpayer money.""}, {""date"": ""2023-02-15"", ""headline"": ""Federal government, not Moderna, should face COVID vaccine patent lawsuit, DoJ says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""Sanders calls Moderna chief to testify on vaccine price hike plans, WP says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""Medicare mulls limiting per month costs for generic drugs at $2"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""Moderna to offer free COVID shots even after pandemic emergency"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-15"", ""headline"": ""Moderna plans to keep COVID vaccine free for consumers, ABC News says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-16"", ""headline"": ""Moderna stock falls on mixed results of flu vaccine mRNA-1010 in phase 3 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-16"", ""headline"": ""Earnings week ahead: Walmart, Nvidia, Home Depot, Alibaba and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-16"", ""headline"": ""Moderna flu vaccine delivers mixed results in trial, shares fall"", ""summary"": ""Moderna Inc on Thursday said its closely watched experimental messenger RNA-based influenza vaccine generated a strong immune response against A strains of the flu but failed to show it was at least as effective as an approved vaccine versus less prevalent influenza B.""}, {""date"": ""2023-02-16"", ""headline"": ""UPDATE 1-Moderna flu vaccine delivers mixed results in trial, shares fall"", ""summary"": ""Moderna Inc on Thursday said its closely-watched experimental messenger RNA-based influenza vaccine generated a strong immune response against A strains of the flu but failed to show it was at least as effective as an approved vaccine versus less prevalent influenza B.  Moderna, whose only marketed product is its COVID-19 shot, has high hopes for its flu vaccine and aims to grab large portions of the respiratory syncytial virus (RSV) and seasonal flu markets with new mRNA vaccines.  The company said its vaccine, called mRNA-1010, generated a stronger immune response for the A/H3N2 and A/H1N1 strains than the marketed vaccine it was tested against in a trial of 6,102 adults aged 18 and over across Argentina, Australia, Colombia, Panama and the Philippines during flu season there.""}, {""date"": ""2023-02-16"", ""headline"": ""Moderna Announces Interim Phase 3 Safety and Immunogenicity Results for mRNA-1010, a Seasonal Influenza Vaccine Candidate"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced interim results from its pivotal Phase 3 safety and immunogenicity trial of (P301), an mRNA-based seasonal influenza (flu) vaccine candidate, in adults. The Phase 3 randomized trial was designed to evaluate the safety and immunogenicity of in adults 18 years and older in the Southern Hemisphere.""}, {""date"": ""2023-02-16"", ""headline"": ""Moderna flu vaccine delivers mixed results in trial"", ""summary"": ""Moderna Inc on Thursday said its experimental messenger RNA-based influenza vaccine generated a strong immune response against A strains of the flu but was inferior to an approved vaccine versus less prevalent influenza B.  Moderna, whose only marketed product is its COVID-19 shot, has high hopes for its flu vaccine and aims to grab large portions of the respiratory syncytial virus (RSV) and seasonal flu markets with new mRNA vaccines.""}, {""date"": ""2023-02-16"", ""headline"": ""Stocks to Watch: iBio, DoorDash, DraftKings, Moderna"", ""summary"": ""By Sabela Ojea iBio Inc. on Thursday disclosed that the MUC16 protein is the target of its latest immune-oncology program. Shares surged 129% in after-hours...""}, {""date"": ""2023-02-16"", ""headline"": ""Stocks making the biggest moves after hours: DoorDash, Applied Materials, DraftKings and more"", ""summary"": ""These are the stocks posting the largest moves in extended trading""}, {""date"": ""2023-02-16"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 2.80% to $172.31 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-16"", ""headline"": ""Moderna Shares Fall 5.9% on Mixed Results From Flu Shot Study"", ""summary"": ""By Denny Jacob Moderna Inc. shares edged down 5.9% to $162 in after-hours trading Thursday following mixed results of an experimental Moderna vaccine against...""}, {""date"": ""2023-02-16"", ""headline"": ""Moderna stock falls 5% after flu vaccine study results"", ""summary"": ""Moderna Inc. shares dove more than 5% in after-hours trading Thursday, after the company announced that a study into a flu vaccine candidate failed to reach...""}, {""date"": ""2023-02-16"", ""headline"": ""Pfizer/BioNTech, Moderna gear up for 2024 London trial over COVID vaccine patents"", ""summary"": ""Pfizer Inc and its German partner BioNTech SE are gearing up for a 2024 trial with Moderna Inc at London's High Court in competing patent lawsuits over their rival COVID-19 vaccines.""}, {""date"": ""2023-02-16"", ""headline"": ""IDNA: Healthcare Dashboard For February"", ""summary"": ""Pharmaceuticals and biotechs still look attractive. We focus on iShares Genomics Immunology and Healthcare ETF. IDNA is an ETF in genomics and immunology. Click here for more.""}, {""date"": ""2023-02-16"", ""headline"": ""Moderna, Pfizer, BioNTech Covid jab patent dispute heads to 2024 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-16"", ""headline"": ""7 Hot Healthcare Stocks With the Potential to Outperform"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-16"", ""headline"": ""Pfizer/ BioNTech, Moderna set for 2024 trial in COVID vaccine patent dispute"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-16"", ""headline"": ""Moderna\u2019s COVID vaccine will remain free for all Americans in coup for Bernie Sanders"", ""summary"": ""Moderna Inc. will keep its COVID-19 vaccine available and free of charge for all people in the U.S. even after the public-health emergency ends.""}, {""date"": ""2023-02-16"", ""headline"": ""Brookline Capital Markets Sticks to Its Buy Rating for Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-16"", ""headline"": ""Coronavirus tally: Moderna promises to keep COVID vaccine available and free for all Americans"", ""summary"": ""Moderna Inc. undefined will keep its COVID-19 vaccines available and free for all people in the U.S. after the public-health emergency ends. The news came as...""}, {""date"": ""2023-02-17"", ""headline"": ""COVID vaccine sales to see decline through end of decade as pandemic eases"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""US STOCKS-S&P 500 ends down as investors fret about interest rates"", ""summary"": ""The S&P 500 ended lower on Friday, weighed down by Microsoft and Nvidia as investors worried that inflation and a strong U.S. economy could put the Federal Reserve on pace for more interest rate hikes.  The see-saw session on Wall Street followed economic data this week that pointed to elevated inflation, a tight job market and resilience in consumer spending, giving the Fed more room for to raise borrowing costs.""}, {""date"": ""2023-02-17"", ""headline"": ""AMC Networks, DraftKings, AutoNation, Deere, and More of Today\u2019s Stock Market Movers"", ""summary"": ""AMC Networks posts better-than-expected adjusted earnings, DraftKings raises guidance for fiscal 2023, and AutoNation and Deere report quarterly earnings that top analysts' estimates.""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna Hypes 'Important Step' In Flu Shot Results, But Market Disagrees"", ""summary"": ""Moderna stock toppled Friday on mixed results for its flu shot \u2014 a rival to experimental vaccines from BioNTech, CureVac and Sanofi.""}, {""date"": ""2023-02-17"", ""headline"": ""US STOCKS-Wall Street drops as investors fret about interest rates"", ""summary"": ""Wall Street dropped on Friday, weighed down by Microsoft and Nvidia as investors worried that inflation and a strong U.S. economy could put the Federal Reserve on pace for more interest rate hikes.  The main indexes were on track to lose ground for the week as economic data pointed to elevated inflation, a tight job market and resilience in consumer spending, giving the Fed more room for to raise borrowing costs.""}, {""date"": ""2023-02-17"", ""headline"": ""US STOCKS-Wall St drops on mounting worries about Fed staying hawkish"", ""summary"": ""U.S. stock indexes fell on Friday, weighed down by energy and megacap growth names, as investors worried that inflation and signs of strength in the U.S. economy could put the Federal Reserve on pace for more interest rate hikes.  Wall Street indexes turned volatile this week following a strong start to 2023 as economic data pointed to elevated inflation, a tight job market and resilience in consumer spending, giving the Fed more room for to raise borrowing costs.  Goldman Sachs and Bank of America forecast three more rate hikes this year and by a quarter of a percentage point each, up from their previous estimate of two rate rises.""}, {""date"": ""2023-02-17"", ""headline"": ""It's Time to Reevaluate Moderna's Charts"", ""summary"": ""Trading volume spiked up in December with the price action but now prices are back below the lows of December putting all those buyers at a loss.  The On-Balance-Volume (OBV) line shows a zigzag pattern following its December zenith.  The trading volume has been light and thus not really attracting institutional buyers.""}, {""date"": ""2023-02-17"", ""headline"": ""Investors Fear Stock Markets Will Give Up 2023 Gains"", ""summary"": ""The stock market continued to move lower on Friday, extending losses from Thursday as investors grew more concerned about the possibility of tighter monetary policy from the Federal Reserve.  Suddenly, market participants who had thought that the Fed might stop raising interest rates entirely now seem to believe that larger rate hikes could come in the short run, potentially bringing about a deeper recession later in 2023.  A couple of stocks showed the cross-currents running through the stock market on Friday.""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slid 3.31% to $166.60 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-02-17"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks end mixed as rate worries resurface"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Health Canada Authorizes Moderna's Omicron-Targeting Bivalent COVID-19 Vaccine in Children & Adolescents (6-17 Years)"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Health Canada has authorized the use of its Omicron-targeting bivalent COVID-19 booster vaccine, mRNA-1273.214 (Spikevax Bivalent Original/Omicron) in children and adolescents 6 to 17 years of age.""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna\u2019s stock hit as flu-vaccine trial fails on one target. Meanwhile, China declares victory over COVID."", ""summary"": ""Moderna Inc.'s stock slid 5% Friday, after the COVID vaccine maker said a trial of a flu-vaccine candidate failed to meet one of its goals.""}, {""date"": ""2023-02-17"", ""headline"": ""Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents"", ""summary"": ""A High Court battle between Pfizer Inc (NYSE: PFE), its partner BioNTech SE (NASDAQ: BNTX) locked in a dispute with the rival COVID-19 vaccine maker Moderna Inc (NASDAQ: MRNA) over patents for vaccine technology is set to be heard in London next year. In August, Moderna filed patent infringement lawsuits against Pfizer/BioNTech in the U.S. and Germany. Moderna said that Pfizer/BioNTech's COVID-19 vaccine infringes patents filed between 2010 and 2016 covering foundational mRNA technology, which i""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna stock declines on mixed flu vaccine trial results"", ""summary"": ""Yahoo Finance's Julie Hyman, Brian Sozzi, and Brad Smith discuss why Moderna stock is down on Friday.""}, {""date"": ""2023-02-17"", ""headline"": ""Three-Stock Lunch: DE, AN and MRNA"", ""summary"": ""Diamond Hill Capital Management's Heather Brilliant joins CNBC's reporter panel on 'Power Lunch' to discuss Deere, AutoNation, and Moderna, three stocks making moves after earnings results.""}, {""date"": ""2023-02-17"", ""headline"": ""IN BRIEF: Moderna gets expanded Canada backing for booster jab"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Midday movers: AMC Networks, AutoNation, DraftKings and more"", ""summary"": ""By Liz Moyer""}, {""date"": ""2023-02-17"", ""headline"": ""Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more"", ""summary"": ""Deere shares popped on strong earnings. ""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna Stock Falls as Study of Flu Vaccine Has Mixed Results"", ""summary"": ""The shot got a strong immune response, but wasn't shown to be more effective than other vaccines.""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna Stock: Looking For The Future In Q4 Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Coronavirus tally: Moderna flu vaccine trial falls short on one goal, sending stock down"", ""summary"": ""Moderna Inc. stock was down 6.6% premarket Friday, after the COVID vaccine maker said a trial of a flu vaccine candidate failed to meet one of its goals. \""While we did not achieve non-inferiority for the Influenza B strains which are more frequent in younger populations, we have already updated the vaccine that we believe could improve immune responses against Influenza B and will seek to quickly confirm those improvements in an upcoming clinical study thanks to the agility of our mRNA platform,""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna: Health Canada Authorizes Omicron-Targeting Vaccine in 6-to-17-Year-Olds"", ""summary"": ""By Denny Jacob Moderna Inc. on Friday said Health Canada authorized the use of its Omicron-targeting bivalent Covid-19 booster vaccine in children and...""}, {""date"": ""2023-02-17"", ""headline"": ""Stocks Extend Slide, Moderna, DraftKings, Deere, Applied Materials In Focus - Five Things To Know"", ""summary"": ""Stock futures extend slide as Treasury yields leap; Moderna slumps after mixed data from flu vaccine trial; DraftKings jumps on narrower Q4 loss, solid revenue outlook; Deere earnings on deck with global equipment demand in focus and Applied Materials sees AI chip demand support firmer Q2 sales.""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna Omicron booster cleared in Canada for children and adolescents"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""BUZZ Investing: 2022`s Hard Hit Stocks Continue To Rebound In 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna says non-inferiority endpoint not met for B strains in flu vaccine study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Health Canada authorizes Moderna`s mRNA-1273.214 in children, adolescents"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna says non-inferiority not met for either endpoint in Phase 3 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Health Canada Authorizes Moderna`s Omicron-Targeting Bivalent COVID-19 Vaccine in Children & Adolescents (6-17 Years)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna`s stock hit as flu-vaccine trial fails on one target. Meanwhile, China declares victory over COVID."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna (MRNA) Receives a Hold from SVB Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Is the Stock Market Open on Presidents` Day 2023?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Why Is Moderna (MRNA) Stock Down 5% Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""10 Sectors Likely To Generate Good Returns In The Next Decade"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""DoorDash, DraftKings, Deere and AutoNation rise premarket; Moderna falls"", ""summary"": ""By Peter Nurse""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna Tanks on Phase 3 Data in Seasonal Influenza"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""5 stocks to watch on Friday: Deere, DoorDash and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Moderna, NatWest, Cognex among premarket losers` pack"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Arcutis Biotherapeutics (ARQT), Moderna (MRNA) and Bio-Rad Laboratories (BIO)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Jefferies says Moderna flu vaccine data doesn`t change improving pipeline thesis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-17"", ""headline"": ""Goldman Sachs Reaffirms Their Buy Rating on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-18"", ""headline"": ""2 Resilient Growth Stocks to Buy and Hold Forever"", ""summary"": ""The kind of market volatility we have experienced in the past year can sometimes rattle investors, drawing their focus away from the long-term mindset that is important to earning excellent returns over time.  Biotech company Moderna (NASDAQ: MRNA) and fintech specialist PayPal (NASDAQ: PYPL) are two such stocks.  Are Moderna's growth days over?""}, {""date"": ""2023-02-19"", ""headline"": ""Walmart, Alibaba, Moderna, and More Stocks for Investors to Watch This Week"", ""summary"": ""Home Depot, Lucid, TJX, and others also report earnings. Investors will see Fed minutes and economic data on manufacturing, home sales, GDP, and income and spending.""}]",{}
6,2023-02-19,166.60000610351562,2023-02-26,139.25999450683594,-0.1641057058526888,D5+,"[{""date"": ""2023-02-19"", ""headline"": ""Walmart, Alibaba, Moderna, and More Stocks for Investors to Watch This Week"", ""summary"": ""Home Depot, Lucid, TJX, and others also report earnings. Investors will see Fed minutes and economic data on manufacturing, home sales, GDP, and income and spending.""}, {""date"": ""2023-02-20"", ""headline"": ""Moderna favored at Morgan Stanley on U.S. support for Arbutus patent case"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-21"", ""headline"": ""MRNA Makes Notable Cross Below Critical Moving Average"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-21"", ""headline"": ""Moderna stock pops after receiving cancer-vaccine candidate gets FDA breakthrough designation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-21"", ""headline"": ""S&P 500 Q4 2022 Earnings Review: Swing And A Miss"", ""summary"": ""As we exit the peak period of earnings season, we review the S&P 500 2022 Q4 earnings season in more detail, providing both aggregate and company level insights.""}, {""date"": ""2023-02-21"", ""headline"": ""Moderna Faces Challenges as Pandemic Eases"", ""summary"": ""Moderna, which spearheaded development of the first vaccines for COVID-19, faces a challenging outlook as vaccination rates increase and infection rates fall.""}, {""date"": ""2023-02-21"", ""headline"": ""Where Will Moderna Be in 5 Years?"", ""summary"": ""The past few years may seem like the best of times for Moderna (NASDAQ: MRNA).  The company launched its very first product: the coronavirus vaccine.  The vaccine also brought Moderna's messenger RNA technology to the forefront.""}, {""date"": ""2023-02-21"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 3.91% to $160.09 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-21"", ""headline"": ""Notable Tuesday Option Activity: MRNA, FSLR, JPM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-21"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Mednax (MD) and Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""What You Missed On Wall Street On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna price target lowered to $185 from $205 at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Hot Stocks: MRNA, TDOC, DPZ drop on earnings; NEO soars"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""GLOBAL BRIEFING: Minutes show majority of Fed backed 25bp hike"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Stocks climb, breaking a 4-day losing streak for Wall Street"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna Pops After FDA Grants Its Cancer Vaccine A Breakthrough Designation"", ""summary"": ""Moderna stock jumped late Wednesday after the FDA granted its Merck-partnered cancer vaccine a breakthrough designation.""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna's combination skin cancer therapy receives FDA's breakthrough tag"", ""summary"": ""Moderna Inc said on Wednesday its experimental personalised mRNA skin cancer vaccine in combination with Merck & Co Inc's drug Keytruda has received breakthrough therapy designation from U.S. regulators as an additional treatment for high risk patients.""}, {""date"": ""2023-02-22"", ""headline"": ""UPDATE 1-Moderna's combination skin cancer therapy receives FDA's breakthrough tag"", ""summary"": ""Moderna Inc said on Wednesday its experimental personalised mRNA skin cancer vaccine in combination with Merck & Co Inc's drug Keytruda has received breakthrough therapy designation from U.S. regulators as an additional treatment for high risk patients.  Shares of Moderna rise 2.5% to $164 after the market.  The breakthrough tag is granted by the U.S. Food and Drug Administration (FDA) based on data from a mid-stage study of the drug that showed the therapy reduced risk of skin cancer's recurrence or death by 44% compared with Keytruda alone.""}, {""date"": ""2023-02-22"", ""headline"": ""REFILE-Moderna's combination skin cancer therapy receives FDA's breakthrough tag"", ""summary"": ""Moderna Inc said on Wednesday its experimental mRNA skin cancer vaccine in combination with Merck & Co Inc blockbuster drug Keytruda has received breakthrough therapy designation from the U.S. Food and Drug Administration (FDA). (Reporting by Khushi Mandowara in Bengaluru...""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna stock pops after cancer-vaccine candidate gets FDA breakthrough designation"", ""summary"": ""MARKET PULSE Moderna Inc. (MRNA) and Merck Inc. (MRK) shares increased in after-hours trading Wednesday after the pharmaceutical companies announced that a cancer-vaccine candidate received the \u201cbreakthrough therapy\u201d designation from the Food and Drug Administration.""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA(R) (pembrolizumab), was Granted Breakthrough Therapy Designation by the FDA for Adjuvant Treatment of Patients With High-Risk Melanoma Following Complete Resection"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that mRNA-4157/V940, an investigational personalized mRNA cancer vaccine, in combination with KEYTRUDA, Merck's anti-PD-1 therapy, has been granted Breakthrough Therapy Designation by the U.S.""}, {""date"": ""2023-02-22"", ""headline"": ""12 Most Profitable Pharmaceutical Stocks Now"", ""summary"": ""In this piece, we will take a look at 12 most profitable pharmaceutical stocks now. For more stocks, head on over to 5 Most Profitable Pharmaceutical Stocks Now. The pharmaceutical industry was the center of attention in 2020 and 2021 after the deadly coronavirus pandemic ravaged the globe and disrupted the way of living. As [\u2026]""}, {""date"": ""2023-02-22"", ""headline"": ""FOMC Meeting Minutes Live: January Fed Minutes Recap"", ""summary"": ""January 2023 Fed Meeting Minutes. What do the latest FOMC meeting minutes mean for investors in the stock market today?""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna co-founder talks COVID-19 vaccines, mRNA growth, agriculture portfolio"", ""summary"": ""Moderna Co-Founder and Flagship Pioneering CEO Noubar Afeyan joins Yahoo Finance Live to discuss building on mRNA technology, the future of vaccines, keeping COVID-19 vaccines free, and the outlook for Moderna\u2019s Senate testimony.""}, {""date"": ""2023-02-22"", ""headline"": ""Stocks making the biggest moves after hours: Nvidia, Etsy, Lucid, Bumble, Moderna and more"", ""summary"": ""These are the stocks posting the largest moves in extended hours trading. ""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 1.20% to $158.17 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-22"", ""headline"": ""NEW YORK MARKET CLOSE: US stocks slip as Fed signals more rate rises"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna, Merck receives FDA breakthrough status for personalized cancer vaccine"", ""summary"": ""CNBC's Meg Tirrell joins 'Closing Bell: Overtime' to report on Merck and Moderna receiving FDA breakthrough status for a personalized cancer vaccine.""}, {""date"": ""2023-02-22"", ""headline"": ""GDP reading, Booking Holdings, Moderna: 3 things to watch"", ""summary"": ""By Liz Moyer""}, {""date"": ""2023-02-22"", ""headline"": ""Drug, Biotech Stocks' Q4 Earnings on Feb 23: MRNA, BHC & More"", ""summary"": ""Let us look at four drug and biotech companies, MRNA, BHC, ALNY and AGIO, which are gearing up for their earnings release.""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna enters R&D collaboration for mRNA gene-editing therapies"", ""summary"": ""Moderna Inc will collaborate with privately-owned Life Edit Therapeutics Inc under an agreement to discover and develop mRNA gene-editing therapies, the companies said on Wednesday.""}, {""date"": ""2023-02-22"", ""headline"": ""UPDATE 1-Moderna enters R&D collaboration for mRNA gene-editing therapies"", ""summary"": ""Moderna Inc will collaborate with privately-owned Life Edit Therapeutics Inc under an agreement to discover and develop mRNA gene-editing therapies, the companies said on Wednesday.  The tie-up will apply Life Edit's diverse collection of new technology for gene editing with the Moderna mRNA platform that was behind its COVID-19 vaccine.  Under the agreement, the companies will collaborate on research and preclinical studies funded by Moderna to develop curative therapies for some of the most challenging genetic diseases.""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna to collaborate with Life Edit on gene editing therapies"", ""summary"": ""Moderna Inc.  (MRNA)  announced Wednesday a collaboration agreement with privately held Life Edit Therapeutics Inc. to discover and develop in vivo gene editing therapies.  Moderna\u2019s stock edged up 0.4% in premarket trading.  The companies will combine the use of Moderna\u2019s mRNA platform and Life Edit\u2019s gene editing technologies to advance therapies against a select set of therapeutic targets.""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna And Life Edit Therapeutics Enter Strategic Collaboration to Accelerate the Development of Novel In Vivo Gene Editing Therapies"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines and Life Edit Therapeutics Inc., an ElevateBio company focused on next-generation gene editing technologies and therapeutics, today announced a strategic research and development collaboration to discover and develop in vivo mRNA gene editing therapies.""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna Q4 results, COVID vaccine`s future in focus with pandemic at `transition point`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Notable earnings before Thursday`s open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Notable companies reporting before tomorrow`s open"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna, Life Edit team up to develop gene editing therapies for genetic diseases"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-22"", ""headline"": ""Moderna, Life Edit enter collaboration for in vivo gene editing therapies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""What You Missed On Wall Street On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Treasury yields little changed as investors assess Fed minutes, data"", ""summary"": ""U.S. Treasury yields fell slightly on Friday morning as investors reacted to the Fed's latest meeting minutes and awaited key inflation and consumer data.""}, {""date"": ""2023-02-23"", ""headline"": ""Is Moderna Stock A Sell After Waning Covid Shots Crush Its 2023 Outlook?"", ""summary"": ""Is Moderna stock a sell after massively missing 2023 sales guidance expectations on a mixed quarterly report? Is MRNA stock a sell?""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna forecasts COVID sales decline as costs rise, shares fall"", ""summary"": ""Moderna Inc on Thursday forecast declining COVID-19 vaccine sales and rising costs for 2023, raising concerns the U.S. biotech company could post a loss this year, and its shares fell 7%.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna (MRNA) Q4 2022 Earnings Call Transcript"", ""summary"": ""My name is Kevin and welcome to Moderna's fourth quarter 2022 earnings call.  At this time, I would like to turn the call over to Lavina Talukdar, head of investor relations at Moderna.  Good morning, everyone, and thank you for joining us on today's call to discuss Moderna's fourth quarter and full year 2022 financial results and business updates.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna\u2019s stock slides as earnings fall short of estimates amid steep decline in COVID-vaccine sales"", ""summary"": ""With the boost Moderna got from COVID vaccines now fading, analysts are focused on the company's pipeline.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna: Covid vaccine sales will drop 73% this year"", ""summary"": ""Moderna Inc. expects sales of its Covid-19 vaccines to drop precipitously this year as global demand for the shots continues to wane.  Meanwhile, unused doses and excess manufacturing capacity are costing Moderna money.  In the fourth quarter, Moderna lost $297 million in expired Covid vaccines, $281 million in cancellation charges on prior purchase commitments, and $376 million in surplus manufacturing capacity \u2014 $954 million in total.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna Peers Over a Scary Profit Cliff"", ""summary"": ""The vaccine maker\u2019s profits will drop sharply this year as the debate around the stock moves to its pipeline of new vaccines and therapies.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna (MRNA) Lags on Q4 Earnings, COVID Jab Sales Down Y/Y"", ""summary"": ""Moderna's (MRNA) fourth-quarter earnings and sales miss expectations. Management reiterates guidance to record a minimum of $5 billion from COVID vaccine sales in 2023.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 6.70% to $147.57 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-23"", ""headline"": ""Asia stocks mixed after Wall St breaks losing streak"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Stocks rise on Wall Street and break a 4-day losing streak"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""NEW YORK MARKET CLOSE: Nvidia boosts Nasdaq; eBay and Moderna tumble"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna misses 4th-quarter profit as royalty payment hits, shares fall"", ""summary"": ""Moderna Inc on Thursday reported fourth-quarter profit that missed Wall Street expectations by almost 23% in part due to a newly-disclosed royalty payment to the U.S. National Institutes of Health (NIH) related to development of the company's COVID-19 vaccine, and higher...""}, {""date"": ""2023-02-23"", ""headline"": ""Falling COVID-19 vaccine sales weigh on Moderna\u2019s Q4 earnings results"", ""summary"": ""Yahoo Finance\u2019s Anjalee Khemlani joins the Live show to discuss fourth-quarter earnings for Moderna, the U.S. FDA\u2019s grant for Moderna\u2019s mRNA cancer vaccine, and the outlook for biotech and pharmaceutical companies.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna's Q4 Earnings Fall 68% On Sliding COVID-19 Vaccine Revenues, Miss Earnings Expectations"", ""summary"": ""Moderna Inc (NASDAQ: MRNA) reported Thursday, a Q4 FY22 EPS of $3.61, compared to the $11.29 posted a year ago, missing the consensus of $4.68. Revenue was $5.08 billion compared to $7.21 billion a year ago, slightly above the consensus of $5.02, mainly due to a decline in COVID-19 vaccine sales. Product sales for the fourth quarter of 2022 were $4.9 billion, a 30% Y/Y decrease primarily driven by lower sales volume compared to overall higher demand a year ago. Also Read: Pfizer/BioNTech Get Rea""}, {""date"": ""2023-02-23"", ""headline"": ""The Covid Downfall Is Here: Moderna's Outlook Misses By More Than $2 Billion"", ""summary"": ""Moderna stock toppled Thursday after missing guidance expectations by at least $2 billion as waning Covid shots champ at sales.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna FY22 Earnings: Key Takeaways - Shares Are Now A Contrarian Trade"", ""summary"": ""Moderna faces a tough 2023 by most measures. Read why Moderna stock may be a contrarian bet as management can still stun the market with its technology and pipeline assets.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna's Cancer Vaccine Wins An FDA Boon, But Shares Drop On Mixed Earnings"", ""summary"": ""Moderna stock reversed lower Thursday after the FDA granted its Merck-partnered cancer vaccine a breakthrough designation.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna Stock Drops on Disappointing Earnings, Falling Covid-19 Vaccine Sales"", ""summary"": ""Shares of the biotech company fell early Thursday, wiping out gains from positive news around its cancer vaccine candidate, as fourth-quarter earnings missed expectations.""}, {""date"": ""2023-02-23"", ""headline"": ""Perion Network and West Fraser Timber have been highlighted as Zacks Bull and Bear of the Day"", ""summary"": ""Perion Network and West Fraser Timber are part of the Zacks Bull and Bear of the Day article.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna (MRNA) Lags Q4 Earnings and Revenue Estimates"", ""summary"": ""Moderna (MRNA) delivered earnings and revenue surprises of -22.53% and 0.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna, Inc. 2022 Q4 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Moderna, Inc.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna, Inc. (MRNA) Q4 2022 Earnings Call Transcript"", ""summary"": ""Moderna, Inc. (NASDAQ:NASDAQ:MRNA) Q4 2022 Earnings Conference Call February 23, 2023 8:00 AM ETCompany ParticipantsLavina Talukdar - Head, Investor RelationsStephane Bancel - Chief...""}, {""date"": ""2023-02-23"", ""headline"": ""Sliding vaccine sales, new costs, shrink Moderna 4Q profit"", ""summary"": ""Moderna\u2019s fourth-quarter profit tumbled 70% as COVID-19 vaccine sales fell and the drugmaker caught up on a royalty payment.  Heavy research and development costs also weighed on Moderna as the vaccine developer looks to strengthen an income statement currently dominated by its Spikevax coronavirus preventive shots.  Moderna said Thursday that its cost of sales jumped nearly a billion dollars to $1.9 billion in the final quarter of 2022.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna\u2019s Earnings, Revenue Fall on Fewer Vaccine Sales"", ""summary"": ""Demand for its Covid-19 vaccine sank from year-earlier highs when the spread of the Omicron variant boosted sales.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna earnings fall short of estimates amid steep decline in COVID vaccine sales, expects to file for approval of RSV vaccine in first half"", ""summary"": ""Moderna Inc.  (MRNA)  said Thursday it had net income of $1.465 billion, or $3.61 a share, in the fourth quarter, down from $4.868 billion, or $11.29 a share, in the year-earlier period.  The decline in sales was mostly due to a steep fall in sales of the company\u2019s COVID vaccines.  Product sales fell 30% to $4.9 billion, due to lower sales volume and lower demand vs. the prior year.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna`s stock slides as earnings fall short of estimates amid steep decline in COVID-vaccine sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna sticks to $5 billion sales view for COVID shot despite strong Q4"", ""summary"": ""Sales of the vaccine, Moderna's sole commercial product, were expected to fall sharply this year from $18.4 billion in 2022 as most people globally have received their shots and boosters, while governments and other agencies cut purchases.  The sales forecast implies a \""possible EPS net loss\"" this year compared to the huge profit its COVID vaccines drove during its peak, Jefferies analyst Michael Yee said in a note.  However, there is a potential for positive cash flow this year if Moderna is able to get more advanced purchase agreements for its COVID shots, Yee said.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna forecasts 2023 COVID vaccine sales below market expectations"", ""summary"": ""Moderna Inc on Thursday reiterated its forecast of $5 billion in sales for its COVID-19 vaccines this year, which was below analysts' estimates as the company anticipated lower demand for the products in the fourth year of the pandemic.""}, {""date"": ""2023-02-23"", ""headline"": ""Stocks making the biggest moves midday: Domino's Pizza, Lucid, Nvidia, Nikola and more "", ""summary"": ""Nvidia shares spiked, while Domino's Pizza dropped. ""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Updates"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the fourth quarter and fiscal year 2022.""}, {""date"": ""2023-02-23"", ""headline"": ""Top Trades of Steve Mandel`s Lone Pine in the 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna yearly revenue boosted by Covid sales, profit falls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Stocks Edge Higher, Nvidia, Moderna, eBay, Wells Fargo In Focus - Five Things To Know"", ""summary"": ""Stock futures higher on Fed minutes relief, tech boost; Nvidia shares surge as AI chip demand powers solid sales outlook; Moderna earnings on deck as drugmaker looks past vaccine growth; eBay shares slump as muted outlook offsets Q4 earnings beat and Wells Fargo cutting more mortgage jobs as market extends slump.""}, {""date"": ""2023-02-23"", ""headline"": ""The Petri Dish: Blindness drug approved; Moderna strikes gene-editing deal"", ""summary"": ""Apellis' new drug is the only FDA-approved treatment for geographic atrophy, a leading cause of blindness.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna falls as waning demand for COVID-19 vaccines hit sales, profit"", ""summary"": ""By Geoffrey Smith""}, {""date"": ""2023-02-23"", ""headline"": ""Unusually active option classes on open February 23rd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna misses on earnings as costs rise from surplus production capacity, lower Covid shot demand"", ""summary"": ""Moderna reported quarterly earnings of $3.61 per share, a 68% decrease from the same period in 2021 when it booked $11.29 per share.""}, {""date"": ""2023-02-23"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Stocks making the biggest moves premarket: Lucid, Nvidia, Dollar General, Sunrun and more"", ""summary"": ""These are the stocks posting the largest moves in early morning trading. ""}, {""date"": ""2023-02-23"", ""headline"": ""Sliding vaccine sales, new costs, squeeze Moderna 4Q profit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Alibaba's and Nvidia's stocks rise, Domino's and Dollar General shares fall, and other stocks on the move"", ""summary"": ""Nvidia's stock rallied to pace the S&P 500's gainers, while Domino's Pizza shares led the losers after the companies reported quarterly results.""}, {""date"": ""2023-02-23"", ""headline"": ""What Makes Moderna (MRNA) an Attractive Investment?"", ""summary"": ""ClearBridge Investments, an investment management company, released its \u201cClearBridge Select Strategy\u201d fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The strategy outperformed its benchmark, the Russell 3000 Index, in the fourth quarter. On an absolute basis, the strategy gained across nine of the 10 sectors in which it was invested. [\u2026]""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna\u2019s stock slides as earnings fall short of estimates "", ""summary"": ""With the boost Moderna got from COVID vaccines now fading, analysts are focused on the company's pipeline.""}, {""date"": ""2023-02-23"", ""headline"": ""Investors could become cautious in near-term on Moderna, says BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna: Q4 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna and Merck receive FDA breakthrough status for personalized cancer vaccine"", ""summary"": ""CNBC's Meg Tirrell reports on news from Moderna and Merck.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna stock dips as Q4 earnings fall; reaffirms COVID vaccine sales outlook of $5B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna (MRNA) Receives a Hold from Bank of America Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna Falls as Q4 Results Disappoint"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna says $2.8B remaining under latest buyback authorization"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna GAAP EPS of $3.61 misses by $1.14, revenue of $5.1B beats by $80M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna reports Q4 EPS $3.61, consensus $4.67"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna backs forecast of $5B in COVID-19 sales contracted for 2023 delivery"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna sees FY23 CapEx at about $1.0B and R&D expense at about $4.5B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna reports Q4 GAAP EPS $3.61 vs. $11.29 y/y"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-23"", ""headline"": ""Moderna, Merck granted FDA Breakthrough Therapy Designation for mRNA-4157/V940"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-24"", ""headline"": ""Pharmas, medtechs dominate list of innovation leaders thanks to patents"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-24"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.""}, {""date"": ""2023-02-24"", ""headline"": ""Moderna to make milestone payments to NIH for COVID vaccine"", ""summary"": ""Moderna Inc will make certain contingent development, commercial and regulatory milestone payments to the U.S. National Institutes of Health (NIH) related to the development of COVID-19 vaccines, the company said in a filing on Friday.""}, {""date"": ""2023-02-24"", ""headline"": ""Domino\u2019s Pizza, Wayfair, Nvidia: Stocks That Defined the Week"", ""summary"": ""Domino\u2019s Pizza, Wayfair, Nvidia, Walmart, Bath & Body Works, Moderna and Netflix were seven major stocks that moved on news this past week.""}, {""date"": ""2023-02-24"", ""headline"": ""Unusual Put Option Trade in Moderna (MRNA)  Worth $4,545.00K"", ""summary"": """"}, {""date"": ""2023-02-24"", ""headline"": ""Unusual Put Option Trade in Moderna (MRNA)  Worth $7,500.88K"", ""summary"": """"}, {""date"": ""2023-02-24"", ""headline"": ""SVB Leerink Downgrades Moderna (MRNA)"", ""summary"": """"}, {""date"": ""2023-02-24"", ""headline"": ""Why Moderna Stock Dropped Today"", ""summary"": ""Shares of Moderna (NASDAQ: MRNA) fell 5.6% on Friday, following bearish analyst commentary.  SVB Securities analyst Mani Foroohar placed an underperform rating on Moderna's stock.  Foroohar believes Moderna's recently released fourth-quarter results and guidance for 2023 show that the pandemic-driven surge in the company's sales and profits is ending.""}, {""date"": ""2023-02-24"", ""headline"": ""Does This Number Mean It's Time to Sell Moderna Stock?"", ""summary"": ""Moderna (NASDAQ: MRNA) investors have gotten used to reports of major growth and billion-dollar-plus quarterly earnings.  The biotech company is a leader in the coronavirus vaccine market -- and its Spikevax product has helped it deliver a whopping $37.8 billion in revenue over the past two years.  The cost of sales for Spikevax totaled 39% of product sales in the fourth quarter -- that's compared to 14% a year ago.""}, {""date"": ""2023-02-24"", ""headline"": ""Q4 2022 Personalis Inc Earnings Call"", ""summary"": ""Q4 2022 Personalis Inc Earnings Call""}, {""date"": ""2023-02-24"", ""headline"": ""The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks"", ""summary"": ""Startling cancer vaccine results from Moderna could drive the company's second act and usher in the next big thing in biotech. Here's what you need to know.""}, {""date"": ""2023-02-24"", ""headline"": ""WHO panel is reviewing whether COVID vaccines need updating, as agency monitors 7 omicron subvariants"", ""summary"": ""Most of the week's COVID news is focused on vaccines, including the big slide in Moderna's revenue caused by falling demand.""}, {""date"": ""2023-02-24"", ""headline"": ""Moderna Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 5.63% to $139.26 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-02-24"", ""headline"": ""Pharma Stock Roundup: FDA Updates for SNY, PFE & Others, EU Nod to AZN Cancer Combo"", ""summary"": ""FDA approves Sanofi's (SNY) Altuviiio and grants a priority tag to Pfizer's (PFE) regulatory applications for pipeline candidates.""}, {""date"": ""2023-02-24"", ""headline"": ""Stocks making the biggest moves midday: Beyond Meat, Live Nation, Yeti, Boeing and more"", ""summary"": ""Beyond meat rallied on a smaller-than-expected loss for the previous quarter. Yeti fell on a Goldman Sachs downgrade.""}, {""date"": ""2023-02-24"", ""headline"": ""WHO panel is reviewing whether COVID vaccines need to be updated "", ""summary"": ""Most of the week's COVID news is focused on vaccines, including the big slide in Moderna's revenue caused by falling demand.""}, {""date"": ""2023-02-24"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-24"", ""headline"": ""Moderna Full Year 2022 Earnings: EPS Misses Expectations"", ""summary"": ""Moderna ( NASDAQ:MRNA ) Full Year 2022 Results Key Financial Results Revenue: US$19.3b (up 4.3% from FY 2021). Net...""}, {""date"": ""2023-02-24"", ""headline"": ""Pfizer, BioNTech seek FDA full approval for Omicron shot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-24"", ""headline"": ""Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-24"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Moderna (MRNA) and Bio-Rad Laboratories (BIO)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-24"", ""headline"": ""Moderna downgraded at SVB to underperform on end of COVID pandemic revenue boom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-24"", ""headline"": ""GLOBAL BROKER RATINGS: Jyske cuts BMW; SocGen cuts Burberry"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-24"", ""headline"": ""Barclays Sticks to Its Buy Rating for Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-24"", ""headline"": ""SVB downgrades Moderna to Underperform as COVID boom reverses"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-24"", ""headline"": ""Moderna downgraded to Underperform from Market Perform at SVB Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-25"", ""headline"": ""10 Most Promising Biotech Stocks According to Analysts"", ""summary"": ""In this article, we discuss 10 most promising biotech stocks according to analysts. If you want to see more stocks in this selection, check out 5 Most Promising Biotech Stocks According to Analysts. Last year was a period of transition for biotech firms. Following significant investment, the availability of cheap capital, and public recognition for [\u2026]""}, {""date"": ""2023-02-26"", ""headline"": ""Baron Health Care Fund Q4 2022 Quarterly Letter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-26"", ""headline"": ""Moderna, Inc. (NASDAQ:MRNA) Q4 2022 Earnings Call Transcript"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA) Q4 2022 Earnings Call Transcript February 23, 2023 Operator: Good morning. My name is Kevin and welcome to Moderna\u2019s Fourth Quarter 2022 Earnings Call. Please be advised this call is being recorded. At this time, I\u2019d like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please [\u2026]""}]",{}
7,2023-02-26,139.25999450683594,2023-03-05,143.1999969482422,0.02829242134727239,U3,"[{""date"": ""2023-02-26"", ""headline"": ""Treasury yields rise slightly to start the week"", ""summary"": ""U.S. Treasury yields were marginally lower on Monday morning as investors continue to monitor the outlook for inflation and the economy.""}, {""date"": ""2023-02-26"", ""headline"": ""Baron Health Care Fund Q4 2022 Quarterly Letter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-26"", ""headline"": ""Moderna, Inc. (NASDAQ:MRNA) Q4 2022 Earnings Call Transcript"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA) Q4 2022 Earnings Call Transcript February 23, 2023 Operator: Good morning. My name is Kevin and welcome to Moderna\u2019s Fourth Quarter 2022 Earnings Call. Please be advised this call is being recorded. At this time, I\u2019d like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please [\u2026]""}, {""date"": ""2023-02-27"", ""headline"": ""The 20 worst U.S. stocks in February: the biggest loser dropped 35%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-27"", ""headline"": ""Noteworthy Tuesday Option Activity: MRNA, CARG, HZNP"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-27"", ""headline"": ""Treasury prices fall slightly to close out bumper month for yields"", ""summary"": ""U.S. Treasury prices fell slightly on Tuesday to close out a bumper month for government bond yields.""}, {""date"": ""2023-02-27"", ""headline"": ""Start Putting Together Your Shopping List For Beaten-Down Tech Stocks"", ""summary"": ""Put together a stock shopping list. You have time to understand the stocks you are investing in.""}, {""date"": ""2023-02-27"", ""headline"": ""Moderna Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 0.71% to $138.27 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-27"", ""headline"": ""Company News for Feb 27, 2023"", ""summary"": ""Companies in The News Are: NVDA, BA, ADBE, MRNA""}, {""date"": ""2023-02-27"", ""headline"": ""3 Crucial Things to Know About Moderna Right Now"", ""summary"": ""During the earlier days of the pandemic, it was easy to see why Moderna (NASDAQ: MRNA) made for a great investment.  The vaccine has generated billions in earnings for Moderna -- and helped it build up a massive cash level.  The year 2023 isn't likely to be Moderna's biggest when it comes to earnings growth.""}, {""date"": ""2023-02-27"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, SGEN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-28"", ""headline"": ""Moderna initiated at outperform at RBC on potential of cancer vaccine candidates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-28"", ""headline"": ""Moderna initiated with an Outperform at RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-28"", ""headline"": ""Novavax Says There Is \u2018Substantial Doubt\u2019 Around Its Ability to Continue Operating This Year"", ""summary"": ""The Covid-19 vaccine maker will be forced to compete again the far-better-resourced Pfizer and Moderna, casting questions over its 2023 revenues.""}, {""date"": ""2023-02-28"", ""headline"": ""11 Most Promising Cancer Stocks According to Analysts"", ""summary"": ""In this article, we discuss 11 most promising cancer stocks according to analysts. If you want to see more stocks in this selection, check out 5 Most Promising Cancer Stocks According to Analysts. The market for community oncology services worldwide is projected to experience substantial growth, with an estimated increase from $47.95 billion in 2022 [\u2026]""}, {""date"": ""2023-02-28"", ""headline"": ""Moderna Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.39% higher to $138.81 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-02-28"", ""headline"": ""Moderna to Present at Cowen's 43rd Annual Health Care Conference"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in a fireside chat at Cowen's 43rd Annual Health Care Conference on Monday, March 6th at 9:10 a.m.""}, {""date"": ""2023-02-28"", ""headline"": ""It\u2019s Crunch Time for RSV Vaccines as FDA Advisers Prepare to Vote"", ""summary"": ""The agency's vaccine-advisory committee is looking at dueling products from Pfizer and GSK. Lots of money is at stake.""}, {""date"": ""2023-02-28"", ""headline"": ""Moderna price target lowered to $200 from $225 at Deutsche Bank"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-28"", ""headline"": ""10 Stocks With Unusual Options Activity: INTC, TSLA, AMD and More"", ""summary"": """"}, {""date"": ""2023-02-28"", ""headline"": ""Moderna, Pfizer: Top mRNA Innovator Stocks are Oversold"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-28"", ""headline"": ""Moderna to Present at Cowen`s 43rd Annual Health Care Conference"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-28"", ""headline"": ""Stocks most and least liked by hedge funds and mutual funds -  Goldman"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-02-28"", ""headline"": ""Moderna\u2019s Covid Boom Is Ending. Why the Outlook Isn\u2019t All Grim."", ""summary"": ""Troubles that were put off during the biotech\u2019s pandemic-era boom, notably various intellectual property wrinkles, are now coming home to roost.""}, {""date"": ""2023-03-01"", ""headline"": ""Novavax: Covid shots became commodities faster than imagined"", ""summary"": ""This is shaping up to be an unpredictable few months for Novavax.  The biotech company\u2019s Covid-19 vaccine finally received US regulatory approval only last summer.  Novavax pitched its protein-based vaccine as an alternative to\u00a0those offered by Moderna and BioNTech/Pfizer.""}, {""date"": ""2023-03-01"", ""headline"": ""Novavax to pause RSV vaccine trial, assess pipeline"", ""summary"": ""Novavax warns of uncertain 2023 outlook as COVID-19 market turns commercial and new CEO calls for pipeline assessment.""}, {""date"": ""2023-03-01"", ""headline"": ""Biotech Stock Roundup: MRNA Q4 Earnings, REGN's Updates, CYTK Receives Setback"", ""summary"": ""Earnings from Moderna (BIIB) and updates from Regeneron (REGN) are the key highlights from the biotech sector during the past week.""}, {""date"": ""2023-03-01"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slid 2.27% to $135.66 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-03-01"", ""headline"": ""Novavax: The Gig Is Up"", ""summary"": ""Novavax has issued dire warnings to shareholders as the company continues to burn substantial amounts of cash. Click here for our take on NVAX stock.""}, {""date"": ""2023-03-01"", ""headline"": ""UBS: Moderna's clinical-stage vaccines could drive post-COVID revenues"", ""summary"": ""By Scott Kanowsky""}, {""date"": ""2023-03-01"", ""headline"": ""New Investor? Buy These 2 Growth Stocks"", ""summary"": ""Amazon (NASDAQ: AMZN) is a leader in two high-growth businesses: e-commerce and cloud computing.  Amazon has already demonstrated it can increase earnings over time thanks to these businesses.  In recent times, a few things have weighed on Amazon, though.""}, {""date"": ""2023-03-01"", ""headline"": ""NVAX Stock Alert: Is Novavax Going Bankrupt?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-01"", ""headline"": ""Retail Earnings Indicate Unclear Outlook. Why the Fed Needs Consumers to Cut Back."", ""summary"": ""China growth, a U.S. TikTok ban?, Pfizer clears FDA vaccine hurdle, and other news to start your day.""}, {""date"": ""2023-03-02"", ""headline"": ""Covid Vaccine Maker Novavax\u2019s\u00a0Flameout Mints\u00a0Shorts $2.7 Billion"", ""summary"": ""(Bloomberg) -- Waning interest in Covid-19 vaccines has left a long-standing drug developer, Novavax Inc., struggling to stay afloat and handed short sellers a windfall.Most Read from BloombergIsrael\u2019s Window to Strike Iran Narrows as Putin Enters EquationTycoon Deripaska Warns Russia May Run Out of Money in 2024Americans Need to Be Richer Than Ever to Buy Their First HomeSorry, Twitter. Elon Found His Next Shiny Object.US Stocks Snap Two Days of Losses; Yields Rise: Markets WrapBets against the""}, {""date"": ""2023-03-02"", ""headline"": ""RBC Capital Initiates Coverage of Moderna (MRNA) with Outperform Recommendation"", ""summary"": """"}, {""date"": ""2023-03-02"", ""headline"": ""Moderna May Be Just Getting Started in This Big Market"", ""summary"": ""Moderna is ready to tackle this market this year -- and revenue should climb once it does.  In fact, Moderna compares the post-pandemic coronavirus vaccine market to that of the flu vaccine.  Worldwide, Moderna has predicted the market could be worth $12 billion to $24 billion -- depending on vaccine price -- if the coronavirus vaccine follows the path of the flu vaccine.""}, {""date"": ""2023-03-02"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. rose 1.62% to $137.86 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-02"", ""headline"": ""Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Zacks.com users have recently been watching Moderna (MRNA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""2023-03-02"", ""headline"": ""The 'Edison Of Medicine' Shows You How To Get More Done"", ""summary"": ""Robert Langer isn't impressed with incremental scientific milestones. The rock star scientist, known as the \""Edison of Medicine,\"" sets and usually reaches the loftiest of goals.""}, {""date"": ""2023-03-02"", ""headline"": ""Interesting MRNA Put And Call Options For April 14th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-02"", ""headline"": ""I Asked ChatGPT for 10 Meme Stocks to Buy. Here`s What It Recommended."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-02"", ""headline"": ""GLOBAL BROKER RATINGS: Numis cuts BT Group to 'sell'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-03"", ""headline"": ""How Much Did US Government Spend On mRNA Vaccine Technology Before And During The Pandemic? The Number Can Be Surprising"", ""summary"": ""The U.S. government invested at least $31.9 billion to develop, produce, and purchase mRNA COVID-19 vaccines, including sizeable investments in the three decades before the pandemic through March 2022, according to a new BMJ study. That includes at least $337 million was invested pre-pandemic. 34 NIH-funded research grants directly related to mRNA covid-19 vaccines were identified. Estimates of the extent of public investment for covid-19 vaccines vary widely. For example, the Biomedical Advance""}, {""date"": ""2023-03-03"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. advanced 3.87% to $143.20 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-03"", ""headline"": ""12 Most Profitable Biotech Stocks Today"", ""summary"": ""In this article, we will discuss the 12 Most Profitable Biotech Stocks Today. You can skip our industry overview and go directly to the 5 Most Profitable Biotech Stocks Today. The term \u201cbiotechnology\u201d refers to the utilization of living organisms or biological systems to create solutions that address various agricultural, industrial, and health-related problems. The most [\u2026]""}, {""date"": ""2023-03-03"", ""headline"": ""12 'Dirt Cheap' Stocks Are Due For A Rally, Analysts Say"", ""summary"": ""The S&P 500 isn't as cheap as it was \u2014 it's up 3.6% this year after all. But analysts still spot relatively bargain-priced stocks due to rally.""}, {""date"": ""2023-03-03"", ""headline"": ""Is Moderna Stock a Buy Now?"", ""summary"": ""The company is looking to transition beyond its COVID-19 vaccine, and that could mean a bumpy ride for investors.""}, {""date"": ""2023-03-03"", ""headline"": ""7 Over-$100 Stocks That Are Worth Every Penny"", ""summary"": ""If searching out over-$100 stocks to buy seems arbitrary, take a step back and consider this. It\u2019s great to have a mix of stocks in your portfolio. There are all sorts of sizes and flavors of stocks from which to choose, including mega-cap stocks and even small-cap stocks. So it\u2019s understandable that when you\u2019re looking for stocks to buy, you may sometimes miss some obvious well-priced choices that are right in front of you. Some of the best names out there fall into the category of over-$100 st""}, {""date"": ""2023-03-04"", ""headline"": ""13 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we will take a look at the 13 most undervalued healthcare stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds. According to a report by T.Rowe Price, healthcare stocks can be generally divided into two [\u2026]""}, {""date"": ""2023-03-04"", ""headline"": ""Pharma R&D funding soared to a new record in 2022 as oncology candidates dominate pipelines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-05"", ""headline"": ""Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks of 2023?"", ""summary"": ""After declining 19% in 2022, the S&P 500 has risen about 4% this year as investors grew accustomed to inflation, rising interest rates, and other macro headwinds.  Let's see if the four worst-performing S&P 500 components so far in 2023 -- Lumen Technologies (NYSE: LUMN), Moderna (NASDAQ: MRNA), Baxter International (NYSE: BAX) and Pfizer (NYSE: PFE) -- are actually contrarian buys.""}, {""date"": ""2023-03-05"", ""headline"": ""Better Growth Stock: Moderna vs. CRISPR Therapeutics"", ""summary"": ""Now is a great time to get in on biotech growth stocks.  Many of them are trading lower than in the past -- yet, at the same time, they're closer than ever to reaching the commercialization of key products.  Two terrific examples of growth stocks to buy today are coronavirus vaccine maker Moderna (NASDAQ: MRNA) and gene editing expert CRISPR Therapeutics (NASDAQ: CRSP).""}]",{}
8,2023-03-05,143.1999969482422,2023-03-12,138.2899932861328,-0.034287735801307506,D4,"[{""date"": ""2023-03-05"", ""headline"": ""Moderna chooses Harwell Campus as site for UK research facility"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-05"", ""headline"": ""5 Stocks ChatGPT Says Will Make Me Rich in 20 Years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-05"", ""headline"": ""Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks of 2023?"", ""summary"": ""After declining 19% in 2022, the S&P 500 has risen about 4% this year as investors grew accustomed to inflation, rising interest rates, and other macro headwinds.  Let's see if the four worst-performing S&P 500 components so far in 2023 -- Lumen Technologies (NYSE: LUMN), Moderna (NASDAQ: MRNA), Baxter International (NYSE: BAX) and Pfizer (NYSE: PFE) -- are actually contrarian buys.""}, {""date"": ""2023-03-05"", ""headline"": ""Better Growth Stock: Moderna vs. CRISPR Therapeutics"", ""summary"": ""Now is a great time to get in on biotech growth stocks.  Many of them are trading lower than in the past -- yet, at the same time, they're closer than ever to reaching the commercialization of key products.  Two terrific examples of growth stocks to buy today are coronavirus vaccine maker Moderna (NASDAQ: MRNA) and gene editing expert CRISPR Therapeutics (NASDAQ: CRSP).""}, {""date"": ""2023-03-06"", ""headline"": ""Moderna CEO pushes back on pricing plans for Covid-19 shot, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-06"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-06"", ""headline"": ""Healthcare Leaders on the Rise of Vaccine Misinformation"", ""summary"": ""At WSJ\u2019s Health Forum, leaders from across the industry talk about the rise in vaccine hesitancy during the Covid-19 pandemic.""}, {""date"": ""2023-03-06"", ""headline"": ""Moderna, Inc. (MRNA) Presents at Cowen 43rd Annual Healthcare Conference (Transcript)"", ""summary"": ""Moderna, Inc. (NASDAQ:NASDAQ:MRNA) Cowen 43rd Annual Healthcare Conference Call March 6, 2023 9:10 AM ETCompany ParticipantsStephen Hoge - PresidentConference Call ParticipantsTyler Van...""}, {""date"": ""2023-03-06"", ""headline"": ""Moderna CEO Defends Pricing Plans for Covid-19 Shot"", ""summary"": ""Moderna  Chief Executive  St\u00e9phane Bancel  pushed back against criticism of the company\u2019s pricing plans for its Covid-19 vaccine at Monday\u2019s Wall Street Journal Health Forum.  Bernie Sanders (I., Vt.), Elizabeth Warren (D., Mass.) and Peter Welch (D., Vt.) have questioned the company\u2019s strategy around commercial pricing, which could be unveiled in the coming months.  Moderna received funding from the U.S. government related to development of its Covid-19 vaccine.""}, {""date"": ""2023-03-06"", ""headline"": ""Moderna eyes human testing of mpox, bird flu vaccines this year: \u2018They\u2019re really for public health\u2019"", ""summary"": ""A shot against mpox would be valuable in case outbreaks reemerge, and the company sees bird flu as a \u201cclear threat,\u201d the company's president said.""}, {""date"": ""2023-03-06"", ""headline"": ""Moderna Eyes Testing Mpox, Bird Flu Vaccines in Humans This Year"", ""summary"": ""(Bloomberg) -- Moderna Inc. is eyeing possible human testing of shots to fight mpox and bird flu this year, as the Covid-19 vaccine maker expands into more public-health immunizations. Most Read from BloombergHolding Cash Will Be a Winning Strategy in 2023, Investors SayTrump\u2019s Threat of a Third-Party Run Is Undercut by \u2018Sore Loser\u2019 LawsUS Banks Are Finally Being Forced to Raise Rates on DepositsTesla Slashes Model S and X Prices for the Second Time This YearTesla\u2019s China Price War Sparks $18 Bi""}, {""date"": ""2023-03-06"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. inched 0.58% higher to $144.03 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-03-06"", ""headline"": ""2 Reasons to Buy Moderna Stock, and 1 Reason to Sell"", ""summary"": ""Moderna (NASDAQ: MRNA) became a household name thanks to its quickly produced and approved coronavirus vaccine in 2020.  As it turns out, there are several compelling reasons why this biopharma is a smart long-term play.  Let's examine two big points in favor of Moderna stock and one point against buying.""}, {""date"": ""2023-03-07"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 2.07% to $141.05 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-07"", ""headline"": ""Pfizer (PFE) or GSK: Who Will Get the First FDA Nod for RSV Jab?"", ""summary"": ""An FDA advisory committee recommended approving Pfizer's (PFE) and GSK's respective RSV vaccines for older adults. Currently, there are no RSV vaccines anywhere in the world.""}, {""date"": ""2023-03-07"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-07"", ""headline"": ""Biden to announce plan to keep Medicare solvent beyond 2050"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-07"", ""headline"": ""Moderna sees several disease growth opportunities, says TD Cowen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-08"", ""headline"": ""Moderna Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.73% higher to $142.08 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-03-08"", ""headline"": ""Six Flags and Equinox Gold have been highlighted as Zacks Bull and Bear of the Day"", ""summary"": ""Six Flags and Equinox Gold have been highlighted as Zacks Bull and Bear of the Day.""}, {""date"": ""2023-03-09"", ""headline"": ""Moderna Stock: Bear vs. Bull"", ""summary"": ""Investors have gotten used to Moderna (NASDAQ: MRNA) delivering earnings growth.  Thanks to its coronavirus vaccine, the biotech has reported billions of dollars in revenue and profit over the past two years.  Does this mean we should forget about investing in Moderna?""}, {""date"": ""2023-03-09"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Moderna Inc. shed 3.32% to $137.36 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-09"", ""headline"": ""Is It Too Late to Buy Moderna Stock?"", ""summary"": ""Moderna (NASDAQ: MRNA) was the star of 2020 and 2021, with its shares skyrocketing as a result of its ambitious work to develop a coronavirus vaccine and get it approved for sale.  Since March 2020, the stock is up 414%.  The near term doesn't look so hot for the biotech as global demand for its only product, a coronavirus jab, seems to be in persistent decline.""}, {""date"": ""2023-03-09"", ""headline"": ""February\u2019s 7 Worst-Performing S&P 500 Stocks to Buy on the Cheap"", ""summary"": ""The S&P 500 lost 2.6% in February. However, on the plus side, the index has gained nearly 5% year-to-date through March 7. So while your first instinct might be to focus on S&P 500 stocks to buy that are on a roll, I\u2019m going with some of the index\u2019s worst-performing stocks from February. According to MarketWatch, the seven worst-performing sectors experienced declines ranging from -7.6% (energy) to -2.5% (consumer staples) in February. For this article, I\u2019ll select seven S&P 500 stocks to buy th""}, {""date"": ""2023-03-09"", ""headline"": ""4 Stocks That Moved the Market in February"", ""summary"": ""The S&P 500 fell in February, halting momentum in the stock market from earlier this year.  Major indexes eventually slumped due to concerns about high interest rates and slowing economic growth, but there were winners and losers within these overall trends.  Shares of Chevron (NYSE: CVX) fell 6.8% in February, primarily due to declining prices for crude oil and natural gas.""}, {""date"": ""2023-03-09"", ""headline"": ""February`s 7 Worst-Performing S&P 500 Stocks to Buy on the Cheap"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-10"", ""headline"": ""Moderna adding 2,000 new workers this year"", ""summary"": ""Moderna will add to its workforce and its U.S. real estate footprint, the biotech company announced in a press release Friday. The employees will be added by the end of the year.""}, {""date"": ""2023-03-10"", ""headline"": ""Moderna loses bid to shift liability in COVID-19 vaccine patent case"", ""summary"": ""Despite the backing of the U.S. government, Moderna Inc on Friday failed to persuade a federal judge it should not have to face a patent lawsuit over its COVID-19 vaccine and that the United States should have been sued instead.""}, {""date"": ""2023-03-10"", ""headline"": ""Moderna (MRNA) Gains As Market Dips: What You Should Know"", ""summary"": ""Moderna (MRNA) closed at $138.29 in the latest trading session, marking a +0.68% move from the prior day.""}, {""date"": ""2023-03-10"", ""headline"": ""Moderna to hire around 2,000 employees amid mRNA development push"", ""summary"": ""Moderna Inc said on Friday it was planning to hire about 2,000 employees globally by 2023-end and set up new offices on the U.S. West Coast, as it aims to scale up development of new products amid declining COVID vaccine sales.""}, {""date"": ""2023-03-10"", ""headline"": ""Novavax Stock: Bear vs. Bull"", ""summary"": ""Novavax (NASDAQ: NVAX) has a track record of major gains and major losses within the past few years.  Novavax shares have dropped a mind-boggling 97% from their peak.  Considering all of this, should you buy Novavax or avoid the stock?""}, {""date"": ""2023-03-10"", ""headline"": ""Moderna to hire around 2,000 employees globally by 2023-end"", ""summary"": ""Moderna Inc said on Friday it was planning to hire about 2,000 employees globally by the year-end and expand its U.S. presence to include new offices on the West Coast.""}, {""date"": ""2023-03-10"", ""headline"": ""UPDATE 2-Moderna to hire around 2,000 employees amid mRNA development push"", ""summary"": ""Moderna Inc said on Friday it was planning to hire about 2,000 employees globally by 2023-end and set up new offices on the U.S. West Coast, as it aims to scale up development of new products amid declining COVID vaccine sales.  The COVID vaccine maker said it will open new offices in California and Seattle, adding that its Genomics unit will expand to south San Francisco.  The latest move comes at a time when Moderna has been working on developing vaccines for skin cancer, flu and respiratory syncytial virus (RSV) using its mRNA technology, which if approved would significantly boost the biotech company that currently relies heavily on its COVID-19 shot.""}, {""date"": ""2023-03-10"", ""headline"": ""Moderna plans to hire 2,000 workers, open new offices in West Coast"", ""summary"": ""Moderna Inc.  (MRNA)  said Friday it is expanding in the U.S., opening new offices in South San Francisco, Calif., and Seattle, and hiring 2,000 workers worldwide by the end of the year.  Seattle will be a technology hub providing support for the whole company, and Moderna\u2019s genomics business will expand to South San Francisco, the company said.  Moderna has U.S. offices in Georgia, Maryland, Massachusetts and New Jersey, with headquarters in Cambridge, Mass. Shares of Moderna have gained 1% in the last 12 months, contrasting with losses of about 8% for the S&P 500 index.""}, {""date"": ""2023-03-10"", ""headline"": ""Moderna Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.68% higher to $138.29 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-10"", ""headline"": ""Moderna to hire around 2,000 employees globally by 2023-end "", ""summary"": ""Moderna Inc said on Friday it was planning to hire about 2,000 employees globally by the year-end and would expand its U.S. presence to include new offices on the West Coast. (Reporting by Raghav Mahobe in Bengaluru; Editing by Anil D'Silva)""}, {""date"": ""2023-03-10"", ""headline"": ""Moderna Outlines Commitment to Corporate Growth and Announces U.S. Expansion in 2023"", ""summary"": ""Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it is expanding its U.S. presence and establishing a corporate presence on the West Coast with new offices in South San Francisco, California and Seattle, Washington. Moderna's Seattle location will provide technology solutions across the enterprise and Moderna Genomics will expand to South San Francisco.""}, {""date"": ""2023-03-10"", ""headline"": ""Where Will Moderna Be In 5 Years?"", ""summary"": ""The biotech company is working on plenty of other potential products in its pipeline that could send its stock higher again -- and it (hopefully) won't need to create a vaccine for an emerging global pandemic this time around.  The Moderna of early 2028 will almost certainly have a few more products on the market than it does today.  Aside from updates to its coronavirus vaccine, it could also be selling jabs for influenza, respiratory syncytial virus (RSV), cytomegalovirus (CMV), and perhaps even a couple of other infectious diseases too, not to mention combination vaccines that inoculate against multiple common viruses at once.""}, {""date"": ""2023-03-10"", ""headline"": ""Moderna expands US footprint with two new offices on west coast"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-10"", ""headline"": ""Wall Street Thinks These 2 Undervalued Stocks Have Exceptional Growth Potential"", ""summary"": ""Most investors know about BioNTech (NASDAQ: BNTX) thanks to the coronavirus vaccine it developed in conjunction with Pfizer, but there will be a lot more to talk about in the company's future, and it's selling at a dirt-cheap valuation today.  BioNTech's price-to-earnings (P/E) ratio is a hair over 3, which is dramatically lower than the market's average of 23 or so -- a surefire sign that the market is pessimistic about its near-term ability to grow its earnings.  Paradoxically, given their bearish revenue estimates, Wall Street analysts are estimating that its share price will rise by around 57% this year -- and there could be some good reasons.""}, {""date"": ""2023-03-10"", ""headline"": ""Moderna announces West Coast expansion; to hire 2K employees in 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-10"", ""headline"": ""Moderna expands U.S. presence, plans to hire 2,000 by end of 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-10"", ""headline"": ""Moderna boosted by expansion plans, while SVB fallout continues to pressure banks and financials"", ""summary"": ""Moderna is planning to hire 2,000 people this year and expand beyond its Cambridge, Mass. base.""}, {""date"": ""2023-03-12"", ""headline"": ""A Nasdaq Bull Market Is Coming: 2 Revolutionary Stocks to Buy and Hold"", ""summary"": ""Last year, the Nasdaq Composite fell into a bear market and lagged behind the other two major U.S. market indexes.  Let's consider two revolutionary companies to invest in before that happens: Moderna (NASDAQ: MRNA) and Exact Sciences (NASDAQ: EXAS).  Moderna became widely known during the pandemic for being one of the leaders in the coronavirus vaccine market.""}]",{}
9,2023-03-12,138.2899932861328,2023-03-19,150.02000427246094,0.08482183495415918,U5+,"[{""date"": ""2023-03-12"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-12"", ""headline"": ""Moderna Gains on Cowen Remarks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-12"", ""headline"": ""A Nasdaq Bull Market Is Coming: 2 Revolutionary Stocks to Buy and Hold"", ""summary"": ""Last year, the Nasdaq Composite fell into a bear market and lagged behind the other two major U.S. market indexes.  Let's consider two revolutionary companies to invest in before that happens: Moderna (NASDAQ: MRNA) and Exact Sciences (NASDAQ: EXAS).  Moderna became widely known during the pandemic for being one of the leaders in the coronavirus vaccine market.""}, {""date"": ""2023-03-13"", ""headline"": ""CNBC Daily Open: Banks got hammered by SVB's collapse. But the Fed might still raise rates "", ""summary"": ""Bank stocks had a very rough Monday in the aftermath of Silicon Valley Bank\u2019s implosion. The 2-year Treasury yield plummeted. ""}, {""date"": ""2023-03-13"", ""headline"": ""My Hedge Against The Silicon Valley Bank Crisis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Why Moderna Stock Zoomed 7% Higher Today"", ""summary"": ""Coronavirus stock Moderna (NASDAQ: MRNA) had a Monday reminiscent of some of its more bullish days in the thick of the pandemic.  On Monday morning, TD Cowen prognosticator Tyler Van Buren changed his recommendation on Moderna from market perform (read: hold) to outperform (buy).  Van Buren sees several catalysts that should push Moderna ahead in the coming years.""}, {""date"": ""2023-03-13"", ""headline"": ""CNBC Daily Open: The bank rout continues. The Fed might still raise rates anyway"", ""summary"": ""Bank stocks had a very rough Monday in the aftermath of Silicon Valley Bank\u2019s implosion. The 2-year Treasury yield plummeted. ""}, {""date"": ""2023-03-13"", ""headline"": ""Moderna shares pop 7% after Cowen upgrades stock, saying it 'will be a leader' in RSV vaccines"", ""summary"": ""Moderna shares closed nearly 7% after TD Cowen upgraded the stock, saying the company will \""be a leader\"" in the RSV vaccine market.\u00a0""}, {""date"": ""2023-03-13"", ""headline"": ""Moderna Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Moderna Inc. rose 6.95% to $147.90 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-03-13"", ""headline"": ""Stocks making the biggest moves midday: First Republic Bank, Moderna, Newmont, Illumina and more"", ""summary"": ""These are the stocks posting the largest moves midday.""}, {""date"": ""2023-03-13"", ""headline"": ""2 Top Biotech Stocks to Buy In March and Hold Forever"", ""summary"": ""Most biotech companies are too risky to even think about holding forever.  Between the big risk of a clinical trial blowing up and the lesser risk of getting one-upped by a competitor's medicine even after successfully moving a drug from the lab to the market, it's incredibly difficult to feel confident in a biotech's long-term future.  Moderna (NASDAQ: MRNA) is a biotech stock that needs no introduction after successfully commercializing its coronavirus vaccine and raking in $18.8 billion in revenue in 2022 as a result.""}, {""date"": ""2023-03-13"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Why did Moderna stock go up today? Street upgrade"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Moderna gains as Cowen upgrades citing a favorable catalyst path"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Why did Moderna stock go up today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Early notable gainers among liquid option names on March 13th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Moderna upgraded to Outperform from Market Perform at TD Cowen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-13"", ""headline"": ""Morgan Stanley Reaffirms Their Hold Rating on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-14"", ""headline"": ""3 Vaccine Stocks to Watch for Their Post-Pandemic Moves"", ""summary"": ""During the Covid-19 pandemic, vaccine stocks shot up on the promise that they could end the lockdowns. Many vaccines were developed, but few were approved. Since the end of 2021, even the approved vaccine developers have seen their stocks slump as part of the biotech price rout. However the winners of the vaccine race are still companies to watch closely for their post-pandemic moves. Pfizer (NYSE:PFE), Moderna (NASDAQ:MRNA) and Novavax (NASDAQ:NVAX) all have Covid-19 vaccines in the U.S. market""}, {""date"": ""2023-03-14"", ""headline"": ""Moderna Announces Phase 2 Data on mRNA-4157/V940, an Investigational mRNA Personalized Cancer Vaccine, to be Presented at the 2023 AACR Annual Meeting"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that two abstracts on mRNA-4157/V940 an investigational mRNA personalized cancer vaccine, have been accepted for presentation at the 2023 American Association of Cancer Research (AACR) Annual Meeting being held April 14-19 in Orlando, FL.""}, {""date"": ""2023-03-14"", ""headline"": ""TD Cowen Upgrades Moderna (MRNA)"", ""summary"": """"}, {""date"": ""2023-03-14"", ""headline"": ""FDA authorizes Pfizer's Covid omicron booster as fourth shot for kids under 5"", ""summary"": ""The FDA authorized Pfizer's omicron booster shot for kids younger than five who were previously vaccinated with three doses of the company's original shot.\u00a0\u00a0""}, {""date"": ""2023-03-14"", ""headline"": ""Moderna Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Moderna Inc. advanced 2.29% to $151.28 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-14"", ""headline"": ""FDA staff report says data shows Pfizer's Covid treatment Paxlovid is effective in high-risk adults"", ""summary"": ""FDA staff said Pfizer's clinical trial results on its Covid antiviral pill Paxlovid support its use in adults at high risk of progressing to severe disease.\u00a0""}, {""date"": ""2023-03-14"", ""headline"": ""Is It Time to Buy the Nasdaq's 3 Worst-Performing February Stocks?"", ""summary"": ""Now that the dust of February has settled, investors can start looking for some stocks that had an abysmal month.  While the Nasdaq-100 fell 2.6% in February, a few stocks had an even worse performance.  The stocks claiming this \""honor\"" were JD.com (NASDAQ: JD), SiriusXM (NASDAQ: SIRI), and Moderna (NASDAQ: MRNA).""}, {""date"": ""2023-03-14"", ""headline"": ""Moderna, Inc.'s (NASDAQ:MRNA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?"", ""summary"": ""With its stock down 25% over the past three months, it is easy to disregard Moderna (NASDAQ:MRNA). But if you pay close...""}, {""date"": ""2023-03-14"", ""headline"": ""A Bull Market Is Coming: 5 Top Stocks to Buy Now"", ""summary"": ""With stock indexes still in the doldrums, you may not be thinking about the next bull market right now.  Today, many top stocks with amazing growth prospects are cheap, beaten down by today's tough market.  When you think of Moderna (NASDAQ: MRNA), you probably think of the coronavirus vaccine.""}, {""date"": ""2023-03-14"", ""headline"": ""Moderna to present mid-stage results on personalized cancer vaccine in April"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-14"", ""headline"": ""Moderna announces two presentations on mRNA-4157/V940 at AACR"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-15"", ""headline"": ""Pfizer (PFE) Gets FDA Nod for Bivalent COVID Jab in Infants"", ""summary"": ""Pfizer (PFE) and partner BioNTech receive FDA label expansion to use their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as a single booster dose in young children under five years.""}, {""date"": ""2023-03-15"", ""headline"": ""ChatGPT Says These 7 Stocks Could Be the Next Trillion-Dollar Companies"", ""summary"": ""Investors will always be on the hunt for the next trillion-dollar companies. This is a milestone that every company aims for, though very few reach. For investors, this means constantly being on the lookout for innovators with revolutionary products that can take them to market capitalizations above $1 trillion. As InvestorPlace analyst Luke Lango notes, in 2022, the iPhone helped Apple (NASDAQ:AAPL) reach that milestone and become the world\u2019s most valuable company with a market cap above $2 tri""}, {""date"": ""2023-03-15"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slid 1.11% to $149.60 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-15"", ""headline"": ""Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Zacks.com users have recently been watching Moderna (MRNA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.""}, {""date"": ""2023-03-15"", ""headline"": ""How a nasal vaccine could reduce the risk of COVID infections \ufffd\ufffd\ufffd and new variants"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-15"", ""headline"": ""Senate Health, Ed, Labor & Pensions Committee to hold a hearing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-15"", ""headline"": ""2 Top Biotech Stocks to Buy for the Long Haul"", ""summary"": ""First, they give you the opportunity to watch a company develop innovative and often life-saving technologies -- and that pipeline progress can drive their shares higher.  Then, if the company successfully brings products to market, a new phase of growth -- in earnings and share performance -- often begins.  One has shown over the past couple of years that its groundbreaking technology works -- and might be applied across many indications.""}, {""date"": ""2023-03-15"", ""headline"": ""How a nasal vaccine could reduce the risk of COVID infections \u2014 and new variants"", ""summary"": ""Three years into the pandemic, the World Health Organization's Joachim Hombach talked with MarketWatch about the future of vaccines.""}, {""date"": ""2023-03-15"", ""headline"": ""Why a nasal vaccine could reduce the risk of COVID infections and new variants"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-16"", ""headline"": ""Moderna (MRNA) Gains But Lags Market: What You Should Know"", ""summary"": ""Moderna (MRNA) closed at $151.78 in the latest trading session, marking a +1.46% move from the prior day.""}, {""date"": ""2023-03-16"", ""headline"": ""This High-Growth Company Is Expanding. Time to Buy the Stock?"", ""summary"": ""Moderna's (NASDAQ: MRNA) reliance on its COVID-19 vaccine has worried some investors.  The vaccine -- Moderna's only commercialized product -- has generated billions of dollars in earnings over the past two years.  Now, though, with vaccine demand on the decline, the biotech company's revenue may look a lot different in the coming quarters.""}, {""date"": ""2023-03-16"", ""headline"": ""Moderna Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. rose 1.46% to $151.78 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-16"", ""headline"": ""PBE: Healthcare Dashboard For March"", ""summary"": ""Healthcare equipment is the less attractive subsector regarding both valuation and quality. Click here to find out why PBE is a Hold.""}, {""date"": ""2023-03-17"", ""headline"": ""Moderna Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 1.16% to $150.02 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-17"", ""headline"": ""COVID-19: Moderna price hike to reflect \u2018the value of the vaccine,\u2019 company president says"", ""summary"": ""Moderna President Stephen Hoge joins Yahoo Finance Live to discuss a post-pandemic market, Sen. Bernie Sanders\u2019 remarks on the COVID-19 vaccine price hike, and the outlook for\u00a0the biotechnology company.""}, {""date"": ""2023-03-17"", ""headline"": ""Better RSV Vaccine Stock: Pfizer, GSK, or Moderna?"", ""summary"": ""No vaccine has been approved to prevent respiratory syncytial virus (RSV), but there are more than 30 different RSV vaccine candidates in clinical trials, according to PATH, a global health organization.  Research from the Centers for Disease Control and Prevention (CDC) estimate that between 60,000 and 160,000 adults 65 and older are hospitalized each year with RSV, and 6,000 to 10,000 older adults die because of it.  One to two out of every 100 children younger than 6 months of age with an RSV infection may need to be hospitalized.""}, {""date"": ""2023-03-17"", ""headline"": ""Is It Time to Buy the S&P 500's 2 Worst-Performing February Stocks?"", ""summary"": ""Silicon Valley Bank and Signature Bankhave already failed.  Credit Suisse\u00a0plunged after it disclosed material weaknesses in its financial reporting, and its biggest investor, the Saudi National Bank, said it wasn't going to come to its rescue.  Let's take a look at the S&P 500's two worst performers from February to see if either of them offers a good buying opportunity.""}, {""date"": ""2023-03-17"", ""headline"": ""Tracking Lone Pine Capital Portfolio - Q4 2022 Update"", ""summary"": ""Lone Pine Capital\u00e2\u0080\u0099s 13F portfolio value decreased marginally from $10.61B to $10.48B this quarter. Click here for a complete analysis of the portfolio.""}, {""date"": ""2023-03-18"", ""headline"": ""1 Green Flag and 1 Red Flag for Novavax"", ""summary"": ""Novavax (NASDAQ: NVAX) has had more than its share of ups and downs over the past few years -- and investors have been along for the ride.  The stock soared 2,700% in 2020 as the company brought its coronavirus vaccine candidate through late-stage clinical trials.  The biotech company's vaccine reached commercialization later than rivals.""}, {""date"": ""2023-03-19"", ""headline"": ""15 Most Promising Stocks to Buy According to Analysts"", ""summary"": ""In this article, we will take a look at the 15 most promising stocks to buy according to analysts. To see more such companies, go directly to 5 Most Promising Stocks to Buy According to Analysts. The international financial system is yet again wavering amid the banking sector problems. Analysts are now processing the possibility [\u2026]""}, {""date"": ""2023-03-19"", ""headline"": ""3 (Good) Reasons Warren Buffett Doesn't Invest in Biotech Stocks"", ""summary"": ""There's a pretty good chance Warren Buffett knows a few things about investing that we don't.  Let's take a look at three of his most likely arguments against buying biotechs.  Biotech stocks are risky, and there isn't really any way of de-risking their line of business, both of which are things that Buffett almost certainly hates about them.""}, {""date"": ""2023-03-19"", ""headline"": ""Pfizer CEO pockets $33M for 2022 after 36% pay hike"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-19"", ""headline"": ""Shareholders may not want to ignore the US$4.3m worth sales made by Moderna, Inc. (NASDAQ:MRNA) insiders this past year"", ""summary"": ""While Moderna, Inc. ( NASDAQ:MRNA ) shareholders have had a good week with the stock up 8.5%, they shouldn't let their...""}]",{}
10,2023-03-19,150.02000427246094,2023-03-26,150.8800048828125,0.005732572896009591,U1,"[{""date"": ""2023-03-19"", ""headline"": ""15 Most Promising Stocks to Buy According to Analysts"", ""summary"": ""In this article, we will take a look at the 15 most promising stocks to buy according to analysts. To see more such companies, go directly to 5 Most Promising Stocks to Buy According to Analysts. The international financial system is yet again wavering amid the banking sector problems. Analysts are now processing the possibility [\u2026]""}, {""date"": ""2023-03-19"", ""headline"": ""3 (Good) Reasons Warren Buffett Doesn't Invest in Biotech Stocks"", ""summary"": ""There's a pretty good chance Warren Buffett knows a few things about investing that we don't.  Let's take a look at three of his most likely arguments against buying biotechs.  Biotech stocks are risky, and there isn't really any way of de-risking their line of business, both of which are things that Buffett almost certainly hates about them.""}, {""date"": ""2023-03-19"", ""headline"": ""Pfizer CEO pockets $33M for 2022 after 36% pay hike"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-19"", ""headline"": ""Shareholders may not want to ignore the US$4.3m worth sales made by Moderna, Inc. (NASDAQ:MRNA) insiders this past year"", ""summary"": ""While Moderna, Inc. ( NASDAQ:MRNA ) shareholders have had a good week with the stock up 8.5%, they shouldn't let their...""}, {""date"": ""2023-03-20"", ""headline"": ""Moderna expects to price its COVID vaccine at about $130 in the US"", ""summary"": ""Moderna Inc expects to price its COVID-19 vaccine at around $130 per dose in the U.S. going forward as purchases move to the private sector from the government, the company\u2019s president Stephen Hoge said in an interview on Monday.""}, {""date"": ""2023-03-20"", ""headline"": ""UPDATE 1-Moderna expects to price its COVID vaccine at about $130 in the US"", ""summary"": ""Moderna Inc expects to price its COVID-19 vaccine at around $130 per dose in the U.S. going forward as purchases move to the private sector from the government, the company\u2019s president Stephen Hoge said in an interview on Monday.  \u201cThere are different customers negotiating different prices right now, which is why it's a little bit complicated,\u201d Hoge said ahead of a Congressional hearing run by Democratic U.S. Senator Bernie Sanders on Moderna\u2019s pricing plans.  Moderna previously said it was considering pricing its COVID vaccine in a range of $110 to $130 per dose in the United States, similar to the range Pfizer Inc said in October it was considering for its rival COVID shots sold in partnership with BioNTech.""}, {""date"": ""2023-03-20"", ""headline"": ""Moderna Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Moderna Inc. rose 3.00% to $154.52 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-03-20"", ""headline"": ""Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'"", ""summary"": ""https://cdn.benzinga.com/files/images/story/2023/03/20/bird_flu-_image_by_jeyaratnam_caniceus_from_pixabay-.jpg?optimize=medium&dpr=2&auto=webp&crop=1200%2C800 Executives at GSK Plc (NYSE: GSK), Moderna Inc (NASDAQ: MRNA), and CSL Seqirus, owned by CSL Ltd (OTC: CSLLY), said they are developing or about to test sample human vaccines against bird flu as a precautionary measure against a future pandemic. Others, like Sanofi SA (NASDAQ: SNY), said they \""stand ready\"" to begin production if needed, w""}, {""date"": ""2023-03-20"", ""headline"": ""2 Undervalued Stocks to Buy Today to Prepare for the Next Bull Market"", ""summary"": ""Rewards that the next bull market will bring are being built right now by farsighted investors who can find opportunities among today's discounted stocks.  While there's no telling exactly when a bull market will develop, planting the seeds of success by buying some shares of cheap yet high-quality companies out there right now is a good move.  With that in mind, here are two businesses you're probably acquainted with that are priced for a no-brainer purchase -- and have a good shot at flourishing in the next bull market and beyond.""}, {""date"": ""2023-03-20"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Moderna (MRNA) and Decibel Therapeutics (DBTX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-20"", ""headline"": ""Very Good News For REIT Investors"", ""summary"": ""Future interest rate expectations are now lower and this is very good news for REITs. Check out a few REIT picks that we are accumulating.""}, {""date"": ""2023-03-20"", ""headline"": ""FOCUS-Vaccine makers prep bird flu shot for humans 'just in case'; rich nations lock in supplies"", ""summary"": ""Some of the world's leading makers of flu vaccines say they could make hundreds of millions of bird flu shots for humans within months if a new strain of avian influenza ever jumps across the species divide.  One current outbreak of avian flu known as H5N1 clade 2.3.4.4b has killed record numbers of birds and infected mammals.  Human cases, however, remain very rare, and global health officials have said the risk of transmission between humans is still low.""}, {""date"": ""2023-03-21"", ""headline"": ""China approves first domestic mRNA vaccine for Covid-19"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-21"", ""headline"": ""BenevolentAI Strengthens its Board of Directors with the Appointment of Digital Innovation Expert Marcello Damiani"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-21"", ""headline"": ""Covid Vaccine Battle Brewing: Moderna's Stephane Bancel Vs. Bernie Sanders"", ""summary"": ""Moderna CEO Stephane Bancel will face off with Sen. Bernie Sanders on Wednesday over the Covid shot. The battle could rock Moderna stock.""}, {""date"": ""2023-03-21"", ""headline"": ""If You Invested $5,000 in Moderna in 2020, This Is How Much You Would Have Today"", ""summary"": ""Moderna's (NASDAQ: MRNA) success in the coronavirus vaccine race has equaled success for early investors.  Let's take a look at how much you would have today if you'd invested $5,000 in Moderna back in 2020.  Moderna became one of the first to bring a coronavirus vaccine candidate into clinical trials.""}, {""date"": ""2023-03-21"", ""headline"": ""Moderna CEO Will Face Senate Committee About Covid Vaccine Pricing. What to Expect."", ""summary"": ""Sen. Bernie Sanders is expected to focus on the company's plans to charge insurers $130 per dose for its Covid-19 vaccine.""}, {""date"": ""2023-03-21"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. shed 1.57% to $152.10 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-21"", ""headline"": ""Moderna CEO faces Sen. Sanders in COVID-19 vaccine pricing hearing Wednesday"", ""summary"": ""Moderna CEO St\u00e9phane Bancel is set to face Sen. Bernie Sanders to defend the company's fast growth and planned price hike of its COVID-19 vaccine.""}, {""date"": ""2023-03-21"", ""headline"": ""Moderna Wants $130 Per COVID-19 Vaccine Dose, US Health Authorities Warn Of Incurable Deadly Fungal Infection, Elon Musk Wants Interest Rate Cut: Today's Top Stories"", ""summary"": ""Reuters Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose Moderna Inc (NASDAQ: MRNA) expects to charge $130 per dose for its COVID-19 vaccine as purchases move to the private sector from the government. \""There are different customers negotiating different prices right now, which is why it's a little bit complicated,\"" the company's president Stephen Hoge said in an interview ahead of a Congressional hearing run by Democratic U.S. Senator Bernie Sanders on Moderna's pricing plans. EU Co""}, {""date"": ""2023-03-21"", ""headline"": ""Moderna Wants To Charge About $130 Per COVID-19 Vaccine Dose"", ""summary"": ""From now on, Moderna Inc (NASDAQ: MRNA) expects to charge $130 per dose for its COVID-19 vaccine as purchases move from the government to the private sector. \""There are different customers negotiating different prices right now, which is why it's a little bit complicated,\"" the company's president Stephen Hoge said in an interview ahead of a Congressional hearing run by Democratic U.S. Senator Bernie Sanders on Moderna's pricing plans. Moderna previously considered pricing its COVID vaccine in a""}, {""date"": ""2023-03-21"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-21"", ""headline"": ""FDA moving towards authorizing second omicron booster, WSJ reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-21"", ""headline"": ""Moderna Mulls COVID-19 Vaccine Price at $130"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-21"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna rebuked over plan to hike Covid vaccine to USD130"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-22"", ""headline"": ""GLOBAL BRIEFING: Dollar softens after dovish Fed rhetoric"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-22"", ""headline"": ""It Will Cost More Than $100 to Get a Moderna Covid Vaccine"", ""summary"": ""Remember when they used to be free? As the US government winds down its pandemic emergency spending, health giant Moderna is preparing to shift its...""}, {""date"": ""2023-03-22"", ""headline"": ""Senators press Moderna CEO on COVID-19 vaccine price hike"", ""summary"": ""Moderna\u2019s CEO on Wednesday defended a plan to more than quadruple the company\u2019s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics.  Stephane Bancel told the Senate Committee on Health, Education, Labor and Pensions that the drugmaker will charge a list price of around $130 per dose for the vaccine in the U.S.  More than 270 million doses of Moderna\u2019s original COVID-19 vaccine and booster shots have been administered in the U.S., according to the U.S. Centers for Disease Control and Prevention.""}, {""date"": ""2023-03-22"", ""headline"": ""Is Moderna Stock A Sell As Senators Eye 400% Price Hike For Covid Shots?"", ""summary"": ""Moderna stock is under pressure as the company contends with a pitfall in Covid shots and plans for a 400% price hike. Is MRNA stock a sell?""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna CEO Faces Senate Grilling Over Price of Covid-19 Vaccine"", ""summary"": ""Sen. Bernie Sanders homed in on the company's plans to charge insurers $130 per dose for its Covid-19 vaccine.""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna CEO defends $130 US COVID vaccine price in Senate hearing"", ""summary"": ""Moderna Inc's chief executive on Wednesday defended the company's plan to quadruple the price of its COVID-19 vaccine, telling a U.S. Senate committee hearing it will no longer have the economies of scale from government procurement when the shots move into the private market...""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 2.58% to $148.18 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna to charge $130 for COVID vaccines in shift to commercial distribution"", ""summary"": ""Pfizer has said it\u2019s considering a similar price for its vaccine.""}, {""date"": ""2023-03-22"", ""headline"": ""UPDATE 2-Moderna CEO defends $130 US COVID vaccine price in Senate hearing"", ""summary"": ""Moderna Inc's chief executive on Wednesday defended the company's plan to quadruple the price of its COVID-19 vaccine, telling a U.S. Senate committee hearing it will no longer have the economies of scale from government procurement when the shots move into the private market.  Moderna CEO Stephane Bancel was called to testify after the company flagged plans to raise the vaccine's price to as much as $130 per dose, drawing the ire of Democratic U.S. Senator Bernie Sanders, who chairs the influential Committee on Health, Education, Labor and Pensions (HELP).  Sanders on Wednesday asked Bancel to reconsider the price hikes, saying they could make it unaffordable for millions of Americans and were unjustified given the government's research contributions and $1.7 billion in assistance in developing the vaccine.""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna defends COVID-19 vaccine price hike before U.S. Senate"", ""summary"": ""Yahoo Finance\u2019s Anjalee Khemlani joins the Live show to discuss Moderna CEO Stephane Bancel\u2019s testimony before the U.S. Senate health committee.""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna CEO Bancel defends $130 COVID vaccine price in Senate hearing"", ""summary"": ""Moderna Inc will no longer have the economies of scale it had in government procurement when its COVID-19 vaccine moves into the private market, Chief Executive Officer Stephane Bancel told lawmakers on Wednesday at a Senate committee hearing as he defended the company's...""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna CEO defends price increase for COVID vaccine to Congress"", ""summary"": ""A hearing focused on Moderna\u2019s plan to raise the price of its COVID-19 vaccine raised longstanding questions about how drugs should be priced in the U.S.""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna CEO Stephane Bancel defends fivefold price hike of Covid vaccine during Senate grilling"", ""summary"": ""Bernie Sanders pressed Stephane Bancel during the Senate hearing to make a commitment that Moderna will not increase the vaccine's list price to $130. ""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna CEO Bancel tells senators COVID vaccine price hikes are appropriate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna to Price Its Covid-19 Vaccine at $130 a Dose"", ""summary"": ""The company is preparing for commercial distribution of the shots as the U.S. winds down its pandemic-emergency purchases.""}, {""date"": ""2023-03-22"", ""headline"": ""Sen. Bernie Sanders grills Moderna CEO over Covid vaccine prices during hearing"", ""summary"": ""CNBC's Meg Tirrell reports on the Senate hearing on drug prices, which featured an exchange between Sen. Bernie Sanders and Moderna CEO St\u00e9phane Bancel.""}, {""date"": ""2023-03-22"", ""headline"": ""The Bank Turmoil Isn\u2019t Over. What It Means for the Fed Looking Forward."", ""summary"": ""Moderna\u2019s CEO is faces a Senate grilling over $130 Covid-19 shot, Google expands public access to its \u2018Bard\u2019 chatbot, and other news to start your day.""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna: Now's Your Chance (Rating Upgrade)"", ""summary"": ""Moderna stock potential is overshadowed by downcast analysts' projections of three years of operating losses until 2025. Click here for our take on MRNA.""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna CEO faces Senate panel as price of COVID-19 vaccine set to quadruple"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-22"", ""headline"": ""Watch: Moderna CEO Stephane Bancel testifies before Senate on Covid vaccine price hike"", ""summary"": ""The Boston biotech company plans to charge $130 per dose once the vaccination program moves to the private market as early as this fall.""}, {""date"": ""2023-03-22"", ""headline"": ""Moderna: Now`s Your Chance (Rating Upgrade)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-22"", ""headline"": ""Senate Health, Ed, Labor & Pensions Committee to hold a hearing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-22"", ""headline"": ""China grants emergency use for first homegrown mRNA COVID vaccine: WSJ"", ""summary"": ""China has granted its first emergency use authorization to a homegrown mRNA COVID vaccine, the Wall Street Journal reported Wednesday. The vaccine, known as...""}, {""date"": ""2023-03-22"", ""headline"": ""China approves emergency use of 1st home-grown mRNA COVID vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""Moderna (MRNA) closed the most recent trading day at $149.42, moving +0.84% from the previous trading session.""}, {""date"": ""2023-03-23"", ""headline"": ""Moderna's Bancel defends COVID-19 vaccine price at Sanders hearing"", ""summary"": ""Moderna's CEO St\u00e9phane Bancel faced off with Sen. Bernie Sanders and others of the Senate HELP committee to defend raising the COVID vaccine price for the commercial market.""}, {""date"": ""2023-03-23"", ""headline"": ""7 Blue-Chip Stocks Sitting in the Sweet Spot"", ""summary"": ""Although blue-chip stocks often carry a reputation for being lumbering giants that might not kill your portfolio but certainly won\u2019t do it any favors, specific stalwarts can get the business done. In other words, these enterprises hit the sweet spot: they\u2019re tied to well-established businesses that also offer double-digit (percentage) upside potential, as determined by Wall Street analysts. Further, adding to the sweet nature of these blue-chip stocks, they\u2019re all undervalued based on earnings m""}, {""date"": ""2023-03-23"", ""headline"": ""A COVID-19 Vaccine Could Cost You Four Times As Much Soon \u2014 Here\u2019s Why"", ""summary"": ""A leading drugmaker's plan to quadruple the price of its COVID-19 vaccine when the public health emergency ends has not gone over well on Capitol Hill, where lawmakers criticized the company's top...""}, {""date"": ""2023-03-23"", ""headline"": ""Moderna signs licensing deal with Generation Bio in push beyond COVID"", ""summary"": ""Moderna Inc has entered a licensing deal with Generation Bio Co to develop treatments targeting the immune system and liver, the latest such transaction by the vaccine maker as it expands beyond its COVID shots.""}, {""date"": ""2023-03-23"", ""headline"": ""Moderna Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.84% higher to $149.42 Thursday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-03-23"", ""headline"": ""Penny Stocks To Buy Under $5? 7 To Watch This Week"", ""summary"": ""Penny stocks to watch under $5 this week.""}, {""date"": ""2023-03-23"", ""headline"": ""Moderna, Generation Bio Collaborate To Develop Non-Viral Genetic Medicines"", ""summary"": ""Moderna Inc (NASDAQ: MRNA) and Generation Bio Co (NASDAQ: GBIO) have collaborated to combine the application of each company's platform by developing novel nucleic acid therapeutics, including those capable of reaching immune cells, to accelerate their respective pipelines of non-viral genetic medicines. \""Non-viral DNA therapeutics may offer durable, redosable, titratable genetic medicines to patients suffering from rare and prevalent diseases on a global scale,\"" said Phillip Samayoa, Chief Stra""}, {""date"": ""2023-03-23"", ""headline"": ""UPDATE 2-Moderna signs licensing deal with Generation Bio in push beyond COVID"", ""summary"": ""Moderna Inc has entered a licensing deal with Generation Bio Co to develop treatments targeting the immune system and liver, the latest such transaction by the vaccine maker as it expands beyond its COVID shots.  Generation Bio's shares rose about 13.14% to $4.40 in premarket trading on Thursday.  Moderna will pay $40 million in cash upfront, and make a $36 million equity investment in Cambridge, Massachusetts-based Generation Bio.""}, {""date"": ""2023-03-23"", ""headline"": ""Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines"", ""summary"": ""Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Generation Bio Co.""}, {""date"": ""2023-03-23"", ""headline"": ""Biotech ETF XBI drops to an 8-month low"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""GBIO Soars on Teaming Up with Moderna"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Moderna (MRNA) and Pyxis Oncology (PYXS)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""Generation Bio, Moderna announce collaboration"", ""summary"": ""Shares of Generation Bio Co. jumped about 28% premarket trading on Thursday after the company announced a collaboration with Moderna Inc. to to develop novel...""}, {""date"": ""2023-03-23"", ""headline"": ""Generation Bio Shares Rise 19% on Moderna Strategic Collaboration"", ""summary"": ""By Denny Jacob Genetic medicine company Generation Bio Co. shares rose 19%, to $4.61, in premarket trading Thursday after it and pharmaceutical company...""}, {""date"": ""2023-03-23"", ""headline"": ""Generation Bio, Moderna Enter Collaboration to Accelerate Non-Viral Genetic-Medicines Pipeline"", ""summary"": ""By Denny Jacob Genetic-medicine company Generation Bio Co. and pharmaceutical company Moderna Inc. on Thursday entered into a strategic collaboration. The...""}, {""date"": ""2023-03-23"", ""headline"": ""Moderna Is Great Value For Money Right Now"", ""summary"": ""Moderna\u00e2\u0080\u0099s investments put it in a strong position to develop new products. Check out why I'm bullish on MRNA stock.""}, {""date"": ""2023-03-23"", ""headline"": ""Generation Bio stock surges ~20% on Moderna pact to develop non-viral genetic drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""Moderna to pay Generation Bio $40M upfront under pact to develop non-viral genetic drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""Moderna, Generation Bio enter collaboration for non-viral genetic medicines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""Generation Bio, Moderna announce strategic collaboration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-23"", ""headline"": ""PRESS DIGEST- Wall Street Journal - March 23"", ""summary"": ""Following are the top stories in the Wall Street Journal.  - Moderna Inc  will price its Covid-19 vaccine at about $130 a dose when it shifts to commercial distribution of the shots later this year, much higher than what the federal government has paid.  - A federal judge found that special counsel Jack Smith's team presented convincing evidence that former U.S. President Donald Trump misled his own lawyers about his retention of classified documents after leaving the White House, according to people familiar with the decision.""}, {""date"": ""2023-03-23"", ""headline"": ""Moderna CEO defends $130 price of Covid-19 vaccine, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-24"", ""headline"": ""Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio"", ""summary"": ""Moderna (MRNA) collaborates with Generation Bio to develop non-viral genetic medicines. For this, it leverages the latter's closed-end DNA (ceDNA) and cell-targeted LNPs (ctLNP) technologies.""}, {""date"": ""2023-03-24"", ""headline"": ""Moderna Inc. stock underperforms Friday when compared to competitors despite daily gains"", ""summary"": ""Shares of Moderna Inc. inched 0.98% higher to $150.88 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-24"", ""headline"": ""Moderna to Host Fourth Annual Virtual Vaccines Day on April 11, 2023"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will present its Vaccines Day for analysts and investors at 8:00 a.m.""}, {""date"": ""2023-03-24"", ""headline"": ""With 65% institutional ownership, Moderna, Inc. (NASDAQ:MRNA) is a favorite amongst the big guns"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Moderna's stock price might be vulnerable to their...""}, {""date"": ""2023-03-25"", ""headline"": ""3 Things About Moderna That Smart Investors Know"", ""summary"": ""Moderna (NASDAQ: MRNA) helped some investors make a fortune over the past few years.  The stock has climbed more than 400% since March 2020 -- that's when the company's coronavirus vaccine program gained traction.  Recently, though, investors have worried about Moderna's post-pandemic revenue, and that's weighed on share performance.""}]",{}
11,2023-03-26,150.8800048828125,2023-04-02,153.5800018310547,0.01789499510116843,U2,"[{""date"": ""2023-03-27"", ""headline"": ""Moderna Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 1.68% to $148.35 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-03-27"", ""headline"": ""As Covid-19 shot sales dwindle, BioNTech doubles down on cancer vaccines"", ""summary"": ""BioNTech is over covid. Or looking past it, at least, planning to invest the company\u2019s pandemic windfall into the development of oncology products.""}, {""date"": ""2023-03-27"", ""headline"": ""Could CRISPR Therapeutics Become the Next Moderna?"", ""summary"": ""CRISPR Therapeutics (NASDAQ: CRSP) has a couple of things in common with a company that's made the headlines over the past few years: coronavirus vaccine maker Moderna (NASDAQ: MRNA).  Today, CRISPR's market value sits at about $3.4 billion.  Since, Moderna has grown to become a $58 billion company, with a blockbuster product and three more potential ones on the horizon.""}, {""date"": ""2023-03-27"", ""headline"": ""Video: S&P 500 Movers: MRNA, FRC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-28"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. dropped 0.96% to $146.92 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-28"", ""headline"": ""2 Nasdaq 100 Stocks to Buy Hand Over Fist Right Now"", ""summary"": ""When there are bargains on stocks with long-term appeal, astute investors make sure to get a few shares while the getting is good.  In truth, Moderna (NASDAQ: MRNA) is a bit of a contrarian purchase at the moment as nobody expects it to one-up its 2022 top line of nearly $19 billion now that sales of its coronavirus vaccine are expected to fall to as low as $5 billion in 2023.""}, {""date"": ""2023-03-28"", ""headline"": ""Gritstone bio draws Buy rating at B. Riley on mRNA potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-29"", ""headline"": ""Moderna (MRNA) Gains But Lags Market: What You Should Know"", ""summary"": ""Moderna (MRNA) closed at $148.80 in the latest trading session, marking a +1.28% move from the prior day.""}, {""date"": ""2023-03-29"", ""headline"": ""J&J Drops Out Of A Key Race, Leaving Pfizer, GSK, Moderna To Duke It Out"", ""summary"": ""Johnson & Johnson ducked out of the RSV vaccine race Wednesday, leaving Pfizer, GSK and Moderna to duke it out.""}, {""date"": ""2023-03-29"", ""headline"": ""Moderna Inc. stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. rallied 1.28% to $148.80 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-29"", ""headline"": ""What WHO\u2019s New Covid-19 Vaccine Guidance Means for Pfizer and Moderna Stock"", ""summary"": ""The two companies have said they expect roughly 100 million Covid-19 vaccines doses to be administered in the U.S. this year.""}, {""date"": ""2023-03-29"", ""headline"": ""Why Is Denali Therapeutics Inc. (DNLI) Down 16% Since Last Earnings Report?"", ""summary"": ""Denali Therapeutics Inc. (DNLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""2023-03-29"", ""headline"": ""J&J backs out of RSV vaccine race with rivals Pfizer and GSK "", ""summary"": ""J&J lagged behind rival drugmakers Pfizer and GSK, both of which made major strides toward U.S. approval of their RSV vaccines in the last month. ""}, {""date"": ""2023-03-29"", ""headline"": ""Moderna's CEO Just Gave Investors a Huge Reason to Sell the Stock"", ""summary"": ""Recently, Moderna (NASDAQ: MRNA)'s CEO highlighted a big risk for the company: Demand for its COVID-19 vaccine is going to crater.  It's a big enough decline to get investors worried.  Moderna is anticipating a big drop in demand this year as concerns around COVID-19 subside.""}, {""date"": ""2023-03-29"", ""headline"": ""The Ultimate Growth Stock to Buy With $150 Right Now"", ""summary"": ""What makes a top growth stock?  It's generated billions of dollars thanks to its coronavirus vaccine -- but the company has other major growth drivers on the way.  Let's find out more about this ultimate growth stock to buy now.""}, {""date"": ""2023-03-30"", ""headline"": ""Catalyst watch: Tesla deliveries, Walmart event and jobs report headline big week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""Top Stock Reports for Walt Disney, Marathon Petroleum & Moderna"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Company (DIS), Marathon Petroleum Corporation (MPC), and Moderna, Inc. (MRNA).""}, {""date"": ""2023-03-30"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 0.91% to $147.44 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-30"", ""headline"": ""Mirati (MRTX) Down 16.1% Since Last Earnings Report: Can It Rebound?"", ""summary"": ""Mirati (MRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""2023-03-30"", ""headline"": ""1 Growth Stock With 741% Upside, According to Wall Street"", ""summary"": ""Shares of biotech Novavax (NASDAQ: NVAX) have plunged 91% in the past year as the company has struggled to make its mark in the coronavirus vaccine market.  Novavax's lack of success in this space is even more troubling, considering global COVID-19 vaccine sales will drop substantially starting this year, so even the leaders in the field have struggled of late.  While it seems highly unlikely that Novavax will soar by that much anytime soon, perhaps the broader question is whether there's a substantial upside ahead for the company.""}, {""date"": ""2023-03-30"", ""headline"": ""Moderna Finalizes Agreement with the Government of the Republic of Kenya to Establish an mRNA Manufacturing Facility"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and the Government of the Republic of Kenya have finalized an agreement to establish an mRNA manufacturing facility in the Republic of Kenya.""}, {""date"": ""2023-03-30"", ""headline"": ""Moderna to produce up to half a billion mRNA vaccines yearly in Kenya"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""Moderna to set up mRNA manufacturing site in Kenya"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Cutera (CUTR), Moderna (MRNA) and BiomX (PHGE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""Moderna finalizes agreement with Government of the Republic of Kenya"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""Moderna, Gandeeva ink pact to research on protein surface structure"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""Brookline Capital Markets Reaffirms Their Buy Rating on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""Gandeeva and Moderna Enter into Cryo-EM Research Collaboration to Explore Protein Surface Structure at Atomic Resolution"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-30"", ""headline"": ""11 Stocks: 9 Dividend Payers 2 For Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-31"", ""headline"": ""Moderna Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Moderna Inc. rallied 4.16% to $153.58 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-03-31"", ""headline"": ""Generation Bio's Collaboration With Moderna Will Either Be Seismic, Or Disastrous"", ""summary"": ""Generation Bio announced a strategic collaboration with Moderna worth $5m upfront plus a $40m equity investment. See what this deal could do for both companies.""}, {""date"": ""2023-03-31"", ""headline"": ""Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Moderna (MRNA). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""2023-03-31"", ""headline"": ""Generation Bio`s Collaboration With Moderna Will Either Be Seismic, Or Disastrous"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-31"", ""headline"": ""The Zacks Analyst Blog Highlights Disney, Marathon Petroleum, Moderna, Nucor and CenterPoint Energy"", ""summary"": ""Disney, Marathon Petroleum, Moderna, Nucor and CenterPoint Energy are included in this Analyst Blog.""}, {""date"": ""2023-03-31"", ""headline"": ""Early notable gainers among liquid option names on March 31st"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-03-31"", ""headline"": ""Gritstone initiated with an Outperform at Evercore ISI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-02"", ""headline"": ""Could This Move by Johnson & Johnson Equal Billions for Moderna?"", ""summary"": ""What does big pharma Johnson & Johnson (NYSE: JNJ) have in common with biotech Moderna (NASDAQ: MRNA)?  Last week, however, Johnson & Johnson said it would discontinue its adult RSV program.  Could the J&J news eventually translate into billions of dollars for Moderna?""}]","{""assetTurnoverTTM"": 0.5901, ""bookValue"": 18863, ""cashRatio"": 0.9834238353815375, ""currentRatio"": 3.4644, ""ebitPerShare"": -0.9037, ""eps"": 0.1951, ""ev"": 56775.42, ""fcfPerShareTTM"": 1.5938, ""grossMargin"": 0.5747, ""inventoryTurnoverTTM"": 3.8826, ""netDebtToTotalCapital"": -0.1238, ""netDebtToTotalEquity"": -0.1303, ""netMargin"": 0.0424, ""operatingMargin"": -0.1966, ""pb"": 3.1401, ""peTTM"": 12.3814, ""pretaxMargin"": -0.1638, ""psTTM"": 3.9334, ""ptbv"": 3.1481, ""quickRatio"": 3.0031, ""receivablesTurnoverTTM"": 7.0271, ""roaTTM"": 0.1875, ""roeTTM"": 0.2587, ""roicTTM"": 0.2456, ""rotcTTM"": 0.2478, ""salesPerShare"": 4.5975, ""sgaToSale"": 0.4253, ""tangibleBookValue"": 18815, ""totalDebtToEquity"": 0.0522, ""totalDebtToTotalAsset"": 0.0408, ""totalDebtToTotalCapital"": 0.0496, ""totalRatio"": 4.5848, ""period"": ""2023-03-31""}"
12,2023-04-02,153.5800018310547,2023-04-09,158.27000427246094,0.030537845979227596,U4,"[{""date"": ""2023-04-02"", ""headline"": ""Could This Move by Johnson & Johnson Equal Billions for Moderna?"", ""summary"": ""What does big pharma Johnson & Johnson (NYSE: JNJ) have in common with biotech Moderna (NASDAQ: MRNA)?  Last week, however, Johnson & Johnson said it would discontinue its adult RSV program.  Could the J&J news eventually translate into billions of dollars for Moderna?""}, {""date"": ""2023-04-03"", ""headline"": ""Treasury yields fractionally lower as slowdown fears persist"", ""summary"": ""U.S. Treasury yields were slightly lower on Tuesday as concerns over economic growth persisted into the second quarter.""}, {""date"": ""2023-04-03"", ""headline"": ""Moderna Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Moderna Inc. advanced 3.84% to $159.48 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-04-03"", ""headline"": ""FDA poised to authorize second Omicron COVID boosters for some - WaPo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-03"", ""headline"": ""MRNA Makes Bullish Cross Above Critical Moving Average"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-04"", ""headline"": ""Treasury yields rise as investors weigh potential for higher Fed rates"", ""summary"": ""U.S. Treasury yields rose Tuesday as traders assessed the likelihood of higher Federal Reserve rates in the future.""}, {""date"": ""2023-04-04"", ""headline"": ""7 Sorry Blue-Chip Stocks to Sell in April Before It\u2019s Too Late"", ""summary"": ""Stock markets have been rising this year, but the gains have not been equal. While many stocks are in the process of recovering, others continue to fall or trade sideways. Somewhat surprisingly, many blue-chip stocks that have been consistent outperformers over the past decade are now lagging the market. These are companies that are household names and familiar to people in their daily lives. For a variety of internal and external reasons, many once much-loved stocks have now fallen out of favor""}, {""date"": ""2023-04-04"", ""headline"": ""Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots"", ""summary"": ""Arbutus Biopharma Corporation (NASDAQ: ABUS) and its licensee Genevant Sciences have sued Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) in the U.S. District Court for the District of New Jersey, seeking damages for infringement of five U.S. patents. Arbutus and Genevant Sciences seek compensation for the unlicensed use of patented lipid nanoparticle (LNP) delivery technologies in Pfizer/BioNTech's famed COVID-19 vaccine. The lawsuit by Arbutus and Genevant says Pfizer/BioNTec""}, {""date"": ""2023-04-04"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. shed 1.86% to $156.52 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-04-04"", ""headline"": ""2 Top Biotech Stocks to Buy in April"", ""summary"": ""Biotech stocks make a great addition to your portfolio at any time.  Axsome Therapeutics (NASDAQ: AXSM) beat the bear market last year.  Each drug could reach peak sales of more than $1 billion, according to analyst and company forecasts.""}, {""date"": ""2023-04-05"", ""headline"": ""Treasury yields slightly higher as investors track key economic data"", ""summary"": ""U.S. Treasury yields were slightly higher as investors assessed recent labor market data in order to gauge the possibility of a recession.""}, {""date"": ""2023-04-05"", ""headline"": ""WHO chief expects COVID emergency to end this year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-05"", ""headline"": ""Moderna (MRNA) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""Moderna (MRNA) closed at $154.61 in the latest trading session, marking a -1.22% move from the prior day.""}, {""date"": ""2023-04-05"", ""headline"": ""Moderna Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. shed 1.22% to $154.61 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-04-06"", ""headline"": ""Catalyst Watch: Eyes on inflation data, big bank earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-06"", ""headline"": ""MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda(R) (Pembrolizumab), Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of Patients With High-Risk Stage III/IV Melanoma Following Complete Resection"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that mRNA-4157/V940, an investigational personalized mRNA cancer vaccine, in combination with KEYTRUDA, Merck's anti-PD-1 therapy, has been granted Priority Medicines (PRIME) scheme designation by the European Medicines Agency (EMA) for the adjuvant""}, {""date"": ""2023-04-06"", ""headline"": ""Moderna, Merck Combined Treatment Gets EMA Designation for Melanoma"", ""summary"": ""By Denny Jacob Pharmaceutical company Moderna Inc. on Thursday said its mRNA-4157/V940 in combination with drugmaker Merck &amp; Co.'s Keytruda was granted...""}, {""date"": ""2023-04-06"", ""headline"": ""Moderna Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Moderna Inc. rose 2.37% to $158.27 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-04-06"", ""headline"": ""5 Top Growth Stocks to Buy Before the Next Bull Market"", ""summary"": ""It's never too early to start planning for the next bull market. Those days of market gains and optimism will be back. History tells us so -- bull markets always have followed bear markets. So, how should you prepare? By taking advantage of the low prices a down market offers us and buying quality companies that could win over time.""}, {""date"": ""2023-04-06"", ""headline"": ""Moderna (MRNA) Receives a Buy from Brookline Capital Markets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-06"", ""headline"": ""Morgan Stanley Sticks to Their Hold Rating for Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-06"", ""headline"": ""Moderna, Merck say mRNA cancer vaccine-KEYTRUDA combo granted PRIME designation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-09"", ""headline"": ""Premier cancer research event, AACR is starting this week; Here is what to expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.5901, ""bookValue"": 18863, ""cashRatio"": 0.9834238353815375, ""currentRatio"": 3.4644, ""ebitPerShare"": -0.9037, ""eps"": 0.1951, ""ev"": 56775.42, ""fcfPerShareTTM"": 1.5938, ""grossMargin"": 0.5747, ""inventoryTurnoverTTM"": 3.8826, ""netDebtToTotalCapital"": -0.1238, ""netDebtToTotalEquity"": -0.1303, ""netMargin"": 0.0424, ""operatingMargin"": -0.1966, ""pb"": 3.1401, ""peTTM"": 12.3814, ""pretaxMargin"": -0.1638, ""psTTM"": 3.9334, ""ptbv"": 3.1481, ""quickRatio"": 3.0031, ""receivablesTurnoverTTM"": 7.0271, ""roaTTM"": 0.1875, ""roeTTM"": 0.2587, ""roicTTM"": 0.2456, ""rotcTTM"": 0.2478, ""salesPerShare"": 4.5975, ""sgaToSale"": 0.4253, ""tangibleBookValue"": 18815, ""totalDebtToEquity"": 0.0522, ""totalDebtToTotalAsset"": 0.0408, ""totalDebtToTotalCapital"": 0.0496, ""totalRatio"": 4.5848, ""period"": ""2023-03-31""}"
13,2023-04-09,158.27000427246094,2023-04-16,157.10000610351562,-0.007392418887732899,D1,"[{""date"": ""2023-04-09"", ""headline"": ""Catalent upgraded at Deutsche Bank on potential upside to forecasts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-09"", ""headline"": ""Cantor biopharma/biotech analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-09"", ""headline"": ""Premier cancer research event, AACR is starting this week; Here is what to expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-10"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-10"", ""headline"": ""Asian shares moderately higher with focus on inflation data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-10"", ""headline"": ""Wall Street drifts ahead of inflation, earnings reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-10"", ""headline"": ""Moderna wins appeals court ruling in Arbutus COVID vaccine patent dispute"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-10"", ""headline"": ""Moderna wins appeal court ruling in Arbutus COVID vaccine patent dispute"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-10"", ""headline"": ""Moderna Stock Yo-Yoes Winning A Key Battle For Its Cancer Vaccine"", ""summary"": ""Moderna stock rose Monday after European regulators granted its Merck-partnered personalized cancer vaccine a key designation.""}, {""date"": ""2023-04-10"", ""headline"": ""S&P 500 futures are little changed as March inflation report looms ahead: Live updates"", ""summary"": ""Two key economic data points weigh on the minds of investors this week: the latest consumer price index and the producer price index readings.""}, {""date"": ""2023-04-10"", ""headline"": ""Moderna says it hopes to offer new vaccines for cancer, heart disease, and other conditions by 2030"", ""summary"": ""Moderna's chief medical officer said advancements in mRNA technology since the outset of the Covid pandemic have ushered in a golden age for new vaccines.\u00a0""}, {""date"": ""2023-04-10"", ""headline"": ""Moderna (MRNA), Merck's Cancer Jab Gets EMA's PRIME Tag"", ""summary"": ""The EMA grants PRIME designation to Moderna's (MRNA) personalized cancer vaccine candidate combined with Merck's Keytruda for treating certain types of melanoma.""}, {""date"": ""2023-04-10"", ""headline"": ""Pfizer CEO signs open letter calling for reversal of Texas abortion pill ruling"", ""summary"": ""Pfizer's CEO was among the more than 200 pharmaceutical company executives who signed the letter after a federal judge's controversial ruling on mifepristone.""}, {""date"": ""2023-04-10"", ""headline"": ""U.S. launches $5B program to speed up development of next-gen COVID vaccines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-10"", ""headline"": ""Moderna, Merck win priority designation for personalized cancer vaccine in EU"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna Stock Skids Below Key Line On Unexpected Flu Shot Debacle"", ""summary"": ""Moderna stock skidded Tuesday on a mixed update for its mRNA-based flu vaccine. The update could impact the shot's commercial timing.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna stock drops on mixed data tied to flu vaccine approval"", ""summary"": ""The Yahoo Finance Live team takes a look at Moderna shares amid the pharmaceutical company\u2019s outlook on its vaccine products.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna fends off Arbutus appeal in COVID-19 vaccine patent fight"", ""summary"": ""A U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp patent related to the companies' legal fight over Moderna's blockbuster COVID-19 vaccines.""}, {""date"": ""2023-04-11"", ""headline"": ""UPDATE 1-Moderna fends off Arbutus appeal in COVID-19 vaccine patent fight"", ""summary"": ""A U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp patent related to the companies' legal fight over Moderna's blockbuster COVID-19 vaccines.  The U.S. Court of Appeals for the Federal Circuit upheld a U.S. Patent and Trademark Office tribunal's ruling that the patent for Arbutus' lipid nanoparticle (LNP) technology was invalid based on an earlier Arbutus patent that disclosed the same invention.  Moderna challenged the patent at the PTO's Patent Trial and Appeal Board in 2018, and the board invalidated it in 2019.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna says flu shot misses early success bar, but expects 2024 revenue"", ""summary"": ""Moderna Inc said on Tuesday its experimental flu vaccine did not meet the criteria for \""early success\"" in a late-stage trial, and its shares fell 3%.""}, {""date"": ""2023-04-11"", ""headline"": ""Dow Jones Hits 2-Month High; Warren Buffett Targets This Group; Solar Stock Pops"", ""summary"": ""The major stock market indexes traded mixed on Tuesday, ahead of Wednesday's inflation report. The Dow Jones and S&P 500 shined, holding near highs of the day. Investors kept their powder dry ahead of the first batch of bank earnings, due on Friday.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna flu shot misses 'early success' bar, shares fall"", ""summary"": ""Moderna Inc said on Tuesday its experimental flu vaccine did not meet the criteria for \""early success\"" in a late-stage trial, and its shares fell 4%.""}, {""date"": ""2023-04-11"", ""headline"": ""How major US stock indexes fared Tuesday 4/11/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 3.06% to $155.25 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna, TSR fall; CarMax, Coinbase rise"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""NEW YORK MARKET CLOSE: US stocks wary ahead of key inflation figures"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Antivaccine Groups See Hope in Abortion-Pill Ruling. What It Means for Pharma."", ""summary"": ""A judge's reversal of the FDA's approval of mifepristone has raised concern that it may not have the last word on what drugs may be prescribed in the U.S.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna Stock Slides Despite Positive Vaccines Update. Here\u2019s Why."", ""summary"": ""The biotech company is working on new drugs for Lyme disease and Covid-19 as it prepares to roll out six new products with \u201csizable markets.\u201d""}, {""date"": ""2023-04-11"", ""headline"": ""Twitter Inc Is Officially Defunct, Alibaba Plans to Integrate ChatGPT Like Chatbot Across Products, Moderna's Flu Shot Study Misses 'Early Success' Criteria: Today's Top Stories"", ""summary"": ""Benzinga Twitter Inc Is Officially Defunct As Elon Musk Pursues' Superapp' Goal Twitter Inc, the parent company of the namesake social media platform, has ceased to exist, and it has now been merged into X Corp., court filings show. 'Chief Twit' Elon Musk also appeared to acknowledge the change early on Tuesday by tweeting out \""X.\"" The development came to light in a court filing of Twitter's corporate disclosure statement in connection with a lawsuit brought about by right-wing activist Laura Lo""}, {""date"": ""2023-04-11"", ""headline"": ""12 Best Covid Treatment Stocks to Buy Today"", ""summary"": ""In this piece, we will take a look at the 12 best covid treatment stocks to buy today. For more stocks, head on over to 5 Best Covid Treatment Stocks to Buy Today. If there\u2019s one thing that can be said for sure, it\u2019s that the coronavirus pandemic has changed the world. The deadly disease, [\u2026]""}, {""date"": ""2023-04-11"", ""headline"": ""S&P 500 Q1 2023 Earnings Preview: Entering An Earnings Recession"", ""summary"": ""Q1 is expected to mark the second consecutive quarter of negative y/y earnings growth, which meets the criteria of an earnings recession.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna's Vaccine Day: Influenza Vaccine Candidate Testing To Continue As It Misses 'Early Success' Threshold"", ""summary"": ""Moderna Inc's (NASDAQ: MRNA) first vaccine candidate against influenza is mRNA-1010, which is being developed in adults. The independent Data and Safety Monitoring Board (DSMB) has completed the first interim efficacy analysis for the second Phase 3 trial (P302) conducted in the Northern Hemisphere to evaluate the safety and non-inferior efficacy compared to a licensed flu vaccine. The DSMB said mRNA-1010 did not meet the statistical threshold necessary to declare early success. The safety board""}, {""date"": ""2023-04-11"", ""headline"": ""Midday movers: CarMax, Moderna, Coinbase Global"", ""summary"": ""By Liz Moyer""}, {""date"": ""2023-04-11"", ""headline"": ""Could Moderna Become a Warren Buffett Stock?"", ""summary"": ""Moderna (NASDAQ: MRNA) is a growth stock that's had plenty of time in the limelight, but that doesn't mean it'd fit the exacting specifications of Warren Buffett.  Berkshire Hathaway's portfolio isn't known for making speculative bets on biotech companies, and the Oracle of Omaha's penchant for reliable growth seems anathema to the industry as a whole, even when considering quality businesses like Moderna.  There are a few reasons why Warren Buffett would probably not want to invest in Moderna today.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna stock slides following experimental flu vaccine setback"", ""summary"": ""Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss the decline in stock for Moderna.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna to Push Backup Experimental Flu Shot After Setback"", ""summary"": ""(Bloomberg) -- Moderna Inc.\u2019s first experimental flu shot didn\u2019t accumulated enough data to determine efficacy in a final-stage study, and the company said it will advance another candidate.Most Read from BloombergKatie Cotton, Guardian of the Apple Brand for 18 Years, DiesElizabeth Holmes Will Have to Wait Out Her Appeal in PrisonTwitter Company \u2018No Longer Exists,\u2019 Is Now Part of Musk\u2019s XTumbling Money Supply Alarms Economists Who Foresaw InflationRich Chinese Splashing Out on Luxury Have Yet t""}, {""date"": ""2023-04-11"", ""headline"": ""These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar"", ""summary"": ""The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna Slumps as Vaccine Data Improves"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""WeightWatchers, CarMax, Moderna, and other stocks on the move"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna says potential flu vaccine needs more study"", ""summary"": ""Moderna shares slipped Tuesday morning after the COVID-19 vaccine developer said its potential flu vaccine needs more study in a late-stage clinical trial.  The company said an independent data and safety monitory board found that the potential vaccine \u201cdid not meet the statistical threshold necessary to declare early success\u201d in the study.  Moderna is developing the vaccine, labeled mRNA-1010, to guard against seasonal flu.""}, {""date"": ""2023-04-11"", ""headline"": ""Stocks making the biggest moves midday: WW International, CarMax, Mohawk, Moderna and more"", ""summary"": ""These are the stocks posting the largest moves in midday trading. ""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna says flu vaccine candidate requires additional study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna says there are not enough cases to declare early success for its mRNA flu vaccine"", ""summary"": ""CNBC's Meg Tirrell reports on news from Moderna that it will delay results from its flu vaccine trials.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna sees up to $15 bln in respiratory vaccine sales in 2027"", ""summary"": ""Moderna Inc said on Tuesday it expects sales from its respiratory vaccines to be between $8 billion and $15 billion in 2027.""}, {""date"": ""2023-04-11"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, LCID"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna is developing a vaccine against the tick-borne Lyme disease, in a first for the company"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Video: S&P 500 Movers: MRNA, KMX"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna says it expects up to $15 billion in sales of Covid, RSV, flu vaccines in 2027"", ""summary"": ""Moderna said it sees a corresponding operating profit from its Covid, RSV, and flu vaccines in the range of $4 billion to $9 billion in 2027. ""}, {""date"": ""2023-04-11"", ""headline"": ""Stocks making the biggest moves premarket: Moderna, CarMax, Whirlpool and more"", ""summary"": ""CarMax soared on the back of better-than-expected quarterly earnings.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna Expects 6 Major Vaccine Launches In Next Few Years"", ""summary"": ""By Dean Seal Moderna Inc. expects to launch six major vaccine products in the next few years. The vaccine maker said Tuesday that it is expanding and...""}, {""date"": ""2023-04-11"", ""headline"": ""Brookline Capital Markets Remains a Buy on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna is developing a Lyme disease vaccine in a first for the company "", ""summary"": ""Moderna Inc. said Tuesday that it's working to develop its first bacterial vaccine to protect against Lyme disease.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna stock dips after flu shot fails to meet early success threshold, trial continues"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna's MRNA cancer vaccine receives EU Prime designation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna to hold a virtual event"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna is developing a vaccine candidate against Lyme disease that would be its first bacterial vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Bank of America Securities Keeps Their Hold Rating on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna expects six major vaccine product launches in next few years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna sees 2027 respiratory product sales $8B-$15B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna says DSMB recommends continuation of efficacy followup for mRNA-1010"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna announces development of candidates for norovirus, lyme disease"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna announces clinical, program updates at 4th Vaccines Day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Moderna Announces Clinical and Program Updates at 4th Vaccines Day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""3 Overvalued Blue-Chip Stocks Not Worth Your Green"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-11"", ""headline"": ""Tracking Philippe Laffont's Coatue Management Portfolio - Q4 2022 Update"", ""summary"": ""Philippe Laffont\u00e2\u0080\u0099s 13F portfolio value increased from $8.61B to $8.92B this quarter. Read more to see the portfolio's full Q4 2022 update.""}, {""date"": ""2023-04-11"", ""headline"": ""These Stocks Are Moving the Most Today: CarMax, Coinbase, Moderna, WW International, and More"", ""summary"": ""CarMax jumps after posting better-than-expected fiscal fourth-quarter earnings, Coinbase surges after Bitcoin tops $30,000 for the first time in 10 months,...""}, {""date"": ""2023-04-11"", ""headline"": ""Tracking Philippe Laffont`s Coatue Management Portfolio - Q4 2022 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""Carisma Therapeutics initiated with an Outperform at Baird"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""Thursday Sector Leaders: Healthcare, Services"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""Moderna (MRNA) Gains As Market Dips: What You Should Know"", ""summary"": ""In the latest trading session, Moderna (MRNA) closed at $155.56, marking a +0.2% move from the previous day.""}, {""date"": ""2023-04-12"", ""headline"": ""JP Morgan Maintains Moderna (MRNA) Neutral Recommendation"", ""summary"": """"}, {""date"": ""2023-04-12"", ""headline"": ""US Court Favors Moderna In COVID-19 Vaccine Patent Infringement Case With Arbutus Biopharma"", ""summary"": ""A U.S. appeals court affirmed a decision to cancel an Arbutus Biopharma Corporation (NASDAQ: ABUS) patent related to a legal fight over Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccines. The U.S. Court of Appeals for the Federal Circuit upheld a U.S. Patent and Trademark Office tribunal's ruling that the patent for Arbutus' lipid nanoparticle (LNP) technology was invalid based on an earlier Arbutus patent that disclosed the same invention. Moderna challenged the patent at the PTO's Patent Trial and""}, {""date"": ""2023-04-12"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. inched 0.20% higher to $155.56 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the...""}, {""date"": ""2023-04-12"", ""headline"": ""Moderna (MRNA) Posts 2027 Biz View, Down 3% on Flu Jab Setback"", ""summary"": ""Moderna (MRNA) expects $8-$15 billion in product revenues from the respiratory vaccine by 2027. Its first influenza vaccine candidate failed to meet the statistical threshold for early success.""}, {""date"": ""2023-04-12"", ""headline"": ""Company News for Apr 12, 2023"", ""summary"": ""Companies in The News Are: MRNA, COIN, NVDA, DVN""}, {""date"": ""2023-04-12"", ""headline"": ""Moderna`s investments in pipeline lead to P&L uncertainty: Bank of America"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""Moderna`s investments in pipeline leads to P&L uncertainty: Bank of America"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""Arrowhead adds 11% as SVB upgrades on compelling risk-reward setup"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""Why Upcoming Bank Earnings Could Hold the Key to Fed\u2019s Next Rate Rise"", ""summary"": ""This time, more than usual, what the banks say will be one of the best forward-looking economic indicators available.  Banks were already tightening lending conditions in January, before the turmoil that brought down Silicon Valley Bank, according to the Federal Reserve\u2019s Senior Loan Officer Opinion Survey.  The question is by how much\u2014is it equivalent to a quarter-point Fed hike, a half-point, or even more?""}, {""date"": ""2023-04-12"", ""headline"": ""Why Is Novavax (NVAX) Stock Moving Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Moderna (MRNA) and REPRO-MED Systems (KRMD)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT) and Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""BofA says `left with more questions than answers` after Moderna Vaccines Day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-12"", ""headline"": ""Morgan Stanley Sticks to Their Hold Rating for Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-13"", ""headline"": ""Carisma jumps 14% as Baird starts at Outperform on lead asset"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-13"", ""headline"": ""Don`t Count Out Moderna Stock (NASDAQ:MRNA) for the Long Term"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-13"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. rose 3.19% to $160.53 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-04-13"", ""headline"": ""Biotech Stock Roundup: MRNA Provides Update, KALA, IFRX Surge on Regulatory News"", ""summary"": ""Regulatory and pipeline updates from Moderna (MRNA) and KALA are the key highlights for the biotech sector.""}, {""date"": ""2023-04-13"", ""headline"": ""Moderna (MRNA) Receives a Sell from SVB Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-13"", ""headline"": ""MRNA June 2nd Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-13"", ""headline"": ""Buffett Thinks This Is the Most Important Quality an Investor Can Have"", ""summary"": ""Warren Buffett is a successful stock picker and his company, Berkshire Hathaway, has regularly outperformed the\u00a0S&P 500 over multiple decades.  Investors can learn a lot from his strategies, which center around value, competitive advantage, and a reasonable growth.  Buffett usually looks for these attributes while searching for the wonderful businesses he invests in.""}, {""date"": ""2023-04-13"", ""headline"": ""Can Pfizer Beat GSK and Moderna in This $10 Billion Market?"", ""summary"": ""Pfizer (NYSE: PFE) and\u00a0GSK (NYSE: GSK) have competed against each other for years.  Moderna (NASDAQ: MRNA) is a more recent rival, with its COVID-19 vaccine, SpikeVax, going head to head with Pfizer's Comirnaty.  Can Pfizer beat GSK and Moderna in this $10 billion market?""}, {""date"": ""2023-04-14"", ""headline"": ""Catalent warns of production issues, finishes day as worst S&P 500 performer"", ""summary"": ""CNBC's Meg Tirrell joins 'Closing Bell: Overtime' to report on Catalent and Moderna.""}, {""date"": ""2023-04-14"", ""headline"": ""Moderna Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slid 2.14% to $157.10 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-04-14"", ""headline"": ""3 Medical Stocks With Solid Growth Potential to Keep Track Of"", ""summary"": ""Here we discuss three medical stocks - AXSM, MRNA and ISRG - that have the potential to create wealth for investors over the coming years.""}, {""date"": ""2023-04-14"", ""headline"": ""Biotech Alert: Searches spiking for these stocks today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-14"", ""headline"": ""Drug manufacturer Catalent`s stock tumbles 25% after profit warning and CFO departure"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-14"", ""headline"": ""Analysts` Top Healthcare Picks: Thermo Fisher (TMO), Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-14"", ""headline"": ""Drug manufacturer Catalent's stock tumbles 25% after profit warning and CFO departure"", ""summary"": ""Drug manufacturer Catalent said higher-than-expected costs and productivity issues at three plants would have a material adverse impact on fiscal...""}, {""date"": ""2023-04-14"", ""headline"": ""Ghana 1st in world to approve new malaria vaccine by Oxford"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-15"", ""headline"": ""Moderna, Merck, And A Personalized Cancer Vaccine: What Does Their AACR Presentaion Tell Us?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-15"", ""headline"": ""Merck, Moderna announce results from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return"", ""summary"": ""An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44% compared with Merck's immunotherapy Keytruda alone, U.S. researchers reported at a medical meeting on Sunday.""}, {""date"": ""2023-04-16"", ""headline"": ""UPDATE 1-Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return"", ""summary"": ""An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44% compared with Merck's immunotherapy Keytruda alone, U.S. researchers reported at a medical meeting on Sunday.  The findings suggest that adding a personalized cancer vaccine based on mRNA technology to Keytruda, which revs up the immune response, could prolong the time patients have without recurrence or death, said Dr. Jeffrey Weber of the NYU Langone Perlmutter Cancer Center, who presented the findings.""}, {""date"": ""2023-04-16"", ""headline"": ""CORRECTED-Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return "", ""summary"": ""An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44% compared with Merck's immunotherapy Keytruda alone, U.S. researchers reported at a medical meeting on Sunday.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna, Merck Show Progress Toward Cancer Vaccines"", ""summary"": ""Moderna  and  Merck  & Co.\u2019s cancer vaccine helped prevent relapse for melanoma patients, results from a midstage trial showed, demonstrating progress in the pursuit of shots to ward off cancer by jump-starting the immune system.  About 79% of high-risk melanoma patients who got the personalized vaccine and Merck\u2019s immunotherapy Keytruda were alive and cancer-free at 18 months, compared with about 62% of patients who received immunotherapy alone, researchers said Sunday.  The 157-person trial offers some of the strongest evidence yet that such vaccines could benefit cancer patients.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna, Merck combo cancer-vaccine treatment shows 'significant' promise"", ""summary"": ""A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study, reducing the risk of recurrence or death by 44%.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna cancer vaccine with Merck's Keytruda delays return of deadly skin cancer"", ""summary"": ""An experimental mRNA vaccine developed by Moderna Inc combined with Merck & Co's blockbuster immunotherapy Keytruda cut the risk of death or recurrence of the most deadly skin cancer by 44% compared Keytruda alone, U.S. researchers reported at a medical meeting on Sunday.""}, {""date"": ""2023-04-16"", ""headline"": ""CORRECTED-Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return"", ""summary"": ""An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44% compared with Merck's immunotherapy Keytruda alone, U.S. researchers reported at a medical meeting on Sunday.  The findings suggest that adding a personalized cancer vaccine based on mRNA technology to Keytruda, which revs up the immune response, could prolong the time patients have without recurrence or death, said Dr. Jeffrey Weber of the NYU Langone Perlmutter Cancer Center, who presented the findings.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Complete Resection versus KEYTRUDA"", ""summary"": ""Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the first presentation of detailed results from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial evaluating mRNA-4157 (V940), an investigational individualized neoantigen therapy (INT), in combination with KEYTRUDA, Merck's anti-PD-1 therapy, in patients""}, {""date"": ""2023-04-16"", ""headline"": ""US executive pay bucked falling stock market in 2022"", ""summary"": ""More than a third of S&P 500 executives received pay rises last year despite negative shareholder returns""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna, Merck, And A Personalized Cancer Vaccine - Updates from AACR"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""Brookline Capital Markets Reaffirms Their Buy Rating on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna, Merck, And A Personalized Cancer Vaccine: What Does Their AACR Presentation Tell Us?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna, Merck combo cancer-vaccine treatment shows \ufffd\ufffd\ufffdsignificant` promise"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.5901, ""bookValue"": 18863, ""cashRatio"": 0.9834238353815375, ""currentRatio"": 3.4644, ""ebitPerShare"": -0.9037, ""eps"": 0.1951, ""ev"": 56775.42, ""fcfPerShareTTM"": 1.5938, ""grossMargin"": 0.5747, ""inventoryTurnoverTTM"": 3.8826, ""netDebtToTotalCapital"": -0.1238, ""netDebtToTotalEquity"": -0.1303, ""netMargin"": 0.0424, ""operatingMargin"": -0.1966, ""pb"": 3.1401, ""peTTM"": 12.3814, ""pretaxMargin"": -0.1638, ""psTTM"": 3.9334, ""ptbv"": 3.1481, ""quickRatio"": 3.0031, ""receivablesTurnoverTTM"": 7.0271, ""roaTTM"": 0.1875, ""roeTTM"": 0.2587, ""roicTTM"": 0.2456, ""rotcTTM"": 0.2478, ""salesPerShare"": 4.5975, ""sgaToSale"": 0.4253, ""tangibleBookValue"": 18815, ""totalDebtToEquity"": 0.0522, ""totalDebtToTotalAsset"": 0.0408, ""totalDebtToTotalCapital"": 0.0496, ""totalRatio"": 4.5848, ""period"": ""2023-03-31""}"
14,2023-04-16,157.10000610351562,2023-04-23,140.85000610351562,-0.10343729706345539,D5+,"[{""date"": ""2023-04-15"", ""headline"": ""Moderna, Merck, And A Personalized Cancer Vaccine: What Does Their AACR Presentaion Tell Us?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-15"", ""headline"": ""Merck, Moderna announce results from Phase 2b KEYNOTE-942/mRNA-4157-P201 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""Noteworthy Monday Option Activity: MRNA, ENPH, TRUP"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna & Merck Are Better Together"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return"", ""summary"": ""An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44% compared with Merck's immunotherapy Keytruda alone, U.S. researchers reported at a medical meeting on Sunday.""}, {""date"": ""2023-04-16"", ""headline"": ""UPDATE 1-Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return"", ""summary"": ""An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44% compared with Merck's immunotherapy Keytruda alone, U.S. researchers reported at a medical meeting on Sunday.  The findings suggest that adding a personalized cancer vaccine based on mRNA technology to Keytruda, which revs up the immune response, could prolong the time patients have without recurrence or death, said Dr. Jeffrey Weber of the NYU Langone Perlmutter Cancer Center, who presented the findings.""}, {""date"": ""2023-04-16"", ""headline"": ""CORRECTED-Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return "", ""summary"": ""An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44% compared with Merck's immunotherapy Keytruda alone, U.S. researchers reported at a medical meeting on Sunday.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna, Merck Show Progress Toward Cancer Vaccines"", ""summary"": ""Moderna  and  Merck  & Co.\u2019s cancer vaccine helped prevent relapse for melanoma patients, results from a midstage trial showed, demonstrating progress in the pursuit of shots to ward off cancer by jump-starting the immune system.  About 79% of high-risk melanoma patients who got the personalized vaccine and Merck\u2019s immunotherapy Keytruda were alive and cancer-free at 18 months, compared with about 62% of patients who received immunotherapy alone, researchers said Sunday.  The 157-person trial offers some of the strongest evidence yet that such vaccines could benefit cancer patients.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna, Merck combo cancer-vaccine treatment shows 'significant' promise"", ""summary"": ""A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study, reducing the risk of recurrence or death by 44%.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna cancer vaccine with Merck's Keytruda delays return of deadly skin cancer"", ""summary"": ""An experimental mRNA vaccine developed by Moderna Inc combined with Merck & Co's blockbuster immunotherapy Keytruda cut the risk of death or recurrence of the most deadly skin cancer by 44% compared Keytruda alone, U.S. researchers reported at a medical meeting on Sunday.""}, {""date"": ""2023-04-16"", ""headline"": ""CORRECTED-Moderna/Merck cancer vaccine plus Keytruda delays skin cancer return"", ""summary"": ""An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44% compared with Merck's immunotherapy Keytruda alone, U.S. researchers reported at a medical meeting on Sunday.  The findings suggest that adding a personalized cancer vaccine based on mRNA technology to Keytruda, which revs up the immune response, could prolong the time patients have without recurrence or death, said Dr. Jeffrey Weber of the NYU Langone Perlmutter Cancer Center, who presented the findings.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Complete Resection versus KEYTRUDA"", ""summary"": ""Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the first presentation of detailed results from the Phase 2b KEYNOTE-942/mRNA-4157-P201 trial evaluating mRNA-4157 (V940), an investigational individualized neoantigen therapy (INT), in combination with KEYTRUDA, Merck's anti-PD-1 therapy, in patients""}, {""date"": ""2023-04-16"", ""headline"": ""US executive pay bucked falling stock market in 2022"", ""summary"": ""More than a third of S&P 500 executives received pay rises last year despite negative shareholder returns""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna, Merck, And A Personalized Cancer Vaccine - Updates from AACR"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""Brookline Capital Markets Reaffirms Their Buy Rating on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna, Merck, And A Personalized Cancer Vaccine: What Does Their AACR Presentation Tell Us?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-16"", ""headline"": ""Moderna, Merck combo cancer-vaccine treatment shows \ufffd\ufffd\ufffdsignificant` promise"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Treasury yields little changed as focus remains on economic outlook, earnings"", ""summary"": ""U.S. Treasury yields were little changed on Tuesday, as investors continued to assess the outlook for the U.S. economy and digested the latest round of corporate earnings.""}, {""date"": ""2023-04-17"", ""headline"": ""These 2 Stocks Were Monday's Big Disappointments"", ""summary"": ""The Nasdaq Composite (NASDAQINDEX: ^IXIC), Dow Jones Industrial Average (DJINDICES: ^DJI), and S&P 500 (SNPINDEX: ^GSPC) all finished higher by about a third of a percent.  In particular, Roblox (NYSE: RBLX) and Moderna (NASDAQ: MRNA) saw substantial losses on the day.  Below, you'll learn more about what happened with both companies and why their investors aren't pleased with what they see ahead.""}, {""date"": ""2023-04-17"", ""headline"": ""S&P 500: Top 5 Performers Today Include Enphase Energy, First Solar"", ""summary"": ""The five best S&P 500 performers Monday included Enphase Energy and First Solar. Moderna was a key laggard. Banks were big winners and losers.""}, {""date"": ""2023-04-17"", ""headline"": ""Why Moderna Stock Plunged Today"", ""summary"": ""Mildly positive results from a phase 2b cancer trial fell short of more hopeful investors' expectations.""}, {""date"": ""2023-04-17"", ""headline"": ""Moderna Crumbles As Cancer Vaccine Data Show A 'Longish And Complex' Road"", ""summary"": ""Moderna stock crumbled Monday after updated results for its Merck-partnered cancer vaccine show a \""longish and complex path\"" toward approval.""}, {""date"": ""2023-04-17"", ""headline"": ""Moderna Cancer-Therapy Sees More Upbeat Data"", ""summary"": ""New data bolster the case for Moderna\u2019s experimental cancer treatment, but the path to turning it into a marketable product remains a long one.""}, {""date"": ""2023-04-17"", ""headline"": ""Wells Fargo's Mohit Bansal on Merck's $10.8B deal to buy Prometheus"", ""summary"": ""Mohit Bansal, Wells Fargo securities analyst, joins 'Closing Bell: Overtime' to discuss Merck's acquisition of Prometheus and Moderna's positive cancer therapy trial results.""}, {""date"": ""2023-04-17"", ""headline"": ""Moderna stock plunges following mixed analyst reviews of cancer vaccine data"", ""summary"": ""Moderna stock plunges following mixed analyst reviews of cancer vaccine data""}, {""date"": ""2023-04-17"", ""headline"": ""Moderna Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 8.36% to $143.97 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-04-17"", ""headline"": ""Stock Market Slides After Mixed Bank Earnings, Meta Downgrade, Google's AI Trauma"", ""summary"": ""Stock market indexes slid lower Monday and were near session lows in the last hour. Bank earnings showed mixed results. State Street Bank led the downside, plunging more than 12%. The Dow Jones Industrial Average was relatively unchanged.""}, {""date"": ""2023-04-17"", ""headline"": ""Moderna (MRNA), Merck's Cancer Jab Delays Melanoma Recurrence"", ""summary"": ""Detailed data from a mid-stage study shows that Moderna (MRNA)/Merck's personalized cancer vaccine candidate reduces the risk of recurrence/death.""}, {""date"": ""2023-04-17"", ""headline"": ""Moderna, Merck's Cancer Vaccines Exhibit Positive Outcomes Under Midstage Trial"", ""summary"": ""Moderna, Inc (NASDAQ: MRNA) and Merck & Company, Inc's (NYSE: MRK) cancer vaccine exhibited positive results against relapse for melanoma patients, results from a midstage trial showed. About 79% of high-risk melanoma patients who got the personalized vaccine and Merck's immunotherapy Keytruda were alive and cancer-free at 18 months, compared with about 62% of patients who received immunotherapy alone, the Wall Street reports citing researchers. Some 157 patients with stage three or four melanom""}, {""date"": ""2023-04-17"", ""headline"": ""Personalis: Revisiting The Investment Thesis"", ""summary"": """"}, {""date"": ""2023-04-17"", ""headline"": ""Stocks making the biggest moves midday: Alphabet, Charles Schwab, State Street, Moderna and more"", ""summary"": ""These are the stocks posting the largest moves in midday trading. ""}, {""date"": ""2023-04-17"", ""headline"": ""5 Penny Stocks With Explosive 5X Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Moderna Slumps as Vaccine Momentum Wanes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""TD Cowen biotech analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Moderna shares fall despite promising data from cancer vaccine trial"", ""summary"": ""Moderna's mRNA vaccine, when combined with Merck's blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer.""}, {""date"": ""2023-04-17"", ""headline"": ""These Stocks Are Moving the Most Today: Prometheus, Merck, Moderna, Charles Schwab, XPeng, and More"", ""summary"": ""Merck agrees to buy Prometheus Biosciences for about $10.8 billion, and Charles Schwab reports quarterly earnings on Monday, kicking off a busy week for corporate results.""}, {""date"": ""2023-04-17"", ""headline"": ""Wall Street Analysts Are Bullish On Moderna Stock Price: Should You Be?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Wall Street Analysts Are Bullish On Moderna Stock Price: Should You?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Enphase Energy (ENPH) Stock Pops After Scoring Another Analyst Upgrade"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Big Bank Earnings Won\u2019t Reveal If the Turmoil Is Over. Here\u2019s What Will."", ""summary"": ""The CBOE Volatility Index (VIX), the so-called fear gauge, closed last week at its lowest level since early January 2022.  The MOVE Index, which tracks Treasury market volatility, has also fallen below where it was before Silicon Valley Bank collapsed last month, Deutsche Bank analysts noted.""}, {""date"": ""2023-04-17"", ""headline"": ""Netflix (NFLX) Stock Slips After Botched \ufffd\ufffd\ufffdLove Is Blind` Live Event"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""This Prediction May Completely Change Your Opinion of Moderna"", ""summary"": ""Moderna (NASDAQ: MRNA) has brought investors great returns -- if you bought the stock in the early days of the pandemic or before that point.  Moderna's reliance on its coronavirus vaccine for revenue has worried some investors.  It may shift your view of Moderna from negative to positive.""}, {""date"": ""2023-04-17"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, ENPH"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""PRST Stock Alert: What to Know About Red-Hot Presto Automation Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Moderna (MRNA) Stock Sinks Despite Positive Cancer Vaccine Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Unusually active option classes on open April 17th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Stocks making the biggest moves premarket: Charles Schwab, Dell, Alphabet, HP Inc. & more"", ""summary"": ""JPMorgan downgraded Dell to neutral from overweight, citing its preference for HP's expected recovery in the PC segment.""}, {""date"": ""2023-04-17"", ""headline"": ""IN BRIEF: Merck, Moderna note positive results for Keytruda, mRNA-4157"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Moderna, Xpeng and Uber rise premarket; State Street falls"", ""summary"": ""By Peter Nurse""}, {""date"": ""2023-04-17"", ""headline"": ""Piper Sandler Sticks to Its Buy Rating for Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Why did Moderna stock drop today? mRNA cancer therapy data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""Prometheus soars 70%, Merck dips after ~$11B buyout deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-17"", ""headline"": ""These Stocks Are Moving the Most Today: State Street, Alphabet, Prometheus, Roblox, Moderna, Enphase, and More"", ""summary"": ""State Street tumbled after a profit miss, Alphabet fell on a report Samsung could switch the default search engine on its smartphones, and Merck agreed to...""}, {""date"": ""2023-04-18"", ""headline"": ""Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Moderna (MRNA) closed the most recent trading day at $142.63, moving -0.93% from the previous trading session.""}, {""date"": ""2023-04-18"", ""headline"": ""FDA Gives Green Signal To Second Omicron-Adapted Booster Shots For People At High Risk From Covid"", ""summary"": ""On Tuesday, the FDA amended the emergency use authorizations (EUAs) of Moderna Inc (NASDAQ: MRNA) and Pfizer Inc (NYSE: PFE), and BioNTech SE's (NASDAQ: BNTX) COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals six months of age and older, including for an additional dose or doses for certain populations. The monovalent Mod""}, {""date"": ""2023-04-18"", ""headline"": ""Bearish Option Trade For MRNA Stock"", ""summary"": ""With low implied volatility right now, a bear put spread on Moderna is a viable strategy to profit on the downside.""}, {""date"": ""2023-04-18"", ""headline"": ""Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat"", ""summary"": ""J&J's unpopular Covid vaccine appeared to bear its last fruit during the first quarter, contributing $747 million in sales. ""}, {""date"": ""2023-04-18"", ""headline"": ""Top Stocks To Buy Now? 3 Healthcare Stocks To Know"", ""summary"": ""Healthcare stocks for your Mid-April 2023 watchlist.""}, {""date"": ""2023-04-18"", ""headline"": ""Extra COVID-19 booster now open to some high-risk Americans"", ""summary"": ""Older Americans and people with weak immune systems can get an extra COVID-19 booster dose this spring.  The Centers for Disease Control and Prevention on Wednesday signed off on a more flexible booster schedule for people who remain at the highest risk from COVID-19 \u2014 giving them the choice of a second \u201cbivalent\u201d Pfizer or Moderna booster, the most up-to-date formula.  \u201cMany in the population are experiencing vaccine fatigue but there is a subset who are eager to receive additional doses,\u201d CDC\u2019s Dr. Sara Oliver told an agency advisory panel that expressed support for the change.""}, {""date"": ""2023-04-18"", ""headline"": ""FDA withdraws authorization for older COVID vaccines by Moderna, Pfizer"", ""summary"": ""The U.S. Food and Drug Administration on Tuesday withdrew its emergency use authorization for older messenger RNA vaccines by Moderna Inc and Pfizer-BioNTech/ as it now recommends the use of newer Omicron-targeting shots for all doses. (Reporting by Leroy Leo in Bengaluru...""}, {""date"": ""2023-04-18"", ""headline"": ""FDA authorizes additional omicron Covid booster for seniors and people with weak immune systems"", ""summary"": ""Although the burden of the pandemic has eased substantially, the CDC says Covid continues to kill more than 1,300 people per week.""}, {""date"": ""2023-04-18"", ""headline"": ""FDA clears extra COVID booster for some high-risk Americans"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""Moderna's Flu Vaccine Struggles: Is Novavax Stock Now a Better Buy?"", ""summary"": ""Moderna (NASDAQ: MRNA) knows that it needs new products.  The good news is that Moderna has three vaccine candidates in late-stage testing.  Moderna reported more disappointing results for its experimental flu vaccine last week.""}, {""date"": ""2023-04-18"", ""headline"": ""Second updated COVID booster dose OKd by FDA for at-risk individuals"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-18"", ""headline"": ""FDA clears second bivalent COVID booster for older individuals"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-19"", ""headline"": ""Moderna (MRNA) Gains As Market Dips: What You Should Know"", ""summary"": ""In the latest trading session, Moderna (MRNA) closed at $142.82, marking a +0.13% move from the previous day.""}, {""date"": ""2023-04-19"", ""headline"": ""Unusual Put Option Trade in Moderna (MRNA)  Worth $5,397.50K"", ""summary"": """"}, {""date"": ""2023-04-19"", ""headline"": ""Unusual Put Option Trade in Moderna (MRNA)  Worth $2,937.00K"", ""summary"": """"}, {""date"": ""2023-04-19"", ""headline"": ""Unusual Put Option Trade in Moderna (MRNA)  Worth $9,077.00K"", ""summary"": """"}, {""date"": ""2023-04-19"", ""headline"": ""Top Companies for Financial Strength"", ""summary"": ""The\u00a0Management Top 250\u00a0ranking, developed by the Drucker Institute, measures corporate effectiveness by examining performance in five categories: customer satisfaction, employee engagement and development, innovation, social responsibility and financial strength.  Moderna scored 93.2 for financial strength, with Apple at 92.7 and Microsoft at 91.7.""}, {""date"": ""2023-04-19"", ""headline"": ""Moderna Stock: Bear vs. Bull"", ""summary"": ""Moderna (NASDAQ: MRNA) has become one of the most talked-about companies on the planet.  Or is Moderna still a hot stock to add to your portfolio?  Moderna's coronavirus vaccine generated more than $17 billion in annual revenue over the past two years.""}, {""date"": ""2023-04-19"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Moderna Inc. inched 0.13% higher to $142.82 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...""}, {""date"": ""2023-04-19"", ""headline"": ""Biotech Stock Roundup: MDGL, PCVX Up on Study Data, MRNA Provides Updates"", ""summary"": ""Pipelines updates from Madrigal (MDGL) and Vaxcyte, (PCVX) are the key highlights of the biotech sector.""}, {""date"": ""2023-04-19"", ""headline"": ""Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales"", ""summary"": ""Abbott Laboratories said Covid-related headwinds may actually be easing. ""}, {""date"": ""2023-04-19"", ""headline"": ""FDA Gives Nod for Using Bivalent Jab for All COVID Vaccinations"", ""summary"": ""To simplify the COVID-19 vaccination schedule for all individuals, the FDA authorizes using bivalent COVID-19 vaccines for all doses administered to individuals aged six years and older.""}, {""date"": ""2023-04-19"", ""headline"": ""FDA approves single booster dose of bivalent COVID vaccine for people aged 65 and older or those with immunocompromise"", ""summary"": ""The U.S. Food and Drug Administration has approved an additional single dose of the bivalent COVID vaccines for individuals above the age of 65 and those...""}, {""date"": ""2023-04-19"", ""headline"": ""CDC endorses second updated COVID jab for seniors, immunocompromised"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""Moderna Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""Treasury yields continue to fall on signs of economic contraction"", ""summary"": ""U.S. Treasury yields dropped further on Friday morning after a round of data indicated that the economy may be contracting.""}, {""date"": ""2023-04-20"", ""headline"": ""Novavax Plummets On Downgrade: Is It The Covid Engine That Couldn't?"", ""summary"": ""Novavax has a solid platform but continues to face a $700 million litigation headwind, an analyst said Thursday as he downgraded NVAX stock.""}, {""date"": ""2023-04-20"", ""headline"": ""Moderna to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023"", ""summary"": ""Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will host a live conference call and webcast at 8:00 a.m.""}, {""date"": ""2023-04-20"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 1.18% to $141.14 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-04-20"", ""headline"": ""New Covid-19 Booster Shots: What to Know"", ""summary"": ""New booster shots are available to bolster people\u2019s protection against Omicron subvariants BA.4 and BA.5.""}, {""date"": ""2023-04-20"", ""headline"": ""Stocks making the biggest moves midday: Tesla, IBM, American Express, AT&T and more"", ""summary"": ""These are the stocks posting the largest moves in midday trading. ""}, {""date"": ""2023-04-20"", ""headline"": ""Where Will Moderna Be in 1 Year?"", ""summary"": ""A lot can happen in 12 months in the active and volatile biotech industry, especially for a company like Moderna (NASDAQ: MRNA).  The vaccine maker has a pipeline full of promising candidates in addition to its commercialized COVID-19 product which is bringing in solid revenue for now.  Key ongoing developments on both fronts will help shape Moderna's long-term prospects, so investors should stay tuned.""}, {""date"": ""2023-04-20"", ""headline"": ""UPDATE 1-WHO launches mRNA vaccine hub in Cape Town"", ""summary"": ""The World Health Organization (WHO) on Thursday officially launched its mRNA vaccine technology hub in Cape Town, a facility established during the COVID-19 pandemic to help poorer countries struggling to gain access to life-saving medication.  In 2021, the WHO picked South African biotech firm Afrigen Biologics and local vaccine-maker Biovac for a proof-of-concept pilot project to give poor and middle-income countries the know-how and licences to make COVID vaccines, in what South African President Cyril Ramaphosa then called a historic step.  Afrigen Biologics has used the publicly available sequence of Moderna Inc's mRNA COVID vaccine to make its own version of the shot - AfriVac 2121 - at lab scale and is now scaling up production.""}, {""date"": ""2023-04-20"", ""headline"": ""Cantor biopharma/biotech analysts to hold an analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science"", ""summary"": ""Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and IBM (NYSE:IBM) today announced an agreement under which Moderna will explore next generation technologies including quantum computing and artificial intelligence to advance and accelerate mRNA research and science.""}, {""date"": ""2023-04-20"", ""headline"": ""Moderna teams up with IBM to put A.I., quantum computing to work on mRNA technology used in vaccines"", ""summary"": ""Moderna's partnership with IBM comes as the drugmaker navigates its post-pandemic boom driven by its mRNA Covid vaccine.\u00a0""}, {""date"": ""2023-04-20"", ""headline"": ""Is Moderna About to Face the Same Challenge as Other Biotechs?"", ""summary"": ""Moderna (NASDAQ: MRNA) has brought in billions thanks to its coronavirus vaccine.  Now, though, the biotech company has to show investors it can excel beyond the coronavirus portfolio.  One of Moderna's programs that have spurred excitement among investors is its personalized cancer vaccine candidate.""}, {""date"": ""2023-04-20"", ""headline"": ""Moderna Teams With IBM to Explore AI, Quantum Computing in Vaccine Development"", ""summary"": ""By Dean Seal Moderna Inc. and International Business Machines Corp. have teamed up to explore the use of artificial intelligence and quantum computing in the...""}, {""date"": ""2023-04-20"", ""headline"": ""Novavax downgraded at TD Cowen citing COVID uncertainty"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""Moderna, IBM to explore quantum computing, generative AI for mRNA science"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-20"", ""headline"": ""WHO officially launches mRNA vaccine hub in Cape Town"", ""summary"": ""The World Health Organization (WHO) on Thursday officially launched its mRNA vaccine technology hub in Cape Town, a facility established during the COVID-19 pandemic to help poorer countries struggling to access life-saving medication.  In 2021, the WHO picked South African biotech firm Afrigen Biologics for a pilot project to give poor and middle-income countries the know-how and licenses to make COVID vaccines, in what South African President Cyril Ramaphosa then called a historic step.  Afrigen Biologics has used the publicly available sequence of Moderna Inc's mRNA COVID vaccine to make its own version of the shot - AfriVac 2121 - at lab scale and is now scaling up production.""}, {""date"": ""2023-04-21"", ""headline"": ""Moderna: Critically Undervalued With a Promising Pipeline"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-21"", ""headline"": ""ClearBridge International Value Strategy Q1 2023 Portfolio Manager Commentary"", ""summary"": """"}, {""date"": ""2023-04-22"", ""headline"": ""Insiders who sold Moderna, Inc.'s (NASDAQ:MRNA) earlier this year didn't have to weather this week's 10% slide"", ""summary"": ""Moderna, Inc.'s (NASDAQ:MRNA) value has fallen 10% in the last week, but insiders who sold US$4.3m worth of stock over...""}, {""date"": ""2023-04-22"", ""headline"": ""Microsoft, Google lead week`s AI action"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-22"", ""headline"": ""Can This AI Deal With IBM Be a Game-Changer for Moderna?"", ""summary"": ""You may not automatically think of artificial intelligence (AI) or quantum computing when you think of biotech giant Moderna (NASDAQ: MRNA).  You might think more about coronavirus vaccines and traditional laboratory work.  After all, Moderna is a leading coronavirus vaccine maker today.""}, {""date"": ""2023-04-22"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": """"}, {""date"": ""2023-04-23"", ""headline"": ""The Best Stocks to Invest $20,000 in Right Now"", ""summary"": ""For instance, one may pay you a top-notch dividend, another may offer you a solid track record of earnings growth, and a third might promise the potential for enormous growth ahead.  If you're a cautious investor, you should favor dividend stocks and companies that have increased their earnings over time.  AbbVie (NYSE: ABBV) is a stock you'll like for its earnings and dividend growth over time.""}]",{}
15,2023-04-23,140.85000610351562,2023-04-30,132.88999938964844,-0.0565140672270692,D5+,"[{""date"": ""2023-04-23"", ""headline"": ""Moderna Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-23"", ""headline"": ""The Best Stocks to Invest $20,000 in Right Now"", ""summary"": ""For instance, one may pay you a top-notch dividend, another may offer you a solid track record of earnings growth, and a third might promise the potential for enormous growth ahead.  If you're a cautious investor, you should favor dividend stocks and companies that have increased their earnings over time.  AbbVie (NYSE: ABBV) is a stock you'll like for its earnings and dividend growth over time.""}, {""date"": ""2023-04-24"", ""headline"": ""Moderna`s mRNA Revolution: Unveiling A World Of Investment Potential Beyond COVID-19"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Moderna Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Moderna initiated with a Neutral at Guggenheim"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-24"", ""headline"": ""Top Biotech Stocks For Q2 2023: First Gem Is BioNTech"", ""summary"": """"}, {""date"": ""2023-04-25"", ""headline"": ""Moderna Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""Insider selling could be signaling recession and a stock market selloff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""Moderna's mRNA Revolution: Unveiling A World Of Investment Potential Beyond COVID-19"", ""summary"": ""With a robust pipeline and promising clinical trial results, Moderna is well-positioned to capitalize on various market opportunities. Click here for more on the stock prospects.""}, {""date"": ""2023-04-25"", ""headline"": ""How to make sense of the new CDC guidelines on covid vaccine boosters for children"", ""summary"": ""Covid vaccines aren\u2019t popular among parents of young American children. As of April 5, just 12% of kids between six months and four years of age had received at least one dose of vaccine, and only about 5% had completed their primary series (three shots).""}, {""date"": ""2023-04-25"", ""headline"": ""CureVac: Potential Of mRNA Tech Beyond Covid-19 Vaccine Development"", ""summary"": ""Clinical candidates being advanced in phase 1 studies from the CureVac pipeline are\u00c2\u00a0for rabies and\u00c2\u00a0oncology. Click for our CVAC stock review.""}, {""date"": ""2023-04-25"", ""headline"": ""3 Cash-Rich Biotech Stocks to Bet on for the Long Haul"", ""summary"": ""The Federal Reserve\u2019s recent interest rate hikes mean banks charge much higher interest rates for loans. The interest on loans can be considered the price of borrowing more money. And since acquiring cash now costs more money, it\u2019s becoming much more complicated for companies to invest. For biotech stocks, the pain is clearly borne by investors, who choose to dive into these capital-intensive businesses. For a cash-strapped company, the rising cost of money can be a death sentence. But cash-rich""}, {""date"": ""2023-04-25"", ""headline"": ""Noteworthy Tuesday Option Activity: MRNA, AMZN, OTIS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-25"", ""headline"": ""Is Moderna Setting Expectations Too High?"", ""summary"": ""Moderna (NASDAQ: MRNA) is going to see its revenue nosedive this year, as demand for its COVID vaccine won't be nearly as strong as it was in the past few years.  The company hopes that through its pipeline, however, it will be able to get its business back to generating growth, and that by 2027 its top line could hit up to $15 billion.  In 2022, Moderna reported $19.3 billion in revenue.""}, {""date"": ""2023-04-26"", ""headline"": ""UPDATE 1-Second judge says US not liable in Moderna COVID-19 vaccine patent case"", ""summary"": ""Moderna Inc failed to persuade a Delaware federal judge on Wednesday to shift liability from the company to the U.S. government for alleged patent infringement by Moderna's COVID-19 vaccine.  Chief Judge Colm Connolly's ruling for Alnylam Pharmaceuticals Inc came just over a month after a different judge in Delaware rejected Moderna's similar motion in another vaccine patent lawsuit.""}, {""date"": ""2023-04-26"", ""headline"": ""Blue-Chip Stocks: 7 Hidden Gems for Long-Term Growth"", ""summary"": ""While most financial advisors may direct you to blue-chip stocks to buy now, the problem with this well-meaning concept is that everybody else also has the same idea. Because of their massive footprint, these high-profile companies feature transparent, predictable businesses. However, the other side of this relationship centers on a decided lack of upside potential. Nevertheless, every now and then, some top enterprises slip under the radar. Here, the best blue-chip stocks for 2023 might not alw""}, {""date"": ""2023-04-26"", ""headline"": ""Moderna\u2019s CEO shares what it was like to leap from pre-revenue startup to household name and Fortune 500 company"", ""summary"": ""The COVID-19 vaccine turned Moderna into a household name. What's next for the company?""}, {""date"": ""2023-04-26"", ""headline"": ""Second judge says US not liable in Moderna COVID-19 vaccine patent case"", ""summary"": ""Moderna Inc failed to persuade a Delaware federal judge on Wednesday to shift liability from the company to the U.S. government for alleged patent infringement by Moderna's COVID-19 vaccine.  Chief Judge Colm Connolly's ruling for Alnylam Pharmaceuticals Inc came just over a month after a different judge in Delaware rejected Moderna's similar motion in another vaccine patent lawsuit.""}, {""date"": ""2023-04-26"", ""headline"": ""Better Buy: Pfizer vs. Moderna"", ""summary"": ""Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) have one big thing in common.  Both companies have dominated the coronavirus vaccine market -- and aim to continue generating blockbuster revenue from their vaccines in a post-pandemic world.  Pfizer is a big pharmaceutical player with many blockbusters on the market.""}, {""date"": ""2023-04-26"", ""headline"": ""Guggenheim Initiates Coverage of Moderna (MRNA) with Neutral Recommendation"", ""summary"": """"}, {""date"": ""2023-04-26"", ""headline"": ""Merck\u2019s First-Quarter Earnings Beat Estimates. The Stock Is Rising."", ""summary"": ""The big pharma company has been getting ready for the loss of patent protection for the cancer immunotherapy Keytruda in 2028. Merck also raised guidance.""}, {""date"": ""2023-04-26"", ""headline"": ""Novavax: Dead Cat Bounce"", ""summary"": ""Novavax bounced on hype while the prospects from the business continue to dim with the demand for Covid vaccines. Click here for our take on VNAX stock.""}, {""date"": ""2023-04-26"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""EU publishes proposed reforms for pharma industry"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-26"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""CDC relaxes COVID-19 vaccination rules for international travelers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-27"", ""headline"": ""Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Moderna (MRNA) closed the most recent trading day at $130.07, moving -0.5% from the previous trading session.""}, {""date"": ""2023-04-27"", ""headline"": ""Moderna (MRNA) Expected to Beat Earnings Estimates: Should You Buy?"", ""summary"": ""Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""2023-04-27"", ""headline"": ""Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Moderna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""2023-04-27"", ""headline"": ""7 Healthcare Stocks With Huge Return Potential for Long-Term Investors"", ""summary"": ""Healthcare stocks are one of the best bets out there. The U.S. spends more on healthcare than any other country. In 2021, America spent 17.8% of its gross domestic product on healthcare, nearly twice as much as the average among OECD nations. Health spending per person in the U.S. was $12,914 in 2021, which was about $5,000 more than any other developed country. All told, the U.S. spends more than $4 trillion each year on healthcare, making it one of the leading sectors of the world\u2019s biggest ec""}, {""date"": ""2023-04-27"", ""headline"": ""3 Stocks That Could Be Worth More Than Berkshire Hathaway by 2030"", ""summary"": ""Berkshire\u00a0Hathaway is an enormous company.  Let's have a look at three companies I think are poised to surpass Berkshire over the next seven years:\u00a0Tesla\u00a0(NASDAQ: TSLA),\u00a0Moderna\u00a0(NASDAQ: MRNA), and\u00a0Nvidia\u00a0(NASDAQ: NVDA).""}, {""date"": ""2023-04-27"", ""headline"": ""Merck revenue falls after dramatic drop in sales of Covid antiviral treatment "", ""summary"": ""Despite the drop in molnupiravir sales, Merck's revenue and adjusted earnings for Q1 2023 beat Wall Street's expectations. ""}, {""date"": ""2023-04-28"", ""headline"": ""Moderna Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Moderna Inc. rallied 2.17% to $132.89 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-04-28"", ""headline"": ""Could The Market Be Wrong About Moderna, Inc. (NASDAQ:MRNA) Given Its Attractive Financial Prospects?"", ""summary"": ""With its stock down 31% over the past three months, it is easy to disregard Moderna (NASDAQ:MRNA). However, a closer...""}, {""date"": ""2023-04-28"", ""headline"": ""Earnings Week Ahead: Apple, Ford, Starbucks, Anheuser Busch, and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""Moderna (MRNA) to Report Q1 Earnings: Will It Beat Estimates?"", ""summary"": ""Investors focus will likely be on Moderna's (MRNA) pipeline, especially its late-stage pipeline candidates, when it reports first-quarter earnings.""}, {""date"": ""2023-04-28"", ""headline"": ""Better Healthcare AI Buy: Moderna vs. Medronic"", ""summary"": ""Artificial intelligence (AI) could be the next big thing in healthcare. Companies may predict surgical outcomes, select the best drug candidates, improve manufacturing processes -- and these are just a few examples.""}, {""date"": ""2023-04-28"", ""headline"": ""Moderna`s COVID vaccine booster gets EMA nod for use in kids over 6"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-28"", ""headline"": ""Moderna tries to show it\u2019s not a \u2018one trick pony\u2019"", ""summary"": ""Moderna\u2019s Covid-19 vaccine saved millions of lives and made the biotech group one of America\u2019s fastest-growing companies.  The US drugmaker is funding an ambitious expansion with the windfall profits generated by its successful Spikevax Covid jab, which is, at present, its only approved product.  \u201cOur base plan is to, hopefully, not lose money but there is a chance we could,\u201d explains Jamey Mock, Moderna\u2019s chief financial officer.""}, {""date"": ""2023-04-30"", ""headline"": ""This Cathie Wood Stock Is Tanking In 2023. Here's Why You Should Be Buying It"", ""summary"": ""While demand for its Covid vaccine may be fading, Moderna has other potential products at various stages of clinical trials.""}, {""date"": ""2023-04-30"", ""headline"": ""Blockbuster IPOs Are Coming To Push The Rally Higher"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-04-30"", ""headline"": ""Weekly Preview: Earnings to Watch This Week 4-30-23 (AMD, AAPL, MRNA, SQ)"", ""summary"": ""This week, Apple, AMD, Moderna, and Square report earnings.""}, {""date"": ""2023-04-30"", ""headline"": ""BioNTech/Pfizer\u2019s mooted EU deal for 70mn Covid shots threatens rivals"", ""summary"": ""A proposed deal between BioNTech/Pfizer and the EU for about 70mn Covid-19 shots a year until 2026 threatens to push rivals Moderna, Novavax, and Sanofi out of the market, risking the regional prevention of Covid-19 being left to just one product.  The bloc is negotiating an amended deal with Pfizer despite the European public prosecutor opening a criminal investigation into their original agreement.  Poland and some other central European countries are refusing to sign the amended deal because they do not want to pay for cancelled doses, according to two of the people.""}]",{}
16,2023-04-30,132.88999938964844,2023-05-07,137.0399932861328,0.031228790093648318,U4,"[{""date"": ""2023-04-30"", ""headline"": ""Blockbuster IPOs Are Coming To Push The Rally Higher"", ""summary"": ""Kenvue, the consumer health product spinoff from Johnson & Johnson, was going to be the biggest in a year. Learn more about the IPOs and my trades.""}, {""date"": ""2023-04-30"", ""headline"": ""This Cathie Wood Stock Is Tanking In 2023. Here's Why You Should Be Buying It"", ""summary"": ""While demand for its Covid vaccine may be fading, Moderna has other potential products at various stages of clinical trials.""}, {""date"": ""2023-04-30"", ""headline"": ""Weekly Preview: Earnings to Watch This Week 4-30-23 (AMD, AAPL, MRNA, SQ)"", ""summary"": ""This week, Apple, AMD, Moderna, and Square report earnings.""}, {""date"": ""2023-04-30"", ""headline"": ""BioNTech/Pfizer\u2019s mooted EU deal for 70mn Covid shots threatens rivals"", ""summary"": ""A proposed deal between BioNTech/Pfizer and the EU for about 70mn Covid-19 shots a year until 2026 threatens to push rivals Moderna, Novavax, and Sanofi out of the market, risking the regional prevention of Covid-19 being left to just one product.  The bloc is negotiating an amended deal with Pfizer despite the European public prosecutor opening a criminal investigation into their original agreement.  Poland and some other central European countries are refusing to sign the amended deal because they do not want to pay for cancelled doses, according to two of the people.""}, {""date"": ""2023-05-01"", ""headline"": ""Why the human genome could be healthcare\u2019s holy grail"", ""summary"": ""23andMe Co-founder & CEO Anne Wojcicki says we\u2019ve only seen the tip of the iceberg for human genomics and DNA research. \u201cLook at all the explosion of all these new technologies with gene therapy, with CRISPR (CRSP), with RNA technologies and understanding the human genome,\u201d Wojcicki told Yahoo Finance at the Milken Global Conference in Beverly Hills, California. Wojcicki says she\u2019s \u2018disappointed\u2019 in the lack of progress around genomics, despite having just crossed a significant milestone, 20 years since the first complete sequencing of the human genome. \u201cI think part of the reason is that genetics tells you a lot about what you're at risk for and it doesn't necessarily financially pay to get you that preventative information and to intervene in that way versus just treating people once they have a disease.\u201d The 23andME (ME) CEO also says they are looking into building new partnerships with pharmaceutical companies once the company\u2019s partnership with GlaxoSmithKline (GSK) ends in July.  Interview Highlights: 1:29 How genetics can tell us more about human diversity 2:20 Why 23andMe CEO is \u2018disappointed\u2019 about genome adoption 5:00 Wojcicki on 23andMe partnership with pharma giant GSK 7:15 Genetics needs to be part of medical school training 8:26 What\u2019s next for 23andMe""}, {""date"": ""2023-05-01"", ""headline"": ""Top Stock Reports for AMD, Cigna & Moderna"", ""summary"": ""Today's Research Daily features new research reports on 12 major stocks, including Advanced Micro Devices, Cigna and Moderna.""}, {""date"": ""2023-05-01"", ""headline"": ""Will Pfizer (PFE) Beat Expectations This Earnings Season?"", ""summary"": ""Higher alliance revenues from Eliquis, higher sales of Prevnar vaccines and drugs like Vyndaqel/Vyndamax are likely to have contributed to Pfizer's (PFE) sales growth in Q1.""}, {""date"": ""2023-05-01"", ""headline"": ""Wall Street Analysts Are Bullish on Top Healthcare Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-01"", ""headline"": ""5 things to know before the stock market opens Monday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""2023-05-01"", ""headline"": ""Moderna co-founder calls on US politicians and judges to stop questioning science"", ""summary"": ""Noubar Afeyan says court rulings on abortion pills and access to healthcare undermine efforts to combat diseases""}, {""date"": ""2023-05-02"", ""headline"": ""You Can Have Dividends and Growth. Here\u2019s How. "", ""summary"": ""Gilead Sciences and Merck offer attractive dividends and the potential for growth in a sluggish economy.""}, {""date"": ""2023-05-02"", ""headline"": ""Big Pharma Stocks Offer Income and Growth Potential. The Case for Gilead Sciences and Merck."", ""summary"": ""Gilead Sciences and Merck offer attractive dividends and the potential for growth in a sluggish economy.""}, {""date"": ""2023-05-02"", ""headline"": ""Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations in The Philippines"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to establish an Enterprise Solutions Hub in the Philippines. The Moderna Enterprise Solutions Hub will provide business services across the Asia Pacific region, where Moderna currently has operations in six markets.""}, {""date"": ""2023-05-02"", ""headline"": ""Moderna Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slid 1.50% to $131.40 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-05-02"", ""headline"": ""Moderna to Report First Quarterly Loss Since Debuting Covid-19 Vaccine"", ""summary"": ""The mRNA drugmaker will look to excite investors with its product pipeline as Covid earnings falter.""}, {""date"": ""2023-05-02"", ""headline"": ""In the wake of Moderna, Inc.'s (NASDAQ:MRNA) latest US$1.8b market cap drop, institutional owners may be forced to take severe actions"", ""summary"": ""Key Insights Institutions' substantial holdings in Moderna implies that they have significant influence over the...""}, {""date"": ""2023-05-02"", ""headline"": ""The Zacks Analyst Blog Highlights Advanced Micro Devices, The Cigna Group, Moderna, Parker-Hannifin and Rollins"", ""summary"": ""Advanced Micro Devices, The Cigna Group, Moderna, Parker-Hannifin and Rollins are included in this Analyst Blog.""}, {""date"": ""2023-05-02"", ""headline"": ""Pfizer earnings and revenue top expectations despite Covid vaccine sales decline"", ""summary"": ""Pfizer topped analysts' expectations with its first-quarter earnings report, despite a sales decline driven by the lower demand for the company's Covid vaccine.""}, {""date"": ""2023-05-02"", ""headline"": ""The 3 Most Talked-About Stocks and Cryptos Right Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-02"", ""headline"": ""Moderna plans to open an enterprise solutions hub in the Philippines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""LONDON BRIEFING: Shell sets USD4 billion buyback; Next backs outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""GLOBAL BRIEFING: China's manufacturing weakens; Fed enacts 25bp hike"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""GSK Stock Jumps After Beating Pfizer, Moderna To The RSV Vaccine Finish Line"", ""summary"": ""GSK stock jumped Wednesday after the drugmaker won the first-ever approval for an RSV vaccine, leading rivals Pfizer and Moderna.""}, {""date"": ""2023-05-03"", ""headline"": ""Moderna Announces Phase 1/2 Data on mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA) to be Presented at the 2023 ASGCT Annual Meeting"", ""summary"": ""Moderna,Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that an abstract reporting on interim data from the Phase 1/2 trial of mRNA-3927, an investigational mRNA therapy for propionic acidemia (PA) has been accepted for presentation at the 2023 American Society of Gene + Cell Therapy (ASGCT) Annual Meeting being held May 16-20, 2023 in Los Angeles, CA.""}, {""date"": ""2023-05-03"", ""headline"": ""Moderna to Report Earnings. What Comes After Covid Vaccine Will Be the Focus."", ""summary"": ""As the biotech reports first-quarter earnings, the focus will be on Moderna's pipeline of future vaccines and cancer treatments and whether they can fill the hole left by dwindling Covid vaccine sales. .""}, {""date"": ""2023-05-03"", ""headline"": ""Moderna Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Moderna Inc. dropped 0.96% to $130.14 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-03"", ""headline"": ""NEW YORK MARKET CLOSE: Banks drag US stocks lower after rate increase"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""Drug, Biotech Stocks' Q1 Earnings on May 4: REGN, ZTS & More"", ""summary"": ""Let us look at four big drug and biotech companies, REGN, ZTS, MRNA and NVO, which are gearing up for their earnings release.""}, {""date"": ""2023-05-03"", ""headline"": ""FDA approves GSK's RSV vaccine for older adults, world's first shot against virus "", ""summary"": ""The FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that targets respiratory syncytial virus to the market. ""}, {""date"": ""2023-05-03"", ""headline"": ""Should You Buy Moderna (MRNA) Ahead of Earnings?"", ""summary"": ""Moderna (MRNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.""}, {""date"": ""2023-05-03"", ""headline"": ""All eyes on Moderna Q1 earnings with focus on pipeline beyond COVID"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-03"", ""headline"": ""Moderna Stock: Looking A Little Undervalued Ahead Of Q1 Earnings"", ""summary"": ""Moderna is reliant on COVID vaccine revenues only in 2023 - no other new products will be launched this year. Check out why I have a buy rating on MRNA stock.""}, {""date"": ""2023-05-04"", ""headline"": ""Tracking Baillie Gifford's 13F Portfolio - Q1 2023 Update"", ""summary"": ""Baillie Gifford\u00e2\u0080\u0099s 13F portfolio value increased from ~$96B to ~$111B this quarter. Click here to see an update on the portfolio for Q1 2023.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna (MRNA) Q1 2023 Earnings Call Transcript"", ""summary"": ""Good morning, everyone, and thank you for joining us on today's call to discuss Moderna's first quarter 2023 financial results and business updates.  On today's call are St\u00e9phane Bancel, our chief executive officer; Stephen Hoge, our president; Arpa Garay, our chief commercial officer; and Jamie Mock, our chief financial officer.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna (MRNA) Q1 Earnings & Sales Top Estimates, Stock Up 2%"", ""summary"": ""Moderna (MRNA) beats expectations for both earnings and sales. The company posts higher-than-expected product sales from its COVID vaccine""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna Jumps On Unexpected First-Quarter Profit Amid Plummeting Covid Sales"", ""summary"": ""Moderna stock jumped Thursday on an unexpected first-quarter gain even as sales plummeted amid waning demand for Covid vaccines.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna reports surprise profit as it books deferred COVID vaccine sales"", ""summary"": ""Moderna Inc on Thursday reported a small profit of 19 cents per share instead of an expected loss as it booked more revenue in the first quarter from last year's deferred orders for its COVID-19 vaccine than had been anticipated.Analysts expected a loss of $1.77 per share...""}, {""date"": ""2023-05-04"", ""headline"": ""MODERNA AND NOVOCOL PHARMA ANNOUNCE FILL-FINISH AGREEMENT FOR CANADIAN-MADE MRNA VACCINES"", ""summary"": ""Moderna, Inc. (NASDAQ: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a long-term agreement with Ontario-based Novocol Pharma, a leading sterile injectable contract development and manufacturing organization (CDMO), to perform aseptic fill-finish, labelling and packaging of mRNA respiratory vaccines expected to be produced in Canada. Fill-finish sterile manufacturing is the final step in the production cycle and includes transferring the""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. advanced 3.22% to $134.33 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-04"", ""headline"": ""Baron Health Care Fund Q1 2023 Shareholder Letter"", ""summary"": ""Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing.""}, {""date"": ""2023-05-04"", ""headline"": ""COVID-19 \u2018is not leaving the planet,\u2019 Moderna CEO says"", ""summary"": ""Moderna Therapeutics CEO St\u00e9phane Bancel joins Yahoo Finance Live to discuss first-quarter earnings, COVID-19 vaccine sales, profit growth, and the outlook for the biotechnology company\u2019s RSV vaccine.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna tops 1Q forecasts; vaccine sales plunge as expected"", ""summary"": ""Sales of Moderna\u2019s COVID-19 vaccine plunged in the first quarter and some expenses soared, but Wall Street expected this and the drugmaker topped expectations.  Moderna said Thursday that revenue from its Spikevax vaccine tumbled to $1.83 billion in the quarter from nearly $6 billion a year ago.  The vaccine makers are shifting to commercial sales this year after selling to the government through huge contracts.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna stock rises on Q1 earnings, positive vaccine guidance"", ""summary"": ""Yahoo Finance Live\u2019s Rachelle Akuffo and Brad Smith discuss the rise in stock for Moderna following first-quarter earnings.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna, Inc. (MRNA) Q1 2023 Earnings Call Transcript"", ""summary"": ""Moderna, Inc. (NASDAQ:NASDAQ:MRNA) Q1 2023 Results Conference Call May 4, 2023 8:00 AM ETCompany ParticipantsLavina Talukdar - Head, Investor RelationsStephane Bancel - Chief Executive...""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna Posts Earnings Beat. There\u2019s Good News on Covid Vaccines Too."", ""summary"": ""The biotech reports first-quarter profit of 19 cents a share, beating estimates of a $1.75 loss. Moderna also reiterates its Covid-19 vaccine sales outlook.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna in fill-finish agreement with Novocol Pharma for mRNA vaccines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna sees Q2 sales $200M-$300M, consensus $982.37M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna up 5% after Q1 results beat estimates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna, Novocol Pharma enter long-term fill-finish agreement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna (MRNA) Q1 Earnings and Revenues Beat Estimates"", ""summary"": ""Moderna (MRNA) delivered earnings and revenue surprises of 110.73% and 60.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""2023-05-04"", ""headline"": ""7 Blue-Chip Stocks That Have Serious Potential for the Long Haul"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""UPDATE 4-Moderna reports surprise profit as it books deferred COVID vaccine sales"", ""summary"": ""Moderna Inc on Thursday reported a small profit of 19 cents per share instead of an expected loss as it booked more revenue in the first quarter from last year's deferred orders for its COVID-19 vaccine than had been anticipated.  The company did not change its forecast of $5 billion in COVID vaccine sales for the year based on advance purchase agreements.  The company expects to sign commercial contracts for updated COVID vaccine boosters over the next few weeks and into the third quarter, Chief Commercial Officer Arpa Garay said on a conference call to discuss results.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna Reports First Quarter 2023 Financial Results and Provides Business Updates"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the first quarter of 2023.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna beats COVID vaccine sales expectations as deferred revenue rolls in"", ""summary"": ""Moderna Inc on Thursday reported stronger-than-expected sales of $1.9 billion for its COVID-19 vaccine in the first quarter, driven by a surge of revenue deferred from 2022, but left its 2023 sales expectations unchanged.  The vaccine maker posted a profit of 19 cents per share, compared with analyst expectations for a loss of $1.77 per share, in part because sales were higher than expected.  Moderna said it continued to expect COVID vaccine sales of $5 billion for the year based on advance purchase agreements.""}, {""date"": ""2023-05-04"", ""headline"": ""\ufffd\ufffd\ufffdCOVID is not going away`: Moderna posts surprise quarterly profit as it looks to fall vaccinations\ufffd\ufffd\ufffd\ufffd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""These Have Been 3 of the Best-Performing Healthcare Stocks Since 2020"", ""summary"": ""The COVID-19 public health emergency is slated to end in the U.S. on May 11.  Three of the best-performing healthcare stocks since then include Moderna\u00a0(NASDAQ: MRNA), McKesson\u00a0(NYSE: MCK), and Eli Lilly\u00a0(NYSE: LLY).  It has multiple products in its approval pipeline, including a vaccine for the respiratory syncytial virus that has been highly effective in late-stage trials.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna CEO St\ufffd\ufffdphane Bancel On Surprise Q1 Profit, Post-Covid Future"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Two Covid Era Stars, Two Different Long-Term Outlooks"", ""summary"": ""With the benefit of 20/20 hindsight, many of the pandemic related market moves that we saw in 2020 and 2021 were ridiculous""}, {""date"": ""2023-05-04"", ""headline"": ""PacWest, First Horizon, Paramount fall premarket; Shopify, Moderna rise"", ""summary"": ""Investing.com -- Stocks in focus in premarket trade on Thursday, May 4th. Please refresh for updates.""}, {""date"": ""2023-05-04"", ""headline"": ""Tracking Baillie Gifford`s 13F Portfolio - Q1 2023 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna posts surprise quarterly profit despite waning demand for Covid vaccines"", ""summary"": ""Moderna maintained its full-year guidance of around $5 billion in revenue from its Covid vaccine, its only marketable product. ""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna: Q1 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""\u2018COVID is not going away\u2019: Moderna posts surprise quarterly profit as it looks to fall vaccinations\u00a0\u00a0"", ""summary"": ""Company aims to take a \u2018sizable share\u2019 of a $30 billion global respiratory vaccine market""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna posts Q1 2023 beat amid stronger than expected vaccine demand"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna stock up premarket after posting surprise profit and revenue that crushed estimates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""Moderna GAAP EPS of $0.19 beats by $1.94, revenue of $1.9B beats by $730M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-04"", ""headline"": ""U.S. stock futures see volatile trading on Fed and bank angst; Apple results loom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-05"", ""headline"": ""Morgan Stanley Maintains Moderna (MRNA) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-05-05"", ""headline"": ""Moderna Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. advanced 2.02% to $137.04 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-05"", ""headline"": ""Moderna, Inc. (NASDAQ:MRNA) Q1 2023 Earnings Call Transcript"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA) Q1 2023 Earnings Call Transcript May 4, 2023 Operator: Good day and thank you for standing by. Welcome to Moderna\u2019s First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. After the speakers\u2019 presentation, there will be a question-and-answer session. Please be advised today\u2019s conference is being [\u2026]""}, {""date"": ""2023-05-05"", ""headline"": ""SVB Securities Keeps Their Sell Rating on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-05"", ""headline"": ""RBC Capital Keeps Their Buy Rating on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-05"", ""headline"": ""Moderna price target lowered to $153 from $185 at Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-05"", ""headline"": ""Analysts` Top Healthcare Picks: Becton Dickinson (BDX), Argenx Se (ARGX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-05"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol Myers (BMY), Chimerix (CMRX) and Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-05"", ""headline"": ""Moderna files automatic mixed securities shelf"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-05"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL), Moderna (MRNA) and AlloVir (ALVR)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-06"", ""headline"": ""Moderna (NASDAQ:MRNA) climbs 3.1% this week, taking three-year gains to 131%"", ""summary"": ""It hasn't been the best quarter for Moderna, Inc. ( NASDAQ:MRNA ) shareholders, since the share price has fallen 21% in...""}, {""date"": ""2023-05-06"", ""headline"": ""Is Moderna Building a Respiratory Vaccine Empire?"", ""summary"": ""Moderna\u00a0(NASDAQ: MRNA) made a name for itself through its coronavirus vaccine.  The vaccine has generated billions of dollars in earnings over the past two years.  Now, however, demand from that star product is on the decline -- and Moderna faces a serious drop in revenue.""}, {""date"": ""2023-05-07"", ""headline"": ""Is Moderna a Value Stock to Buy Right Now?"", ""summary"": ""Moderna (NASDAQ: MRNA) can be described in several ways.  One description of Moderna you probably won't hear very often, however, is value stock.  There is an argument to be made that Moderna is a value stock.""}]",{}
17,2023-05-07,137.0399932861328,2023-05-14,129.3000030517578,-0.056479791400852464,D5+,"[{""date"": ""2023-05-07"", ""headline"": ""Is Moderna a Value Stock to Buy Right Now?"", ""summary"": ""Moderna (NASDAQ: MRNA) can be described in several ways.  One description of Moderna you probably won't hear very often, however, is value stock.  There is an argument to be made that Moderna is a value stock.""}, {""date"": ""2023-05-08"", ""headline"": ""Goldman Sachs\u2019 Top 15 Stock Picks for 2023"", ""summary"": ""In this piece, we will take a look at Goldman Sachs\u2019 Top 15 Stock Picks for 2023. For more top stocks, head on over to Goldman Sachs\u2019 Top 5 Stock Picks for 2023. After a vicious drubbing in 2022 that led to growth and technology stocks sometimes bleeding as much as half of their value [\u2026]""}, {""date"": ""2023-05-08"", ""headline"": ""Moderna Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 3.86% to $131.75 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-08"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, ZS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-08"", ""headline"": ""Rates Have Risen. Here Are 5 Stocks With Little Debt"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""15 Biggest Immunotherapy Companies in the World"", ""summary"": ""In this article, we will take a look at the 15 biggest immunotherapy companies in the world. If you want to see more companies in this selection, go to the 5 Biggest Immunotherapy Companies in the World. The immunotherapy industry is a rapidly growing field that is focused on developing treatments that harness the power [\u2026]""}, {""date"": ""2023-05-09"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. advanced 1.53% to $133.77 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-09"", ""headline"": ""Here's How Moderna Plans to Win in the Post-Emergency COVID Vaccine Market"", ""summary"": ""High demand for coronavirus vaccines earlier in the pandemic pushed Moderna's (NASDAQ: MRNA) earnings into the stratosphere.  In fact, Moderna could continue to generate billions in revenues annually from its first -- and so far, only -- approved product.  For example, Moderna sold its vaccine to the U.S. government for about $26 a dose.""}, {""date"": ""2023-05-09"", ""headline"": ""Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know"", ""summary"": ""Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""2023-05-09"", ""headline"": ""S&P 500 2023 Q1 Earnings Review: A Strong Start To The Year"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""Novavax`s stock soars 51% after positive COVID and flu trial data and news of plan to lay off 25% of workforce"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""COVID-19 vaccine maker Novavax to chop workforce, expenses"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-09"", ""headline"": ""Novavax shares rise after company unveils positive vaccine data, plan to cut 25% of workforce"", ""summary"": ""Novavax still reported bleak first-quarter earnings and revenue that missed Wall Street's estimates. ""}, {""date"": ""2023-05-09"", ""headline"": ""Novavax\u2019s stock soars 51% after positive COVID and flu trial data and news of plan to lay off 25% of workforce"", ""summary"": ""The news helped ease fears raised by the company's \""going-concern\"" language earlier this year.""}, {""date"": ""2023-05-09"", ""headline"": ""26. ElevateBio"", ""summary"": ""With biotech partners including Moderna, ElevateBio brings deep lab expertise to the emerging race for life-saving gene and cell therapies.""}, {""date"": ""2023-05-10"", ""headline"": ""Unusual Put Option Trade in Moderna (MRNA)  Worth $21,296.60K"", ""summary"": """"}, {""date"": ""2023-05-10"", ""headline"": ""Unusual Put Option Trade in Moderna (MRNA)  Worth $21,737.60K"", ""summary"": """"}, {""date"": ""2023-05-10"", ""headline"": ""Moderna Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. shed 2.20% to $130.83 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-10"", ""headline"": ""Novavax`s stock soars after positive COVID and flu trial data and news of plan to lay off 25% of workforce"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-10"", ""headline"": ""Parnassus Value Equity Fund`s 1st-Quarter Commentary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-11"", ""headline"": ""3 Healthcare Stocks to Buy and Hold for the Next 10 Years"", ""summary"": ""It's always a great idea to buy stocks and hold them for the long term. That means at least five years. This offers you the opportunity to benefit from any dividend payments and/or growth in earnings.""}, {""date"": ""2023-05-11"", ""headline"": ""Pfizer CEO says Medicare will likely face legal action over drug price negotiations"", ""summary"": ""Pfizer CEO Albert Bourla argued the Biden administration's plan will cut profits and force Big Pharma companies to pull back on developing medicines. ""}, {""date"": ""2023-05-11"", ""headline"": ""Moderna Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slid 1.85% to $128.41 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-11"", ""headline"": ""The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer"", ""summary"": ""Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) are two healthcare companies aiming to produce a vaccine for the respiratory syncytial virus (RSV).  In trials, their vaccine candidates have been proving highly effective, and it may not be long before these COVID-19 vaccine makers are fighting for market share again -- this time in the RSV market.  The Food and Drug Administration (FDA) recently approved an RSV vaccine, and it wasn't from either of these two companies.""}, {""date"": ""2023-05-11"", ""headline"": ""MRNA June 30th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-11"", ""headline"": ""25 Best Hospitals for Cancer Treatment in the World"", ""summary"": ""In this article, we will discuss the 25 best hospitals for cancer treatment in the world. To skip the detailed analysis and recent updates about the oncology market, go directly to the 5 Best Hospitals for Cancer Treatment in the World. The oncology segment in the healthcare industry is a fast-growing market due to several [\u2026]""}, {""date"": ""2023-05-12"", ""headline"": ""Moderna Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.69% higher to $129.30 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-12"", ""headline"": ""Q1 2023 Gritstone bio Inc Earnings Call"", ""summary"": ""Q1 2023 Gritstone bio Inc Earnings Call""}, {""date"": ""2023-05-12"", ""headline"": ""Here's why Covid vaccines will still be free for uninsured Americans as public health emergency ends"", ""summary"": ""The Biden administration and drugmakers Pfizer and Moderna have announced programs that aim to help uninsured Americans access Covid shots for free. ""}, {""date"": ""2023-05-13"", ""headline"": ""Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too"", ""summary"": ""Novavax (NASDAQ: NVAX) investors have been on edge ever since the company fell behind in the coronavirus vaccine race.  To make matters worse, earlier this year, Novavax even questioned its ability to continue operations.  Jacobs revealed details about his strategy to cut costs, manage cash flow, and match Novavax's size to the demand for its only product: the coronavirus vaccine.""}, {""date"": ""2023-05-14"", ""headline"": ""Warning! 3 Stocks That Are Waving Big Red Flags"", ""summary"": ""The current recovery in the stock market has been uneven. Tech is booming, financials are lagging and everything in between is a mixed bag. This is frustrating, especially as some once dominant stocks continue to fall to new lows. This has created some stocks with big red flags that could crash. Many strong businesses that are household names are seeing their share prices continue to slump as the market contends with a range of issues that include high interest rates, failing banks and a looming""}, {""date"": ""2023-05-14"", ""headline"": ""Cash-strapped Novavax urges governments to honour Covid jab deals"", ""summary"": ""The new chief executive of Novavax has urged governments to honour Covid-19 vaccine purchase commitments as the once high-flying US biotech battles to stay afloat amid a collapse in demand for jabs.  John Jacobs told the Financial Times there was no guarantee governments would deliver on all their existing commitments with the company, which include $2.1bn in advanced purchase agreements signed with the US biotech group stretching into 2025.  Novavax is one of a handful of vaccine makers, along with BioNTech/Pfizer and Moderna, which are approved to supply Covid jabs in the US, EU and other western countries.""}]",{}
18,2023-05-14,129.3000030517578,2023-05-21,126.23999786376953,-0.0236659328365475,D3,"[{""date"": ""2023-05-14"", ""headline"": ""Warning! 3 Stocks That Are Waving Big Red Flags"", ""summary"": ""The current recovery in the stock market has been uneven. Tech is booming, financials are lagging and everything in between is a mixed bag. This is frustrating, especially as some once dominant stocks continue to fall to new lows. This has created some stocks with big red flags that could crash. Many strong businesses that are household names are seeing their share prices continue to slump as the market contends with a range of issues that include high interest rates, failing banks and a looming""}, {""date"": ""2023-05-14"", ""headline"": ""Cash-strapped Novavax urges governments to honour Covid jab deals"", ""summary"": ""The new chief executive of Novavax has urged governments to honour Covid-19 vaccine purchase commitments as the once high-flying US biotech battles to stay afloat amid a collapse in demand for jabs.  John Jacobs told the Financial Times there was no guarantee governments would deliver on all their existing commitments with the company, which include $2.1bn in advanced purchase agreements signed with the US biotech group stretching into 2025.  Novavax is one of a handful of vaccine makers, along with BioNTech/Pfizer and Moderna, which are approved to supply Covid jabs in the US, EU and other western countries.""}, {""date"": ""2023-05-15"", ""headline"": ""Universal flu vaccine based on mRNA tech to be tested by National Institutes of Health"", ""summary"": ""Scientists hope the vaccine will protect against a variety of flu strains and provide long-term immunity so people do not have to receive a shot every year. \u00a0""}, {""date"": ""2023-05-15"", ""headline"": ""Moderna Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.74% higher to $130.26 Monday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-05-15"", ""headline"": ""An Intrinsic Calculation For Moderna, Inc. (NASDAQ:MRNA) Suggests It's 46% Undervalued"", ""summary"": ""Key Insights The projected fair value for Moderna is US$241 based on 2 Stage Free Cash Flow to Equity Moderna is...""}, {""date"": ""2023-05-15"", ""headline"": ""Up 40% in 1 Day, Is Novavax Stock a Buy Now?"", ""summary"": ""On May 9, Novavax (NASDAQ: NVAX) shareholders got a much-needed reprieve from the stock's downward trajectory over the last year.  Novavax's decline is a regrettable one.  Its coronavirus vaccine candidate ran into regulatory issues during clinical development, and arrived on the market much later than those of competitors like Pfizer and Moderna.""}, {""date"": ""2023-05-15"", ""headline"": ""Is It Too Late to Buy Moderna Stock?"", ""summary"": ""Demand for Moderna's (NASDAQ: MRNA) one and only product is on the decline.  As we approach a post-pandemic situation, Moderna already has started to feel the impact.  Does today's drop in vaccine sales mean it's too late to buy Moderna stock?""}, {""date"": ""2023-05-16"", ""headline"": ""Could Latecomer Moderna Match Big Pharma Rivals in RSV?"", ""summary"": ""Moderna (NASDAQ: MRNA) started its billion-dollar story with the coronavirus vaccine.  The company plans to submit its candidate for use in older adults to regulators soon and aims for a 2024 launch.  The U.S. Food and Drug Administration (FDA) recently approved GSK's vaccine -- the first RSV vaccine to ever win a nod.""}, {""date"": ""2023-05-16"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 3.95% to $125.11 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-16"", ""headline"": ""Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry"", ""summary"": ""Flagship Pioneering, the bioplatform innovation company, today announced the launch of Metaphore Biotechnologies, a company harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. Two years into development, Flagship has made an initial commitment of $50 million to advance Metaphore's MIMiC\u2122 platform and build its pipeline for patients with autoimmune, metabolic, or oncology indications.""}, {""date"": ""2023-05-17"", ""headline"": ""This Fund Owns SpaceX, Moderna, and ByteDance. Buy It at a Discount."", ""summary"": ""The world\u2019s largest closed-end fund, Scottish Mortgage Investment Trust, is now trading at a 23% discount to its net asset value. Top holdings include...""}, {""date"": ""2023-05-17"", ""headline"": ""Moderna Inc. stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.37% higher to $125.57 Wednesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-05-17"", ""headline"": ""Ready to Buy the Dip? This Biotech Stock Is a Smart Buy"", ""summary"": ""Moderna (NASDAQ: MRNA) saw its shares jump in 2021 and 2022 on the back of strong sales of its COVID-19 vaccine Spikevax.  Spikevax helped prove to the world the effectiveness of messenger RNA (mRNA) technology.  The company advanced three COVID-19 vaccines from phase 1 to commercial status in a year.""}, {""date"": ""2023-05-18"", ""headline"": ""Catalyst watch: Eyes on Ford event, Virgin Galactic launch, Nvidia earnings and Microsoft conference"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-18"", ""headline"": ""CureVac`s Lawsuit against Pfizer, BioNTech Picks Up Steam"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-18"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Moderna Inc. sank 0.19% to $125.33 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-18"", ""headline"": ""Pfizer: Ridiculous Selloff To A 2-Year Low"", ""summary"": ""Pfizer hits a two-year low on COVID vaccines revenue pessimism, but valuation is attractive as sellers rushed out. Click here to read more on PFE stock.""}, {""date"": ""2023-05-18"", ""headline"": ""Here's How Moderna Turned a Profit in Q1 Despite Its Sales Declining by 69%"", ""summary"": ""Moderna (NASDAQ: MRNA) surprised investors last quarter when it didn't incur a loss despite a significant drop in sales.  For the first three months of 2023, Moderna's revenue totaled just under $1.9 billion, which is just a fraction of the $6.1 billion it reported in the same period last year.  Meanwhile, its operating expenses, totaling $2.2 billion, rose by more than 21%.""}, {""date"": ""2023-05-18"", ""headline"": ""3 Magnificent Growth Stocks to Buy to Help Build a Millionaire Portfolio"", ""summary"": ""It's never too early to start building a portfolio that may eventually make you a millionaire.  Today, many growth stocks are suffering, but in some cases, prospects over time remain bright.  Amazon (NASDAQ: AMZN) was on an earnings roll, delivering gains in net income year after year -- until last year, when the company swung to a loss for the first time since 2014.""}, {""date"": ""2023-05-18"", ""headline"": ""Here\u2019s Why You Should Hold Moderna (MRNA)"", ""summary"": ""Baron Funds, an investment management company, released its \u201cBaron Health Care Fund\u201d first quarter 2023 investor letter. A copy of the same can be downloaded here. The first quarter was difficult for the fund, as it failed to participate in the broader market rally and declined 3.69% compared to the 3.27% decline for the benchmark Russell [\u2026]""}, {""date"": ""2023-05-18"", ""headline"": ""Alltrna Engineers tRNA Oligonucleotide with Improved Potency and Activity for In Vivo Readthrough of Premature Termination Codons"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-19"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. inched 0.73% higher to $126.24 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-19"", ""headline"": ""Biotech Stocks Are Already Risky -- Now There Are 3 New Headwinds to Face in 2023"", ""summary"": ""Biotech investors love to take on oodles of risk in hopes of getting an outsized reward when one of their bets finally pays off.  While NHPs account for only 0.5% of the animal models used in biomedicine, biotechs and other researchers in the U.S. have faced a shortage of NHPs since at least 2019.""}, {""date"": ""2023-05-19"", ""headline"": ""Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meeting"", ""summary"": ""Moderna,Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, reported on interim data from the Phase 1/2 trial of mRNA-3927, an investigational mRNA therapy for propionic acidemia (PA), presented at the 2023 American Society of Gene + Cell Therapy (ASGCT) Annual Meeting.""}, {""date"": ""2023-05-19"", ""headline"": ""Geo Capital Gestora de Recursos Ltd Buys 4, Sells 1 in 1st Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-19"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Moderna (MRNA), Regeneron (REGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-19"", ""headline"": ""Moderna shares Phase 1/2 data for mRNA therapy targeted at rare metabolic disorder"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-19"", ""headline"": ""Moderna reports interim data from Phase 1/2 trial of mRNA-3927"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-19"", ""headline"": ""Phase 1/2 Interim Data on Moderna`s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meeting"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-20"", ""headline"": ""CureVac\u2019s Lawsuit against Pfizer, BioNTech Picks Up Steam"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-20"", ""headline"": ""Should Investors Worry About Moderna Inc`s Insider Sells?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-21"", ""headline"": ""Billions of dollars at stake as FDA shortcut allows half-proven drugs - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-21"", ""headline"": ""This Insider Just Sold Shares of Moderna Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
19,2023-05-21,126.23999786376953,2023-05-28,126.23999786376953,0.0,U0,"[{""date"": ""2023-05-21"", ""headline"": ""Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-21"", ""headline"": ""Billions of dollars at stake as FDA shortcut allows half-proven drugs - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-21"", ""headline"": ""This Insider Just Sold Shares of Moderna Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-22"", ""headline"": ""Healthcare Stocks Thrive on Fresh Round of COVID-19 in China"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-22"", ""headline"": ""COVID vaccine stocks light up amid fears of new infections in China"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-22"", ""headline"": ""Debt Ceiling Concerns Nudge Stocks Lower And Treasury Yields Higher; Technical Analyst Predicts Uptrend To Continue"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-22"", ""headline"": ""BioNTech: Able To Tap Into High Medical Need PD-L1 Refractory NSCLC Market"", ""summary"": ""BioNTech SE has initiation of a phase 3 study using BNT316 as a monotherapy for PD-1/PD-L1 refractory non-small cell lung cancer. Click here to read more.""}, {""date"": ""2023-05-22"", ""headline"": ""Moderna Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.40% higher to $126.74 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-22"", ""headline"": ""Moderna (MRNA) Posts Upbeat Data on Protein Replacement Therapy"", ""summary"": ""Interim data from a study shows that Moderna's (MRNA) investigational therapy for propionic acidemia (PA) exhibited early signs of dose-dependent pharmacology and potential clinical benefits.""}, {""date"": ""2023-05-22"", ""headline"": ""Here\u2019s what Pfizer and Moderna say is next for their Covid vaccines"", ""summary"": ""Pfizer and Moderna are ushering in a new era for their Covid shots that aims to simplify what people need to do to coexist with the virus. ""}, {""date"": ""2023-05-22"", ""headline"": ""Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich \u2026 or Broke."", ""summary"": ""These biotech stocks are swinging for the fences. They may hit homers, they may strike out. But you\u2019ll definitely want to watch them. Biotech stocks have been a high risk, high reward proposition in recent years. Many biotech companies soared high during the pandemic only to crash hard in its aftermath. We now search through the wreckage to see which will soar again, and which are best left for dead. For an investor who wants stability and low risk, there are plenty of big biotech stocks out the""}, {""date"": ""2023-05-23"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""CNBC Daily Open: A debt ceiling deal won't fix everything"", ""summary"": ""The only story to be made of yesterday\u2019s market moves is that, well, there wasn\u2019t one.  Markets are still in reactive mode, not a sustained rally.""}, {""date"": ""2023-05-23"", ""headline"": ""GeoVax's Next-Gen Single Dose COVID-19 Vaccine Shows Promising Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""CNBC Daily Open: A debt ceiling deal won\u2019t solve everything"", ""summary"": ""The only story to be made of yesterday\u2019s market moves is that, well, there wasn\u2019t one.  Markets are still in reactive mode, not a sustained rally.""}, {""date"": ""2023-05-23"", ""headline"": ""Report of new COVID wave in China pushes shares of vaccine makers higher"", ""summary"": ""Dr. Kavita Patel, fmr. White House health policy director, joins 'Fast Money' to discuss the latest reports of a possible uptick of COVID cases in China, the immunity situation in the country, and the impact an outbreak could have on U.S. companies.""}, {""date"": ""2023-05-23"", ""headline"": ""Moderna Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Moderna Inc. advanced 8.69% to $137.75 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-23"", ""headline"": ""Seres Q1 Earnings: Major News For Investors"", ""summary"": ""The latest reporting from Seres Therapeutics resolves many of the issues that have caused the stock price to fall. Click here to read an analysis of MCRB.""}, {""date"": ""2023-05-23"", ""headline"": ""Is Moderna Stock a Buy Now?"", ""summary"": ""Biotech giant Moderna (NASDAQ: MRNA) made a name for itself in the past couple of years as it developed and marketed one of the most successful coronavirus vaccines.  Demand for coronavirus vaccines has started to fall, affecting Moderna's revenue.  Is Moderna's stock worth considering, especially at current levels?""}, {""date"": ""2023-05-23"", ""headline"": ""Is Trending Stock Moderna, Inc. (MRNA) a Buy Now?"", ""summary"": ""Moderna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.""}, {""date"": ""2023-05-23"", ""headline"": ""Moderna call volume above normal and directionally bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""3 Stocks You'll Be Glad You Bought at These Prices"", ""summary"": ""The good news is you really don't have to -- and you still can win in the stock market.  The success of Moderna's (NASDAQ: MRNA) blockbuster coronavirus vaccine helped the stock soar earlier in the pandemic.  Here's why they shouldn't: The vaccine represents just the beginning of Moderna's growth story.""}, {""date"": ""2023-05-23"", ""headline"": ""Early notable gainers among liquid option names on May 23rd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""6 Stocks With Heavy Call Flow: ENPH, META, MRNA, MSFT, NVDA, QCOM"", ""summary"": """"}, {""date"": ""2023-05-23"", ""headline"": ""Why did Moderna stock jump today? Renewed COVID fears"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""Moderna, BioNTech other Covid vaccine makers jump amid China Covid scare"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-23"", ""headline"": ""China's new Covid surge could result in 65M infections a week, Bloomberg says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Noteworthy Thursday Option Activity: MRNA, AAPL, ANET"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""7 Stocks That Even Company Insiders are Selling"", ""summary"": ""Insider buying, or the legal, reported purchase of shares in a company by its C-suite/board members/large shareholders, is considered a bullish signal. However, does that mean it is best to sell/avoid stocks insiders are selling? Put simply, it depends. Heavy insider selling, or even a lack of insider buying, can sometimes be a sign that those most \u201cin the know\u201d at a company are not very confident in its future prospects. Then again, much like with \u201coutsider\u201d investors, lack of confidence isn\u2019t""}, {""date"": ""2023-05-24"", ""headline"": ""Unusual Put Option Trade in Moderna (MRNA)  Worth $18,396.00K"", ""summary"": """"}, {""date"": ""2023-05-24"", ""headline"": ""Unusual Put Option Trade in Moderna (MRNA)  Worth $14,364.00K"", ""summary"": """"}, {""date"": ""2023-05-24"", ""headline"": ""Durham firm inks billion-dollar deal with Novo Nordisk to discover new treatments"", ""summary"": ""A life sciences company in Durham has secured a major partnership to discover new gene therapy treatments.""}, {""date"": ""2023-05-24"", ""headline"": ""Vertex: CF Focus, Potential To Alter Acute Pain Treatment Market Landscape"", ""summary"": ""Vertex Pharmaceuticals Incorporated data readout from a phase 3 program could be released by the 1st half of 2024. Find out why VRTX stock is a Strong Buy.""}, {""date"": ""2023-05-24"", ""headline"": ""Moderna Spikes Amid Covid Fears, but Is It Just a False Positive?"", ""summary"": ""The Moving Average Convergence Divergence (MACD) oscillator is below the zero line telling us that MRNA lacks trend strength.  In this daily Point and Figure chart of MRNA, below, I can see a potential upside price target in the $179 area.  This weekly Point and Figure chart of MRNA, below, shows us the same $179 price target as the daily chart above.""}, {""date"": ""2023-05-24"", ""headline"": ""Novavax: Sell The Covid Rips"", ""summary"": ""Novavax stock continues to rally on positive Covid news, but the vaccine demand continues to trend lower. Click for our outlook on NVAX stock.""}, {""date"": ""2023-05-24"", ""headline"": ""Moderna shares react to Covid resurgence news in China"", ""summary"": ""Yahoo Finance Live discusses a drop in shares of Moderna after a report of a resurgence of Covid in China.""}, {""date"": ""2023-05-24"", ""headline"": ""Moderna: Don't Try To Catch The Falling Knives"", ""summary"": ""Moderna investors have endured a lot of pain this year as the company struggles to live with life after COVID. Click here to read my analysis of MRNA stock.""}, {""date"": ""2023-05-24"", ""headline"": ""Stocks making the biggest moves midday: Abercrombie & Fitch, Palo Alto Networks, Moderna and more"", ""summary"": ""These are the stocks posting the largest moves in midday trading. ""}, {""date"": ""2023-05-24"", ""headline"": ""As Debt Ceiling Talks Wobble, Investors Look To May Fed Minutes, Nvidia Earnings For Direction"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Looking At Moderna's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Unusually active option classes on open May 24th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-24"", ""headline"": ""Stocks making the biggest moves premarket: Moderna, Kohl's, Intuit, Analog Devices & more"", ""summary"": ""These are the stocks posting the largest moves in premarket trading. ""}, {""date"": ""2023-05-25"", ""headline"": ""Baillie Gifford Dumps Salesforce, Loads Up on AMD"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Possible Bearish Signals With Moderna Insiders Disposing Stock \\"", ""summary"": ""The fact that multiple Moderna, Inc. ( NASDAQ:MRNA ) insiders offloaded a considerable amount of shares over the past...""}, {""date"": ""2023-05-25"", ""headline"": ""Financial Literacy for All Welcomes American Express, Dow Jones, and Moderna to its Mission of Advancing Financial Literacy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""7 Top Stock Tips for June 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""Interesting MRNA Put And Call Options For July 7th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""BioNTech readying next COVID shot in line with WHO guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-25"", ""headline"": ""BioNTech readying next COVID shot in line WHO guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""Pfizer, Moderna hit with new Alnylam patent lawsuits over COVID-19 vaccines"", ""summary"": ""Biotech company Alnylam Pharmaceuticals Inc filed new lawsuits on Friday against Pfizer Inc and Moderna Inc in Delaware federal court, again claiming that the companies' COVID-19 vaccines infringe its patents.""}, {""date"": ""2023-05-26"", ""headline"": ""Next Covid Boosters to Target New Strain"", ""summary"": ""Health authorities and vaccine makers are moving toward targeting the next shot on a form of the XBB strain that is now circulating widely in the U.S.""}, {""date"": ""2023-05-26"", ""headline"": ""Moderna Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slid 0.18% to $126.24 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-26"", ""headline"": ""Health authorities to target next COVID shot to new strain, WSJ says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""UPDATE 1-Moderna says looking for opportunities in China after registering legal entity"", ""summary"": ""U.S. vaccine maker Moderna said on Friday it was looking for opportunities in China after confirming that it had registered a legal entity in the world's second largest economy.  The U.S. pharmaceutical and biotech firm registered a unit called Moderna (China) Biotech Limited in Shanghai on May. 24 with capital of $100 million, according to Chinese data providers including company database Qichacha.  \""We are exploring opportunities to engage in the market and bring the power of Moderna\u2019s mRNA platform to the people of China,\"" a spokesperson said in response to a query from Reuters.""}, {""date"": ""2023-05-26"", ""headline"": ""Moderna says looking for opportunities in China after registering legal entity"", ""summary"": ""BEIJING (Reuters) -Vaccine maker Moderna Inc said on Friday it was looking for opportunities in China after confirming that it had registered a legal entity in the world's second largest economy.  The U.S. biotech firm registered a unit called Moderna (China) Biotech Ltd in Shanghai on May. 24 with capital of $100 million, according to Chinese data providers including company database Qichacha.  \""We are exploring opportunities to engage in the market and bring the power of Moderna's mRNA platform to the people of China,\"" a company spokesperson said in response to a query from Reuters.""}, {""date"": ""2023-05-26"", ""headline"": ""Moderna registers biotech unit in China with $100M investment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-26"", ""headline"": ""Moderna registers biotech firm in Shanghai, local media reports"", ""summary"": ""Moderna has registered a biotech firm in China's financial hub Shanghai with capital of $100 million, according to Chinese data providers including company database Qichacha.""}, {""date"": ""2023-05-26"", ""headline"": ""Biggest gainers, decliners since the pandemic among Mass. public companies"", ""summary"": ""Three years since the pandemic upended the economy, here are the Massachusetts public companies that made it through in the best \u2014 and worst \u2014 shape.""}, {""date"": ""2023-05-27"", ""headline"": ""Moderna Inc CEO Stephane Bancel Sells 80,000 Shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
20,2023-05-28,126.23999786376953,2023-06-04,130.50999450683594,0.0338244353241699,U4,"[{""date"": ""2023-05-29"", ""headline"": ""Looking At Moderna's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""Carisma Therapeutics Shines on New Cancer Treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""Do You Really Want AI To Pick Your Stocks?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-30"", ""headline"": ""Cramer says the money's in tech this year, tread carefully when it comes to any other sector"", ""summary"": ""If you stray from tech this year, you might lose, CNBC's Jim Cramer told investors on Tuesday.""}, {""date"": ""2023-05-30"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. rose 2.10% to $128.89 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-30"", ""headline"": ""Moderna, Inc. (NASDAQ:MRNA) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?"", ""summary"": ""With its stock down 8.4% over the past week, it is easy to disregard Moderna (NASDAQ:MRNA). However, a closer look at...""}, {""date"": ""2023-05-30"", ""headline"": ""Moderna Announces Phase 2 Data on mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, to be Presented at the 2023 ASCO Annual Meeting"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that two abstracts on mRNA-4157 (V940), an investigational mRNA individualized neoantigen therapy, have been accepted for presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting being held June 2-6 in Chicago, IL.""}, {""date"": ""2023-05-30"", ""headline"": ""If You Invested $2,500 in Moderna in 2019, This Is How Much You Would Have Today"", ""summary"": ""You'd have a lot more money, but only if you resisted the temptation to take the initial profits.""}, {""date"": ""2023-05-31"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. sank 0.92% to $127.71 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-05-31"", ""headline"": ""Heard on the Street: Investors Are Too Bearish on Vaccine-Makers"", ""summary"": ""OVER $300 BILLION That's how much has been wiped off the combined market value of [Moderna](https://www.wsj.com/market-data/quotes/MRNA), [Pfizer](https://www.wsj.com/market-data/quotes/PFE) and [BioNTech](https://www.""}, {""date"": ""2023-05-31"", ""headline"": ""3 Innovative Growth Stocks to Buy for Next-Gen Profits"", ""summary"": ""In a globally synchronized world, there are big opportunities across sectors. This has intensified competition as companies look to grab a share of the pie. It eventually boils down to the survival of the fittest. In the context of corporations, the innovation factor determines the \u201cfittest.\u201d Therefore, this column focuses on innovative growth stocks for future profits. It goes without saying that the basic screening criteria are to investigate companies with high investment in research and deve""}, {""date"": ""2023-05-31"", ""headline"": ""Vaccine Fatigue Can Give Your Portfolio a Booster"", ""summary"": ""Moderna Pfizer  and its partner  BioNTech  are among the biggest losers in the healthcare sector this year, dropping more than 25% each.  The declines have been driven by a sense that, as the Covid-19 emergency enters the rearview mirror, demand for boosters will continue to wane.  Just last week, the European Commission cut the number of vaccines it is purchasing from Pfizer and BioNTech.""}, {""date"": ""2023-05-31"", ""headline"": ""2 Healthcare AI Stocks to Buy on the Dip"", ""summary"": ""Artificial intelligence (AI) could change the way we treat and prevent illnesses, which makes it a highly valuable opportunity for companies.  In fact, the global AI healthcare market is set to reach more than $100 billion later this decade, a Markets and Markets report shows.  Two perfect examples are biotech Moderna (NASDAQ: MRNA) and medical device giant Medtronic (NYSE: MDT).""}, {""date"": ""2023-05-31"", ""headline"": ""Carisma spikes as Jefferies issues Buy citing lead asset"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-05-31"", ""headline"": ""Carisma Therapeutics assumed at Buy from Hold at Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""Moderna Inc. stock rises Friday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""Johnson & Johnson COVID vaccine authorization revoked by FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""Catalyst Watch: Apple's WWDC event, OPEC fallout and REITs on display"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-01"", ""headline"": ""Moderna to Present at Upcoming Conferences in June 2023"", ""summary"": ""Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in the following upcoming investor conferences:""}, {""date"": ""2023-06-01"", ""headline"": ""Moderna Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.63% higher to $128.52 Thursday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-06-01"", ""headline"": ""COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring?"", ""summary"": ""The number of people with COVID-19 has been rising rapidly in China in recent weeks, and there are concerns that the government in Beijing could consider reviving its strict lockdown policies again.  COVID-19 cases have been surging in China, largely due to the spread of the omicron XBB variants.  In February, the Centers for Disease Control and Prevention pointed to early study results showing that for the\u00a0 bivalent vaccine boosters created to target omicron variants, \""[vaccine effectiveness] was generally similar against BA.5-related infections [original omicron] and XBB/XBB.1.5-related infections.\""""}, {""date"": ""2023-06-01"", ""headline"": ""MRNA July 14th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-02"", ""headline"": ""10 Stocks Jim Cramer and Hedge Funds Have In Common"", ""summary"": ""In this article, we will be taking a look at 10 stocks Jim Cramer and hedge funds have in common. To see more of these stocks, you can go directly to see 5 Stocks Jim Cramer and Hedge Funds Have In Common. \u201cIf You Use NVIDIA\u2019s Chips, You Can Speak In The Vernacular Of ChatGPT\u201d [\u2026]""}, {""date"": ""2023-06-02"", ""headline"": ""Moderna Inc. stock underperforms Friday when compared to competitors despite daily gains"", ""summary"": ""Shares of Moderna Inc. advanced 1.55% to $130.51 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-02"", ""headline"": ""Better Healthcare AI Stock: Moderna vs. Doximity"", ""summary"": ""The AI in healthcare market is expected to top $100 billion by the end of the decade, and some companies are already leveraging this technology to advance their work.  Two great examples are Moderna (NASDAQ: MRNA) and Doximity (NYSE: DOCS).  Moderna isn't a novice when it comes to AI.""}, {""date"": ""2023-06-02"", ""headline"": ""Oppenheimer biotech analyst to hold a reception"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-03"", ""headline"": ""Recent uptick might appease Moderna, Inc. (NASDAQ:MRNA) institutional owners after losing 4.8% over the past year"", ""summary"": ""Key Insights Institutions' substantial holdings in Moderna implies that they have significant influence over the...""}, {""date"": ""2023-06-03"", ""headline"": ""As the market starts to cool down, Cramer says don't be afraid to stay bullish "", ""summary"": """"}]",{}
21,2023-06-04,130.50999450683594,2023-06-11,123.26000213623047,-0.05555124263089084,D5+,"[{""date"": ""2023-06-04"", ""headline"": ""Looking At Moderna's Recent Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""$100 Invested In This Stock 5 Years Ago Would Be Worth $700 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data"", ""summary"": ""Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a midstage trial, the companies reported on Monday.""}, {""date"": ""2023-06-05"", ""headline"": ""UPDATE 1-Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data"", ""summary"": ""Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a mid-stage trial, the companies reported on Monday.  With this and earlier data, Moderna is considering seeking faster approval from regulators for the treatment, the company told investors after having presented the results at the American Society of Clinical Oncology meeting in Chicago.  \""Some of the residual uncertainty seems to be going away on that potential (option),\"" said Moderna President Stephen Hoge.""}, {""date"": ""2023-06-05"", ""headline"": ""Moderna, Inc. (MRNA) ASCO Investor Event Conference (Transcript)"", ""summary"": ""Moderna, Inc. (NASDAQ:NASDAQ:MRNA) ASCO Investor Event Conference Call June 5, 2023 7:00 PM ETCompany ParticipantsLavina Talukdar - Senior Vice President and Head of Investor...""}, {""date"": ""2023-06-05"", ""headline"": ""Moderna and Merck Report Significant Success in Investigational Skin Cancer Therapy, Cuts Risk Of Distant Metastasis Or Death By 65%"", ""summary"": ""Moderna Inc (NASDAQ: MRNA) and Merck & Co Inc (NYSE: MRK) announced distant metastasis-free survival (DMFS) results from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study of mRNA-4157 (V940) plus Keytruda for resected high-risk melanoma. The candidate is an investigational individualized neoantigen therapy. The companies recently announced the first presentation of the study's primary endpoint, recurrence-free survival, from the Phase 2 KEYNOTE-942/mRNA-4157-P201 trial in April 2023 at the American""}, {""date"": ""2023-06-05"", ""headline"": ""Moderna Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 1.23% to $128.90 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-06-05"", ""headline"": ""Here is What to Know Beyond Why Moderna, Inc. (MRNA) is a Trending Stock"", ""summary"": ""Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""2023-06-05"", ""headline"": ""Moderna and Merck Announce mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Complete Resection Versus KEYTRUDA"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced distant metastasis-free survival (DMFS) results from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study, a clinical trial evaluating mRNA-4157 (V940), an investigational individualized neoantigen therapy (INT), in combination with KEYTRUDA,""}, {""date"": ""2023-06-05"", ""headline"": ""Moderna and Merck reveal new data on individualized cancer treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""Moderna and Merck cancer vaccine used with Keytruda reduces risk of deadly skin cancer spreading"", ""summary"": ""Melanoma is responsible for the large majority of skin cancer deaths, according to the American Cancer Society.""}, {""date"": ""2023-06-05"", ""headline"": ""Early notable gainers among liquid option names on June 5th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""Moderna/ Merck cancer shot with Keytruda cut melanoma spread"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-05"", ""headline"": ""2 Blue-Chip REITs At Big Discounts"", ""summary"": ""Real estate is the worst-performing sector of the stock market over the last year as the market has shunned REITs. Click here for our exclusive top 2 REIT picks.""}, {""date"": ""2023-06-05"", ""headline"": ""Moderna, Merck announce DMFS results from Phase 2b study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-06"", ""headline"": ""Moderna, Pfizer hit with new patent lawsuits over COVID vaccines"", ""summary"": ""Biotech firm Promosome LLC sued Moderna, Pfizer and BioNTech in federal court in San Diego, California, on Tuesday, accusing their COVID-19 vaccines of infringing a patent related to messenger RNA technology.""}, {""date"": ""2023-06-06"", ""headline"": ""Moderna Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slid 1.55% to $126.90 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-06"", ""headline"": ""Moderna (MRNA), Merck's Cancer Jab Delays Melanoma Spreading"", ""summary"": ""Updated data from a mid-stage study showed that Moderna (MRNA)/Merck's personalized cancer vaccine combined with Keytruda reduces the skin cancer's spreading by 65% in melanoma patients.""}, {""date"": ""2023-06-06"", ""headline"": ""3 Biotech Stocks to Sell in June Before They Crash and Burn"", ""summary"": ""The biotechnology sector has seen better days. From the heady days of the pandemic when companies were racing to develop a vaccine against Covid-19, the industry is now enduring a hangover as both demand and sales decline. This means there\u2019s more than a couple biotech stocks to sell. The iShares US Pharmaceuticals ETF (NYSEARCA:IHE) that tracks the industry is down 10% over the last 12 months and major players such as Pfizer (NYSE:PFE) have seen their share price decline 25% so far in 2023. The""}, {""date"": ""2023-06-06"", ""headline"": ""SEC Accuses Binance & Coinbase Of Acting As Unregistered Broker, Binance Takes Biggest Hit As $300M In Crypto Positions Liquidated In 24 Hours, JPMorgan Clarifies CEO Jamie Dimon Not Running For Presidency: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-06"", ""headline"": ""Novavax's New Vaccine Approach Set to Tackle Rising COVID-19 Emerging Variants"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-06"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Ultragenyx Pharmaceutical (RARE), Seagen (SGEN) and Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-06"", ""headline"": ""Narrow market proving a headwind for mutual funds, opportunity for hedge funds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-07"", ""headline"": ""Moderna Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-07"", ""headline"": ""Moderna Inc. stock falls Wednesday, still outperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 1.02% to $125.61 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-06-07"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 1.02% to $125.61 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-06-07"", ""headline"": ""As AI advances in healthcare, industry players wrestle with its risks"", ""summary"": ""Accuracy of health information, privacy and equity are among executives\u2019 key concerns as health AI rapidly evolves.""}, {""date"": ""2023-06-07"", ""headline"": ""Another Patent Dispute Emerges: Small Biotech Firm Sues Moderna, Pfizer, and BioNTech Over COVID-19 Vaccine Tech"", ""summary"": ""Pfizer Inc (NYSE: PFE), BioNTech SE (NASDAQ: BNTX), and Moderna Inc (NASDAQ: MRNA) were named in lawsuits by Promosome accusing their COVID-19 vaccines of infringing a patent related to messenger RNA (mRNA) technology. The small biotechnology firm claims that its scientists, including Nobel laureate Gerald Edelman, who died in 2014, Vincent Mauro, and two colleagues from The Scripps Research Institute, developed a method used in the COVID-19 vaccines. The lawsuit claims that one of the scientist""}, {""date"": ""2023-06-07"", ""headline"": ""Those who invested in Moderna (NASDAQ:MRNA) three years ago are up 118%"", ""summary"": ""While Moderna, Inc. ( NASDAQ:MRNA ) shareholders are probably generally happy, the stock hasn't had particularly good...""}, {""date"": ""2023-06-07"", ""headline"": ""ChatGPT's Parent Has No IPO Plans, CNN CEO Chris Licht Out, Kim Kardashian's Bid To Dismiss EthereumMax Lawsuit Rejected: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-07"", ""headline"": ""Patent Dispute Emerges: Small Biotech Firm Sues Moderna, Pfizer, and BioNTech Over COVID-19 Vaccine Tech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-07"", ""headline"": ""Pfizer, Moderna face new patent lawsuits over COVID vaccine tech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-07"", ""headline"": ""SVB Securities Keeps Their Sell Rating on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-08"", ""headline"": ""Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Moderna (MRNA) closed at $124.94, marking a -0.53% move from the previous day.""}, {""date"": ""2023-06-08"", ""headline"": ""These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?"", ""summary"": ""Shares of e-commerce company Etsy (NASDAQ: ETSY) have dropped more than 20% so far this year.  First, Etsy has managed to keep the gains it made over the past few years.  The company's total gross merchandise sales (GMS) soared more than 200% in the first quarter compared to the same quarter four years ago.""}, {""date"": ""2023-06-08"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Moderna Inc. sank 0.53% to $124.94 Thursday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-08"", ""headline"": ""Moderna, Inc. (MRNA) Presents at Jefferies Global Healthcare Conference (Transcript)"", ""summary"": ""Moderna, Inc. (NASDAQ:NASDAQ:MRNA) Jefferies Global Healthcare Conference June 8, 2023 10:30 AM ETCompany ParticipantsStephen Hoge - PresidentConference Call ParticipantsMichael Yee -...""}, {""date"": ""2023-06-08"", ""headline"": ""Interesting MRNA Put And Call Options For July 28th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-08"", ""headline"": ""SVB Securities bullish on CureVac, initiates with an Outperform"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-09"", ""headline"": ""10 Quantum Computing Stocks Billionaires Are Loading Up On"", ""summary"": ""In this article, we will take a look at the 10 quantum computing stocks billionaires are purchasing. If you want to skip our detailed analysis of the industry and its growth prospects, go to the 5 Quantum Computing Stocks Billionaires Are Loading Up On. As reported in one of our articles earlier, the size of the [\u2026]""}, {""date"": ""2023-06-09"", ""headline"": ""Moderna Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Moderna Inc. shed 1.34% to $123.26 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-09"", ""headline"": ""13 Best Future Stocks for the Long-Term"", ""summary"": ""In this piece, we will take a look at the 13 best future stocks for the long-term. For more stocks, head on over to 5 Best Future Stocks for the Long-Term. Investing these days is a ride not for the faint hearted. Within a couple of years, stocks that were once thought to be immune [\u2026]""}, {""date"": ""2023-06-09"", ""headline"": ""S&P 500 Bull Market Kicks Off, But The Dominance Of 7 Stocks Leaves S&P 493 In The Dust"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-09"", ""headline"": ""Moderna Inc CEO Stephane Bancel Sells 80,000 Shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-10"", ""headline"": ""Does Moderna's Cancer Breakthrough Make It a Good Stock to Buy Now?"", ""summary"": ""Cancer vaccines have been around a long time, but they usually don't produce such compelling results.""}]",{}
22,2023-06-11,123.26000213623047,2023-06-18,128.72999572753906,0.04437768535216313,U5,"[{""date"": ""2023-06-12"", ""headline"": ""Moderna Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.21% higher to $123.52 Monday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-06-12"", ""headline"": ""Get Out Now! 3 Value Stocks That Are Poised to Plunge."", ""summary"": ""With the stock market rising quickly, many companies have become expensive. Understandably, investors are considering value stocks as an alternative to frothy growth picks. But not all cheap equities are created equal. In fact, in the case of these three overvalued value stocks to sell, the apparent discount is an illusion. That\u2019s because these firms will likely see their profits and cash flows decline over time. It\u2019s a good sign when a company is quite profitable historically. But that\u2019s not en""}, {""date"": ""2023-06-12"", ""headline"": ""Moderna: Likely To Drop Further (Technical Analysis)"", ""summary"": ""Moderna faces significant bearish pressure on its shares despite promising clinical trial results for its cancer vaccine. Read my technical analysis of MRNA here.""}, {""date"": ""2023-06-12"", ""headline"": ""Updated Covid vaccines need to target XBB omicron variants this fall, FDA staff says "", ""summary"": ""Vaccine manufacturers Pfizer, Moderna and Novavax will be expected to update their shots according to the strain the FDA selects for the fall. ""}, {""date"": ""2023-06-12"", ""headline"": ""Moderna's Weakness Is Your Opportunity"", ""summary"": ""Moderna is expected to have negative profits in 2023, impacting the company's strong net-cash position. Click for our view of MRNA stock prospects.""}, {""date"": ""2023-06-12"", ""headline"": ""3 Top AI Stocks to Buy Hand Over Fist"", ""summary"": ""Looking to invest in Artificial Intelligence (AI)?  You may immediately think of tech companies.  Today, let's take a look at an e-commerce player and two healthcare companies that have been using AI for a while.""}, {""date"": ""2023-06-12"", ""headline"": ""The First Vaccines for RSV Are Coming Soon. What to Know."", ""summary"": ""The U.S. is on the brink of rolling out a number of shots designed to prevent RSV in young children and in older adults.""}, {""date"": ""2023-06-13"", ""headline"": ""Tracking Philippe Laffont's Coatue Management Portfolio - Q1 2023 Update"", ""summary"": ""Philippe Laffont\u00e2\u0080\u0099s 13F portfolio value increased from $8.92B to $15.04B this quarter. Read more on the portfolio and its holdings here.""}, {""date"": ""2023-06-13"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. advanced 3.61% to $127.98 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-13"", ""headline"": ""Pfizer: Deeper Value Found Amidst Diversified Pipelines"", ""summary"": ""Pfizer presents a buying opportunity as value has deepened following weak price action due to post-pandemic revenue concerns. Read why PFE stock is a Buy.""}, {""date"": ""2023-06-13"", ""headline"": ""Vast utility for weight loss drugs will more than pay for themselves, says Eli Lilly CEO David Ricks"", ""summary"": ""Eli Lilly CEO David Ricks joins CNBC's Bertha Coombs and 'The Exchange' live from the World Medical Innovation Forum to discuss Eli Lilly's alzheimer's treatment, concerns over coverage reimbursement schemes, and upcoming drug price negotiations.""}, {""date"": ""2023-06-13"", ""headline"": ""7 Stocks to Sell in June Before They Crash and Burn"", ""summary"": ""As we pass the halfway mark of 2023, it\u2019s time to consider which stocks to sell in June. If investors continue to have trouble understanding whether the markets are due for another correction soon it\u2019s for good reason. June tends to be a historically tough month for markets. That\u2019s a negative. Yet, a potential Fed pivot and the recent artificial intelligence boom both provide reasons for optimism. Then again, AI could be a bubble in itself. It has fueled the upward movement of tech giants which""}, {""date"": ""2023-06-13"", ""headline"": ""Moderna (MRNA) Gets a Hold from Bank of America Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-13"", ""headline"": ""Moderna Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-14"", ""headline"": ""Moderna Inc. stock rises Thursday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-14"", ""headline"": ""FDA advisors back updating COVID shots to monovalent XBB-lineage"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-14"", ""headline"": ""Axsome (AXSM) Soars 8.1%: Is Further Upside Left in the Stock?"", ""summary"": ""Axsome (AXSM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.""}, {""date"": ""2023-06-14"", ""headline"": ""Moderna, Inc. (MRNA) Presents at Goldman Sachs 44th Annual Global Healthcare Conference (Transcript)"", ""summary"": ""Moderna, Inc. (NASDAQ:NASDAQ:MRNA) Goldman Sachs 44th Annual Global Healthcare Conference June 14, 2023 7:40 PM ETCompany ParticipantsJamey Mock - CFOLavina Talukdar - Head of IRConference...""}, {""date"": ""2023-06-14"", ""headline"": ""Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Moderna (MRNA) closed at $126.05 in the latest trading session, marking a -1.51% move from the prior day.""}, {""date"": ""2023-06-14"", ""headline"": ""Moderna Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 1.51% to $126.05 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-14"", ""headline"": ""Covid vaccine maker Novavax sees a pathway to survival \u2013 but it won\u2019t be easy "", ""summary"": ""Cash-strapped Covid vaccine Novavax still faces a nunber of challenges, chiefly competing with Pfizer and Moderna in the U.S. commercial market this fall. ""}, {""date"": ""2023-06-15"", ""headline"": ""FDA advises COVID vaccine makers to produce updated shots against XBB1.5"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-15"", ""headline"": ""Noteworthy Friday Option Activity: MRNA, MSFT, COST"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-15"", ""headline"": ""FDA panel recommends updated COVID-19 vaccines targeting XBB.1.5 subvariant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-15"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. advanced 3.12% to $129.98 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-15"", ""headline"": ""FDA advisers endorse updating COVID vaccines to target latest omicron strain"", ""summary"": ""The COVID-19 vaccines are on track for a big recipe change this fall.""}, {""date"": ""2023-06-15"", ""headline"": ""FDA advisors recommend that new Covid vaccines target an omicron XBB variant this fall "", ""summary"": ""The FDA advisory panel's recommendation is a win for Covid vaccine makers Pfizer, Moderna and Novavax, which will race to deliver updated shots for the fall. ""}, {""date"": ""2023-06-15"", ""headline"": ""The FDA Is Prepping for Fall Covid Boosters. The Next Step Is Today."", ""summary"": ""The agency's vaccines advisors will meet Thursday to settle on a design for this year\u2019s updated Covid-19 vaccine.""}, {""date"": ""2023-06-16"", ""headline"": ""How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-16"", ""headline"": ""Moderna (MRNA) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""Moderna (MRNA) closed the most recent trading day at $128.73, moving -0.96% from the previous trading session.""}, {""date"": ""2023-06-16"", ""headline"": ""Moderna Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Moderna Inc. dropped 0.96% to $128.73 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-16"", ""headline"": ""FDA Panel Endorses Updating COVID Jab to Target XBB Strain"", ""summary"": ""An FDA panel unanimously recommends updating COVID vaccines to target one of the currently dominating XBB strains of the virus.""}, {""date"": ""2023-06-16"", ""headline"": ""Pfizer, Moderna, and Novavax Gear Up for XBB.1.5 Strain Targeted Vaccines as FDA AdCom Unanimously Support"", ""summary"": ""Thursday, the FDA's Vaccines and Related Biological Products Advisory Committee all 21 members voted \""Yes,\"" recommending that updated monovalent COVID shots in the fall and winter targeting the XBB variants, which are now the dominant strains of the SARS-CoV-2 virus in the world. The agency dropped the original coronavirus strain (Wuhan strain) from the formulation. Since earlier this year, the XBB lineage has dominated infections across the United States and the world, starting with XBB.1.5 and""}, {""date"": ""2023-06-16"", ""headline"": ""FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall "", ""summary"": ""The FDA's decision is a win for vaccine makers Pfizer, Moderna and Novavax, which have all been developing versions of their Covid shots to target XBB.1.5.""}, {""date"": ""2023-06-16"", ""headline"": ""Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know"", ""summary"": ""Recently, Zacks.com users have been paying close attention to Moderna (MRNA). This makes it worthwhile to examine what the stock has in store.""}, {""date"": ""2023-06-16"", ""headline"": ""FDA advisors raise doubts about seasonal updates to Covid vaccines as with flu shots"", ""summary"": ""The panel's concerns push back against the FDA's proposed shift to annual Covid shots \u2014 an approach that vaccine makers like Pfizer are already preparing for. ""}, {""date"": ""2023-06-16"", ""headline"": ""Exit Strategy: Get Out of These 3 Poor-Performing Stocks Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-18"", ""headline"": ""7 Value Stocks to Dump Before They Decline Even Further"", ""summary"": ""The key to making profits in the markets has been to buy large-cap growth stocks, and sell value stocks. At least, that\u2019s what it seems like, when you take into account that the surge of the S&P 500 index year-to-date is largely attributable to big gains among big tech stocks. Although not for certain, this trend could continue in the near-term. Ongoing economic issues like high inflation, high interest rates, and slowing economic growth are keeping value stocks at depressed prices. Meanwhile, s""}, {""date"": ""2023-06-18"", ""headline"": ""How to Retire Rich: Biotech Stocks Edition"", ""summary"": ""Among the most difficult endeavors when it comes to deciphering the best retirement planning stocks is to identify companies that will remain relevant for years, if not decades to come. While no guarantees exist for anything, those who focus on investing in biotech own a clear advantage. Almost surely, the underlying sector \u2013 which falls under the broad healthcare industry \u2013 is permanently relevant. Further, I submitted a query on ChatGPT to extract key reasons why biotech stocks for retirement""}, {""date"": ""2023-06-18"", ""headline"": ""Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 48% Discount?"", ""summary"": ""Key Insights The projected fair value for Moderna is US$247 based on 2 Stage Free Cash Flow to Equity Current share...""}]",{}
23,2023-06-18,128.72999572753906,2023-06-25,118.5,-0.07946862477329031,D5+,"[{""date"": ""2023-06-18"", ""headline"": ""7 Value Stocks to Dump Before They Decline Even Further"", ""summary"": ""The key to making profits in the markets has been to buy large-cap growth stocks, and sell value stocks. At least, that\u2019s what it seems like, when you take into account that the surge of the S&P 500 index year-to-date is largely attributable to big gains among big tech stocks. Although not for certain, this trend could continue in the near-term. Ongoing economic issues like high inflation, high interest rates, and slowing economic growth are keeping value stocks at depressed prices. Meanwhile, s""}, {""date"": ""2023-06-18"", ""headline"": ""How to Retire Rich: Biotech Stocks Edition"", ""summary"": ""Among the most difficult endeavors when it comes to deciphering the best retirement planning stocks is to identify companies that will remain relevant for years, if not decades to come. While no guarantees exist for anything, those who focus on investing in biotech own a clear advantage. Almost surely, the underlying sector \u2013 which falls under the broad healthcare industry \u2013 is permanently relevant. Further, I submitted a query on ChatGPT to extract key reasons why biotech stocks for retirement""}, {""date"": ""2023-06-18"", ""headline"": ""Is Moderna, Inc. (NASDAQ:MRNA) Trading At A 48% Discount?"", ""summary"": ""Key Insights The projected fair value for Moderna is US$247 based on 2 Stage Free Cash Flow to Equity Current share...""}, {""date"": ""2023-06-19"", ""headline"": ""Civitas and Mueller Can Boast High Profit, Low Debt"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-19"", ""headline"": ""Why Peter Hotez says he won\u2019t debate RFK Jr. after weekend of Rogan, Musk taunts"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-20"", ""headline"": ""Moderna Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-20"", ""headline"": ""20 Worst Performing S&P 500 Stocks in 2023"", ""summary"": ""In this article, we discuss 20 worst performing S&P 500 stocks in 2023. If you want to skip our detailed analysis of the stock market outlook, skip over to 5 Worst Performing S&P 500 Stocks in 2023. Wall Street analysts are still largely split when it comes to their forecasts for the S&P 500 index, [\u2026]""}, {""date"": ""2023-06-20"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. shed 3.50% to $124.23 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-20"", ""headline"": ""Sanders launches Senate probe into Amazon's safety practices and asks workers to share stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-20"", ""headline"": ""Alexandria Research completes sale of five facilities, reiterates 2023 guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-20"", ""headline"": ""What Do Bears Know About Novavax That Bulls Don't?"", ""summary"": ""Novavax (NASDAQ: NVAX) soared early in the coronavirus vaccine race.  Novavax launched a vaccine -- but about a year after rivals Pfizer and Moderna, so it lost out on lots of the initial early pandemic revenue.  Novavax is on track to provide an updated vaccine this fall.""}, {""date"": ""2023-06-20"", ""headline"": ""Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head start"", ""summary"": ""The FDA's strain selection puts Pfizer, Moderna and Novavax on track to deliver updated coronavirus shots in time for the fall. ""}, {""date"": ""2023-06-20"", ""headline"": ""5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-21"", ""headline"": ""Moderna files for FDA authorization for updated COVID-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-21"", ""headline"": ""If You Invested $100 In This Stock 5 Years Ago, You Would Have $600 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-21"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 2.54% to $121.07 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-21"", ""headline"": ""GSK\u2019s RSV Vaccine Could Be Effective for Longer. What That Means."", ""summary"": ""The drugmaker says its RSV shot prevents disease for 18 months.""}, {""date"": ""2023-06-22"", ""headline"": ""6 Director Elections In 2023 That Were Surprisingly Close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""Moderna Inc. stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""Smith & Wesson Brands, CarMax And 3 Stocks To Watch Heading Into Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Moderna (MRNA) closed at $120.48, marking a -0.49% move from the previous day.""}, {""date"": ""2023-06-22"", ""headline"": ""UPDATE 2-Moderna seeks US FDA authorization for updated COVID vaccine"", ""summary"": ""Moderna said on Thursday it has completed a submission to the U.S. Food and Drug Administration seeking authorization for its updated COVID-19 vaccine to target the XBB.1.5 subvariant.  The submission from the company follows the FDA's advice last week to manufacturers that are updating their COVID-19 vaccines to develop monovalent shots to target XBB.1.5.  Monovalent, or single-target, vaccines would be a change from the most recent bivalent COVID boosters that targeted both the original and Omicron strains of the coronavirus.""}, {""date"": ""2023-06-22"", ""headline"": ""Moderna Files for FDA Authorization of Its Updated COVID-19 Vaccine"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has completed submission of a regulatory application to the U.S.""}, {""date"": ""2023-06-22"", ""headline"": ""Biotech ETFs in Focus on Covid Vaccines' Fall Rollout"", ""summary"": ""The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.""}, {""date"": ""2023-06-22"", ""headline"": ""Moderna Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 0.49% to $120.48 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-22"", ""headline"": ""Moderna files for FDA approval of updated Covid vaccine for fall "", ""summary"": ""Moderna said the submission is based on the FDA's recommendation that vaccine makers update their jabs to target omicron subvariant XBB.1.5. ""}, {""date"": ""2023-06-22"", ""headline"": ""Moderna Unusual Options Activity For June 22"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""CDC Advisors Offer Lukewarm Endorsement of GSK, Pfizer RSV Vaccines. What to Know."", ""summary"": ""A key committee backed a policy saying adults 65 and older \""may receive\"" the shots, rather than one saying the injections \""are recommended.\""""}, {""date"": ""2023-06-22"", ""headline"": ""Interesting MRNA Put And Call Options For August 4th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""Moderna Seeks FDA Nod For Updated COVID-19 Vaccine To Tackle Dominant Strain: The Hill"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-22"", ""headline"": ""Moderna files application with FDA for updated COVID shot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-23"", ""headline"": ""Moderna Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 1.64% to $118.50 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-23"", ""headline"": ""Moderna (MRNA) Seeks FDA Nod for Updated COVID-19 Vaccine"", ""summary"": ""Moderna's (MRNA) updated COVID-19 vaccine is designed to target the XBB.1.5 sublineage. The company expects the vaccine to be available for the fall season, provided the FDA authorizes the same.""}, {""date"": ""2023-06-24"", ""headline"": ""10 Personalized Medicine Stocks Billionaires Are Loading Up On"", ""summary"": ""In this article, we will take a look at the 10 personalized medicine stocks billionaires are purchasing. If you want to skip our detailed analysis of the industry and its growth prospects, go to the 5 Personalized Medicine Stocks Billionaires Are Loading Up On. According to Allied Market Research, the global personalized medicine industry is set [\u2026]""}, {""date"": ""2023-06-24"", ""headline"": ""Wall Street Says This Beaten-Down Stock May Climb Nearly 78%. Is That Too Optimistic?"", ""summary"": ""Moderna (NASDAQ: MRNA) once delivered rapid multibagger returns -- and was the stock everyone wanted to own.  The coronavirus vaccine maker rose by more than 400% in 2020 and soared even more in the first half of 2021.  Wall Street analysts, as a group, are a lot more optimistic about its prospects.""}]",{}
24,2023-06-25,118.5,2023-07-02,121.5,0.025316455696202445,U3,"[{""date"": ""2023-06-25"", ""headline"": ""Moderna Inc. stock rises Monday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-25"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-25"", ""headline"": ""Steve Weiss Once Predicted Moderna Stock Would Rise 500% And Trade Like Amazon: Now He's Selling As The CEO Dumps Shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-25"", ""headline"": ""Noteworthy Monday Option Activity: MRNA, AMZN, ENPH"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-25"", ""headline"": ""Moderna Stock Price Forecast: UBS Sees A 60% Upside"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-25"", ""headline"": ""Analysts Reconsider MRNA Stock, Share Prices Improve"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Pfizer and Moderna: The Vaccine Boom is Over, and Shares are Plunging"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""UPDATE 1-Biogen shareholders back Susan Langer as director"", ""summary"": ""Biogen shareholders elected former company executive Susan Langer as a director on Monday, weeks after her romantic partner, Alex Denner, vacated the seat and the board nominated her to replace him.  Langer, 32, had served in various roles at the biotech company from 2013 to 2019.  Denner was a hedge fund manager, who had been a Biogen director since 2009 and headed the company's nominating and governance committee.""}, {""date"": ""2023-06-26"", ""headline"": ""UBS Upgrades Moderna (MRNA)"", ""summary"": """"}, {""date"": ""2023-06-26"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks stutter as Russian drama plays out"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Moderna stock up after UBS upgrade"", ""summary"": ""Moderna shares are up after the stock receives an upgrade from UBS. Yahoo Finance Live breaks down the company's stock movement.""}, {""date"": ""2023-06-26"", ""headline"": ""Moderna Stock Is a Buy. The Pipeline Is Underappreciated, Says Analyst."", ""summary"": ""UBS analyst Eliana Merle upgraded Moderna stock to Buy from Neutral, but trimmed the price target. The Covid and RSV businesses alone are worth $123 a share, she says.""}, {""date"": ""2023-06-26"", ""headline"": ""IN THE KNOW: UBS sees success for Moderna ahead as Covid unwinds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Post-COVID-19: How the COVAX Initiative Could Redirect its $2.6B Surplus to Fight Future Pandemics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Stocks making the biggest moves midday: Pfizer, Lucid, WSFS Financial and more"", ""summary"": ""These are the stocks posting the largest moves in midday trading. ""}, {""date"": ""2023-06-26"", ""headline"": ""Tracking Lone Pine Capital Portfolio - Q1 2023 Update"", ""summary"": ""Lone Pine Capital's 13F portfolio value increased from $10.48B to $10.80B in Q1 2023, with the number of holdings decreasing from 30 to 29. Read more here.""}, {""date"": ""2023-06-26"", ""headline"": ""Analyst Ratings for Moderna"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Moderna Pipeline For Any Vaccine Beyond Covid Is 'Underappreciated,' Analyst Says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Alphabet downgraded, Moderna upgraded: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Tesla, Alphabet fall premarket; Moderna, Lucid Group rise"", ""summary"": ""Investing.com -- Stocks in focus in premarket trade on Monday, June 26th. Please refresh for updates.""}, {""date"": ""2023-06-26"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Stocks making the biggest premarket moves: Tesla, Moderna, Alphabet, PacWest and more"", ""summary"": ""These are the stocks posting the largest moves in the premarket.""}, {""date"": ""2023-06-26"", ""headline"": ""Monday\u2019s Top Analyst Upgrades and Downgrades: Accenture, Moderna, Tesla, Under Armour, Wayfair, Welltower and More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Amazon, Marriott And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""GLOBAL BROKER RATINGS: UBS likes Moderna; Goldman Sachs cuts Tesla"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""Moderna raised to Buy at UBS on underappreciated pipeline"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-26"", ""headline"": ""UBS upgrades Moderna to buy while cutting price target"", ""summary"": ""UBS upgraded its rating on vaccine maker Moderna to buy from neutral on valuation grounds, but cut its price target to $191 from $221. \u201cWe acknowledge the...""}, {""date"": ""2023-06-26"", ""headline"": ""Moderna upgraded to Buy from Neutral at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-27"", ""headline"": ""Moderna Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-27"", ""headline"": ""REGN, CTLT Continue Sliding Following FDA Rejection of Eylea Drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-27"", ""headline"": ""Moderna Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-27"", ""headline"": ""Moderna Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.22% higher to $120.67 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-27"", ""headline"": ""How to Invest $10,000 -- No Matter What the Market is Doing"", ""summary"": ""One of the biggest questions on investors' minds these days is this: Have we reached a new bull market?  The good news is you don't have to invest for a bear market or a bull market.  A good example is coronavirus vaccine maker Moderna (NASDAQ: MRNA).""}, {""date"": ""2023-06-28"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-28"", ""headline"": ""Moderna says updated COVID vaccine will be ready for the fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-28"", ""headline"": ""Moderna (MRNA) Gains As Market Dips: What You Should Know"", ""summary"": ""Moderna (MRNA) closed at $123 in the latest trading session, marking a +1.93% move from the prior day.""}, {""date"": ""2023-06-28"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. rallied 1.93% to $123.00 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-28"", ""headline"": ""Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It"", ""summary"": ""Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.""}, {""date"": ""2023-06-28"", ""headline"": ""3 Pharma Stocks That Have Big Investors Running for the Exit"", ""summary"": ""Pharmaceutical stocks are trailing the market this year. So far in 2023, the Dow Jones U.S. Select Pharmaceuticals Index is down 5.4% while all three major indices are positive on the year. The declining investor interest in pharma stocks is a sharp reversal from the pandemic when the shares of many leading drugmakers were sitting at all-time highs. As Covid-19 slid into our collective rearview mirror, pharma stocks have declined sharply. Companies with multiple best-selling medications and stro""}, {""date"": ""2023-06-28"", ""headline"": ""Citi screens for most crowded short stocks with new model"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-29"", ""headline"": ""Moderna Billionaire Set to Score 3,000% Gain on Tiny Biotech"", ""summary"": ""(Bloomberg) -- Noubar Afeyan became a billionaire backing Moderna Inc., the dark horse biotech firm that became a household name due to its lifesaving Covid vaccine. He just added to his fortune after another one of his long-shot bets quintupled in value.Most Read from BloombergSwitzerland Blocks Sale of Leopard 1 Tanks Bound for UkraineA $100 Billion Wealth Migration Tilts US Economy\u2019s Center of Gravity SouthPutin Claims He\u2019s Back in Control. Russia\u2019s Elite Isn\u2019t SureSupreme Court Rejects Use o""}, {""date"": ""2023-06-29"", ""headline"": ""MODERNA INITIATES ROLLING SUBMISSION TO HEALTH CANADA FOR UPDATED COVID-19 VACCINE"", ""summary"": ""Moderna, Inc. (NASDAQ: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has initiated the filing of a rolling New Drug Submission (NDS) to Health Canada for its updated monovalent COVID-19 vaccine, SPIKEVAX\u00ae XBB.1.5 (mRNA-1273.815) targeting the omicron subvariant XBB.1.5 of SARS-CoV-2. This follows Moderna's submission to the U.S. Food and Drug Administration for authorization.""}, {""date"": ""2023-06-29"", ""headline"": ""Moderna Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 0.72% to $122.11 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-29"", ""headline"": ""Moderna Files Submission to Health Canada for Updated Covid-19 Vaccine"", ""summary"": ""By Stephen Nakrosis \n\n\n  Moderna on Thursday said it submitted a rolling new drug submission to Health Canada for an updated Covid-19 vaccine. \n\n  Moderna previously submitted its updated its monovalent Covid-19 vaccine, Spikevax XBB.1.5, to the U.S. F...""}, {""date"": ""2023-06-29"", ""headline"": ""Moderna and 7 More Stocks That Can Beat Apple in Second Half"", ""summary"": ""Big Tech is having its best start to the year ever. But a different group of stocks may thrive in the second half.""}, {""date"": ""2023-06-29"", ""headline"": ""Moderna initiates rolling NDS to Health Canada for updated COVID-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-29"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-29"", ""headline"": ""8 Beaten Up Stocks to Buy for Second-Half Turnarounds"", ""summary"": ""Big Tech is having its best start to the year ever. But a different group may thrive in the second half.""}, {""date"": ""2023-06-29"", ""headline"": ""MRNA August 11th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-29"", ""headline"": ""Moderna and 7 More Stocks That Can Beat Big Tech in the Second Half"", ""summary"": ""Big Tech is having its best start to the year ever. But a different group may thrive in the second half.""}, {""date"": ""2023-06-29"", ""headline"": ""Goldman adds 39 new stocks to its Sharpe Ratio basket with megacaps absent"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-30"", ""headline"": ""Moderna Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 0.50% to $121.50 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-06-30"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-30"", ""headline"": ""Medicare revises guidance on drug price negotiations amid lawsuits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-06-30"", ""headline"": ""Declining Stock and Solid Fundamentals: Is The Market Wrong About Moderna, Inc. (NASDAQ:MRNA)?"", ""summary"": ""With its stock down 20% over the past three months, it is easy to disregard Moderna (NASDAQ:MRNA). However, stock...""}, {""date"": ""2023-07-02"", ""headline"": ""3 stocks that could still light up 2023 just like July 4 fireworks"", ""summary"": ""The stock market's strong year has essentially been driven by less than 20 stocks. But could the second half of the year see some surprise winners that have under-performed thus far?""}]","{""assetTurnoverTTM"": 0.4352, ""bookValue"": 16949, ""cashRatio"": 1.2170989433237271, ""currentRatio"": 3.3939, ""ebitPerShare"": -4.9003, ""eps"": -3.622, ""ev"": 43545.934, ""fcfPerShareTTM"": -1.979, ""grossMargin"": -1.125, ""inventoryTurnoverTTM"": 3.4454, ""netDebtToTotalCapital"": -0.1541, ""netDebtToTotalEquity"": -0.1635, ""netMargin"": -4.0116, ""operatingMargin"": -5.4273, ""pb"": 2.7327, ""peTTM"": 38.3736, ""pretaxMargin"": -5.0843, ""psTTM"": 4.3474, ""ptbv"": 2.7402, ""quickRatio"": 2.9459, ""receivablesTurnoverTTM"": 7.2898, ""roaTTM"": 0.0493, ""roeTTM"": 0.0662, ""roicTTM"": 0.0626, ""rotcTTM"": 0.0266, ""salesPerShare"": 0.9029, ""sgaToSale"": 2.125, ""tangibleBookValue"": 16903, ""totalDebtToEquity"": 0.0608, ""totalDebtToTotalAsset"": 0.0471, ""totalDebtToTotalCapital"": 0.0573, ""totalRatio"": 4.4344, ""period"": ""2023-06-30""}"
25,2023-07-02,121.5,2023-07-09,118.87000274658203,-0.021646067929365964,D3,"[{""date"": ""2023-07-02"", ""headline"": ""Moderna files for European authorization of updated COVID vaccine"", ""summary"": ""U.S. biotech firm Moderna\nsaid on Monday it had submitted a regulatory application to the\nEuropean Medicines Agency  seeking authorization for its\nupdated COVID-19 vaccine to target the XBB.1.5...""}, {""date"": ""2023-07-02"", ""headline"": ""3 stocks that could still light up 2023 just like July 4 fireworks"", ""summary"": ""The stock market's strong year has essentially been driven by less than 20 stocks. But could the second half of the year see some surprise winners that have under-performed thus far?""}, {""date"": ""2023-07-03"", ""headline"": ""Moderna (MRNA) Submits Filing in EU for Updated COVID-19 Jab"", ""summary"": ""Moderna's (MRNA) updated COVID-19 vaccine is designed to target the XBB.1.5 sublineage. If the filing is approved in the EU, the vaccine will be made available for the fall season.""}, {""date"": ""2023-07-03"", ""headline"": ""Moderna Submits Regulatory Application to the European Medicines Agency for Its Updated COVID-19 Vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-03"", ""headline"": ""Moderna applies for EU approval of updated COVID-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-03"", ""headline"": ""CarMax, Walmart And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-03"", ""headline"": ""Moderna submits EMA regulatory filing for updated Covid-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-03"", ""headline"": ""Moderna submits regulatory application to EMA for updated COVID-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-03"", ""headline"": ""Moderna Seeks European Nod For Updated COVID-19 Vaccine Shot To Tackle New Dominant Strain"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-04"", ""headline"": ""Dow ends down over 100 points after Fed minutes show almost all policy makers expect additional rate increases"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-04"", ""headline"": ""Moderna\u2019s stock pops as company wins China business and seeks regulatory nods for RSV vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna (NYSE:MRNA) Chooses to Cater to Chinese Consumers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna To Develop mRNA Vaccines in China"", ""summary"": ""The US and China may be taking jabs at one another over trade and other stuff, but that isn't stopping Beijing from inviting an American company...""}, {""date"": ""2023-07-05"", ""headline"": ""3 Value Stocks to Consider Selling Before They Do Your Portfolio In"", ""summary"": ""Selling value stocks is vital for investors who prioritize safeguarding their portfolios. Within portfolio management, it becomes imperative to identify the opportune moment to divest from value stocks that fail to deliver anticipated returns. Although it may appear counter-intuitive to relinquish these previously promising investments, it is essential to acknowledge that their present state of overvaluation has eroded their value proposition. The allure of undervalued stocks lies in the potenti""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna (MRNA) Gains As Market Dips: What You Should Know"", ""summary"": ""Moderna (MRNA) closed the most recent trading day at $123.54, moving +1.49% from the previous trading session.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna Shares Advance After Striking mRNA Drug Development Deal With China"", ""summary"": ""Moderna shares rose 1.5% on Wednesday after signing an agreement with China to research, develop, and make mRNA treatments there.""}, {""date"": ""2023-07-05"", ""headline"": ""Shanghai Authorities Signed MoU With Moderna On Wednesday - Government Statement"", ""summary"": ""Shanghai City Government:\n              * SHANGHAI AUTHORITIES SIGNED MOU WITH MODERNA ON\nWEDNESDAY - GOVERNMENT STATEMENT\n              Source text\nFurther company coverage:\n\n            ...""}, {""date"": ""2023-07-05"", ""headline"": ""Cramer examines the worst performers from the first half of 2023, explains why the market seems narrow"", ""summary"": ""CNBC's Jim Cramer told investors on Wednesday that if they're waiting for the market to broaden for a rally, they might be waiting forever.""}, {""date"": ""2023-07-05"", ""headline"": ""US STOCKS-Wall Street dips on jitters ahead of Fed minutes"", ""summary"": ""Wall Street's main indexes fell on Wednesday ahead of the Federal Reserve's June meeting minutes, while weak U.S. and China economic data as well as rising Sino-U.S. tensions dented investor sentiment.  May U.S. factory orders rose less than expected, according to a Commerce Department report, fanning fears of a slowdown due to high interest rates after data on Monday showed manufacturing slumped further last month.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. rallied 1.49% to $123.54 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-07-05"", ""headline"": ""NEW YORK MARKET CLOSE: Fed eyes more rate hikes keeping Dow in check"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Markets Fall at Midday Ahead of the Release of the Fed's Latest Meeting Minutes"", ""summary"": ""U.S. equities declined at midday on Wednesday, July 5, 2023, ahead of the release of meeting minutes from the Fed's June policy meeting.""}, {""date"": ""2023-07-05"", ""headline"": ""Three-Stock Lunch: UPS, Moderna and Coinbase"", ""summary"": ""Michael Landsberg, Landsberg Bennett Private Wealth Management CIO, joins 'Power Lunch' to discuss Landsberg's thoughts on three stocks: UPS, Moderna, and Coinbase.""}, {""date"": ""2023-07-05"", ""headline"": ""Stock market today: Dow slips as Fed minutes show more hikes ahead; Meta jumps"", ""summary"": ""By Yasin Ebrahim""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna stock surges on China expansion deal"", ""summary"": ""Moderna shares are surging after the company announced a new expansion deal to develop and manufacture mRNA medicines in China. Yahoo Finance's Rachelle Akuffo breaks down the deal.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna Initiates Regulatory Application Process Seeking Approval For Its RSV Vaccine In Older Adults"", ""summary"": ""Moderna Inc (NASDAQ: MRNA) provided an update on regulatory submissions for the mRNA-1345 vaccine to prevent RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease in adults aged 60 years or older. mRNA-1345 is an investigational RSV vaccine with a single mRNA sequence encoding for a stabilized prefusion F glycoprotein. The vaccine uses the same lipid nanoparticles as in the Moderna COVID-19 vaccines. The company has submitted marketing authorization applications""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna Stock Is Surging on Deal to Make Vaccines in China"", ""summary"": ""Drugmaker Moderna reached an agreement to produce mRNA vaccines in China. One report noted the company could invest up to $1 billion in the country.""}, {""date"": ""2023-07-05"", ""headline"": ""Trending : Moderna Makes RSV Vaccine Submissions, Plans to Develop mRNA Meds in China"", ""summary"": ""14:03 ET -- Moderna is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The Cambridge, Mass.-based vaccine maker plans to...""}, {""date"": ""2023-07-05"", ""headline"": ""AstraZeneca, Moderna Stocks Rise"", ""summary"": ""Two large drugmakers are advancing in early trading Wednesday. + AstraZeneca's New-York listed ADR rose 2.6% shortly after the open; shares in the drugmaker sold off Monday after it reported mixed results in a trial for an experimental cancer drug.""}, {""date"": ""2023-07-05"", ""headline"": ""Stocks making the biggest moves midday: Meta Platforms, Coinbase, UPS, General Motors & more"", ""summary"": ""These are the stocks posting the largest moves in midday trading. ""}, {""date"": ""2023-07-05"", ""headline"": ""US STOCKS-Wall Street set to open lower, all eyes on Fed minutes"", ""summary"": ""Wall Street futures fell on Wednesday as investors awaited minutes of the Federal Reserve's June meeting for clues on the central bank's monetary policy path, while Sino-U.S. tensions and weak economic data from Beijing dented sentiment.  Rate-sensitive megacap companies such as Microsoft and Alphabet slid 0.9% and 0.6%, respectively, in premarket trading.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna Strikes mRNA Drug Pact With Chinese Authorities: Report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna seeks regulatory approval of RSV vaccine for people 60 and older"", ""summary"": ""Moderna has submitted its RSV vaccine for people 60 and older regulatory approval in the United States and elsewhere in the world, the company said.\nWe are proud to announce these filings for the use...""}, {""date"": ""2023-07-05"", ""headline"": ""US biotech Moderna strikes deal to develop mRNA drugs in China"", ""summary"": ""US drugmaker Moderna has struck a deal to make messenger RNA drugs for use in China, despite the tensions between Washington and Beijing.  The biotech said on Wednesday that it had reached an agreement with authorities in Beijing to research, develop and manufacture drugs that would \u201cnot be exported\u201d.  Drugmakers remain interested in expanding in China, which faces an ageing population, higher rates of chronic diseases and health concerns stemming from an increasingly westernised diet.""}, {""date"": ""2023-07-05"", ""headline"": ""UPDATE 2-Moderna starts application process for RSV vaccine for older adults"", ""summary"": ""Moderna Inc said on Wednesday it had started the application process to get an approval for its respiratory syncytial virus (RSV) vaccine in older adults with regulators in the United States, Australia and Europe.  It is aiming to be the third vaccine maker to get an approval in the country after GSK and Pfizer Inc.  Moderna has also submitted applications to the European, Swiss and Australian regulators, the company said.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna Makes Regulatory Submissions for RSV Vaccine Candidate >MRNA"", ""summary"": ""By Colin Kellaher Moderna on Wednesday said it has launched efforts to win approval in the U.S., Europe and Australia for its mRNA-1345 investigational...""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345"", ""summary"": ""Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older.""}, {""date"": ""2023-07-05"", ""headline"": ""EXCLUSIVE: Top 10 Most-Searched Tickers On Benzinga Pro In Q2 \u2014 Tesla, Nvidia, C3.ai, Meta Platforms, Microsoft And More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna stock pops after company makes regulatory submissions in U.S., Europe, Switzerland and Australia for its RSV vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""UPDATE 1-Moderna agrees deal in China with view to  developing mRNA medicines"", ""summary"": ""Vaccine maker Moderna Inc said on Wednesday it had signed a memorandum of understanding and a land collaboration agreement to work towards opportunities for it to research, develop and manufacture mRNA medicines in China.  Chinese media outlet Yicai reported on Tuesday that Moderna was set to make its first investment in China that could be worth around $1 billion, and that Chief Executive Officer St\u00e9phane Bancel was visiting Shanghai.  Moderna said in May it was looking for opportunities in China after registering a legal entity in the world's second-largest economy.""}, {""date"": ""2023-07-05"", ""headline"": ""MRNA Stock Jumps as It Progresses with RSV Vaccine Application"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Is Moderna Heading for a Critical Moment?"", ""summary"": ""Moderna (NASDAQ: MRNA) has generated billions of dollars in sales and profit from its coronavirus vaccine.  This doesn't mean the revenue opportunity is over, though.  Let's take a closer look at exactly how important this moment will be for Moderna.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna says it has signed deal in China with view to research and make mRNA medicines"", ""summary"": ""Vaccine maker Moderna Inc said on Wednesday it had signed a memorandum of understanding and a land collaboration agreement to work towards opportunities for it to research, develop and manufacture mRNA medicines in China.  Chinese media outlet Yicai reported on Tuesday that Moderna was set to make its first investment in China that could be worth around $1 billion, and that Chief Executive Officer St\u00e9phane Bancel is in Shanghai.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna strikes deal to develop mRNA drugs in China "", ""summary"": ""The deal is the biotech company's first agreement with China after the Asian nation repeatedly refused to accept mRNA vaccines from U.S.-based manufacturers. ""}, {""date"": ""2023-07-05"", ""headline"": ""Early notable gainers among liquid option names on July 5th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Unusually active option classes on open July 5th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna to invest $1 billion in China to develop mRNA medicines - reports"", ""summary"": ""Investing.com -- Shares in Moderna (NASDAQ:MRNA) moved higher on Wednesday after media reports said that the drugmaker had signed a memorandum of understanding and a land collaboration agreement with China to research and develop messenger RNA medicines in the country.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna submits global regulatory submission for respiratory vaccine"", ""summary"": ""Moderna Inc on Wednesday said it submitted a marketing authorisation application for the investigational respiratory syncytial virus vaccine mRNA-1345, with the European Medicines Agency, Swissmedic,...""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna, Inc."", ""summary"": ""Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus  Vaccine, MRNA-1345\nModerna has submitted marketing authorization applications for the investigational RSV vaccine,...""}, {""date"": ""2023-07-05"", ""headline"": ""Yicai says Moderna set to invest $1B in China, Bloomberg reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna starts application process for RSV vaccine approval in older adults"", ""summary"": ""Moderna Inc said on\nWednesday it had started the application process for its\nrespiratory syncytial virus  vaccine, seeking approval to\nbe used in older adults, with various regulators, including...""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna starts application process for approval of RSV vaccine"", ""summary"": ""Moderna Inc said on\nWednesday it had started the application process for approval of\nits respiratory syncytial virus  vaccine with various\nregulators, including those in the United States and...""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna files global marketing submissions for RSV shot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Rivian, Moderna and Wolf stocks rise, UPS and Generac shares fall, and other stocks the move"", ""summary"": ""Rivian's stock climbed Wednesday after Amazon said it had rolled out the first delivery vans from the electric-vehicle maker. UPS, Microsoft shares were also...""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna signs deal in China to develop mRNA medicines - Reuters"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna provides update on regulatory submissions for mRNA-1345"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-05"", ""headline"": ""Dow remains lower, Nasdaq wavers after Fed minutes show almost all policy makers expect additional rate increases"", ""summary"": ""U.S. stocks remain lower on Wednesday, after minutes of the Fed's last policy meeting show almost all participants expect additional interest-rate increases.""}, {""date"": ""2023-07-05"", ""headline"": ""Moderna Set to Invest $1 Billion in China, Yicai Reports"", ""summary"": ""(Bloomberg) -- Moderna Inc. is set to announce its first investment in China as early as Wednesday as heightened geopolitical tensions puts the spotlight on the Asian nation\u2019s efforts to rebuild ties with foreign firms.Most Read from BloombergUS Stocks Mixed as Tech Giants Hold Onto Gains: Markets WrapEarth Keeps Breaking Temperature Records Due to Global WarmingXi\u2019s Metal Curbs Risk Backfiring as G-7 Seeks China AlternativeLazard Fires Senior Banker for Inappropriate Behavior at PartyChina Rest""}, {""date"": ""2023-07-06"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-06"", ""headline"": ""Wait Before Buying Moderna Stock, Says Bear Signal"", ""summary"": ""MRNA's 60-day moving average has stymied the equity in the past""}, {""date"": ""2023-07-06"", ""headline"": ""Moderna: Potential To Get Second Product To Market"", ""summary"": ""Moderna has submitted multiple regulatory submission of mRNA-1345 and more regulatory submissions are expected in coming months. Click here for more on MRNA stock.""}, {""date"": ""2023-07-06"", ""headline"": ""Moderna Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 4.25% to $118.29 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-07-06"", ""headline"": ""Novo Nordisk spent $11 million on Ozempic promotion"", ""summary"": ""Novo Nordisk spent $11 million on food and travel for doctors to promote weight loss and type 2 diabetes drug Ozempic. Yahoo Finance Healthcare Reporter Anjalee Khemlani discusses Novo Nordisk's lobbying, as well as Moderna's deal with China.""}, {""date"": ""2023-07-06"", ""headline"": ""Moderna (MRNA) Initiates Rolling BLA Filing for RSV Vaccine"", ""summary"": ""Alongside the FDA filing, Moderna (MRNA) submits similar filings in Europe and Australia, seeking approval for using its RSV vaccine in older adults aged 60 years and above.""}, {""date"": ""2023-07-06"", ""headline"": ""Biotech Stock Roundup: BMRN's Gene Therapy Gets Approval, SGTX Up on Buyout by LLY"", ""summary"": ""Regulatory and acquisition updates from BioMarin (BMRN) and Sigilon (SGTX) are in focus in the biotech sector.""}, {""date"": ""2023-07-06"", ""headline"": ""A Big Test Is Looming for Pfizer, Moderna, and Novavax"", ""summary"": ""Pfizer\u00a0(NYSE: PFE),\u00a0Moderna\u00a0(NASDAQ: MRNA), and Novavax (NASDAQ: NVAX) were all popular stocks to own when demand for COVID vaccines was strong.  Demand for vaccines is still there, but whether it's enough for these companies to hit their forecasts this year is questionable.""}, {""date"": ""2023-07-06"", ""headline"": ""Stocks making the biggest moves midday: JetBlue, Affirm, Genius Sports, Sweetgreen and more"", ""summary"": ""These are the stocks posting the largest moves midday.""}, {""date"": ""2023-07-06"", ""headline"": ""With 66% ownership of the shares, Moderna, Inc. (NASDAQ:MRNA) is heavily dominated by institutional owners"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Moderna's stock price might be vulnerable to their...""}, {""date"": ""2023-07-06"", ""headline"": ""Video: S&P 500 Movers: MRNA, KDP"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-06"", ""headline"": ""Keurig Dr Pepper\u2019s stock climbs on upgrade, Exxon shares slip after update, and other stocks on the move"", ""summary"": ""Meta Platforms, Exxon Mobil and Spirit Airlines shares are all on the move.""}, {""date"": ""2023-07-06"", ""headline"": ""Dow ends nearly 370 points lower as jobs data triggers jump in bond yields"", ""summary"": ""U.S. stocks end lower Thursday after a report from ADP showed the private sector created nearly half a million new jobs in June.""}, {""date"": ""2023-07-07"", ""headline"": ""Week In Review: Billion Dollar Deals - Moderna\u2019s Shanghai Investment And F-Star\u2019s Takeda Collaboration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-07"", ""headline"": ""Moderna Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.49% higher to $118.87 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-07-07"", ""headline"": ""Novavax's (NVAX) COVID Jab Gets Full Approval in Europe"", ""summary"": ""Novavax's (NVAX) protein-based COVID-19 vaccine, Nuvaxovid, gets full marketing authorization for COVID patients in Europe.""}, {""date"": ""2023-07-07"", ""headline"": ""Company News for Jul 7, 2023"", ""summary"": ""Companies in The News Are: JBLU, AAL, F, MRNA, GENI.""}, {""date"": ""2023-07-09"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-09"", ""headline"": ""Are We Heading for a Recession? Here's What Investors Should Do."", ""summary"": ""Are we heading for a recession?  Meanwhile, the economy has shown a certain degree of resilience -- and some economists\u00a0say a recession could happen later or not at all.  Should you go for growth stocks that tend to outperform in strong economies?""}, {""date"": ""2023-07-09"", ""headline"": ""Week In Review: Billion Dollar Deals - Moderna's Shanghai Investment And F-Star's Takeda Collaboration"", ""summary"": ""Moderna signed a deal to set up operations in Shanghai that will develop and make mRNA products specifically for the China\u00e2\u0080\u0099s market. Click here to read more.""}]","{""assetTurnoverTTM"": 0.4352, ""bookValue"": 16949, ""cashRatio"": 1.2170989433237271, ""currentRatio"": 3.3939, ""ebitPerShare"": -4.9003, ""eps"": -3.622, ""ev"": 43545.934, ""fcfPerShareTTM"": -1.979, ""grossMargin"": -1.125, ""inventoryTurnoverTTM"": 3.4454, ""netDebtToTotalCapital"": -0.1541, ""netDebtToTotalEquity"": -0.1635, ""netMargin"": -4.0116, ""operatingMargin"": -5.4273, ""pb"": 2.7327, ""peTTM"": 38.3736, ""pretaxMargin"": -5.0843, ""psTTM"": 4.3474, ""ptbv"": 2.7402, ""quickRatio"": 2.9459, ""receivablesTurnoverTTM"": 7.2898, ""roaTTM"": 0.0493, ""roeTTM"": 0.0662, ""roicTTM"": 0.0626, ""rotcTTM"": 0.0266, ""salesPerShare"": 0.9029, ""sgaToSale"": 2.125, ""tangibleBookValue"": 16903, ""totalDebtToEquity"": 0.0608, ""totalDebtToTotalAsset"": 0.0471, ""totalDebtToTotalCapital"": 0.0573, ""totalRatio"": 4.4344, ""period"": ""2023-06-30""}"
26,2023-07-09,118.87000274658203,2023-07-16,121.3499984741211,0.020863091362302244,U3,"[{""date"": ""2023-07-09"", ""headline"": ""Goldman Sachs sees rays of hope in underperforming health sector"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-09"", ""headline"": ""Are We Heading for a Recession? Here's What Investors Should Do."", ""summary"": ""Are we heading for a recession?  Meanwhile, the economy has shown a certain degree of resilience -- and some economists\u00a0say a recession could happen later or not at all.  Should you go for growth stocks that tend to outperform in strong economies?""}, {""date"": ""2023-07-09"", ""headline"": ""Week In Review: Billion Dollar Deals - Moderna's Shanghai Investment And F-Star's Takeda Collaboration"", ""summary"": ""Moderna signed a deal to set up operations in Shanghai that will develop and make mRNA products specifically for the China\u00e2\u0080\u0099s market. Click here to read more.""}, {""date"": ""2023-07-10"", ""headline"": ""Moderna Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Moderna Inc. rose 3.55% to $123.09 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-07-10"", ""headline"": ""Novavax stock spikes 20% after company snags $350 million from Canada for unused Covid shots"", ""summary"": ""Canada's Covid shot settlement is a sign of hope for investors after Novavax raised doubts about its ability to stay in business earlier this year.\u00a0""}, {""date"": ""2023-07-10"", ""headline"": ""The Perfect 10 Portfolio Is Ready to Roll"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""RBC Capital Sticks to Its Buy Rating for Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""Tesla, Netflix And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-10"", ""headline"": ""Evelo spikes on $25.5M private placement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-11"", ""headline"": ""S&P 500 Q2 2023 Earnings Preview: A Repeat Performance?"", ""summary"": ""Over the last three months, Q2 EPS estimate declined from $54.24 to $52.81 per share, resulting in analysts downgrading y/y growth expectations by 2.5 ppt heading into earnings season.""}, {""date"": ""2023-07-11"", ""headline"": ""Prime Day for the Stock Market? Disney, Moderna, and 13 More That Look Like Bargains."", ""summary"": ""Amazon Prime shopping days are here, and everyone loves good deals, Barron's looked for some in the stock market, and found 15 stocks primed to go higher.""}, {""date"": ""2023-07-11"", ""headline"": ""Get another COVID-19 booster in the fall, Canada's immunization panel recommends"", ""summary"": ""OTTAWA \u2014 Canadians should get another COVID-19 vaccine booster in the fall if it's been at least six months since their last dose or COVID-19 infection, the National Advisory Committee on...""}, {""date"": ""2023-07-11"", ""headline"": ""We've only seen the beginning of Moderna's story, says Goldman Sachs' Salveen Richter"", ""summary"": ""Salveen Richter, Goldman Sachs lead biotech analyst, joins 'Closing Bell Overtime' to discuss the biotech sector and how investors should play in the space.""}, {""date"": ""2023-07-11"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 0.78% to $122.13 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-07-11"", ""headline"": ""Morgan Stanley Maintains Moderna (MRNA) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-07-11"", ""headline"": ""Prime Day for Stocks? Disney, Moderna and 13 More That Look Like Bargains."", ""summary"": ""Amazon Prime shopping days are here, and everyone loves good deals, Barron's looked for some in the stock market, and found 15 stocks primed to go higher.""}, {""date"": ""2023-07-11"", ""headline"": ""EXCLUSIVE: The 20 Most-Searched For Tickers On Benzinga Pro From The First Six Months Of 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-12"", ""headline"": ""2-year Treasury yield continues to slide after cool June CPI figure"", ""summary"": ""U.S. Treasury yields were mostly lower on Thursday after June's inflation print came in cooler than expected.""}, {""date"": ""2023-07-12"", ""headline"": ""2Q23 Earnings: Where Street Estimates Are Too Low And Who Should Beat"", ""summary"": ""Street Earnings are lower than Core Earnings for 146 companies in the S&P 500, representing 28% of the market cap of the S&P 500.""}, {""date"": ""2023-07-12"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. rallied 3.10% to $125.92 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-07-12"", ""headline"": ""Nvidia invests $50 million in biotech company Recursion for AI drug discovery "", ""summary"": ""Nvidia is investing in Recursion, which uses AI models to identify new therapies and offers those models to its partners, including Roche and Bayer.""}, {""date"": ""2023-07-12"", ""headline"": ""Check Out What Whales Are Doing With MRNA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-12"", ""headline"": ""3 Things About Vertex Pharmaceuticals That Smart Investors Know"", ""summary"": ""Vertex Pharmaceuticals'\u00a0(NASDAQ: VRTX) stock has climbed nearly 20% so far this year, and for good reason.  The biotech company completed a regulatory submission for what may become its next blockbuster product.  Vertex and partner CRISPR Therapeutics hope to launch exa-cel, a gene-editing treatment for blood disorders, as soon as next year.""}, {""date"": ""2023-07-13"", ""headline"": ""Moderna initiated with a Reduce at HSBC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-13"", ""headline"": ""Moderna (MRNA) Gains But Lags Market: What You Should Know"", ""summary"": ""In the latest trading session, Moderna (MRNA) closed at $126.62, marking a +0.56% move from the previous day.""}, {""date"": ""2023-07-13"", ""headline"": ""15 Deadliest Cancers in the U.S."", ""summary"": ""In this article, we will discuss the 15 deadliest cancers in the U.S. To skip our detailed analysis and recent updates regarding cancer research and the oncology market, go directly to the 5 Deadliest Cancers in the U.S. Cancer stands as a pervasive, highly destructive, and agonizing disease, with a significant global impact. Cancer, also [\u2026]""}, {""date"": ""2023-07-13"", ""headline"": ""Moderna Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.55% higher to $126.61 Thursday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-07-13"", ""headline"": ""Biden administration to provide free Covid vaccines to uninsured Americans this fall through end of 2024"", ""summary"": ""The HHS program aims to maintain broad access to Covid shots and treatments after the federal government shifts those products to the commercial market.\u00a0""}, {""date"": ""2023-07-13"", ""headline"": ""Biden administration asks Pfizer, Moderna and Novavax for 'reasonable' prices on updated Covid vaccines"", ""summary"": ""Pfizer, Moderna and Novavax have not disclosed the exact pricing of their new vaccines, which will target the circulating omicron subvariant XBB.1.5.\u00a0""}, {""date"": ""2023-07-13"", ""headline"": ""Did Nvidia Make Recursion Pharmaceuticals (RXRX) Stock the Next AI Play?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-13"", ""headline"": ""Moderna: Buy While It's Cheap (Rating Upgrade)"", ""summary"": ""Moderna is on track to achieve about $2B of its FY23 $5B COVID vaccine revenue target in H1 but may fall short unless sales momentum improves in H2. Learn more about MRNA here.""}, {""date"": ""2023-07-13"", ""headline"": ""7 Biotech Stocks to Sell in July"", ""summary"": ""Biotech may be a great sector for risk-seeking investors to find opportunity. That said, for every biotech stock worth buying, there are plenty that fit into the \u201cbiotech stocks to sell\u201d category. For one, while biotechs are some of the riskier stocks out there, that doesn\u2019t mean all of them offer the possibility of outsized rewards. Plenty of names in this category have massive downside risk, while at the same time offering questionable upside potential. Other biotechs may have tremendous upsid""}, {""date"": ""2023-07-14"", ""headline"": ""HSBC Initiates Coverage of Moderna (MRNA) with Reduce Recommendation"", ""summary"": """"}, {""date"": ""2023-07-14"", ""headline"": ""Moderna Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 4.15% to $121.35 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-07-14"", ""headline"": ""Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-14"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, TEAM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-14"", ""headline"": ""MODERNA TO REPORT SECOND QUARTER 2023 FINANCIAL RESULTS ON THURSDAY, AUGUST 3, 2023"", ""summary"": ""CAMBRIDGE - Moderna, Inc. , a biotechnology company pioneering messenger RNA  therapeutics and vaccines, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on...""}, {""date"": ""2023-07-14"", ""headline"": ""Treasury yields moderate after two-day slide on light inflation data"", ""summary"": ""U.S. Treasury yields climbed on Friday, reversing some of the sharp declines seen in the last two sessions on the back of cooler-than-expected inflation prints.""}, {""date"": ""2023-07-16"", ""headline"": ""Those who invested in Moderna (NASDAQ:MRNA) three years ago are up 28%"", ""summary"": ""While Moderna, Inc. ( NASDAQ:MRNA ) shareholders are probably generally happy, the stock hasn't had particularly good...""}, {""date"": ""2023-07-16"", ""headline"": ""Buy/Sell: Wall Street's top 10 stock calls this week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.4352, ""bookValue"": 16949, ""cashRatio"": 1.2170989433237271, ""currentRatio"": 3.3939, ""ebitPerShare"": -4.9003, ""eps"": -3.622, ""ev"": 43545.934, ""fcfPerShareTTM"": -1.979, ""grossMargin"": -1.125, ""inventoryTurnoverTTM"": 3.4454, ""netDebtToTotalCapital"": -0.1541, ""netDebtToTotalEquity"": -0.1635, ""netMargin"": -4.0116, ""operatingMargin"": -5.4273, ""pb"": 2.7327, ""peTTM"": 38.3736, ""pretaxMargin"": -5.0843, ""psTTM"": 4.3474, ""ptbv"": 2.7402, ""quickRatio"": 2.9459, ""receivablesTurnoverTTM"": 7.2898, ""roaTTM"": 0.0493, ""roeTTM"": 0.0662, ""roicTTM"": 0.0626, ""rotcTTM"": 0.0266, ""salesPerShare"": 0.9029, ""sgaToSale"": 2.125, ""tangibleBookValue"": 16903, ""totalDebtToEquity"": 0.0608, ""totalDebtToTotalAsset"": 0.0471, ""totalDebtToTotalCapital"": 0.0573, ""totalRatio"": 4.4344, ""period"": ""2023-06-30""}"
27,2023-07-16,121.3499984741211,2023-07-23,126.43000030517578,0.04186239715642048,U5,"[{""date"": ""2023-07-16"", ""headline"": ""Those who invested in Moderna (NASDAQ:MRNA) three years ago are up 28%"", ""summary"": ""While Moderna, Inc. ( NASDAQ:MRNA ) shareholders are probably generally happy, the stock hasn't had particularly good...""}, {""date"": ""2023-07-16"", ""headline"": ""Buy/Sell: Wall Street's top 10 stock calls this week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""Moderna president Hoge sells 15,000 common shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-17"", ""headline"": ""If You Invested $1000 In This Stock 5 Years Ago, You Would Have $6,600 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""Check Out What Whales Are Doing With MRNA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""Moderna Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.01% higher to $122.61 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-07-18"", ""headline"": ""How Is The Market Feeling About Moderna?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-18"", ""headline"": ""Pfizer and Flagship Pioneering to invest $100 million to develop treatments for unmet medical needs"", ""summary"": ""Pfizer Inc. and Flagship Pioneering said Tuesday they are investing a total of $100 million upfront to explore opportunities to develop 10 single-asset...""}, {""date"": ""2023-07-18"", ""headline"": ""Moderna Co-Founder\u2019s Firm Bought Up This Embattled Biotech Stock"", ""summary"": ""Flagship Pioneering, an investment vehicle helmed by Noubar Afeyan, a co-founder of Moderna and its chairman, bought $12.5 million of shares of biotech Evelo.""}, {""date"": ""2023-07-19"", ""headline"": ""Uber and Snowflake Make Morningstar List of Undervalued Growth Stocks"", ""summary"": ""Growth stocks have surged 33% so far this year, and some have more room for gains, according to Morningstar.""}, {""date"": ""2023-07-19"", ""headline"": ""3 Healthcare Stocks to Buy and Hold for the Next 10 Years"", ""summary"": ""The healthcare sector is unlikely to become obsolete anytime soon, but individual companies can very much get left behind if they fail to keep up with the changing dynamics of the industry.  Let's look at three healthcare stocks that are leaders or innovators in their respective niches and could provide excellent returns in the next 10 years: Vertex Pharmaceuticals (NASDAQ: VRTX), Moderna (NASDAQ: MRNA), and Gilead Sciences (NASDAQ: GILD).  Vertex Pharmaceuticals has soundly beaten the market in the past 10 years, and the company is in an excellent position to do so in the next decade.""}, {""date"": ""2023-07-19"", ""headline"": ""Prediction: This Beaten-Down Stock Will Be a Biotech Giant by 2030"", ""summary"": ""When you think of biotech giants, you may think of Amgen or Biogen. These companies have brought significant treatments to market over time -- and have generated billions of dollars in earnings, too. Most investors would be happy to find the next company set to follow in their footsteps.""}, {""date"": ""2023-07-19"", ""headline"": ""ClearBridge Select Strategy Q2 2023 Portfolio Manager Commentary"", ""summary"": ""The ClearBridge Select Strategy performed in line with its benchmark during the second quarter of 2023. Click here to read the full fund letter.""}, {""date"": ""2023-07-19"", ""headline"": ""5 Beaten-Down Healthcare Stocks With Potential for a Rebound"", ""summary"": ""Investors have fled healthcare stocks this year, ducking out of a trade that seemed a smart defensive play last year, as market conditions have changed.""}, {""date"": ""2023-07-19"", ""headline"": ""Coinbase Global, Moderna And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-20"", ""headline"": ""Obey the Sell Signals: 3 Blue-Chip Stocks to Let Go"", ""summary"": ""FOMO is carrying the day, week and month on Wall Street. And the rally is starting to spread beyond the tech sector. This means some blue-chip stocks are beginning to catch a bid. That\u2019s encouraging news. However, while this rally may have legs, there are still some blue-chip stocks to avoid. Blue-chip stocks are sought after for their financial stability. These companies tend to stack quarter after quarter of solid revenue and earnings. And many pay dividends, which adds to their appeal. But no""}, {""date"": ""2023-07-20"", ""headline"": ""Moderna (MRNA) Stock Moves -0.32%: What You Should Know"", ""summary"": ""Moderna (MRNA) closed at $124.77 in the latest trading session, marking a -0.32% move from the prior day.""}, {""date"": ""2023-07-20"", ""headline"": ""Tesla Q2 Earnings Confirm Our Thesis, It Is One Of The Most Overvalued Stocks"", ""summary"": ""Tesla stock is overvalued and should be closer to $26 per share. Learn why TSLA's fundamentals are disconnected from reality.""}, {""date"": ""2023-07-20"", ""headline"": ""Moderna Inc. stock falls Thursday, still outperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 0.32% to $124.77 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-07-21"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. rose 1.33% to $126.43 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-07-22"", ""headline"": ""Moderna director sells $1.88M in common stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
28,2023-07-23,126.43000030517578,2023-07-30,118.66000366210938,-0.06145690598996478,D5+,"[{""date"": ""2023-07-23"", ""headline"": ""Moderna Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-23"", ""headline"": ""Fentanyl Crisis In US: Biden Administration Contemplates Easing Sanctions on China's Forensic Institute"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023"", ""summary"": ""Growth investors are frequently looking for biotech stocks to buy. So what exactly is a biotech stock? It\u2019s a company that\u2019s somehow involved in the creation of innovative drugs. This can be through research, development, or production. This sector saw a huge pandemic-related boost when the mRNA technology that many of them specialize in was thrust into the spotlight. The biotech industry is underpinned by some pretty undeniable growth trends. First and foremost is the aging global population. A""}, {""date"": ""2023-07-24"", ""headline"": ""AstraZeneca (AZN) to Report Q2 Earnings: What's in the Cards?"", ""summary"": ""Higher sales of AstraZeneca's (AZN) key medicines, Lynparza, Tagrisso, Imfinzi and Farxiga, are likely to have driven sales, partially offset by lower sales of legacy drugs.""}, {""date"": ""2023-07-24"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Moderna Is Fairly Valued, Balancing Declining COVID-19 Base Business with Promising Future Pipeline: Analyst"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Cathie Wood's Ark Buy More Moderna Shares As It Trims Stake In This Warren Buffett-Backed EV Maker"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Cathie Wood's Ark Invest Makes Major Moves In This Warren Buffett-Backed EV Company, Moderna"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Tesla downgraded, Netflix upgraded: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Moderna price target lowered to $165 from $175 at TD Cowen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Moderna initiated with a Market Perform at William Blair"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-24"", ""headline"": ""Moderna Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-25"", ""headline"": ""Moderna Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-25"", ""headline"": ""Moderna On Cathie Wood's Radar Ahead Of Q2 Results: Ark Boosts Stake In COVID-19 Vaccine Maker By $12M This Week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-25"", ""headline"": ""Notable Wednesday Option Activity: MRNA, ANET, GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-25"", ""headline"": ""Moderna Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 0.93% to $121.87 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-07-25"", ""headline"": ""Moderna Unusual Options Activity For July 25"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-25"", ""headline"": ""Pfizer and Moderna\u2019s parent are investing $100 million in a new partnership to find the next big drug"", ""summary"": ""\""What we are doing now, I don\u2019t think anyone has done so far,\"" Pfizer CEO Albert Bourla says.""}, {""date"": ""2023-07-25"", ""headline"": ""William Blair Initiates Coverage of Moderna (MRNA) with Market Perform Recommendation"", ""summary"": """"}, {""date"": ""2023-07-25"", ""headline"": ""TD Cowen Maintains Moderna (MRNA) Outperform Recommendation"", ""summary"": """"}, {""date"": ""2023-07-26"", ""headline"": ""$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,400 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-26"", ""headline"": ""Moderna (MRNA) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""In the latest trading session, Moderna (MRNA) closed at $120.65, marking a -1% move from the previous day.""}, {""date"": ""2023-07-26"", ""headline"": ""Report: Moderna inks large sublease in Seattle"", ""summary"": ""Around 70 Seattle LinkedIn users list Moderna as their employer, and Moderna's website lists 46 open positions here.""}, {""date"": ""2023-07-26"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 1.00% to $120.65 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-07-26"", ""headline"": ""UPDATE 3-Moderna/Merck begins late-stage study of skin cancer vaccine combination"", ""summary"": ""Moderna and its partner Merck said on Wednesday that they had begun enrolling patients in a late-stage study testing their personalized mRNA-based skin cancer vaccine in combination with the immunotherapy Keytruda.  Data from a mid-stage study in 157 patients had shown that the vaccine combination cut the risk of recurrence or death by 44% in patients with melanoma, the most deadly form of skin cancer, when compared with Keytruda alone.  The companies are testing the vaccine in melanoma patients whose tumors were surgically removed before being treated with either the drug-vaccine combination or Keytruda alone.""}, {""date"": ""2023-07-26"", ""headline"": ""Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings"", ""summary"": ""Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.""}, {""date"": ""2023-07-26"", ""headline"": ""Individualized Cancer Treatment: Merck/Moderna's Personalized Skin Cancer Therapy Enters Late-Stage Of Development"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-26"", ""headline"": ""CORRECTED-UPDATE 2-Moderna/Merck begins late-stage study of skin cancer vaccine combination"", ""summary"": ""Moderna said on Wednesday it has begun enrolling patients in a late-stage study evaluating its and partner Merck's personalised mRNA-based skin cancer vaccine in combination with the drugmaker's blockbuster therapy Keytruda.  Data from a mid-stage study had shown that the combination cut the risk of recurrence or death of melanoma, the most deadly form of skin cancer, by 44% when compared with Keytruda alone.  The companies would now test if the combination would be effective in cutting the risk of disease recurrence in a larger trial of about 1,089 patients.""}, {""date"": ""2023-07-26"", ""headline"": ""Merck and Moderna Initiate Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA\u00ae (pembrolizumab) for Adjuvant Treatment of Patients with Resected High-Risk (Stage IIB-IV) Melanoma"", ""summary"": ""RAHWAY, N.J. & CAMBRIDGE, Mass., July 26, 2023--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced the initiation of the pivotal Phase 3 randomized V940-001 clinical trial evaluating V940 (mRNA-4157), an investigational individualized neoantigen therapy (INT), in combination with KEYTRUDA, Merck\u2019s anti-PD-1 therapy, as an adjuvant treatment in""}, {""date"": ""2023-07-26"", ""headline"": ""Moderna, Merck begin phase 3 trial on mRNA melanoma combo treatment"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-26"", ""headline"": ""Merck and Moderna launch late-stage trial of V940 with Keytruda as treatment for high-risk melanoma"", ""summary"": ""Merck & Co. and Moderna Inc. said Wednesday they have launched a Phase 3 trial of Moderna\u2019s V940 in combination with Merck\u2019s Keytruda as a treatment for...""}, {""date"": ""2023-07-26"", ""headline"": ""Merck, Moderna initiate Phase 3 study of V940 in combination with Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Earnings week ahead: Amazon, Apple, Pfizer, Starbucks, Uber and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-27"", ""headline"": ""Cathie Wood Is Buying Up Shares of This Beaten-Down Biotech. Should You?"", ""summary"": ""Cathie Wood is known for betting on innovative companies, with the idea that they'll deliver game-changing results over the long term.  The founder of ARK Invest loves these players' exciting products or product candidates and their potential for earnings and share performance down the road.  In the investor's latest shopping spree, she snapped up more than 98,800 shares of Moderna (NASDAQ: MRNA) over a two-day period.""}, {""date"": ""2023-07-27"", ""headline"": ""Moderna Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 1.77% to $118.51 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-07-27"", ""headline"": ""BioNTech And Moderna: Fallen Angels Of The COVID Era Are Buys Ahead Of Earnings"", ""summary"": ""BioNTech and Moderna will always be compared due to the phenomenal success of their COVID vaccines. Click here to see our take on BNTX stock now.""}, {""date"": ""2023-07-28"", ""headline"": ""As COVID-19 Cases Spike This Summer, Healthcare Experts See It As Recurring Theme And Recommend These Measures"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""Moderna Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.13% higher to $118.66 Friday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-07-28"", ""headline"": ""Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III"", ""summary"": ""AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results.""}, {""date"": ""2023-07-28"", ""headline"": ""Worried about Lyme disease? CDC warns that 450,000 people may have been infected by a tick-related meat allergy."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""William Blair to hold a webinar on initiation of coverage"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""Earnings This Week: Apple, Amazon And AMD"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""Moderna director sells $1.81M in common stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-28"", ""headline"": ""20 Countries With Highest Rates of Cancer"", ""summary"": ""In this article, we\u2019ll take a detailed look at the 20 countries with the highest rates of cancer. For a quick overview of the top five countries, read our article 5 Countries With Highest Rates of Cancer. Cancer, a pervasive and devastating disease, leaves a profound global impact. Also known as malignant tumors or neoplasms, [\u2026]""}, {""date"": ""2023-07-29"", ""headline"": ""RSV treatment market to surge past $9B by 2029"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-29"", ""headline"": ""What is alpha-gal syndrome? CDC warns 450,000 people may have had this tick-related meat allergy."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
29,2023-07-30,118.66000366210938,2023-08-06,108.19000244140625,-0.08823530168191307,D5+,"[{""date"": ""2023-07-29"", ""headline"": ""RSV treatment market to surge past $9B by 2029"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-30"", ""headline"": ""7 Stocks to Buy Before They Surpass 2021 Highs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""15 Worst Performing NASDAQ Stocks In 2023"", ""summary"": ""In this article, we discuss 15 worst performing NASDAQ stocks in 2023. If you want to skip our detailed discussion on the stock market performance this year, head directly to 5 Worst Performing NASDAQ Stocks In 2023. The tech rally so far in 2023 has fueled the momentum of the NASDAQ 100 Index, as it [\u2026]""}, {""date"": ""2023-07-31"", ""headline"": ""3 Health Care Stocks That Fit Ben Graham's Lost Formula"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""Stocks That Hit 52-Week Lows On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""Moderna Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Moderna Inc. dropped 0.84% to $117.66 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-07-31"", ""headline"": ""Moderna (MRNA) to Report Q2 Earnings: Will It Beat Estimates?"", ""summary"": ""Investors' focus will likely be on updates on Moderna's (MRNA) pipeline, especially its late-stage pipeline candidates when it reports second-quarter earnings.""}, {""date"": ""2023-07-31"", ""headline"": ""Tracking Baillie Gifford's 13F Portfolio - Q2 2023 Update"", ""summary"": ""Baillie Gifford's 13F portfolio value increased from ~$111B to ~$118B this quarter. Top three holdings make up ~17% of the portfolio. Click here to read more.""}, {""date"": ""2023-07-31"", ""headline"": ""Merck Q2 Earnings Preview: Analyst Expectations, Jim Cramer's View, And The Spotlight On Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""5 things to know before the stock market opens Monday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""2023-07-31"", ""headline"": ""Accenture, Hewlett Packard Enterprise And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-07-31"", ""headline"": ""7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""Notable Wednesday Option Activity: MRNA, CNNE, NVCR"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""3 \u2018Strong Buy\u2019 Biotech Stocks You Should Be Loading Up On Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. shed 3.16% to $113.94 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-08-01"", ""headline"": ""Daiichi COVID vaccine endorsed in Japan; Shionogi\u2019s shot declined"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-01"", ""headline"": ""Merck Earnings Top Expectations. More M&A Could Be Next."", ""summary"": ""CFO Caroline Litchfield said sales of the company\u2019s cancer treatments and vaccines were growing and more M&A could be on the horizon.""}, {""date"": ""2023-08-01"", ""headline"": ""Moderna Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""Baillie Gifford Reduces Stake in Upwork Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""Baillie Gifford Reduces Stake in SiteOne Landscape Supply Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""Baillie Gifford Acquires Significant Stake in Sweetgreen Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""What You Missed On Wall Street On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""U.S. stocks edge lower after biggest drop in 3 months"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""GLOBAL BRIEFING: China's services see strong growth in July"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""Stock futures are little changed Wednesday night after U.S. downgrade spurs a selloff: Live updates"", ""summary"": ""Fitch\u2019s recent downgrade of the United States\u2019 long-term rating dragged down investors\u2019 spirits \u2013 as well as the major averages.""}, {""date"": ""2023-08-02"", ""headline"": ""NEW YORK MARKET CLOSE: Fitch downgrade sparks retreat on Wall Street"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""Should You Buy Moderna (MRNA) Ahead of Earnings?"", ""summary"": ""Moderna (MRNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.""}, {""date"": ""2023-08-02"", ""headline"": ""Moderna's COVID-19 vaccine safest, most effective for older adults, study says"", ""summary"": ""In examining real-world data on the long-term health of elderly patients who received the COVID-19 vaccine, researchers at Brown University and Boston-based Hebrew SeniorLife determined that the...""}, {""date"": ""2023-08-02"", ""headline"": ""Possible Bearish Signals With Moderna Insiders Disposing Stock"", ""summary"": ""The fact that multiple Moderna, Inc. ( NASDAQ:MRNA ) insiders offloaded a considerable amount of shares over the past...""}, {""date"": ""2023-08-02"", ""headline"": ""Can Moderna spring a surprise for Q2 2023 despite falling vaccine demand"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""Moderna's COVID-19 vaccine proves safest, most effective for older adults, study says"", ""summary"": ""In examining real-world data on the long-term health of elderly patients who received the COVID-19 vaccine, researchers at Brown University and Boston-based Hebrew SeniorLife determined that the...""}, {""date"": ""2023-08-02"", ""headline"": ""GSK sues Pfizer in U.S. court for patent infringement over RSV vaccine"", ""summary"": ""Both RSV vaccines were approved by the U.S. Food and Drug Administration for use in adults 60 and above.""}, {""date"": ""2023-08-02"", ""headline"": ""Check Out What Whales Are Doing With MRNA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-02"", ""headline"": ""Moderna Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""What You Missed On Wall Street On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna Inc. stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Q2 2023 Moderna Inc Earnings Call"", ""summary"": ""Q2 2023 Moderna Inc Earnings Call""}, {""date"": ""2023-08-03"", ""headline"": ""Stocks That Hit 52-Week Lows On Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Deutsche Bank Downgrades Moderna (MRNA)"", ""summary"": """"}, {""date"": ""2023-08-03"", ""headline"": ""Moderna's Game Over? Not Quite, As Company Boosts Its 2023 Outlook"", ""summary"": ""Moderna raised its outlook for the year on Thursday, predicting $6 billion to $8 billion in Covid vaccine sales. MRNA stock edged down.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna (MRNA) Price Target Decreased by 5.49% to 206.23"", ""summary"": """"}, {""date"": ""2023-08-03"", ""headline"": ""Health Care Down Slightly After Moderna, Merck KGaA Earnings -- Health Care Roundup"", ""summary"": ""Health-care companies fell slightly after mixed earnings reports. Moderna shares were more or less flat after the biotech concern, which developed one of the...""}, {""date"": ""2023-08-03"", ""headline"": ""Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work."", ""summary"": ""The biggest names in Covid are updating their vaccines for a fall campaign, but that might not bolster Pfizer stock and Moderna stock.""}, {""date"": ""2023-08-03"", ""headline"": ""NEW YORK MARKET CLOSE: Rising yields and looming jobs report limit Dow"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""US STOCKS-S&P 500, Dow slip in volatile session as yields rise, earnings disappoint"", ""summary"": ""The Dow and the S&P 500 slipped in choppy trading on Thursday as a jump in bonds yields, downbeat corporate earnings and a slew of economic data pointing to stubborn inflation kept investors on edge.  Market participants have been keeping a close watch on data as they fear the Federal Reserve may stick to its rate-hike path if it fails to bring inflation within its targeted range.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna (MRNA) Beats on Q2 Earnings & Sales, Raises '23 View"", ""summary"": ""Moderna (MRNA) beats expectations for earnings and sales. Management raises its product revenue guidance based on potential U.S. demand for COVID vaccines during the upcoming fall season.""}, {""date"": ""2023-08-03"", ""headline"": ""Trending : Moderna Posts Loss as Vaccine Sales Decline"", ""summary"": ""1458 ET -- Moderna is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The company reported a $1.38 billion quarterly loss....""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna (MRNA) Q2 2023 Earnings Call Transcript"", ""summary"": ""Good morning, everyone, and thank you for joining us on today's call to discuss Moderna's second-quarter 2023 financial results and business updates.  On today's call are St\u00e9phane Bancel, our chief executive officer; Stephen Hoge, our president; Arpa Garay, our chief commercial officer; and Jamie Mock, our chief financial officer.""}, {""date"": ""2023-08-03"", ""headline"": ""US STOCKS-Wall St slides on rising bond yields, mixed earnings"", ""summary"": ""Wall Street's main indexes slipped on Thursday as a jump in bonds yields, a mixed bag of corporate earnings and a slew of economic data pointing to stubborn inflation kept investors on edge.  Market participants have been keeping a close watch on data as they fear the Federal Reserve may stick to its rate hike path if it fails to bring inflation within its targeted range.  Another report showed the U.S. services sector slowed in July, but businesses faced higher prices for inputs as demand continued to hold up, suggesting a long and slow road to low inflation.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna Raises Hope, Concern, With Update on Sales of Covid-19 Vaccine"", ""summary"": ""The vaccine maker  Moderna  offered a mixed report about sales of its Covid-19 vaccine, leaving uncertainty about the main issue affecting its near-term prospects.  Moderna  (ticker: MRNA) raised its projection for Covid-19 vaccine sales this year, saying it now expects full-year sales of between $6 billion and $8 billion, up from its previous forecast of at least $5 billion.  At the same time, however, the company said that $1 billion of Covid-19 vaccines originally intended to be delivered in 2023 under advance-purchase agreements had been deferred until 2024.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna shares up after hiking forecast on Covid-19 vaccine"", ""summary"": ""Moderna stock is on the rise after the company hikes its full-year forecast on its Covid-19 vaccine. Yahoo Finance Live's Julie Hyman breaks down the story.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna ups forecast for fall Covid vaccines, but there's one question mark"", ""summary"": ""With the fall launch of its updated Covid-19 vaccine likely weeks away, Moderna Inc. is forecasting sales of $6 to $8 billion, up from the $5 billion it previously forecast. But there's one major unknown for the Cambridge biotech.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna, Inc. (MRNA) Q2 2023 Earnings Call Transcript"", ""summary"": ""Moderna, Inc. (NASDAQ:NASDAQ:MRNA) Q2 2023 Results Earnings Conference Call August 3, 2023 8:00 AM ETCompany ParticipantsLavina Talukdar - Head, Investor RelationsSt\u00c3\u00a9phane Bancel - Chief...""}, {""date"": ""2023-08-03"", ""headline"": ""Midday movers: Qualcomm, PayPal, DoorDash, Moderna and more"", ""summary"": ""Investing.com -- U.S. stocks were rebounding on Thursday, with investors getting set for earnings reports from tech giants Apple (NASDAQ:AAPL) and Amazon (NASDAQ:AMZN).""}, {""date"": ""2023-08-03"", ""headline"": ""US STOCKS-Wall St set to open lower as Treasury yields hit nine-month high"", ""summary"": ""Most megacap growth and technology stocks including Apple , Alphabet and Microsoft slipped between 0.3% and 0.7% in premarket trading, as yields on the 10-year note rose to a nine-month high.  The yield on the 10-year benchmark note rose 1.2 basis points to 4.158% after the jobless claims data.  \""I would take that (jobless claims) data as a non-event, it is right on target,\"" said Andre Bakhos, managing member at Ingenium Analytics.""}, {""date"": ""2023-08-03"", ""headline"": ""Stocks edge higher as S&P 500 consolidates after biggest drop in 3 months"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna (MRNA) Reports Q2 Loss, Tops Revenue Estimates"", ""summary"": ""Moderna (MRNA) delivered earnings and revenue surprises of 5.73% and 18.32%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""2023-08-03"", ""headline"": ""Regeneron Pharmaceuticals Inc: A Biotech Powerhouse with High Outperformance Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Nasdaq turns positive, U.S. stocks pare losses after productivity report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""UPDATE 4-Moderna sees up to $4 billion in 2023 sales from private market for COVID shots"", ""summary"": ""Moderna Inc on Thursday forecast as much as $4 billion in revenue from its COVID-19 vaccine when sales shift to a private market from government contracts this year, and said it expects demand to grow further in 2024 and match the market for flu shots.  The vaccine maker anticipates $4 billion in sales to governments this year, and between $2 and $4 billion in a private market for the shot in the United States and other countries.  It had previously expected sales of $5 billion from government contracts.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna sees up to $4 billion in 2023 sales from private market for COVID shots"", ""summary"": ""(Reuters) -Moderna Inc on Thursday forecast as much as $4 billion in revenue from its COVID-19 vaccine when sales shift to a private market from government contracts this year, and said it expects demand to grow further in 2024 and match the market for flu shots.  The vaccine maker anticipates $4 billion in sales to governments this year, and between $2 and $4 billion in a private market for the shot in the United States and other countries.  It had previously expected sales of $5 billion from government contracts.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna sees up to $8 bln in 2023 COVID vaccine sales on private market hopes"", ""summary"": ""Moderna Inc on Thursday raised its annual forecast for COVID-19 vaccine sales to up to $8 billion on hopes of a boost in the fall season as sales move to a private market in the United States from government contracts.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna Reports Second Quarter 2023 Financial Results and Provides Business Updates"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today reported financial results and provided business updates for the second quarter of 2023.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna sees 2023 COVID-19 vaccine sales of $6B-$8B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna reports Q2 EPS ($3.62), consensus ($3.92)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""First Week of January 2025 Options Trading For Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna Lifts 2023 COVID-19 Vaccine Sales Outlook, Despite Over 90% Fall In Q2 Sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna : 2Q 2023 Earnings Call Presentation"", ""summary"": ""Second Quarter 2023 Financial Results\n        \n        \n          August 3, 2023\n        \n      \n      \n        \n          \u00a9 2023 Moderna, Inc. All rights reserved.\n       ...""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna downgraded at Deutsche Bank on outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""TOP NEWS: Moderna turns to loss amid fewer Covid-related sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""U.S. stocks headed for 3rd straight drop as jobs report, earnings from Apple, Amazon loom"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Deutsche downgrades Moderna to Hold on low revenue visibility"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna, Inc. 2023 Q2 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Moderna, Inc.""}, {""date"": ""2023-08-03"", ""headline"": ""Stocks making the biggest moves premarket: Qualcomm, Moderna, PayPal and more"", ""summary"": ""These are the stocks posting the largest moves in premarket trading.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna downgraded to Hold from Buy at Deutsche Bank"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna (NASDAQ:MRNA) Expects Upbeat COVID-19 Vaccine Sales for 2023; Late Stage Pipeline Impresses"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""5 things to know before the stock market opens Thursday"", ""summary"": ""Here are the most important news items that investors need to start their trading day.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna revenue beats estimates despite COVID vaccine sales slump"", ""summary"": ""Investing.com -- Moderna (NASDAQ:MRNA) has reported better-than-expected revenue in the second quarter despite falling steeply due to weaker post-pandemic demand for its COVID-19 vaccine.""}, {""date"": ""2023-08-03"", ""headline"": ""U.S. stock futures point to third straight drop to kick off August"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna\u2019s stock jumps 5% premarket after narrower-than-expected loss and revenue beat"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna shares rise on better Covid vaccine outlook despite sharp drop in sales"", ""summary"": ""Moderna and its rivals Pfizer and Novavax have all seen a steep drop in sales of Covid vaccines and treatments as the world moves on from the pandemic. \u00a0""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna's stock jumps 5% premarket after narrower-than-expected loss and revenue beat"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna raises COVID vaccine sales outlook despite 94% Q2 drop"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""US Stock Futures Dip As Apple, Amazon Earnings Loom: Analyst Warns Of 'Perfectly Normal' 5% Pullback This Month"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""U.S. stocks fall for third day as bond yields surge"", ""summary"": ""U.S. stocks end lower Thursday as a global bond market selloff sent yields higher.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna (MRNA) Gets a Hold from Bank of America Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Moderna beats Q2 top and bottom line estimates; updates FY23 outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Baillie Gifford Boosts Stake in Sweetgreen Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-03"", ""headline"": ""Apple among BofA picks for options opportunity on earnings surprise"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""Morgan Stanley Maintains Moderna (MRNA) Equal-Weight Recommendation"", ""summary"": """"}, {""date"": ""2023-08-04"", ""headline"": ""B of A Securities Maintains Moderna (MRNA) Neutral Recommendation"", ""summary"": """"}, {""date"": ""2023-08-04"", ""headline"": ""RBC Capital Maintains Moderna (MRNA) Outperform Recommendation"", ""summary"": """"}, {""date"": ""2023-08-04"", ""headline"": ""Moderna (MRNA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates"", ""summary"": ""While the top- and bottom-line numbers for Moderna (MRNA) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.""}, {""date"": ""2023-08-04"", ""headline"": ""TD Cowen Downgrades Moderna (MRNA)"", ""summary"": """"}, {""date"": ""2023-08-04"", ""headline"": ""Apple downgraded, Amazon upgraded: Wall Street's top analyst calls"", ""summary"": ""Apple downgraded, Amazon upgraded: Wall Street's top analyst calls""}, {""date"": ""2023-08-04"", ""headline"": ""What To Do After July's Job Report"", ""summary"": ""Employment increased by 187,000 in July, led by healthcare, social assistance, financial activities, and wholesale trade. Read what the latest jobs report means for markets.""}, {""date"": ""2023-08-04"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""Moderna under pressure as TD Cowen becomes latest to downgrade"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""Friday\u2019s Top Wall Street Analyst Upgrades and Downgrades: Etsy, Moderna, Qualcomm, Roku, Ross Stores, Royal Caribbean, Southwest Airlines, Wayfair and More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""Friday\u2019s Top Upgrades and Downgrades: DXC Technology, Etsy, Moderna, PagSeguro Digital, Qualcomm, Roku, Ross Stores, Royal Caribbean Cruises, Southwest Airlines, Spirit AeroSystems, StoneCo, Wayfair"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""Moderna price target lowered to $175 from $275 at Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""Moderna price target lowered to $150 from $175 at BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-04"", ""headline"": ""4 big analyst cuts: Etsy slashed to market perform, Moderna downgraded twice"", ""summary"": ""\""We are late on this one. You live and you learn. We were hoping that Q3 GMS guidance and management commentary could draw a line in the sand on the business returning to growth, but it wasn't quite as reassuring.\""""}, {""date"": ""2023-08-04"", ""headline"": ""Moderna downgraded to Market Perform from Outperform at TD Cowen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-05"", ""headline"": ""10 Oversold Blue Chip Stocks To Buy"", ""summary"": ""In this article, we will be taking a look at 10 oversold blue chip stocks to buy. To skip our detailed analysis of current market conditions, you can go directly to see the 5 Oversold Blue Chip Stocks To Buy. The markets have been full of surprises so far this year. With rampant inflation and [\u2026]""}, {""date"": ""2023-08-05"", ""headline"": ""Moderna, Inc. (NASDAQ:MRNA) Q2 2023 Earnings Call Transcript"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA) Q2 2023 Earnings Call Transcript August 3, 2023 Moderna, Inc. misses on earnings expectations. Reported EPS is $-3.62 EPS, expectations were $3.84. Operator: Good day and thank you for standing by. Welcome to Moderna Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. After the speakers\u2019 [\u2026]""}]",{}
30,2023-08-06,108.19000244140625,2023-08-13,101.48999786376953,-0.06192813038584888,D5+,"[{""date"": ""2023-08-06"", ""headline"": ""Moderna Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-06"", ""headline"": ""Why did Moderna stock go down today? Bearish views pile up"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-07"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-07"", ""headline"": ""Moderna Weakens With No Bottom in Sight"", ""summary"": ""Vaccine maker Moderna has slumped to a new 52-week low Monday. Let's check out the trends and conditions of the charts and indicators. In the daily bar chart of MRNA, below, I can see a weak setup. The shares have been in a downward trend since December.""}, {""date"": ""2023-08-07"", ""headline"": ""People are 'scratching and clawing' for negative narrative around obesity drugs: Mizuho's Jared Holz"", ""summary"": ""Jared Holz, Mizuho healthcare sector specialist, joins 'Fast Money' to talk Eli Lilly earnings, obesity drug demand and more.""}, {""date"": ""2023-08-07"", ""headline"": ""Is Moderna (MRNA) a Potential Value Trap? A Deep Dive into the Financials"", ""summary"": ""Assessing Moderna's Stock Value Amidst Market Fluctuations""}, {""date"": ""2023-08-07"", ""headline"": ""Stocks Rebound, Value Makes Comeback, Treasury Yields  Resume Climb: What's Driving Markets Monday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-07"", ""headline"": ""Can Novavax beat in Q2 amid pressure on COVID vaccine sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-07"", ""headline"": ""Stocks making the biggest moves midday: Tesla, Berkshire Hathaway, PayPal, Cinemark and more"", ""summary"": ""These are the stocks posting the largest moves in midday trading. ""}, {""date"": ""2023-08-07"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, BKNG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-07"", ""headline"": ""Monday\u2019s Top Wall Street Analyst Upgrades and Downgrades: Amazon, Apple, Block, Coinbase, Datadog, Fortinet, Gilead Sciences, Moderna, Nvidia, PayPal, Petrobras and More"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-07"", ""headline"": ""Analysts Are Bullish on Top Healthcare Stocks: Moderna (MRNA), SAGE Therapeutics (SAGE)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-07"", ""headline"": ""BioNTech Stock Was a Covid Darling. Now It\u2019s Paying the Price."", ""summary"": ""Sales drop by more than expected in the second quarter, but BioNTech says its new 'variant-adapted Covid-19 vaccine' is still on track.""}, {""date"": ""2023-08-08"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-08"", ""headline"": ""Institutional owners may consider drastic measures as Moderna, Inc.'s (NASDAQ:MRNA) recent US$6.3b drop adds to long-term losses"", ""summary"": ""Key Insights Significantly high institutional ownership implies Moderna's stock price is sensitive to their trading...""}, {""date"": ""2023-08-08"", ""headline"": ""15 Worst Performing Biotech Stocks in 2023"", ""summary"": ""In this article, we discuss 15 worst performing biotech stocks in 2023. If you want to skip our detailed discussion about the biotech industry, head directly to 5 Worst Performing Biotech Stocks in 2023. The biotech industry was the center of global attention during the pandemic. With accelerated efforts to come up with vaccinations to [\u2026]""}, {""date"": ""2023-08-09"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""WHO names Eris a COVID variant of interest. Here\u2019s what you need to know."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""3 Healthcare Stocks to Sell in August Before They Crash and Burn"", ""summary"": ""Healthcare continues to lag in the broader market. Year to date, the Standards and Practices (S&P) 500 Health Care index is down 2% versus a 17% gain in the benchmark S&P 500 index. The declines among healthcare stocks are broad-based, with health insurers, pharmaceutical companies and device manufacturers all trailing the stock market. Fears of a recession and a presidential election cycle kicking into gear help to account for the declines. Spending on non-urgent medical procedures tends to tap""}, {""date"": ""2023-08-09"", ""headline"": ""Unusual Put Option Trade in Moderna (MRNA)  Worth $9,868.50K"", ""summary"": """"}, {""date"": ""2023-08-09"", ""headline"": ""WHO names newly dominant EG.5 strain as COVID 'variant of interest'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""The 3 Best Healthcare Stocks to Buy in August"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-09"", ""headline"": ""Alltrna Announces Series B Raise of $109 Million to Advance tRNA Medicines for Stop Codon Disease"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""Buy Merck (MRK) Stock Now to Ride a Wave Higher in Healthcare"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-10"", ""headline"": ""The Moderna COVID-19 vaccine was the ultimate home run for this biotech venture firm. It\u2019s a tough act to follow"", ""summary"": ""Unorthodox, brash, and sometimes controversial, Flagship Pioneering is looking for its next blockbuster.""}, {""date"": ""2023-08-10"", ""headline"": ""Vertex: Continued Advances In Cystic Fibrosis Market With Expansion Plans"", ""summary"": ""Vertex Pharmaceuticals is performing well in cystic fibrosis market with its drug Trikafta, leading to 2023 guidance increase. Find out why VRTX stock is a Strong Buy.""}, {""date"": ""2023-08-10"", ""headline"": ""Moderna Falling As Vaccine Hesitancy Rises"", ""summary"": ""Moderna's stock has dropped further as revenues plunge with faltering Covid-19 vaccine sales. Read more here.""}, {""date"": ""2023-08-10"", ""headline"": ""Warning: MRNA is at high risk of performing badly"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-11"", ""headline"": ""3 Pharma Stocks to Sell in August Before They Crash and Burn"", ""summary"": ""With pharmaceutical companies, it\u2019s all about the pipeline of new medications. Drugmakers, and their pharma stocks, are judged based on sales of current medications and potential sales of future prescriptions. Analysts and investors alike are always on the lookout for the next blockbuster drug. This helps to explain why the stocks of pharmaceutical companies with weight-loss medications in their pipeline have gone through the roof this year. Wall Street sees weight loss drugs as the next frontie""}, {""date"": ""2023-08-11"", ""headline"": ""Covid Vaccine Revenues Are Caving. New Boosters May Not Help."", ""summary"": ""Moderna and Pfizer expected strong demand for the latest Covid shots. Now they're walking back those projections.""}, {""date"": ""2023-08-11"", ""headline"": ""WHO names Eris a coronavirus variant of interest. Here\u2019s what you need to know."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-11"", ""headline"": ""Meet Eris, The COVID Variant Behind A Summer Resurgence In Cases: 3 Drugmakers Prep Fall Booster Shots"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-12"", ""headline"": ""Moderna, Inc.'s (NASDAQ:MRNA) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?"", ""summary"": ""It is hard to get excited after looking at Moderna's (NASDAQ:MRNA) recent performance, when its stock has declined 22...""}, {""date"": ""2023-08-13"", ""headline"": ""15 Worst Performing Healthcare Stocks in 2023"", ""summary"": ""In this article, we discuss 15 worst performing healthcare stocks in 2023. If you want to skip our detailed discussion about the healthcare industry, head directly to 5 Worst Performing Healthcare Stocks in 2023. In 2021, healthcare spending in the United States accounted for over 18.3% of its GDP and the national healthcare expenditure came [\u2026]""}, {""date"": ""2023-08-13"", ""headline"": ""New Covid Strain Arrives as Vaccine Makers Gear Up"", ""summary"": ""Pfizer, Moderna, and Novavax are getting ready to roll out updated Covid-19 vaccines that will target recent strains, though not specifically the most...""}, {""date"": ""2023-08-13"", ""headline"": ""Inside COVID-19 vaccine makers: Hope vs hype"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
31,2023-08-13,101.48999786376953,2023-08-20,101.62000274658203,0.0012809625140302039,U1,"[{""date"": ""2023-08-13"", ""headline"": ""Moderna Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-13"", ""headline"": ""15 Worst Performing Healthcare Stocks in 2023"", ""summary"": ""In this article, we discuss 15 worst performing healthcare stocks in 2023. If you want to skip our detailed discussion about the healthcare industry, head directly to 5 Worst Performing Healthcare Stocks in 2023. In 2021, healthcare spending in the United States accounted for over 18.3% of its GDP and the national healthcare expenditure came [\u2026]""}, {""date"": ""2023-08-13"", ""headline"": ""New Covid Strain Arrives as Vaccine Makers Gear Up"", ""summary"": ""Pfizer, Moderna, and Novavax are getting ready to roll out updated Covid-19 vaccines that will target recent strains, though not specifically the most...""}, {""date"": ""2023-08-13"", ""headline"": ""Inside COVID-19 vaccine makers: Hope vs hype"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""As the new Eris Covid variant spreads across the world, here\u2019s what we know so far"", ""summary"": ""EG.5 or \""Eris,\"" now the dominant variant in the United States, is currently thought to have the same risk level as existing variants. ""}, {""date"": ""2023-08-14"", ""headline"": ""Moderna Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""UMass Chan Medical School announces enrollment in study to examine impact of cytomegalovirus (CMV) transmission in early education settings"", ""summary"": ""UMass Chan Medical School today announced it will begin enrolling participants at group child care and early childhood education settings in Worcester and Cambridge to examine the impact of cytomegalovirus (CMV) transmission. The study is a collaboration with Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA)-based therapeutics and vaccines, which is currently researching a vaccine for CMV.""}, {""date"": ""2023-08-14"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""China Looks to Attract Foreign Investment as Its Economy Struggles"", ""summary"": ""(Bloomberg) -- China\u2019s latest attempt to reverse the nation\u2019s foreign investment slump includes pledges to offer overseas firms better tax treatment and make it easier for them to obtain visas, as officials try to allay fears about doing business in the world\u2019s second-largest economy. Most Read from BloombergOutsider Milei Upends Argentina\u2019s Election With Primary WinAmerica\u2019s Fastest Growing City Is Embracing \u2018Yellowstone\u2019 ManiaZuckerberg Says \u2018Time to Move On\u2019 From Musk Cage FightRuble Sinks to""}, {""date"": ""2023-08-14"", ""headline"": ""New Covid vaccines are on the way as 'Eris' variant rises"", ""summary"": ""A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly received even as hospitalizations from \""Eris\"", a variant of the Omicron form of the coronavirus, rise around the country.  Some public health experts hope that Americans will welcome the new shot as they would a flu jab.  In the fall of 2022, by which time most people had either had the COVID virus or the vaccine, fewer than 50 million people got the shots.""}, {""date"": ""2023-08-14"", ""headline"": ""UMass Chan Medical School to begin enrolling study on CMV transmission"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""$1000 Invested In This Stock 5 Years Ago Would Be Worth $5,300 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-14"", ""headline"": ""Flagship Pioneering Appoints Jason Gardner as CEO-Partner and CEO of Ampersand Biomedicines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""Outlook For Healthcare Sector As Obesity Drugs Gain Popularity"", ""summary"": ""Risk-on sentiment and end of pandemic boom have weighed on healthcare. Health insurers and medical device firms have held up better. Growing opportunity in obesity treatments.""}, {""date"": ""2023-08-15"", ""headline"": ""Can Moderna (MRNA) Diversify Beyond Its COVID-19 Jab Sales?"", ""summary"": ""With COVID-19 vaccine sales declining, Moderna (MRNA) is accelerating the development of its non-COVID pipeline. It is gearing up for potential product launches over the next three years.""}, {""date"": ""2023-08-15"", ""headline"": ""Alltrna Expands Leadership Team with Appointments of Chief Scientific Officer and Chief Technology Officer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-15"", ""headline"": ""Your Mid-August Market Update: Selling And Scanning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Moderna says updated COVID vaccine effective against widely circulating Eris variant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""MRNA Stock Alert: Why Is Moderna Up 7% Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Stocks Waver Amid Rising Treasury Yields; Oil Leads, Bitcoin Dips: Thursday's Market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Piper Sandler's Craig Johnson breaks down the technicals of NVDA, ANF, MRNA & MSFT"", ""summary"": ""Craig Johnson, Piper Sandler, joins 'Power Lunch' to discuss technical support for Nvidia, Abercrombie & Fitch, Moderna and Microsoft.""}, {""date"": ""2023-08-16"", ""headline"": ""S&P 500 2023 Q2 Earnings Review: Revenues Miss Analyst Expectations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-16"", ""headline"": ""Cheaper Alternatives of Weight-Loss Drugs? Chinese Pharma Companies Are Working On a Local Version"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Moderna Inc. stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""As COVID hospitalizations rise, Pfizer and Moderna say updated shots show promise against Eris variant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Moderna\u2019s (NASDAQ:MRNA) Updated COVID Vaccine Effective Against Eris Variant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Friday Sector Laggards: Healthcare, Financial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Jonathan Van-Tam joins Covid vaccine maker Moderna"", ""summary"": ""One of the architects of Britain\u2019s pandemic response has taken a role advising Covid vaccine maker Moderna.""}, {""date"": ""2023-08-17"", ""headline"": ""Moderna's updated COVID vaccine effective against 'Eris' variant in humans"", ""summary"": ""Moderna said on Thursday an initial study data showed its updated COVID-19 vaccine to be effective against the \""Eris\"" and \""Fornax\"" subvariants in humans.  The company expects the updated shot to be available, pending approval from health regulators in the United States, Europe and elsewhere, in the coming weeks for the fall vaccination season.  Moderna and other COVID-19 vaccine makers Novavax, Pfizer and German partner BioNTech SE have created versions of their shots aimed at the XBB.1.5 subvariant.""}, {""date"": ""2023-08-17"", ""headline"": ""Ross Stores, Applied Materials, Moderna: After-hour movers"", ""summary"": ""Yahoo Finance Live's Seana Smith takes a look at the stock action surrounding Ross Stores (ROST) and semiconductor company Applied Materials (AMAT) after both companies reported earnings beats, as well as Moderna (MRNA) shares after publishing positive trial results for its updated COVID vaccine.""}, {""date"": ""2023-08-17"", ""headline"": ""Moderna Clinical Trial Data Confirm Its Updated COVID-19 Vaccine Generates Robust Immune Response in Humans Against Widely Circulating Variants"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA) today announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall 2023 vaccination season showed a significant boost in neutralizing antibodies against EG.5 and FL.1.5.1 variants.""}, {""date"": ""2023-08-17"", ""headline"": ""Jonathan Van-Tam takes role at vaccine maker Moderna"", ""summary"": ""Sir Jonathan Van-Tam, who became a prominent figure in the UK government\u2019s pandemic response, has taken a role as senior medical consultant at Covid vaccine maker Moderna.  The UK\u2019s former deputy chief medical officer, who gained celebrity status among the British public during the pandemic and was affectionately known as \u201cJVT\u201d, took up the role as part-time adviser to Moderna in May, according to official filings.  As part of his duties during the pandemic, Van-Tam was a member of the Vaccine Taskforce, which the government said made decisions on \u201call vaccine supply contracts and major investments in manufacturing and clinical opportunities\u201d.""}, {""date"": ""2023-08-17"", ""headline"": ""Moderna says new Covid vaccine was effective against Eris variant in early trial "", ""summary"": ""Moderna's vaccine and new shots from Pfizer and Novavax are slated to roll out within weeks, pending potential approvals from the Food and Drug Administration.\u00a0""}, {""date"": ""2023-08-17"", ""headline"": ""Moderna's (NASDAQ:MRNA) investors will be pleased with their notable 46% return over the last three years"", ""summary"": ""It hasn't been the best quarter for Moderna, Inc. ( NASDAQ:MRNA ) shareholders, since the share price has fallen 22% in...""}, {""date"": ""2023-08-17"", ""headline"": ""Moderna call volume above normal and directionally bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Early notable gainers among liquid option names on August 17th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Why did BioNTech stock go up today? Rising COVID rates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Moderna hires former UK government health official"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Moderna updated COVID-19 vaccine effective against Eris, Fornax variants"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-17"", ""headline"": ""Moderna hires former former UK government health official"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-18"", ""headline"": ""BUZZ Investing: A Shift In Market Leadership"", ""summary"": ""7 tech stocks accounted for almost 75% of the S&P 500's year-to-date gains, marking the technical start of a new bull market, even as investors raised concerns about narrow market breadth.""}, {""date"": ""2023-08-18"", ""headline"": ""Buy Moderna and BioNTech Stock. Both Pharmas Have Strong Drug Pipelines and Plenty of Cash."", ""summary"": ""Moderna and BioNTech are no longer minting money from Covid vaccines. But both have strong drug pipelines and plenty of cash.""}, {""date"": ""2023-08-18"", ""headline"": ""Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance"", ""summary"": ""Pfizer stock and Moderna stock dipped Friday \u2014 giving back some of their late Thursday gains on an upswing related to their updated Covid shots.""}, {""date"": ""2023-08-18"", ""headline"": ""Moderna (MRNA) Updated COVID Jab Effective Against Eris Variant"", ""summary"": ""Moderna's (MRNA) updated monovalent COVID-19 vaccine generates a robust immune response against the dominating Eris variant and another rapidly spreading virus strain in a clinical study.""}, {""date"": ""2023-08-18"", ""headline"": ""2 Biotech Stocks That Could Make You Richer"", ""summary"": ""Neither is performing particularly well this year compared to the broader market, but don't let that chase you away.""}, {""date"": ""2023-08-18"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""Applied Materials shares climb after boosting its forecast on rising demand for AI computing and internet-connected devices, while ADRs of Chinese EV maker XPeng slide after a decline in deliveries. Here\u2019s what investors need to know today.""}, {""date"": ""2023-08-18"", ""headline"": ""New Covid vaccines from Pfizer, Moderna and Novavax will likely protect against Eris variant"", ""summary"": ""The drugmakers designed their updated coronavirus shots to target the omicron subvariant XBB.1.5, which is slowly declining nationwide. ""}, {""date"": ""2023-08-18"", ""headline"": ""SpaceX On Par With Intel, Disney; US Weight Loss Drugs Pricier; Moderna, Pfizer's Shot Effective Against New Variant: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-18"", ""headline"": ""Diluting worker pledges leaves Labour open to fire from all sides"", ""summary"": ""Risks of the party\u2019s strategy heighten as officials enjoy less freedom to tailor messages to certain audiences""}, {""date"": ""2023-08-18"", ""headline"": ""Moderna, Pfizer's Updated COVID Shot Shows Effectiveness Against 'Eris' Variant In Early Human, Preclinical Studies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-18"", ""headline"": ""Parnassus Comments on Moderna"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-18"", ""headline"": ""Jerome Dodson's Parnassus Value Equity Fund Commentary"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-18"", ""headline"": ""Moderna president Hoge sells 15,000 common shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-19"", ""headline"": ""EXPLAINER-Eris, BA.2.86: Do I need to worry about COVID again?"", ""summary"": ""The World Health Organization and the U.S. Centers for Disease Control and Prevention are tracking a new, highly mutated lineage of the virus that causes COVID-19.  Six cases in four countries have been detected since late July.  Scientists are keeping an eye on the new lineage, named BA.2.86, because it has 36 mutations that distinguish it from the currently-dominant XBB.1.5 variant.""}, {""date"": ""2023-08-20"", ""headline"": ""Biden administration to urge Americans get new COVID-19 boosters"", ""summary"": ""The Biden administration plans to urge all Americans to get a booster shot for the coronavirus this autumn to counter a new wave of infections, a White House official said on Sunday.  The official said that while the Centers for Disease Control and Prevention are reporting an increase in infections and hospital admissions from the virus, overall levels remain low.  On Thursday, Moderna said initial data showed its updated COVID-19 vaccine is effective against the \""Eris\"" and \""Fornax\"" subvariants in humans.""}, {""date"": ""2023-08-20"", ""headline"": ""\u2018Programmable Planet\u2019 Review: Biology\u2019s Big Bonus"", ""summary"": ""The idea of using life to improve life, the guiding principle of bioengineering, is yielding exciting results.""}, {""date"": ""2023-08-20"", ""headline"": ""RSV vaccine sales for elderly expected to top $10B by 2030 in G7 nations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
32,2023-08-20,101.62000274658203,2023-08-27,111.93000030517578,0.10145637945222874,U5+,"[{""date"": ""2023-08-20"", ""headline"": ""Crude Oil Falls; Nikola Shares Plummet"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-20"", ""headline"": ""Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-20"", ""headline"": ""Biden administration to urge Americans get new COVID-19 boosters"", ""summary"": ""The Biden administration plans to urge all Americans to get a booster shot for the coronavirus this autumn to counter a new wave of infections, a White House official said on Sunday.  The official said that while the Centers for Disease Control and Prevention are reporting an increase in infections and hospital admissions from the virus, overall levels remain low.  On Thursday, Moderna said initial data showed its updated COVID-19 vaccine is effective against the \""Eris\"" and \""Fornax\"" subvariants in humans.""}, {""date"": ""2023-08-20"", ""headline"": ""\u2018Programmable Planet\u2019 Review: Biology\u2019s Big Bonus"", ""summary"": ""The idea of using life to improve life, the guiding principle of bioengineering, is yielding exciting results.""}, {""date"": ""2023-08-20"", ""headline"": ""RSV vaccine sales for elderly expected to top $10B by 2030 in G7 nations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Novavax (NASDAQ:NVAX) Surges Following Success Against COVID-19 Variants"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Novavax (NASDAQ:NVAX) Surges Following Success Against Eris, Omicron"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""S&P 500 Gains and Losses Today: Tech Stocks Lead Index Higher"", ""summary"": ""The S&P 500 posted a 0.7% gain to start the trading week on Monday, Aug. 21, 2023, boosted by strong performance from technology stocks.""}, {""date"": ""2023-08-21"", ""headline"": ""Why Moderna, BioNTech SE, and Novavax Surged Today"", ""summary"": ""The companies have developed vaccines for the current dominant strain of COVID, and the Biden administration is getting behind a new booster campaign.""}, {""date"": ""2023-08-21"", ""headline"": ""Shares of Moderna and Other COVID-19 Vaccine Makers Surge Amid Booster Push as Cases Rise"", ""summary"": ""Shares of COVID-19 vaccine makers including Moderna and Novavax surged on Monday after a report that the Biden administration plans to urge Americans to get booster shots for the fall, as new subvariants emerge and cases rise.""}, {""date"": ""2023-08-21"", ""headline"": ""Moderna, Pfizer stocks rise amid new Covid variants"", ""summary"": ""Covid vaccine maker stocks including Moderna (MRNA), Pfizer (PFE), and BioNTech (BNTX), rose as concerns grow about new Covid variants.""}, {""date"": ""2023-08-21"", ""headline"": ""Moderna Surges On A Second, Unexpected Shot At The Cancer Vaccine Market"", ""summary"": ""Moderna stock surged Monday after the biotech company inked a deal with China's Carsgen to study a new cancer vaccine regimen.""}, {""date"": ""2023-08-21"", ""headline"": ""S&P 500: Cybersecurity Giant Soars On Earnings; Tesla, Nvidia Are Big Winners"", ""summary"": ""Palo Alto surged Monday after earnings, leading the S&P 500. Megacaps Tesla and NVDA were big winners too, with Nvidia earnings looming.""}, {""date"": ""2023-08-21"", ""headline"": ""Markets Mixed in Midday Trading as Tech Stocks Surge"", ""summary"": ""U.S. equity markets were mixed in midday trading on Monday, Aug. 21, 2023 as tech stocks surged and Treasury yields rose.""}, {""date"": ""2023-08-21"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. rose 9.31% to $111.08 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-08-21"", ""headline"": ""NEW YORK MARKET CLOSE: Tech rebounds led by Nvidia but blue-chips flag"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Moderna Stock Rises Ahead of Fall Covid-19 Booster Campaign"", ""summary"": ""It has been a tough year for the stock prices of Covid-19 vaccine makers, but today is a different story. Moderna shares are up 7% Monday, after a Biden administration official urged Americans to get booster shots for the disease this fall.""}, {""date"": ""2023-08-21"", ""headline"": ""11 Most Profitable Biotech Stocks Today"", ""summary"": ""In this piece, we will take a look at the 11 most profitable biotechnology stocks to buy today. If you want to skip our introduction to the biotechnology industry and want to take a look at the top five stocks in this list, then head on over to 5 Most Profitable Biotech Stocks Today. Biotechnology [\u2026]""}, {""date"": ""2023-08-21"", ""headline"": ""Vaccine makers light up as COVID hospitalizations rise"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Covid vaccine stocks jump as new variants emerge ahead of fall shot rollout"", ""summary"": ""Novavax, Moderna, Pfizer and its partner BioNTech are slated to roll out new shots designed to target the omicron subvariant XBB.1.5 this fall. ""}, {""date"": ""2023-08-21"", ""headline"": ""US Stocks Mixed, Treasury Yields Soar To More Than A Decade High: What's Driving Markets Monday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Dow Tumbles Over 100 Points; Timber Pharmaceuticals Shares Spike Higher"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Moderna, BioNTech And Other Big Stocks Moving Higher On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Moderna short-sellers lose $119m in 24 hours amid new Covid vaccine success"", ""summary"": ""On 17 August, Moderna shares jumped by more than 7%""}, {""date"": ""2023-08-21"", ""headline"": ""Moderna call volume above normal and directionally bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Nvidia, Zoom, Moderna, Baidu, Tesla: Why These Five Stocks Are Drawing Investors' Attention Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Early notable gainers among liquid option names on August 21st"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""CureVac price target lowered to $8 from $10 at BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Will The Bears Deliver The Knockout? Prepare For The Upcoming Week With Mando Trading!"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Moderna signs cancer vaccine deal with China-based CARsgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-21"", ""headline"": ""Moderna: Buy Before The Fall Covid-19 Wave"", ""summary"": ""Moderna's COVID-19 vaccine was found to be over 95% effective at preventing illness, hospitalizations, and deaths. Find out why MRNA stock is a buy.""}, {""date"": ""2023-08-22"", ""headline"": ""S&P 500 Gains and Losses Today: Banking Stocks Lose Ground After S&P Downgrades"", ""summary"": ""The S&P 500 dipped 0.3% on Tuesday, Aug. 22, 2023, dragged down by weakness in the banking sector following S&P's downgrade of several lenders.""}, {""date"": ""2023-08-22"", ""headline"": ""Covid-19 Hospitalizations Jump. So Could Vaccine Demand."", ""summary"": ""Drugmakers like Pfizer and Moderna tamped down expectations. Now, cases are increasing. And investors are turning bullish.""}, {""date"": ""2023-08-22"", ""headline"": ""Covid Hospitalizations Jump. So Could Vaccine Demand."", ""summary"": ""Drugmakers like Pfizer and Moderna tamped down expectations. Now, cases are increasing. And investors are turning bullish.""}, {""date"": ""2023-08-22"", ""headline"": ""Markets Mixed Midday as Bank Stocks Face Pressure After Downgrades"", ""summary"": ""U.S. equity markets were mixed in midday trading on Tuesday, Aug. 22, 2023 as bank stocks lost ground after S&P downgraded several U.S. banks.""}, {""date"": ""2023-08-22"", ""headline"": ""Moderna Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Moderna Inc. rallied 4.65% to $116.24 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-08-22"", ""headline"": ""U.S. Govt to Urge Citizens to Get New COVID-19 Shots"", ""summary"": ""Shares of COVID-19 vaccine makers soared after reports suggest that the Biden administration will start a campaign urging citizens to vaccinate themselves with updated shots vaccine in the upcoming fall.""}, {""date"": ""2023-08-22"", ""headline"": ""Check Out What Whales Are Doing With MRNA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-22"", ""headline"": ""Novavax shares surge after drugmaker says new Covid vaccine was effective against Eris variant"", ""summary"": ""Novavax's vaccine and new shots from Pfizer and Moderna are expected to roll out in the U.S. within weeks, pending potential approvals from the FDA. ""}, {""date"": ""2023-08-22"", ""headline"": ""Early notable gainers among liquid option names on August 22nd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-22"", ""headline"": ""Unusually active option classes on open August 22nd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-22"", ""headline"": ""Novavax (NVAX) Stock Is Getting Ready to Rally Again"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-22"", ""headline"": ""Novavax says updated COVID vaccine effective against Eris, other new variants"", ""summary"": ""Novavax Inc. said Tuesday that its updated COVID-19 vaccine has shown promise against newer strains of the virus. In small animal and non-human primate...""}, {""date"": ""2023-08-22"", ""headline"": ""Tuesday Talk: Monday Rebound"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-22"", ""headline"": ""Lions Gate brings back mask mandate as COVID cases resurge in LA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-23"", ""headline"": ""Is Moderna Stock A Buy As Covid Hospitalizations \u2014 And Its Shares \u2014 Rise?"", ""summary"": ""Is Moderna stock a buy as Covid hospitalizations rise, possibly boosting vaccine demand? Is MRNA stock a buy right now?""}, {""date"": ""2023-08-23"", ""headline"": ""Moderna Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Moderna Inc. slumped 0.67% to $115.46 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-08-23"", ""headline"": ""Novavax (NVAX) Updated COVID Jab Effective Against Eris Variant"", ""summary"": ""In studies on small animals and primates, Novavax's (NVAX) updated monovalent COVID-19 vaccine generates a robust immune response against the currently dominating Eris variant.""}, {""date"": ""2023-08-23"", ""headline"": ""New COVID variant can cause infection in those previously vaccinated - CDC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-23"", ""headline"": ""CARsgen Announced 2023 Interim Results"", ""summary"": ""SHANGHAI - CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced its 2023 Interim...""}, {""date"": ""2023-08-23"", ""headline"": ""When can I get a Covid booster? Here's what to know about fall vaccines"", ""summary"": ""This fall marks the first time that vaccines will be available to fight the triple threat of Covid-19, flu and respiratory syncytial virus, or RSV. Some Massachusetts scientists are at the center of the upcoming vaccine campaigns. Here's what to expect this fall.""}, {""date"": ""2023-08-23"", ""headline"": ""The Zacks Analyst Blog Highlights Moderna, BioNTech, Novavax and Pfizer"", ""summary"": ""Moderna, BioNTech, Novavax and Pfizer are included in this Analyst Blog.""}, {""date"": ""2023-08-24"", ""headline"": ""CDC advisors to meet Sept. 12 to discuss new COVID shots"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-24"", ""headline"": ""Covid Boosters Will Come Later Than Last Year, Despite Rising Hospitalizations"", ""summary"": ""The variant that the updated vaccines were designed to target has already all-but-disappeared from the U.S., and new ones have emerged.""}, {""date"": ""2023-08-24"", ""headline"": ""Moderna Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 2.43% to $112.65 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-08-24"", ""headline"": ""Biotech Alert: Searches spiking for these stocks today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-24"", ""headline"": ""The Petri Dish: Selecta gets selective with drug programs; Moderna enters 2nd cancer vaccine collab"", ""summary"": ""A Watertown biotech trimmed its pipeline again, setting aside all of its experimental drugs except one. It's the second time the company has cut programs this year. Plus other life sciences news you may have missed.""}, {""date"": ""2023-08-25"", ""headline"": ""UPDATE 1-Alnylam to appeal ruling on patents related to Moderna's COVID vaccines"", ""summary"": ""Alnylam Pharmaceuticals said on Friday it plans to appeal a ruling by the U.S. District Court for the District of Delaware on two patents asserted against Moderna for the latter's COVID-19 vaccine Spikevax.  Cambridge, Massachusetts-based Alnylam sued both Moderna and Pfizer Inc in Delaware last year, seeking royalties for the lipid nanoparticle (LNP) technology their vaccines use to deliver genetic material known as mRNA.  The cases are part of a wave of patent lawsuits that have been filed over technology used in the COVID-19 shots, including one filed by Moderna against Pfizer last year.""}, {""date"": ""2023-08-25"", ""headline"": ""Alnylam to appeal ruling on patents related to Moderna's COVID vaccines"", ""summary"": ""Alnylam Pharmaceuticals saidon Friday it plans to appeal a ruling by the U.S. District Courtfor the District of Delaware on two patents asserted againstModerna for the latter's COVID-19 vaccine...""}, {""date"": ""2023-08-25"", ""headline"": ""Moderna Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slumped 0.64% to $111.93 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-08-25"", ""headline"": ""Moderna Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-25"", ""headline"": ""7 F-Rated Biotech Stocks You Shouldn\u2019t Touch With a 10-Foot Pole"", ""summary"": ""Investing in biotech stocks can be challenging. The rewards can be great when your company hits on a popular drug, treatment or product. But there are also plenty of pitfalls that make such investments a risk. Biotech stocks represent companies that develop products and technology involving genetics and molecular biology. Some of them develop new drugs, therapies and medical treatments. Others develop genetically modified organisms to improve crop yield or the nutritional content of food.Investo""}, {""date"": ""2023-08-25"", ""headline"": ""The Nvidia Distraction Is Over. Jackson Hole, Powell, Bonds Take Center Stage."", ""summary"": ""Hawaiian Electric suspends dividend as troubles build, fast-fashion rivals Shein and Forever 21 team up, and other news to start your day.""}, {""date"": ""2023-08-25"", ""headline"": ""Alnylam intends to appeal ruling on two patents asserted against Moderna"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-26"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Spotify""}, {""date"": ""2023-08-27"", ""headline"": ""18 Best 52-Week Low Stocks To Buy Now"", ""summary"": ""In this article, we will take a look at the 18 best 52-week low stocks to buy now. To see more such companies, go directly to 5 Best 52-Week Low Stocks To Buy Now. US stock markets are jittery after Fed Chair Jerome Powell made it clear that inflation is still high and needs further [\u2026]""}, {""date"": ""2023-08-27"", ""headline"": ""Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca"", ""summary"": ""WIR China and Poland partner to create a new drug distribution network. Click here to read more about the past week's new deals, financings, and approvals. ""}]",{}
33,2023-08-27,111.93000030517578,2023-09-03,112.55999755859375,0.005628493269903334,U1,"[{""date"": ""2023-08-27"", ""headline"": ""Alnylam appealing patent ruling in case against Moderna"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-27"", ""headline"": ""18 Best 52-Week Low Stocks To Buy Now"", ""summary"": ""In this article, we will take a look at the 18 best 52-week low stocks to buy now. To see more such companies, go directly to 5 Best 52-Week Low Stocks To Buy Now. US stock markets are jittery after Fed Chair Jerome Powell made it clear that inflation is still high and needs further [\u2026]""}, {""date"": ""2023-08-27"", ""headline"": ""Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca"", ""summary"": ""WIR China and Poland partner to create a new drug distribution network. Click here to read more about the past week's new deals, financings, and approvals. ""}, {""date"": ""2023-08-28"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""COVID is evolving quickly in white-tailed deer, study finds"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""Early notable gainers among liquid option names on August 28th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""More Trouble Ahead For Bulls? Prepare For The Busy Upcoming Week With Mando Trading!"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""Ross Stores, Vertex Pharmaceuticals And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-28"", ""headline"": ""Hedge and mutual funds rotate from tech; see the stocks they love and shun"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""5 Things to Know About the New \u2018Pirola\u2019 Variant of Covid"", ""summary"": ""Scientists still don\u2019t know how widespread or infectious the BA. 2.86 variant is, or if it causes different or more serious symptoms than other Covid-19 strains.""}, {""date"": ""2023-08-29"", ""headline"": ""Invaio achieves first registration for citrus greening solution featuring Trecise\u2122 technology"", ""summary"": ""Invaio Sciences, a bio platform company accelerating the leap to nature-positive agriculture, today announced that its Citrus Health solution to suppress citrus greening in oranges received approval from the Florida Department of Agriculture and Community Services (FDACS) under section 24(c) of the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA).""}, {""date"": ""2023-08-29"", ""headline"": ""Want to diversify your stock-market investments away from top-heavy indexes? Here\u2019s another easy way."", ""summary"": ""The Invesco S&P 500 GARP ETF selects rapidly growing companies that are trading at lower valuations than the tech highfliers that dominate the stock market.""}, {""date"": ""2023-08-29"", ""headline"": ""Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-29"", ""headline"": ""Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-30"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. inched 0.54% higher to $116.62 Wednesday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-08-30"", ""headline"": ""Pfizer, Moderna And COVID Vaccine Patents: Implications Of Legal Cases"", ""summary"": ""Moderna and Pfizer/BioNTech earned more than $110 billion from their COVID vaccines. Read how patent infringement cases could impact their respective businesses.""}, {""date"": ""2023-08-30"", ""headline"": ""Moderna to Host\u00a0Investor Event - R&D Day and Business Updates"", ""summary"": ""Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - R&D Day and Business Updates at 1:00 p.m.""}, {""date"": ""2023-08-30"", ""headline"": ""CapitalGainsReport : Top Corona Stocks Watchlist (AXLA, BIXT, TOMDF, NVAX, MRNA)"", ""summary"": ""Covid infections are on the rise. Hospitalizations are at 15,000 in the United States and rising on a week to week basis. It's up over double the low 6,300 cases set in June. To make matters worse...""}, {""date"": ""2023-08-31"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Moderna Inc. shed 3.04% to $113.07 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-08-31"", ""headline"": ""Pfizer (PFE) & BioNTech Get CHMP Nod for Updated Covid-19 Jab"", ""summary"": ""Pfizer (PFE) and partner BioNTech receive a positive recommendation from the CHMP for its Omicron XBB.1.5-adapted Covid-19 vaccine.""}, {""date"": ""2023-08-31"", ""headline"": ""Moderna Unusual Options Activity For August 31"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-08-31"", ""headline"": ""MODERNA TO HOST INVESTOR EVENT, R&D DAY AND BUSINESS UPDATES"", ""summary"": ""CAMBRIDGE - Moderna, Inc. today announced that it will host its Investor Event - R&D Day and Business Updates at 1:00 p.m. ET on Wednesday, September 13, 2023.The event will include presentations...""}, {""date"": ""2023-09-01"", ""headline"": ""Lilly, Novo Nordisk top pharma performers in August; AstraZeneca, Roche lag"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-01"", ""headline"": ""Moderna Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 0.45% to $112.56 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-09-01"", ""headline"": ""Catalent Stock Soars on Agreement With Activist Investor Elliott Management"", ""summary"": ""Battered drug manufacturer agrees to add directors and engage in a strategic review. Wall Street takes a wait-and-see-attitude.""}, {""date"": ""2023-09-02"", ""headline"": ""An Insider At Moderna Lowered Their Holding Recently"", ""summary"": ""From what we can see, insiders were net sellers in Moderna, Inc.'s ( NASDAQ:MRNA ) during the past 12 months. That is...""}, {""date"": ""2023-09-02"", ""headline"": ""Surprise! This Potential AI Winner Isn't a Tech Stock."", ""summary"": ""In Boston Consulting Group's list of top AI innovators, Moderna and Tesla are the only nontech companies to make the top six.  Moderna is on the road to scoring a big win in the field of AI -- and that could equal victory for investors, too.  Since then, the product has generated billions of dollars in earnings, and though demand has declined from early pandemic days, Moderna expects the vaccine to remain a blockbuster product.""}, {""date"": ""2023-09-02"", ""headline"": ""3 Beaten-Down Biotech Stocks Bound for a Bounce Back"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
34,2023-09-03,112.55999755859375,2023-09-10,107.63999938964844,-0.043710006002658064,D5,"[{""date"": ""2023-09-04"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Pfizer stock hits 52-week low as Moderna rolls out data on rival COVID shot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Moderna Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""FDA said to clear updated COVID shots as early as Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""FDA plans to ok updated versions of Covid booster as soon as Friday, NBC says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""New Covid-19 Variant Might Not Be That Bad. More Boosters Are Coming Soon."", ""summary"": ""Hospitalizations are rising in the U.S., bringing the virus back to public attention for the first time since the winter.""}, {""date"": ""2023-09-05"", ""headline"": ""Novavax (NVAX) Stock Increases 9% in a Month: Here's Why"", ""summary"": ""This growth in Novavax (NVAX) is likely due to the rising COVID-19 infection cases in the United States. Management claims its updated vaccine is effective against the newly emerged virus variants.""}, {""date"": ""2023-09-05"", ""headline"": ""Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""A Bull Trap Or More Gas In The Tank? Prepare For The Upcoming Week With MandoTrading!"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-05"", ""headline"": ""Coronavirus Cases Are on the Rise -- Should You Buy Vaccine Stocks?"", ""summary"": ""At the same time, market leaders Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) reported drastic declines in vaccine sales -- and the companies' stock prices remained in the doldrums.  Pfizer and Moderna have predicted the virus will follow that of the flu, peaking seasonally -- and spurring people to go for annual vaccinations.""}, {""date"": ""2023-09-05"", ""headline"": ""McDonald's, Moderna And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna Inc. stock rises Thursday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Pfizer Stock (NYSE:PFE) Hits a New Low; What\u2019s Ahead?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry"", ""summary"": ""On Tuesday, UK regulators joined their US and European peers in approving an updated COVID-19 vaccine by Pfizer Inc (NYSE: PFE) and its German partner BioNTech (NASDAQ: BNTX) that targets only the Omicron XBB.1.5 subvariant. Moderna Inc (NASDAQ: MRNA) and Novavax (NASDAQ: NVAX) have also created the so-called monovalent versions of their shots that target the XBB.1.5 subvariant of the virus. XBB.1.5 was the most dominant variant across the globe earlier this year, which is why it was selected by""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna to Participate at Morgan Stanley 21st Annual Global Healthcare Conference"", ""summary"": ""Moderna, Inc. (Nasdaq:MRNA), today announced its participation in a fireside chat at Morgan Stanley's 21st Annual Global Healthcare Conference on Tuesday, September 12th at 12:15 p.m.""}, {""date"": ""2023-09-06"", ""headline"": ""Here's How Moderna's Updated Covid Shot Stacks Up Against Highly Mutated 'Pirola' Variant"", ""summary"": ""Moderna stock slipped Wednesday after the company said its updated Covid vaccine can take on a highly mutated strain nicknamed \""pirola.\""""}, {""date"": ""2023-09-06"", ""headline"": ""Latest vaccines help tackle highly mutated new Covid variant"", ""summary"": ""Early studies have provided hope that the newest Covid-19 vaccines will help protect people against the highly mutated new variant BA.2.86, which scientists had feared could prove dangerous.  Moderna, Pfizer and BioNTech said on Wednesday that a lab test showed its latest vaccine, which was designed to tackle the prevalent XBB.1.5 variant, also elicits antibodies to the more recently emerged strain BA.2.86.  The Boston-based biotech\u2019s announcement follows early research from scientists at Harvard and Sweden\u2019s Karolinska Institute that suggested that people who had been infected with the XBB.1.5 variant could also make antibodies against BA.2.86.""}, {""date"": ""2023-09-06"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks slip after robust services sector print"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna Says Covid Booster Works Against New Variant. What to Know About Fall Shots."", ""summary"": ""Americans\u00a0are starting to roll up their sleeves for an array of shots to stem the anticipated tide of respiratory infections this fall, including the latest Covid-19 subvariants.  Moderna on Sept. 6 said that its updated booster shot generates immune responses believed to be protective against newer variants.  Health officials expect the flu and respiratory syncytial virus to join the mix in coming months.""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna Vaccine Is Effective Against New Covid Strain. Its Stock Is Dropping."", ""summary"": ""Moderna  \u2018s updated Covid-19 vaccine helps fight the new variants of the virus that are circulating, including the BA.2.86 subvariant,\u00a0the company said Wednesday.  Over the last few weeks, The Centers for Disease Control and Prevention has detected a new variant called BA.2.86 in samples from infected people and sewer water in the U.S. and several other countries.  Clinical trial data from Moderna (ticker: MRNA) shared on Wednesday suggested its shot increased antibodies in humans against the BA.2.86 Covid strain by almost ninefold.""}, {""date"": ""2023-09-06"", ""headline"": ""Trending : Moderna Updated Covid Vaccine Effective on Newest Variants"", ""summary"": ""14:19 ET -- Moderna is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The vaccine and drug company said clinical trial data...""}, {""date"": ""2023-09-06"", ""headline"": ""Roku, Toast, Gitlab and Moderna rise premarket;  Southwest Airlines falls"", ""summary"": ""Investing.com -- U.S. futures traded marginally lower Wednesday, as higher oil prices and weak global economic data weighed on sentiment.""}, {""date"": ""2023-09-06"", ""headline"": ""UPDATE 1-Moderna says updated COVID vaccine is effective against newer variant"", ""summary"": ""Moderna on Wednesday said clinical trial data showed its updated COVID-19 vaccine will likely be effective against the highly-mutated BA.2.86 subvariant of the coronavirus that has raised fears of a resurgence of infections.  The company said its shot generated an 8.7-fold increase in neutralizing antibodies in humans against BA.2.86, which is being tracked by the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC).  \u201cWe think this is news people will want to hear as they prepare to go out and get their fall boosters,\u201d Moderna head of infectious diseases Jacqueline Miller said in an interview, adding that the data should also help reassure regulators.""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna : latest COVID vaccine effective against new variant"", ""summary"": ""STORY: Drugmaker Moderna on Wednesday said its updated COVID-19 vaccine will likely be effective against the highly-mutated BA.2.86 subvariant of the coronavirus... based on info from clinical trial...""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna Stock Gains. Its Vaccine Is Effective Against New Covid Strain."", ""summary"": ""Moderna  \u2018s updated Covid-19 vaccine helps fight the new variants of the virus that are circulating, including the BA.2.86 subvariant,\u00a0the company said Wednesday.  Over the last few weeks, The Centers for Disease Control and Prevention has detected a new variant called BA.2.86 in samples from infected people and sewer water in the U.S. and several other countries.  Clinical trial data from Moderna (ticker: MRNA) shared on Wednesday suggested its shot increased antibodies in humans against the BA.2.86 Covid strain by almost ninefold.""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna says updated COVID vaccine is effective against newer variant"", ""summary"": ""Moderna on Wednesday said clinical trial data showed its updated COVID-19 vaccine will likely be effective against the highly-mutated BA.2.86 subvariant of the coronavirus that has raised fears of a resurgence of infections.""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine Generates Strong Immune Response in Humans Against BA.2.86"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA) today announced that clinical trial data from its research assay confirm its updated COVID-19 vaccine, which is pending approval by the U.S. Food and Drug Administration for the fall 2023 vaccination season, generates an 8.7-fold increase in neutralizing antibodies in humans against BA.2.86 (Pirola), a variant under monitoring.""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna says COVID-19 vaccine update effective against highly mutated strain"", ""summary"": ""Moderna announced on Wednesday that its updated COVID-19 vaccine currently pending approval by the Food and Drug Administration is effective against the new highly-mutated variant of the virus.The...""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna says updated COVID vaccine effective against new variant"", ""summary"": ""Investing.com -- Moderna Inc (NASDAQ:MRNA) has announced that its updated COVID-19 vaccine generates a strong immune response against a new variant of the virus that has raised concerns over a possible spike in cases.""}, {""date"": ""2023-09-06"", ""headline"": ""This Down-on-Its-Luck Biotech Could Surge 150%, Wall Street Says. Should You Buy the Stock?"", ""summary"": ""Today, Novavax is getting ready to compete in the fall vaccine market -- one that's in transition.""}, {""date"": ""2023-09-06"", ""headline"": ""iPhone 15 May Face Hurdle In China, FTC Could Prosecute Amazon.com Over Antitrust Claims, United Airlines Planes Back In Air: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna says updated Covid vaccine fares well against new variant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Is Moderna's New Vaccine the Answer to the Highly Mutated BA.2.86 COVID-19 Variant?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: Moderna (MRNA), Dexcom (DXCM) and BioNTech SE (BNTX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""7 Biotech Stocks to Sell in September Before They Crash & Burn"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna says updated COVID vaccine effective against BA.2.86 Pirola variant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna says COVID shot strongly responded to Pirola variant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-06"", ""headline"": ""Moderna announces clinical trial data on updated Covid-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""Moderna urges shareholders to reject TRC Capital's 'mini-tender' offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""Moderna Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""Existing antibodies reportedly effective against new COVID-19 variant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""Catalyst Watch: Arm IPO, Apple event, and Senate AI Forum with Musk, Zuckerberg, and Gates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-07"", ""headline"": ""Jets' Aaron Rodgers shows support for unvaccinated tennis star Novak Djokovic"", ""summary"": ""FLORHAM PARK, N.J. \u2014 Aaron Rodgers crossed an item off his sports bucket list \u2014 and then made a statement with a more visible crossout.The New York Jets quarterback attended the U.S. Open on...""}, {""date"": ""2023-09-07"", ""headline"": ""U.S. First Lady Tests Positive for COVID as Cases Spike \u2014 Is It Time to Jump Back Into Vaccine Stocks?"", ""summary"": ""Covid is back in the headlines again. Turns out first lady Jill Biden has tested positive for Covid-19, albeit suffering only from \u201cmild symptoms.\u201d Meanwhile, President Joe Biden\u2019s test results have come back as negative. However, it\u2019s not only at the White House where the coronavirus is making an unwelcome return. On the back of an upward curve that started toward the end of July, over the past week, Covid hospitalizations have witnessed a 16% uptick in the US. This spike comes against a backdr""}, {""date"": ""2023-09-07"", ""headline"": ""Moderna (MRNA) Updated COVID Jab Effective Against Pirola Variant"", ""summary"": ""Clinical study data shows Moderna's (MRNA) updated COVID-19 vaccine generates a robust immune response against newer circulating variants, including Pirola and Eris.""}, {""date"": ""2023-09-07"", ""headline"": ""EXPLAINER-Do I need to worry about COVID again?"", ""summary"": ""New data from scientists and vaccine makers Moderna and Pfizer/BioNTech suggests that a newer, highly mutated variant of the virus that causes COVID-19 is not as alarming as some experts had feared when it was first detected several weeks ago.  Nicknamed \""Pirola\"" on social media, the BA.2.86 Omicron subvariant is being tracked by both the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC).  What is new about COVID?""}, {""date"": ""2023-09-08"", ""headline"": ""Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Moderna (MRNA) closed at $107.64, marking a -0.66% move from the previous day.""}, {""date"": ""2023-09-08"", ""headline"": ""Moderna Recommends Shareholders Reject \u201cMini-Tender\u201d Offer by TRC Capital Investment Corporation"", ""summary"": ""Moderna, Inc. (Nasdaq:MRNA) has been notified that TRC Capital Investment Corporation (TRC Capital) has made an unsolicited \""mini-tender\"" offer to purchase up to 1,000,000 shares of Moderna's common stock, at an offer price of $107.56 per share.""}, {""date"": ""2023-09-08"", ""headline"": ""IN BRIEF: Moderna urges shareholders not to accept TRC \""mini-tender\"""", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""Biotech Stock Roundup: MRNA's Vaccine Update, AMGN & HZNP Clear FTC Lawsuit & More"", ""summary"": ""Pipeline and regulatory updates from (MRNA) and Amgen (AMGN) are in focus in the biotech sector.""}, {""date"": ""2023-09-08"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-08"", ""headline"": ""Institutional investors may adopt severe steps after Moderna, Inc.'s (NASDAQ:MRNA) latest 3.7% drop adds to a year losses"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Moderna's stock price might be vulnerable to their...""}, {""date"": ""2023-09-08"", ""headline"": ""COVID Vaccine Sales Are Declining. But Here's How They're Still Driving Growth at Moderna."", ""summary"": ""Right now, Moderna (NASDAQ: MRNA) generates pretty much all of its revenue from one product: its coronavirus vaccine.  Before you turn your back on Moderna stock, though, there's something you should know: Vaccine sales still are driving growth at this innovative biotech.  Now you might ask, \""How can you say the vaccine is driving growth?\"" After all, sales of the product fell 94% in the most recent quarter, and even though the vaccine still should generate blockbuster revenue, it's set to come in lower than the $18.4 billion\u00a0reported last year.""}, {""date"": ""2023-09-08"", ""headline"": ""2 Nasdaq 100 Stocks That Are Surefire Buys in September and 1 to Avoid Like the Plague"", ""summary"": ""Two high-growth Nasdaq 100 stocks are phenomenal businesses hiding in plain sight, while another Nasdaq 100 component comes with outsize risk.""}, {""date"": ""2023-09-08"", ""headline"": ""England confirms 34 COVID cases linked to highly mutated variant - UKSHA"", ""summary"": ""UK Health Security Agency said on Friday that 34 COVID-19 cases linked to the highlymutated variant BA.2.86 had been identified in England. The Omicron offshoot carries more than 35...""}, {""date"": ""2023-09-08"", ""headline"": ""Moderna urges shareholders to reject \""undervalued\"" mini-tender offer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-09"", ""headline"": ""10 Biotech Stocks with Biggest Upside"", ""summary"": ""In this article, we discuss 12 biotech stocks with biggest upside. If you want to skip our detailed discussion on the recent developments in the biotech industry, you can go directly to 5 Biotech Stocks with Biggest Upside. According to Precedence Research, the size of the biotechnology industry stood at $1.22 trillion at the end [\u2026]""}, {""date"": ""2023-09-09"", ""headline"": ""3 Meme Stocks That Could Actually Rebound in Q4"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""Apple Stock, Adobe, Oracle, Moderna, Lennar, Inflation Data, and More to Watch This Week"", ""summary"": ""The Consumer Price Index is expected to be up 3.6%. Results from Oracle, Adobe, and Lennar. And a policy decision from the European Central Bank.""}]",{}
35,2023-09-10,107.63999938964844,2023-09-17,114.58999633789062,0.06456704745123365,U5+,"[{""date"": ""2023-09-10"", ""headline"": ""Novavax updated COVID vaccine ready for US distribution"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""Moderna Inc. stock falls Monday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""Check Out What Whales Are Doing With MRNA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""FDA green lights Moderna, Pfizer updated COVID-19 vaccines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""Notable Monday Option Activity: MRNA, DVN, GOOGL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""Moderna announces FDA approval for updated COVID-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""Pfizer and Moderna updated COVID vaccines approved by FDA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-10"", ""headline"": ""Apple Stock, Adobe, Oracle, Moderna, Lennar, Inflation Data, and More to Watch This Week"", ""summary"": ""The Consumer Price Index is expected to be up 3.6%. Results from Oracle, Adobe, and Lennar. And a policy decision from the European Central Bank.""}, {""date"": ""2023-09-11"", ""headline"": ""Moderna Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""CDC panel okays updated COVID-19 shots for ages 6 months and older"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""US FDA approves updated Covid vaccines from Pfizer and Moderna"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""CDC advisers recommend updated COVID shots for people 6 months of age and older"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Novavax updated COVID shot to be reviewed by FDA 'expeditiously'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Updated Covid vaccines, Oracle earnings, Tesla stock jumps: Top Stories"", ""summary"": ""The U.S. Food and Drug Administration has approved updated Covid vaccines from Pfizer (PFE) and Moderna (MRNA) to combat new virus variants amid a surge in new cases and hospitalizations. Oracle (ORCL) shares moved lower in after-hours trading after reporting mixed fiscal first quarter results. Lastly, Tesla (TSLA) stock jumped after Morgan Stanley (MS) upgraded the stock to \""Overweight\"" from \""Equal Weight\"" and issued a $400 price target, citing a potential boost from its Dojo supercomputer. Yahoo Finance's Akiko Fujita breaks down the top stories of the day.""}, {""date"": ""2023-09-11"", ""headline"": ""FDA Approves Newest Covid-19 Boosters"", ""summary"": ""Vaccine specialists say the updated shots should protect against strains now circulating. The boosters should be available within days.""}, {""date"": ""2023-09-11"", ""headline"": ""Moderna Teams With Germany's Immatics to Develop Cancer Vaccines and Therapies"", ""summary"": ""Moderna and German biotech firm Immatics announced an agreement to work on development of vaccines and treatments for cancer using the science behind Moderna\u2019s COVID-19 shots.""}, {""date"": ""2023-09-11"", ""headline"": ""Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters"", ""summary"": ""Novavax stock crumbled Monday after the Food and Drug Administration signed off on updated Covid boosters from rivals Pfizer and Moderna.""}, {""date"": ""2023-09-11"", ""headline"": ""FDA approves new Covid-19 boosters from Pfizer and Moderna"", ""summary"": ""The US federal drug regulator has approved new Covid-19 boosters from Moderna and Pfizer, as it moves to contain infections from spreading more quickly in the US.  Anyone 5 years of age and older will be eligible to receive an updated jab from either Moderna or BioNTech/Pfizer as long as it has been at least two months since a previous Covid-19 vaccination, the Food and Drug Administration said on Monday.  \u201cThe FDA anticipates that the updated vaccines will be available in the near future,\u201d the regulator said, without giving a specific date.""}, {""date"": ""2023-09-11"", ""headline"": ""Pfizer and Moderna Covid Vaccines Approved by FDA. When They Could Become Available."", ""summary"": ""This year\u2019s rollout marks a definitive transition to a commercial market for the shots., which had previously been purchased by the U.S. government.""}, {""date"": ""2023-09-11"", ""headline"": ""US approval of fall boosters comes amid uptick in COVID-19 cases"", ""summary"": ""The U.S. Food and Drug Administration (FDA) approved updated COVID-19 booster shots today, setting the stage for a fall vaccine push to combat the still-circulating virus.""}, {""date"": ""2023-09-11"", ""headline"": ""FDA authorizes updated Covid-19 vaccines, with CDC sign-off to come soon"", ""summary"": ""The U.S. Food and Administration has given the green light to updated mRNA-based Covid-19 vaccines, the second-to-last step before the new shots can make their way to patients.""}, {""date"": ""2023-09-11"", ""headline"": ""Health Care Higher on Inflation Bets -- Health Care Roundup"", ""summary"": ""Health-care companies rose as traders rotated into defensive sectors ahead of key inflation data. The Food and Drug Administration cleared updated Covid-19 shots, one from Pfizer and BioNTech,...""}, {""date"": ""2023-09-11"", ""headline"": ""Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA) today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application(sBLA) for Spikevax\u00ae for ages 12 years and above. Emergency Use Authorization (EUA) for the Moderna COVID-19 Vaccine was also received for individuals 6 months through 11 years of age.""}, {""date"": ""2023-09-11"", ""headline"": ""Explainer-Who should get a COVID vaccine this year?"", ""summary"": ""The U.S. drug regulator authorized updated COVID-19 vaccines from Pfizer and its partner BioNTech as well as from Moderna on Monday as the country prepares to start an autumn vaccination campaign...""}, {""date"": ""2023-09-11"", ""headline"": ""Moderna enters cancer collaboration with Immatics worth $1.8B"", ""summary"": ""Moderna Inc. has entered its third cancer-related collaboration, following on the apparent success of the cancer vaccine it developed with Merck & Co.""}, {""date"": ""2023-09-11"", ""headline"": ""New Pfizer and Moderna COVID shots approved by FDA"", ""summary"": ""CDC is set to vote on the new shots Tuesday, but questions remain about costs for uninsured people.""}, {""date"": ""2023-09-11"", ""headline"": ""US approves updated COVID vaccines to rev up protection this fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""FDA approves updated omicron variant vaccines from Moderna, Pfizer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Moderna to Pay Immatics Up to $1.8 Billion in Cancer-Drug Deal"", ""summary"": ""(Bloomberg) -- Moderna Inc. agreed to pay German biotechnology company Immatics NV as much as $1.8 billion in a broad-ranging, multiyear collaboration on developing cancer therapies using messenger RNA and other technologies.Most Read from BloombergTrudeau Is Stuck in India With Faulty Aircraft After Hearing Criticism From ModiThe Mighty American Consumer Is About to Hit a Wall, Investors SayMeloni Tells China That Italy Plans to Exit Belt and RoadIndia\u2019s G-20 Win Shows US Learning How to Counte""}, {""date"": ""2023-09-11"", ""headline"": ""Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer"", ""summary"": ""Flagship Pioneering, the bioplatform innovation company, announced today the appointment of Amanda Kay as Senior Partner and Chief Business Development Officer. In this role, she will be responsible for driving and supporting business development across the Flagship ecosystem, leading the effort to forge strong partnerships between Flagship companies and the biopharma industry. She will also work closely with the Pioneering Medicines unit of Flagship as we continue to invest in and grow our corp""}, {""date"": ""2023-09-11"", ""headline"": ""MODERNA RECOMMENDS SHAREHOLDERS REJECT 'MINI-TENDER' OFFER BY TRC CAPITAL INVESTMENT CORPORATION"", ""summary"": ""CAMBRIDGE - Moderna, Inc. has been notified that TRC Capital Investment Corporation has made an unsolicited 'mini-tender' offer to purchase up to 1,000,000 shares of Moderna's common stock, at an...""}, {""date"": ""2023-09-11"", ""headline"": ""Immatics shares rise on Moderna cancer collaboration"", ""summary"": ""Immatics NV shares gained more than 6% premarket on Monday after the company announced a collaboration with Moderna Inc. to research and develop new cancer...""}, {""date"": ""2023-09-11"", ""headline"": ""Moderna, Immatics to work jointly on cancer vaccines"", ""summary"": ""Sept 11 - Vaccine maker Moderna said on Monday it had strucka deal with Immatics for developing cancer vaccines andtherapies and would pay the drug...""}, {""date"": ""2023-09-11"", ""headline"": ""Immatics Shares Rise Premarket on Collaboration With Moderna >IMTX"", ""summary"": ""By Colin Kellaher Shares of Immatics moved higher in premarket trading Monday after the clinical-stage biopharmaceutical company formed a collaboration with...""}, {""date"": ""2023-09-11"", ""headline"": ""Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Moderna in pact with Immatics for cancer therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Moderna, Immatics announce strategic multi-platform collaboration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""The latest Covid boosters could roll out within days, NY Times says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-11"", ""headline"": ""Moderna, Pfizer Get FDA Nod For Omicron COVID Boosters While Novavax Waits"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""Moderna Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""Stock market today: Asian shares mostly higher after US inflation data ease rate hike worries"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""Stock market today: Wall Street churns to a mixed finish after highly anticipated inflation data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""Dow falls 100 points after higher-than-expected August inflation report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""Dow struggles to find direction after hotter-than-expected August inflation report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""CDC Endorses Covid-19 Boosters for Everyone Aged 6 Months and Older"", ""summary"": ""The FDA cleared shots from Pfizer and Moderna that are expected to protect against the latest Omicron subvariants.""}, {""date"": ""2023-09-12"", ""headline"": ""CDC advisers recommend Covid vaccine boosters for kids & adults"", ""summary"": ""A Centers for Disease Control advisory panel is recommending adults and children older than six months get the latest Covid vaccine booster shots. The panel approved the vaccines from Pfizer (PFE) and Moderna (MRNA). Novavax (NVAX) is still awaiting authorization from the U.S. Food and Drug Administration for its booster. Yahoo Finance Health Care Reporter Anjalee Khemlani explains the story.""}, {""date"": ""2023-09-12"", ""headline"": ""Covid Boosters Against New Variants Could Be Available Within Days. What to Know About Fall Shots."", ""summary"": ""Americans are starting to roll up their sleeves for an array of shots to stem the anticipated tide of respiratory infections this fall, including the latest Covid-19 subvariants.""}, {""date"": ""2023-09-12"", ""headline"": ""Health Canada approves Moderna COVID-19 vaccine for Omicron, urges boosters"", ""summary"": ""Canadian health officials on Tuesday authorized Moderna's COVID-19 vaccine targeting the Omicron subvariant, urging all Canadians over the age of six months to get fresh  inoculations as the nation sees an uptick in infections.  Health Canada said in a statement that it has determined that the Moderna SPIKEVAX COVID-19 vaccine targeting the Omicron XBB.1.5 vaccine meets the department\u2019s stringent safety, efficacy and quality requirements.  \""We are absolutely encouraging people to get protected both with COVID-19 vaccine and the flu shot,\"" Canada's Chief Public Health Officer Theresa Tam said during a news conference after the announcement, adding that Canadians can expect to start receiving the new shots in the beginning of October.""}, {""date"": ""2023-09-12"", ""headline"": ""Americans can now get an updated COVID-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""CDC recommends updated COVID shots for people 6 months of age and older"", ""summary"": ""Newly approved Pfizer and Moderna vaccines to hit pharmacies for fall vaccination season.""}, {""date"": ""2023-09-12"", ""headline"": ""US CDC panel recommends broad use of updated COVID-19 vaccines"", ""summary"": ""A U.S. Centers for Disease Controland Prevention advisory panel on Tuesday called for abroad use of the updated COVID-19 vaccines approved by thegovernment - covering ages 6 months and up - paving...""}, {""date"": ""2023-09-12"", ""headline"": ""Moderna (MRNA), Immatics Ink Deal to Develop New Cancer Therapies"", ""summary"": ""The deal will combine Moderna (MRNA) and Immatics' (IMTX) proprietary platforms to develop innovative immunotherapies for cancer.""}, {""date"": ""2023-09-12"", ""headline"": ""Moderna, Inc. (MRNA) Morgan Stanley 21st Annual Global Healthcare Conference (Transcript)"", ""summary"": ""Moderna, Inc. (NASDAQ:NASDAQ:MRNA) Morgan Stanley 21st Annual Global Healthcare Conference September 12, 2023 12:15 PM ETCompany ParticipantsStephane Bancel - CEOConference Call...""}, {""date"": ""2023-09-12"", ""headline"": ""FDA Approves Pfizer & Moderna's New COVID Booster Vaccines"", ""summary"": ""Pfizer (PFE)/ BioNTech (BNTX), and Moderna's (MRNA) updated mRNA vaccines are now approved for individuals 12 years of age and older and are authorized under emergency use for individuals 6 months through 11 years of age.""}, {""date"": ""2023-09-12"", ""headline"": ""UPDATE 1-US CDC to decide who should get the new COVID shots"", ""summary"": ""A U.S. Centers for Disease Control and Prevention (CDC) advisory panel is due on Tuesday to recommend whether the updated COVID-19 shots formulated by vaccine manufacturers should be given broadly or just to specific populations at higher risk during this fall's vaccination campaign.  The updated shots are part of a push by public health officials to align the next COVID vaccines more closely with the actual circulating variant of the virus, similar to the way annual flu shots are designed.  The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID vaccines made by Pfizer and its German partner BioNTech SE as well as by Moderna .""}, {""date"": ""2023-09-12"", ""headline"": ""CDC Advisers Weigh Covid-19 Booster Guidance as Latest Variants Spread"", ""summary"": ""The Food and Drug Administration on Monday cleared updated boosters from Pfizer and Moderna for people six months and older.""}, {""date"": ""2023-09-12"", ""headline"": ""Moderna to charge $129 for COVID shot, Pfizer $120, Bloomberg reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""Canada Approves Use of Moderna's Covid-19 Booster"", ""summary"": ""By Robb M. Stewart Canada's health regulator has authorized the use of Moderna's latest Covid-19 booster targeting the Omicron XBB.1.5 subvariant for anyone six months of age and older. ...""}, {""date"": ""2023-09-12"", ""headline"": ""Health Canada approves updated Moderna vaccine for COVID-19"", ""summary"": ""OTTAWA \u2014 Health Canada has authorized the use of an updated Moderna vaccine for COVID-19 for all Canadians over the age of six months.The new vaccine targets the XBB.1.5 variant of the virus that...""}, {""date"": ""2023-09-12"", ""headline"": ""CP NewsAlert : Health Canada approves updated Moderna vaccine for COVID-19"", ""summary"": ""OTTAWA \u2014 Health Canada has authorized the use of an updated Moderna vaccine for COVID-19 for all Canadians over the age of six months.The decision was posted to the Health Canada website this...""}, {""date"": ""2023-09-12"", ""headline"": ""Health Canada approves updated Moderna COVID-19 vaccineModerna"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""US CDC contemplates who should get the new COVID shots"", ""summary"": ""A U.S. Centers for Disease Control and Prevention (CDC) advisory panel is due on Tuesday to recommend whether the updated COVID-19 shots formulated by vaccine manufacturers should be given broadly or just to specific populations at higher risk during this fall's vaccination campaign.  The updated shots are part of a push by public health officials to align the next COVID vaccines more closely with the actual circulating variant of the virus, similar to the way annual flu shots are designed.  The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID vaccines made by Pfizer and its German partner BioNTech SE as well as by Moderna .""}, {""date"": ""2023-09-12"", ""headline"": ""MODERNA AND IMMATICS ANNOUNCE STRATEGIC MULTI-PLATFORM COLLABORATION TO DEVELOP INNOVATIVE ONCOLOGY THERAPEUTICS"", ""summary"": ""CAMBRIDGE - Moderna, Inc. and Immatics N.V. , a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, today announced a...""}, {""date"": ""2023-09-12"", ""headline"": ""DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""The 3 Most Undervalued Biotech Stocks to Buy in September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""PFE, MRNA: Vaccine Makers Get a Boost from FDA Nod"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""Novavax Stock (NASDAQ:NVAX) Has a Shot at Recovering"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""CDC recommends COVID-19 shots for people age six months and older (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-12"", ""headline"": ""Insider Sell: Chief Legal Officer Shannon Klinger Sells 557 Shares of Moderna Inc"", ""summary"": ""On September 8, 2023, Shannon Klinger, Chief Legal Officer of Moderna Inc (NASDAQ:MRNA), sold 557 shares of the company.""}, {""date"": ""2023-09-13"", ""headline"": ""CDC says COVID, flu, and RSV could cause 'tripledemic'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""The 3 Most Undervalued Pharma Stocks to Buy in September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna (NASDAQ:MRNA) Surges after Landing EU Approval"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Florida contradicts CDC, advises against new COVID booster for people younger than 65"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""S&P 500 Gains and Losses Today: Index Little Changed After Inflation Data"", ""summary"": ""US equities were mixed on Sept. 13, 2023, with the S&P 500 Index rising 0.1% after Labor Department reported core consumer inflation that was higher than estimates.""}, {""date"": ""2023-09-13"", ""headline"": ""US STOCKS-S&P 500 ends higher as CPI data cements bets for Fed pause"", ""summary"": ""The S&P 500 and Nasdaq ended higher on Wednesday after data showing a moderate increase in consumer prices in August cemented expectations that the Federal Reserve will leave interest rates unchanged in September.  Apple dipped 1.2%, down for a second day after unveiling new iPhones on Tuesday while leaving prices unchanged.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna Surges After Flu Shot Beats Out Widely Used Sanofi, GSK Vaccines"", ""summary"": ""Moderna said Wednesday its flu shot outperformed broadly used vaccines from Sanofi and GSK. The results bolstered Moderna stock.""}, {""date"": ""2023-09-13"", ""headline"": ""US STOCKS-Wall Street ends mixed as CPI data cements bets for Fed pause"", ""summary"": ""Stocks on Wall Street ended mixed on Wednesday as data showing a moderate increase in consumer prices in August cemented expectations that the Federal Reserve will leave interest rates unchanged in September.  The S&P 500 consumer discretionary index climbed as Ford Motor rallied on the vehicle maker's plans to double the production of its hybrid F-150 pickup trucks in 2024.  Data showed consumer prices increased by the most in 14 months in August as gasoline prices surged, but the annual rise in underlying inflation was the smallest in nearly two years.""}, {""date"": ""2023-09-13"", ""headline"": ""Stocks to Watch Wednesday: Ford, GM, Virtu, BP, Oracle"", ""summary"": ""**\u2197\ufe0f** [**Ford (F)**](https://www.wsj.com/market-data/quotes/F), [**General Motors (GM)**](https://www.wsj.com/market-data/quotes/GM): The auto stocks gained ahead in premarket trading as talks with the United Auto Workers union continued ahead of the expiration of current contracts on Thursday.""}, {""date"": ""2023-09-13"", ""headline"": ""Is Moderna Stock A Buy As Its Case For A New Flu Vaccine Finally Pans Out?"", ""summary"": ""Is Moderna stock a buy after the company announced positive results for its flu shot? Is MRNA stock a buy right now?""}, {""date"": ""2023-09-13"", ""headline"": ""Mainz Biomed Paves The Way For Early Colorectal Cancer Diagnosis And Even Prevention"", ""summary"": ""By the words of Dr. Ruediger Dahlke, cancer is a caricature of today\u2019s modern society as it reflects the dark side \u2018growth\u2019. Our civilization is clearly more on the dark side of growth with technology advancing but not with our wellbeing in mind as everything seems to be thriving, besides our soul. By not taking the soul along for the growth journey, the lack of growth in consciousness sinks to the body which shows us what is all really about. Perhaps this is why science has been struggling to f""}, {""date"": ""2023-09-13"", ""headline"": ""Stock Market Not Too Rattled By Inflation Data; Trucking Stock Gets A Bounce"", ""summary"": ""The stock market held onto modest gains following CPI data. Shares of J.B. Hunt Transport Services rallied after its president gave encouraging words.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna Reports Successful Trial of Flu Vaccine, Plans More Treatments Ahead"", ""summary"": ""Moderna (MRNA) was the best-performing stock in the S&P 500 as the vaccine maker reported its experimental flu shot met its primary endpoint in a Phase 3 trial.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna: Is It Time to Take a Shot?"", ""summary"": ""Moderna has been cut in half since December and may now look more attractive to investors.     Let's check out the trends, charts and indicators of MRNA.     In this daily bar chart of MRNA, below, I can see that prices have worked lower since December with a number of bounces along the way.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna Rises on Positive Results From Flu Vaccine,  and Other Plans to Move Beyond Covid"", ""summary"": ""Moderna expects to launch up to 15 new products over the next five years 'addressing high unmet needs.'""}, {""date"": ""2023-09-13"", ""headline"": ""Europe Set To Launch Anti-Subsidy Probe Into Chinese EVs, American Airlines and Spirit Lower Profit Outlook, Manchester United's New Shirt Sponsor: Today's Top Stories"", ""summary"": ""Financial Times Europe Set To Launch Anti-Subsidy Probe Into Chinese Electric Vehicles Chinese electric vehicle company stocks, including XPeng Inc (NYSE: XPEV), NIO Inc (NYSE: NIO), and Li Auto Inc (NASDAQ: LI), are trading lower Wednesday after Brussels shared plans to launch an anti-subsidy investigation into Chinese EVs that are \""distorting\"" the EU market. European Commission President Ursula von der Leyen announced during her annual address to EU lawmakers, expressing concern over the influ""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna CEO on New Flu Vaccine, Curing Cancer"", ""summary"": ""Stephane Bancel, Moderna CEO, talks about seeking regulatory approval for a new version of its influenza vaccine, and new ways to treat and detect cancer. He speaks on \""Bloomberg Markets.\"" Follow Bloomberg for business news & analysis, up-to-the-minute market data, features, profiles and more: http://www.bloomberg.com Connect with us on... Twitter: https://twitter.com/business Facebook: https://www.facebook.com/bloombergbusiness/ Instagram: https://www.instagram.com/quicktake/?hl=en""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna Poised to Seek Flu Shot Approval After Trial Results"", ""summary"": ""(Bloomberg) -- Moderna Inc. said a reformulated version of its messenger-RNA based flu shot met its primary goals in a final-stage trial \u2014 a result that could pave the way for the company to seek regulatory approval for the influenza vaccine.Most Read from BloombergCiti Plans Job Cuts as It Revamps Top Management StructureChina Sows Fresh Confusion About Apple With Security RemarksCaesars Entertainment Paid Millions to Hackers in AttackLuxury Cruise Ship Full of Australians Stuck in Greenland Ar""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna stock rises on positive results in flu vaccine trial"", ""summary"": ""Moderna (MRNA) shares are ticking up this morning after the pharmaceutical company published positive data from its latest flu vaccine trial. Yahoo Finance Health Care Reporter Anjalee Khemlani outlines Moderna's new post-COVID strategy to expand personalized care, quoting CFO James Mock's plans to prepare new COVID, RSV, and flu vaccines this season.""}, {""date"": ""2023-09-13"", ""headline"": ""Ford, BP, Tesla, Moderna rise premarket; Spirit Airlines, Nio fall"", ""summary"": ""Investing.com -- U.S. futures traded marginally lower Wednesday, as investors cautiously awaited the release of consumer inflation data which could provide clues as to future Federal Reserve monetary policy.""}, {""date"": ""2023-09-13"", ""headline"": ""5 things to know about the new COVID-19 vaccine"", ""summary"": ""The shot, which guards against the current variants, is now available""}, {""date"": ""2023-09-13"", ""headline"": ""How Moderna is expanding its product pipeline beyond COVID"", ""summary"": ""Moderna has an ambitious pipeline as it hopes to maintain COVID-19 success momentum.""}, {""date"": ""2023-09-13"", ""headline"": ""US STOCKS-Wall St set to open subdued as CPI data fuels higher-for-longer rate worries"", ""summary"": ""Wall Street's main indexes were set to open subdued on Wednesday as data showed consumer prices clocked their highest rise in more than a year in August, fanning fears the Federal Reserve could keep interest rates higher for longer.  Data showed consumer price inflation rose in line with expectations on a monthly basis by 0.6% in August, compared with a 0.2% rise in July, but core inflation rose by more-than-expected 0.3% last month.  On a yearly basis, the headline inflation rose marginally higher than expected at 3.7% in August compared with a 3.2% increase in the previous month.""}, {""date"": ""2023-09-13"", ""headline"": ""Five things to know about the new COVID-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Barclays projects over $5B COVID booster sales in fall 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Rocket Pharmaceuticals, Moderna rise; American Airlines, Spirit Airlines fall, Wednesday, 9/13/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""US Stocks Rise Despite Hot Inflation As Fed Sentiment Remains Unshaken: What's Driving Markets Wednesday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Novavax dealt setback as FDA, CDC approve Moderna, Pfizer Covid-19 vaccines"", ""summary"": ""Rivals Moderna and Pfizer will get a head start on distribution after regulators approved their vaccine candidates this week.""}, {""date"": ""2023-09-13"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna sees combo flu/COVID vaccine available as early as 2025"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna up after forecasting up to $15B in sales by 2027 from respiratory drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Interesting MRNA Put And Call Options For January 2026"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Biggest stock movers today: Grab Holdings, Workhorse Group, Rocket Pharmaceuticals and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna, REV Group, Rocket Pharmaceuticals And Other Big Stocks Moving Higher On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna price target lowered to $140 from $160 at Argus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Early notable gainers among liquid option names on September 13th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna (NASDAQ:MRNA) Jumps on Positive Phase 3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Why Is Moderna Stock Trading Higher Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""4 stocks to watch on Wednesday: American Airlines, Moderna and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Say Goodbye to Free COVID-19 Shots: CDC Approves Priced Boosters for Omicron Subvariants"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna sees $10B \u2013 $15B sales from launching new products by 2028"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna aims to prove it\u2019s \u2018more than a COVID company\u2019\u00a0"", ""summary"": ""As COVID vaccine sales fall, Moderna releases positive results from mRNA flu vaccine, adds new development programs""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna aims to prove it\u2019s \u2018more than a COVID company\u2019"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""Moderna Expands the Field of mRNA Medicine with Positive Clinical Results Across Cancer, Rare Disease, and Infectious Disease"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-13"", ""headline"": ""U.S. stocks close mostly higher despite inflation edging up in August"", ""summary"": ""U.S. stock indexes closed mostly higher on Wednesday, as investors digested the latest consumer-price index data showing inflation picked up in August, but...""}, {""date"": ""2023-09-14"", ""headline"": ""More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""UPDATE 1-US STOCKS-Wall Street ends higher on economic data; Arm soars in debut"", ""summary"": ""The S&P 500 ended higher on Thursday as hotter-than-expected economic data eased worries about a recession without raising fears of a Federal Reserve rate hike next week, while Arm Holdings soared in its stock market debut.  SoftBank's Arm was valued at nearly $60 billion in a strong Nasdaq debut, with the chip designer's shares soaring nearly 25% in their first day of trading.""}, {""date"": ""2023-09-14"", ""headline"": ""US STOCKS-Wall Street ends higher on economic data; Arm soars in debut"", ""summary"": ""The S&P 500 ended higher on Thursday as hotter-than-expected economic data eased worries about a recession without raising fears of a Federal Reserve rate hike next week, while Arm Holdings soared in its stock market debut.  SoftBank's Arm was valued at nearly $60 billion in a strong Nasdaq debut, with the chip designer's shares soaring nearly 25% in their first day of trading.""}, {""date"": ""2023-09-14"", ""headline"": ""Moderna culls four drug programs"", ""summary"": ""Moderna Inc. is slashing four drug programs as it marches forward with vaccines against infectious diseases and cancer.""}, {""date"": ""2023-09-14"", ""headline"": ""Argus Research Maintains Moderna (MRNA) Buy Recommendation"", ""summary"": """"}, {""date"": ""2023-09-14"", ""headline"": ""Moderna (MRNA) Posts '28 Biz View, Up 3% on Upbeat Flu Jab Data"", ""summary"": ""Moderna's (MRNA) reformulated influenza vaccine candidate meets the primary endpoint in a late-stage study. It expects to launch up to 15 new products in the next five years.""}, {""date"": ""2023-09-14"", ""headline"": ""EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna\u2019s Updated Covid-19 Vaccine in The European Union"", ""summary"": ""Moderna, Inc. (Nasdaq:MRNA) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending marketing authorization for Spikevax, its updated COVID-19 vaccine containing spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals six months of age and older.""}, {""date"": ""2023-09-14"", ""headline"": ""Biotech Stock Roundup: MRNAs Pipeline News, RCKT, BCYC Rally on Study Updates"", ""summary"": ""Pipeline and regulatory updates from Moderna (MRNA) and Rocket Pharmaceuticals (RCKT) are in focus in the biotech sector.""}, {""date"": ""2023-09-14"", ""headline"": ""Moderna (MRNA) Surges 3.2%: Is This an Indication of Further Gains?"", ""summary"": ""Moderna (MRNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.""}, {""date"": ""2023-09-14"", ""headline"": ""Why COVID Vaccine Demand Might Not Be That Strong"", ""summary"": ""COVID hospitalizations are rising, but they're nowhere near the levels they were at a year or two ago.""}, {""date"": ""2023-09-14"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Moderna, Inc. (MRNA) R&D Day and Business Updates (Transcript)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Moderna celebrates positive opinion from EMA for updated Covid vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Moderna wins EU recommendation for updated COVID shot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""The Petri Dish: Former bluebird CFO to lead startup, Moderna flu vaccine succeeds in Phase 3"", ""summary"": ""The CFO who left bluebird bio last fall after nearly nine years has found a new roost. Plus other life sciences news you may have missed.""}, {""date"": ""2023-09-14"", ""headline"": ""Moderna says CHMP adopts positive opinion on updated Covid-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Novavax Is a Step Behind, Again. Should You Be Worried?"", ""summary"": ""In the earliest days of the coronavirus vaccine race, Novavax (NASDAQ: NVAX) stood out as a potential winner.  Novavax fell behind, launching its vaccine as late as 1 1/2 years after rivals Pfizer and Moderna.  As a result, Novavax lost out on the biggest revenue opportunity, and its shares have been on the decline ever since.""}, {""date"": ""2023-09-14"", ""headline"": ""Market seems 'only focused on Covid' for Moderna, says Jefferies"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Tracking Philippe Laffont's Coatue Management Portfolio - Q2 2023 Update"", ""summary"": ""Coatue Management's 13F portfolio value increased by 35% to $20.41B in Q2 2023. Click here to read the portfolio's full Q2 2023 update.""}, {""date"": ""2023-09-14"", ""headline"": ""The Labor Market In Australia Remains Resilient"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""The 7 Best Meme Stocks to Buy Now: September 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Barclays Sticks to Its Buy Rating for Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""Moderna (MRNA) Gets a Hold from Morgan Stanley"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-14"", ""headline"": ""\u2018This Is Not a Covid Vaccine Company,\u2019 Moderna CEO Says"", ""summary"": ""Stephane Bancel told Barron's the company won't be defined by its Covic-19 vaccine even as it uses the same technology to develop other vaccines.""}, {""date"": ""2023-09-14"", ""headline"": ""Analysts Have Conflicting Sentiments on These Healthcare Companies: Moderna (MRNA) and Alnylam Pharma (ALNY)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-15"", ""headline"": ""Moderna (MRNA) Gains As Market Dips: What You Should Know"", ""summary"": ""Moderna (MRNA) closed at $114.59 in the latest trading session, marking a +1.58% move from the prior day.""}, {""date"": ""2023-09-15"", ""headline"": ""US NIH begins human trials of 'universal' flu vaccine"", ""summary"": ""The U.S. National Institutes of Health (NIH) said on Friday that it has begun an early-stage study on its experimental vaccine targeting six strains of influenza virus.  The vaccine candidate, FluMos-v2, is designed to offer protection against four strains of the influenza A virus and two strains of influenza B virus, the health agency said.""}, {""date"": ""2023-09-15"", ""headline"": ""Moderna Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Moderna Inc. rose 1.58% to $114.59 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-09-15"", ""headline"": ""Is Moderna Stock a Top Buy?"", ""summary"": ""Biotechnology stocks have the potential to deliver outstanding returns for investors.  Indeed, some of the best-performing stocks in the past two decades have emerged from the biotech industry.  The fiercely competitive nature of the industry and the limited lifespan of branded medications can cause significant fluctuations in the stock prices of biotech companies.""}, {""date"": ""2023-09-15"", ""headline"": ""Moderna (MRNA) Receives CHMP Nod for Updated COVID Vaccine"", ""summary"": ""Clinical data from studies on Moderna's (MRNA) updated COVID vaccine shows improved antibody responses against multiple circulating variants, including BA.2.86, EG.5 and FL.1.5.1 variants.""}, {""date"": ""2023-09-15"", ""headline"": ""Pharma Stock Roundup: FDA Nod to Updated PFE, MRNA COVID Jabs, & More"", ""summary"": ""The FDA authorizes Pfizer (PFE) and Moderna's (MRNA) updated mRNA-based COVID-19 vaccines. Novo Nordisk (NVO) conducts a two-for-one split of its shares and ADRs.""}, {""date"": ""2023-09-15"", ""headline"": ""Moderna Unusual Options Activity For September 15"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-15"", ""headline"": ""UPDATE 1-UK regulator approves Moderna's updated COVID vaccine"", ""summary"": ""The UK drug regulator said on Friday it has approved an updated COVID-19 vaccine by Moderna, making it the second shot  to be used in the country's vaccination campaign this autumn.  The updated shot, branded Spikevax, to target the XBB.1.5 variant of Omicron, is indicated for use in adults and children aged 6 months and above.  The approval for the shot from the Medicines and Healthcare products Regulatory Agency follows the European regulatory panel's recommendation on Thursday.""}, {""date"": ""2023-09-15"", ""headline"": ""Biotech Alert: Searches spiking for these stocks today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-15"", ""headline"": ""This 1 Number May Completely Change Your Opinion About Moderna"", ""summary"": ""Moderna offered investors more details about its projects and prospects this week during its annual R&D Day.  If you're worried about Moderna, one number may completely change your mind.  The company is set to launch its updated coronavirus vaccine, right on time for the fall vaccination season.""}, {""date"": ""2023-09-16"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will this morning on Seeking Alpha, iTunes, Spotify.""}, {""date"": ""2023-09-17"", ""headline"": ""The 'tripledemic' threat to be less severe this season"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-17"", ""headline"": ""Looking for Growth? These Companies' Revenue May Skyrocket"", ""summary"": ""You might find candidates in any industry, but today I'll look at two biotech companies and one consumer goods company that truly stand out.  Moderna (NASDAQ: MRNA) today is known for its blockbuster coronavirus vaccine.  The company said this week it plans on launching as many as 15 products in the next five years and bringing possibly 50 new candidates into clinical studies.""}, {""date"": ""2023-09-17"", ""headline"": ""New Cancer Drugs Are Changing the Odds. The Latest on Treatments."", ""summary"": ""Over the past decade, a series of drugs and vaccines that use our immune systems to fight cancer have arrived. Survival times for some deadly cancers are climbing.""}]",{}
36,2023-09-17,114.58999633789062,2023-09-24,99.98999786376953,-0.12741075958384873,D5+,"[{""date"": ""2023-09-17"", ""headline"": ""What You Missed On Wall Street On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-17"", ""headline"": ""Moderna (NASDAQ:MRNA) Plunges as COVID-19 Market Collapses"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-17"", ""headline"": ""Moderna (NASDAQ:MRNA) Plunges as COVID-19 Shot Market Collapses"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-17"", ""headline"": ""Moderna (NASDAQ:MRNA)Plunges as COVID-19 Shot Market Collapses"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-17"", ""headline"": ""Vaccine makers slip as Pfizer CFO sees weaker demand for COVID shots"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-17"", ""headline"": ""The 'tripledemic' threat to be less severe this season"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-17"", ""headline"": ""Looking for Growth? These Companies' Revenue May Skyrocket"", ""summary"": ""You might find candidates in any industry, but today I'll look at two biotech companies and one consumer goods company that truly stand out.  Moderna (NASDAQ: MRNA) today is known for its blockbuster coronavirus vaccine.  The company said this week it plans on launching as many as 15 products in the next five years and bringing possibly 50 new candidates into clinical studies.""}, {""date"": ""2023-09-17"", ""headline"": ""New Cancer Drugs Are Changing the Odds. The Latest on Treatments."", ""summary"": ""Over the past decade, a series of drugs and vaccines that use our immune systems to fight cancer have arrived. Survival times for some deadly cancers are climbing.""}, {""date"": ""2023-09-18"", ""headline"": ""Moderna\u2019s Stock Is S&P 500\u2019s Biggest Loser Today"", ""summary"": ""Moderna stock dropped 9.1% on Monday despite little fundamental news being reported on the company.  The most notable headline involved Noubar Afeyan, a co-founder of Moderna (ticker: MRNA) and board member, who sold 15,000 shares of Moderna for a total value of $1.65 million, according to a filing with the Securities and Exchange Commission made public on Friday.  Moderna also gained 8.3% from Monday through Friday of last week, suggesting that today\u2019s move might have simply been the kind of volatility typically associated with Moderna shares.""}, {""date"": ""2023-09-18"", ""headline"": ""S&P 500 Gains and Losses Today: Index Little Changed Ahead of Fed Decision"", ""summary"": ""U.S. equities were little changed as the S&P 500 gained 0.07% on Sept. 18, 2023 ahead of the Federal Reserve's decision on interest rates this week.""}, {""date"": ""2023-09-18"", ""headline"": ""Moderna, Pfizer Stocks Fall With Weak Expected Covid Vaccine Demand"", ""summary"": ""Shares of vaccine makers moved lower Monday after Pfizer's finance chief predicted weaker demand for Covid shots this year. Pfizer CFO David Denton said his company projects a roughly 24% Covid vaccination rate in the U.""}, {""date"": ""2023-09-18"", ""headline"": ""Shares of COVID-19 Vaccine Makers Fall After Pfizer CFO Warns of Outlook 'Haircut'"", ""summary"": ""Moderna was the worst-performing stock in the S&P 500, and Pfizer shares dropped as well after Pfizer CFO David Denton said the outlook for vaccine rates this year got a significant \""haircut.\""""}, {""date"": ""2023-09-18"", ""headline"": ""Stocks to Watch Monday: Airbnb, Blackstone, Stitch Fix"", ""summary"": ""\u2198\ufe0f [**Societe Generale (FR: GLE)**](https://www.wsj.com/market-data/quotes/SCGLY): The French bank's shares fell more than 9% after it cut its [annual targets for revenue growth](https://www.wsj.com/livecoverage/stock-market-today-dow-jones-09-18-2023/card/soci-t-g-n-rale-shares-sink-after-new-ceo-lays-out-strategy-MtXmLwmH15ZoAkO2YSeI).""}, {""date"": ""2023-09-18"", ""headline"": ""Markets Edge Higher at Midday Ahead of This Week's Fed Meeting"", ""summary"": ""U.S. equities were climbing at midday as the market looks ahead to this week\u2019s decision by the Federal Reserve on the future of interest rate hikes. The Dow, S&P 500, and Nasdaq posted small gains.""}, {""date"": ""2023-09-18"", ""headline"": ""Moderna Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 9.12% to $104.14 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-09-18"", ""headline"": ""NEW YORK MARKET CLOSE: Stocks tread water ahead of interest rate calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""Moderna slips 8% as Pfizer COVID shot forecast weighs on shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""Stocks Edge Higher As Dollar Takes Breather, Tesla And Automakers Decline: What's Driving Markets Monday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""Stocks Sluggish As Oil, Bond Yields Rise"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""UPDATE 3-Pfizer forecasts 24% COVID vaccination rate in US this year"", ""summary"": ""Pfizer expects 24% of the U.S. population, or about 82 million people, to receive COVID-19 shots this year, CFO David Denton said at a conference on Monday, reiterating the vaccine maker's estimates from earlier this year.  The U.S. Food and Drug Administration has authorized updated COVID vaccines from Pfizer and its partner BioNTech, as well as from Moderna, as the country prepares to start a fall vaccination campaign.  A third vaccine from Novavax is also under review.""}, {""date"": ""2023-09-18"", ""headline"": ""Canopy Growth, DocGo And Other Big Stocks Moving Lower On Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""Pfizer sees 24% of eligible Americans getting COVID-19 boosters"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""Interesting MRNA Put And Call Options For October 20th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, SIRI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""Video: S&P 500 Movers: MRNA, CPRT"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-18"", ""headline"": ""Here Are 15 New Reasons to Be Bullish About Moderna Stock"", ""summary"": ""Since the start of 2020, Moderna (NASDAQ: MRNA) stock is up an astounding 438%.  In the announcement, management celebrated the successful conclusion of the phase 3 trials of the company's flu vaccine.  It also noted that it would soon submit the data for its respiratory syncytial virus (RSV) drug to regulators for their evaluation too.""}, {""date"": ""2023-09-19"", ""headline"": ""Price Targets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-19"", ""headline"": ""Updated Covid Vaccine US Rollout Hit by Insurance Coverage Delays - What It Means?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-19"", ""headline"": ""3 Stocks to Avoid Like the Plague Right Now: MRNA, GPS, PTON"", ""summary"": ""The Federal Reserve is set to make its next move shortly, and it could send a shock through the market. With already high interest rates, a sticky inflation problem and an uncertain economic outlook, many investors are taking a cautious approach for the rest of 2023. And there should be particular concern about companies that were beneficiaries of the unique economic conditions from 2020-22 and are not nearly as well-positioned going forward. It\u2019s time to remove these three stocks to avoid from""}, {""date"": ""2023-09-19"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. rose 2.50% to $106.74 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-09-19"", ""headline"": ""New Covid-19 Vaccines Are Here. What to Know About Fall Shots."", ""summary"": ""Americans are starting to roll up their sleeves for an array of shots to stem the anticipated tide of respiratory infections this fall, including the latest Covid-19 subvariants.""}, {""date"": ""2023-09-19"", ""headline"": ""UPDATE 2-Moderna to cut mRNA drug substance production at Lonza facility"", ""summary"": ""Moderna said on Tuesday it will cut production of mRNA drug substance for its COVID-19 vaccine at Lonza's facility in Switzerland this quarter as part of a plan to align manufacturing of the shots with lower post-pandemic demand.  The U.S. company had said last week it was in talks with its partners that fill vials and syringes globally to downsize vaccine production.  Such a move will help Moderna adjust to the sharp fall in demand for COVID vaccines as payers cut back orders for the shots, partly following the end of the public health emergency for the disease.""}, {""date"": ""2023-09-19"", ""headline"": ""Moderna, Pfizer on the move on concerns about weak demand for COVID vaccines"", ""summary"": ""Shares of Moderna (MRNA) and Pfizer (PFE) are on the move after Pfizer CFO David Denton projected a COVID vaccination rate of only 24% this year in the U.S. The demand for COVID vaccinations has dwindled, with data indicating it's less than half of what is expected for flu shots. Despite Moderna's efforts to expand its business, it remains heavily reliant on COVID vaccinations and booster shots. Yahoo Finance's Seana Smith and Brad Smith discuss the details of how the declining demand for COVID immunizations could affect vaccine makers moving forward.""}, {""date"": ""2023-09-19"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""Grocery delivery company Instacart priced its initial public offering at $30 a share ahead of its debut on the Nasdaq and Google rolled out new features for its Bard artificial intelligence AI chatbot. Here\u2019s what investors need to know today.""}, {""date"": ""2023-09-19"", ""headline"": ""Check Out What Whales Are Doing With MRNA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-19"", ""headline"": ""Moderna to end mRNA COVID shot production at Lonza plant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-19"", ""headline"": ""Early notable gainers among liquid option names on September 19th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-19"", ""headline"": ""GeoVax Labs publishes data from Phase 2 trial of next-gen COVID-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-19"", ""headline"": ""Amazon, Moderna And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-19"", ""headline"": ""These Stocks Are Moving the Most Today: Instacart, Disney, NIO, Bausch Health, Enphase, U.S. Steel, Rocket Lab, and More"", ""summary"": ""Instacart opens for trading 40% above its IPO price, Disney aims to nearly double its investment in its parks, experiences, and products segment over the...""}, {""date"": ""2023-09-20"", ""headline"": ""Novavax updated COVID shot to get EU review in October"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-20"", ""headline"": ""Pfizer (NYSE:PFE) Slips as Paxlovid Proves Less Effective"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-20"", ""headline"": ""U.S. to offer free at-home COVID-19 tests again, starting next week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-20"", ""headline"": ""New Covid-19 Vaccines and More Free Mail-Order Tests. What to Know for This Fall."", ""summary"": ""Americans are starting to roll up their sleeves for shots to stem the expected tide of respiratory infections this fall, including the latest Covid-19 subvariants.""}, {""date"": ""2023-09-20"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 3.01% to $103.53 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-09-20"", ""headline"": ""With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?"", ""summary"": ""The Food and Drug Administration (FDA) just approved the updated Omicron-adapted COVID-19 booster shots from Moderna (NASDAQ: MRNA) and the COVID-19 booster that Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) collaborated on.  While the news will certainly help the pharmaceutical companies' bottom lines, it's important to look deeper to see if any of these three stocks make a solid investment today.  At first glance, Pfizer's stock appears to be a screaming deal.""}, {""date"": ""2023-09-20"", ""headline"": ""Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-20"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, LULU"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-20"", ""headline"": ""2 Unstoppable Growth Stocks to Buy in 2023 and Beyond"", ""summary"": ""Two candidates with loads of potential are Moderna (NASDAQ: MRNA) and Teladoc Health (NYSE: TDOC).  Moderna's earnings soared over the past two years thanks to its blockbuster COVID-19 vaccine.  Moderna has set out a plan that could result in $30 billion in sales down the road, which surpasses its peak of about $18 billion in coronavirus vaccine sales.""}, {""date"": ""2023-09-20"", ""headline"": ""Beware! 3 Value Stocks Waving Massive Red Flags Right Now."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-20"", ""headline"": ""Beware! 3 Nasdaq Stocks Waving Massive Red Flags Right Now."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-21"", ""headline"": ""Moderna: Covid Curse"", ""summary"": ""Moderna's outlook dims as lower Covid vaccine demand impacts revenues, while aggressive spending on R&D forecasts potential losses. Learn more on MRNA stock here.""}, {""date"": ""2023-09-21"", ""headline"": ""Sanofi CEO: How AI may ease the pressure of Medicare price negotiations"", ""summary"": ""Sanofi is all in on AI and thinks it could help alleviate patent timeline pressures from the Inflation Reduction Act.""}, {""date"": ""2023-09-21"", ""headline"": ""Moderna Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 3.19% to $100.23 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-09-21"", ""headline"": ""Biden admin. funding production of new at-home COVID tests"", ""summary"": ""The Biden administration will be providing $600 million to fund the production of new at-home COVID-19 tests as U.S. cases tick higher. Yahoo Finance Health Reporter Anjalee Khemlani breaks down the status of new vaccines in development and how the U.S. may be responding to new variant strains. For more expert insight and the latest market action,\u00a0click here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-09-21"", ""headline"": ""Moving Beyond COVID: A\u00a0 Conservative Options Income Strategy For Moderna"", ""summary"": ""Analysts have soured on Moderna's prospects, despite recent good news in its drug pipeline. Click here to read why MRNA stock is a Buy.""}, {""date"": ""2023-09-21"", ""headline"": ""Biotech Stock Roundup: GSK's Drug Approval, MRNA's Vaccine News, PTCT & SPRY Down"", ""summary"": ""Regulatory updates from GSK and Moderna (MRNA) are in focus in the biotech sector.""}, {""date"": ""2023-09-21"", ""headline"": ""Lonza confirms 2023 outlook; Moderna lowers production at Lonza site"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-21"", ""headline"": ""Merck (MRK) Keytruda Cervical Cancer sBLA Gets FDA Priority Tag"", ""summary"": ""The FDA grants priority review to Merck's (MRK) sBLA seeking expanded use of Keytruda for an earlier stage of cervical cancer disease.""}, {""date"": ""2023-09-21"", ""headline"": ""Novavax: The Short Squeeze Story Isn't A Complete No-Brainer"", ""summary"": ""The high level of short interest in Novavax makes a short squeeze a possibility. Read more to see a detailed analysis on NVAX stock.""}, {""date"": ""2023-09-21"", ""headline"": ""Moderna: Fortune Favors The Brave"", ""summary"": ""Investors in Moderna face challenges as selling pressure persists, but the company expects COVID revenue growth, possibly leading to an upward re-rating.""}, {""date"": ""2023-09-21"", ""headline"": ""Does This Message From Moderna Mean Bad News for Novavax?"", ""summary"": ""Moderna (NASDAQ: MRNA) recently gave an update on its pipeline and future goals, and the biotech had a lot to say.  This doesn't mean Moderna is forgetting about the coronavirus vaccine though.  In fact, this market giant announced something that could impact smaller rival Novavax (NASDAQ: NVAX).""}, {""date"": ""2023-09-21"", ""headline"": ""Moderna, Inc.'s (NASDAQ:MRNA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?"", ""summary"": ""It is hard to get excited after looking at Moderna's (NASDAQ:MRNA) recent performance, when its stock has declined 14...""}, {""date"": ""2023-09-21"", ""headline"": ""$10,000 Invested in These Growth Stocks Could Make You a Fortune Over the Next 10 Years"", ""summary"": ""I favor holding onto these players for the long term to truly benefit from their earnings potential.""}, {""date"": ""2023-09-21"", ""headline"": ""Looking Into Moderna's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-21"", ""headline"": ""HP Inc. appoints David Meline to board of directors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-22"", ""headline"": ""Moderna (MRNA) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""Moderna (MRNA) closed the most recent trading day at $99.99, moving -0.24% from the previous trading session.""}, {""date"": ""2023-09-22"", ""headline"": ""Moderna Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 0.24% to $99.99 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-09-22"", ""headline"": ""The Covid Booster Rollout Is a Mess. That\u2019s Good News for Pfizer and Moderna."", ""summary"": ""While shortages and insurance mix-up are a pain for patients, things are looking up for vaccine makers.""}, {""date"": ""2023-09-22"", ""headline"": ""Moderna Is Expecting Massive Growth Over the Next Decade. Is the Stock a No-Brainer Buy?"", ""summary"": ""Moderna (NASDAQ: MRNA) has become a well-known name in healthcare over the past few years thanks to its COVID-19 vaccine.  Moderna has very high hopes, but are they too good to be true?  To say Moderna has an aggressive growth plan would be an understatement.""}, {""date"": ""2023-09-23"", ""headline"": ""Moderna: Now That The COVID Party Is Over, What's Next?"", ""summary"": ""The sentiments surrounding COVID-19 vaccines appear to be pessimistic, with moderating demand triggering headwinds to MRNA's FQ2'23 performance. Read more here.""}, {""date"": ""2023-09-23"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Spotify.""}, {""date"": ""2023-09-24"", ""headline"": ""Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now."", ""summary"": ""Healthcare stocks generally offer a lot of upside. The cost of healthcare is incredibly expensive in the United States and the companies that deliver it tend to do very well overall. However, as with any sector, there are bound to be losers \u2013 and these healthcare stocks to avoid unfortunately make that list. These companies are showing signs of trouble at the moment which is enough to spur investors to avoid them. In fact, the companies discussed here are showing substantial signs of distress. A""}, {""date"": ""2023-09-24"", ""headline"": ""Free Covid Tests Are Coming. Here\u2019s How to Get Yours."", ""summary"": ""Americans can order four more free Covid-19 tests from the government starting Monday, amid evidence of rising infections and hospitalizations.""}, {""date"": ""2023-09-24"", ""headline"": ""Updated COVID boosters to divide America"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-24"", ""headline"": ""Have you gotten your shot? 5 things to know about the new COVID-19 vaccine."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
37,2023-09-24,99.98999786376953,2023-10-01,103.29000091552734,0.03300333155576096,U4,"[{""date"": ""2023-09-24"", ""headline"": ""Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now."", ""summary"": ""Healthcare stocks generally offer a lot of upside. The cost of healthcare is incredibly expensive in the United States and the companies that deliver it tend to do very well overall. However, as with any sector, there are bound to be losers \u2013 and these healthcare stocks to avoid unfortunately make that list. These companies are showing signs of trouble at the moment which is enough to spur investors to avoid them. In fact, the companies discussed here are showing substantial signs of distress. A""}, {""date"": ""2023-09-24"", ""headline"": ""Free Covid Tests Are Coming. Here\u2019s How to Get Yours."", ""summary"": ""Americans can order four more free Covid-19 tests from the government starting Monday, amid evidence of rising infections and hospitalizations.""}, {""date"": ""2023-09-24"", ""headline"": ""Updated COVID boosters to divide America"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-24"", ""headline"": ""Have you gotten your shot? 5 things to know about the new COVID-19 vaccine."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-25"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-25"", ""headline"": ""New COVID vaccine rollout running into insurance, supply roadblocks"", ""summary"": ""The rollout of new COVID-19 vaccines is being obstructed by insurance and supply roadblocks, as customers experience issues with getting insurers to agree on vaccine coverage. The Department of Health and Human Services wrote a letter to insurers stating, \""Your obligation as a plan or issuer to ensure that your members have coverage for COVID-19 vaccines without cost sharing is not conditional upon parties' compliance.\"" Yahoo Finance Health Care Reporter Anjalee Khemlani breaks down the news. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-09-25"", ""headline"": ""Moderna Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 1.82% to $98.17 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-09-25"", ""headline"": ""How to Find Strong Medical Stocks Slated for Positive Earnings Surprises"", ""summary"": ""The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.""}, {""date"": ""2023-09-25"", ""headline"": ""Shutdown, Strikes, Sticky Inflation, and More\u2026 Brace for a Bumpy Fourth Quarter"", ""summary"": ""Hollywood writers reach deal to end strike, President Biden to join auto workers on picket line, and other news to start your day.""}, {""date"": ""2023-09-25"", ""headline"": ""ProFound Therapeutics Expands Leadership Team With Appointment of Klaus Urbahns as Chief Scientific Officer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-26"", ""headline"": ""Moderna Talks Offer Hope for Enhanced COVID-19 Vaccine Availability In Europe"", ""summary"": ""European countries are actively negotiating a fresh COVID-19 vaccine procurement agreement with Moderna Inc (NASDAQ: MRNA) as concerns mount within EU health authorities regarding a surge in coronavirus infections. Member states can express their interest in the deal individually, and the Financial Times reported that at least eight EU countries have already shown interest in participating. This potential deal comes at a time when Pfizer maintains near-monopoly status on COVID-19 vaccine supplie""}, {""date"": ""2023-09-26"", ""headline"": ""Don\u2019t Miss the Boom: 3 Healthcare Stocks Set to Explode Higher"", ""summary"": ""According to the American Medical Association, U.S. healthcare spending totaled $4.3 trillion in 2021, equal to nearly $13,000 per person. Overall medical expenses account for nearly 20% of U.S. gross domestic product (GDP). America today spends more on healthcare per capita than any other country. By 2030, one in five Americans (20%) is forecast to be age 65 or older. For these reasons, the healthcare sector is a long-term, growth opportunity for investors. In fact, all segments are forecast to""}, {""date"": ""2023-09-26"", ""headline"": ""Moderna Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Moderna Inc. slipped 0.05% to $98.12 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-09-26"", ""headline"": ""US STOCKS-Wall St poised for weak open as rate worries keep Treasury yields elevated"", ""summary"": ""Wall Street's main indexes were on track for a lower open on Tuesday as investors continued to grapple with the prospects of a prolonged restrictive monetary policy by the Federal Reserve and its subsequent impact on the economy.  \""A polarized political environment, uncertainty on macroeconomic conditions, and then you throw a government shutdown on top of it will create a gray area where there's no clear path,\"" said Chris Giamo, head of commercial banking at TD Bank.  At 8:15 a.m. ET, Dow e-minis were down 111 points, or 0.32%, S&P 500 e-minis were down 15.5 points, or 0.35%, and Nasdaq 100 e-minis were down 54.5 points, or 0.36%.""}, {""date"": ""2023-09-26"", ""headline"": ""UPDATE 2-EU in talks with Moderna over new deal for COVID vaccines - FT"", ""summary"": ""The European Union is in talks with Moderna over a new supply deal for the company's COVID-19 vaccines amid concerns over a rise in infections in the region, the Financial Times reported on Tuesday, citing two people familiar with the matter.  The company supplied its COVID vaccines to the EU during the pandemic, but the contract for its Omicron-adjusted vaccines ended in August last year and was not renewed.  \""Moderna manufactured its updated COVID-19 vaccine at risk to ensure we could support member states with their upcoming vaccination campaigns,\"" a company spokesperson said, adding the updated shot was approved in Europe and ready to be supplied.""}, {""date"": ""2023-09-26"", ""headline"": ""EU in talks with Moderna over new vaccine supply deal"", ""summary"": ""Brussels is negotiating a new Covid-19 vaccine procurement deal with US drugmaker Moderna as EU health authorities grow concerned about a rise in coronavirus infections.  The deal is being negotiated between Brussels and the biotechnology group, two people familiar with the matter said, with member states able to confirm their interest on an individual basis.  At least eight EU countries were interested in opting into a new supply deal, one of the people said, adding that the contract was specifically for messenger ribonucleic acid-based Covid-19 vaccines.""}, {""date"": ""2023-09-26"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-26"", ""headline"": ""The Big Pharma Stock Trade: Weight Loss Is In, Covid-19 Is Out"", ""summary"": ""The pharmaceuticals sector is enduring a tough year in the stock market. Companies selling weight-loss drugs are a big exception.""}, {""date"": ""2023-09-26"", ""headline"": ""Moderna, EU negotiate new vaccine supply agreement, FT reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-26"", ""headline"": ""Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks."", ""summary"": ""Outside of a handful of highflying technology stocks, U.S. stocks have been practically flat in 2023, but on Wall Street, some analysts remain as bullish as...""}, {""date"": ""2023-09-27"", ""headline"": ""Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine"", ""summary"": ""Pharma companies across the globe, including Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA), are harnessing the potential of mRNA which is creating plenty of space for scientific improvement in the fight against pathogens. The world learned about messenger RNA molecules and their flexibility, speed and power during the COVID-19 battle. Although this virus is still present, mRNA vaccines helped the world cope with this unprecedented health challenge and move on. But this technology is also""}, {""date"": ""2023-09-27"", ""headline"": ""Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-27"", ""headline"": ""Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-27"", ""headline"": ""DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-27"", ""headline"": ""Flagship Pioneering Named to Fortune's 2023 \""Change the World\"" List"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?"", ""summary"": ""Despite slowing COVID-19 vaccine sales these healthcare titans are trading at more reasonable valuations with a lot of the risk-to-reward being priced into their stocks considering their earnings potential.""}, {""date"": ""2023-09-28"", ""headline"": ""Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Moderna (MRNA) closed at $100.27, marking a +0.83% move from the previous day.""}, {""date"": ""2023-09-28"", ""headline"": ""What to know as fall vaccinations against COVID, flu and RSV get underway"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. inched 0.83% higher to $100.27 Thursday, on what proved to be an all-around great trading session for the stock market, with the...""}, {""date"": ""2023-09-28"", ""headline"": ""Covid-19 Vaccine Uptake Could Beat Expectations, Poll Indicates"", ""summary"": ""The consensus view had been that Americans are tired of lining up for the shots. Manufacturers have pulled back from usage estimates made early this year.""}, {""date"": ""2023-09-28"", ""headline"": ""Check Out What Whales Are Doing With MRNA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-28"", ""headline"": ""Swissmedic clear's Moderna Switzerland's COVID-19 vaccine Spikevax XBB.1.5"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""Moderna Recommends Shareholders Reject Amended \u201cMini-Tender\u201d Offer by TRC Capital Investment Corporation"", ""summary"": ""CAMBRIDGE, MA / ACCESSWIRE / September 29, 2023 / Moderna, Inc. (NASDAQ:MRNA) has become aware that TRC Capital Investment Corporation (TRC Capital) has amended its unsolicited \""mini-tender\"" offer to purchase up to 1,000,000 shares of Moderna's common ...""}, {""date"": ""2023-09-29"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. rallied 3.01% to $103.29 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-09-29"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-09-29"", ""headline"": ""If I Could Only Buy 3 Stocks in 2023, I'd Pick These"", ""summary"": ""CRISPR Therapeutics (NASDAQ: CRSP) specializes in gene editing, or the repair of faulty genes responsible for disease.  Right now, CRISPR is heading for its biggest moment ever -- a regulatory decision on what may become its first commercialized product.  The U.S. Food and Drug Administration (FDA) is set to decide on exa-cel for sickle cell disease in December and on exa-cel for beta thalassemia in March.""}, {""date"": ""2023-09-30"", ""headline"": ""Moderna's Shares Could Take Off if These 2 Things Happen"", ""summary"": ""Moderna (NASDAQ: MRNA) used to be a stock market star, climbing 1,700% from the start of 2020 through July of 2021.  Investors liked that, and it clearly showed in the stock performance.  After all, the vaccine is Moderna's only product right now, and demand for it has declined.""}, {""date"": ""2023-09-30"", ""headline"": ""Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine"", ""summary"": ""Once a relatively unknown biotech company, Moderna (NASDAQ: MRNA) became a household name when it became one of the first companies to offer a vaccine for the COVID-19 virus.  At its peak, Moderna saw quarterly revenue of $7 billion as it sold vaccines to the world.  Its stock price followed suit, reaching an all-time high of $484 in mid-2021.""}]","{""assetTurnoverTTM"": 0.3995, ""bookValue"": 13455, ""cashRatio"": 0.6686431014823261, ""currentRatio"": 2.4627, ""ebitPerShare"": -5.2808, ""eps"": -9.5276, ""ev"": 37112.02, ""fcfPerShareTTM"": -6.9738, ""grossMargin"": -0.2239, ""inventoryTurnoverTTM"": 4.4321, ""netDebtToTotalCapital"": -0.1556, ""netDebtToTotalEquity"": -0.164, ""netMargin"": -1.9825, ""operatingMargin"": -1.0989, ""pb"": 2.9223, ""pretaxMargin"": -1.0694, ""psTTM"": 4.3108, ""ptbv"": 2.9321, ""quickRatio"": 2.2383, ""receivablesTurnoverTTM"": 3.9996, ""roaTTM"": -0.1518, ""roeTTM"": -0.2027, ""roicTTM"": -0.192, ""rotcTTM"": -0.1476, ""salesPerShare"": 4.8058, ""sgaToSale"": 1.2239, ""tangibleBookValue"": 13410, ""totalDebtToEquity"": 0.0539, ""totalDebtToTotalAsset"": 0.0373, ""totalDebtToTotalCapital"": 0.0511, ""totalRatio"": 3.2444, ""period"": ""2023-09-30""}"
38,2023-10-01,103.29000091552734,2023-10-08,103.87999725341797,0.005712037299458794,U1,"[{""date"": ""2023-10-01"", ""headline"": ""Developers of mRNA Vaccines Honored with Nobel Prize"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-01"", ""headline"": ""3 Revolutionary Stocks I'd Buy Right Now Without Hesitation"", ""summary"": ""These companies are helping change medicine; they could make boatloads of money along the way.""}, {""date"": ""2023-10-01"", ""headline"": ""Biotech Stocks Mixed as MRNA Honored at Nobel Prizes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""Novavax spikes as FDA clears updated COVID shot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""Moderna Unusual Options Activity For October 03"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""Pioneers of mRNA Find Redemption in Nobel Prize"", ""summary"": ""Katalin Karik\u00f3 and Drew Weissman\u2019s path to winning the Nobel Prize on Monday began at a photocopy machine.""}, {""date"": ""2023-10-02"", ""headline"": ""Moderna Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.02% higher to $103.31 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-10-02"", ""headline"": ""Years of research laid the groundwork for speedy COVID-19 shots"", ""summary"": ""The Nobel Prize in Medicine was awarded Monday to two scientists whose work led to the mRNA vaccines against COVID-19.  A head start helped -- over a decade of behind-the-scenes research that had new vaccine technology poised for a challenge just as the coronavirus erupted.  \u201cThe speed is a reflection of years of work that went before,\u201d Dr. Anthony Fauci, the top U.S. infectious disease expert, told The Associated Press.""}, {""date"": ""2023-10-02"", ""headline"": ""Katalin Karik\u00f3, Drew Weissman Win Nobel Prize in Medicine for mRNA Vaccine"", ""summary"": ""Katalin Karik\u00f3 and Drew Weissman won the Nobel Prize in Physiology or Medicine for discoveries that enabled the development of effective mRNA vaccines against Covid-19.""}, {""date"": ""2023-10-02"", ""headline"": ""Scientists Whose Work Led to Covid mRNA Vaccines Receive Nobel Prize in Medicine"", ""summary"": ""The research done by the two scientists was crucial for the technology used by Pfizer/BioNTech and Moderna in developing their Covid-19 vaccines.""}, {""date"": ""2023-10-02"", ""headline"": ""Nobel Prize awarded to mRNA COVID vaccine pioneers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""Vaccine Breakthrough Behind Pfizer, Moderna Shots Wins Nobel"", ""summary"": ""(Bloomberg) -- Katalin Kariko and Drew Weissman won the Nobel Prize in medicine for research that laid the groundwork for some of the best-selling medicines of all time: the messenger-RNA vaccines against Covid-19.Most Read from BloombergWhy a US Recession Is Still Likely \u2014 and Coming SoonOnce Unthinkable Bond Yields Now the New Normal For MarketsCongress Averts US Government Shutdown Hours Before DeadlineAging Trees Show a Crisis Looms for the World\u2019s Everything OilSevere Crash Is Coming for US""}, {""date"": ""2023-10-02"", ""headline"": ""Have The Bulls Returned? Get Prepared For October And Q4 With Markets With Mando!"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""Nobel Prize Honors Scientists Behind mRNA Vaccines Against Covid-19"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-02"", ""headline"": ""Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Dow snaps three-day losing streak after softer-than-expected ADP jobs data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Moderna Inc. stock rises Wednesday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Market Today: Walmart's Shift in Shopper Behavior, COVID-19 Vaccine Updates, and NextEra ..."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""When Fundamentals And Fear Diverge: Navigating The Growth Stock Divide In 2023"", ""summary"": ""A notable characteristic of the Q3 2023 market was the continued underperformance of high-growth technology and innovation stocks, despite many of them reporting robust fundamental results.""}, {""date"": ""2023-10-03"", ""headline"": ""4M Americans received updated COVID-19 vaccines in Sept.: report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""U.S. stocks rise after softer-than-expected ADP jobs data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Moderna (NASDAQ:MRNA) Gains on COVID-19 and Flu Shot Combination"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Dow falls, Nasdaq rises after softer-than-expected ADP jobs data"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Moderna (NASDAQ:MRNA) Gains Fractionally on Combination COVID-19 / Flu Shot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Novavax Covid Booster Gets FDA Nod"", ""summary"": ""(Bloomberg) -- Novavax Inc.\u2019s updated version of its Covid-19 shot gained US regulators\u2019 authorization for emergency use amid a rocky rollout of competitors\u2019 offerings.Most Read from BloombergKey Taiwan Tech Firms Helping Huawei With China Chip PlantsWhy a US Recession Is Still Likely \u2014 and Coming SoonStocks, Bonds Sell Off as Volatility Makes Return: Markets WrapAirbnb Is Fundamentally Broken, Its CEO Says. He Plans to Fix It.JPMorgan\u2019s Dimon Predicts 3.5-Day Work Week for Next Generation Thank""}, {""date"": ""2023-10-03"", ""headline"": ""Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna"", ""summary"": ""The Food and Drug Administration signed off on Novavax's updated Covid booster late Tuesday, and NVAX stock surged just before the close.""}, {""date"": ""2023-10-03"", ""headline"": ""Novavax Stock Jumps After FDA Approves Updated Covid Vaccine"", ""summary"": ""Shares were up more than 10% on the news, which came more than three weeks after vaccines from Moderna and Pfizer.""}, {""date"": ""2023-10-03"", ""headline"": ""US adds another option for fall COVID vaccination with updated Novavax shots"", ""summary"": ""U.S. regulators on Tuesday authorized another option for fall COVID-19 vaccination, updated shots made by Novavax.  Updated vaccines from Pfizer and Moderna began rolling out last month, intended for adults and children as young as age 6 months.  Now the Food and Drug Administration has added another choice \u2013- reformulated Novavax shots open to anyone age 12 and older.""}, {""date"": ""2023-10-03"", ""headline"": ""UPDATE 1-US FDA authorizes Novavax's updated COVID shot, shares rise"", ""summary"": ""The U.S. Food and Drug Administration said on Tuesday it has authorized an updated version of Novavax's COVID-19 vaccine for emergency use in individuals aged 12 years and older.  Novavax shares jumped 12% to $7.95.  The Maryland-based company, whose COVID vaccine is its lone marketed product, has adopted cost-cutting measures and is counting on commercial sales of its updated shot to help it stay afloat.""}, {""date"": ""2023-10-03"", ""headline"": ""Novavax expects COVID-19 boosters to be available next week"", ""summary"": ""Novavax gets green light from FDA, awaits CDC recommendation for booster COVID doses.""}, {""date"": ""2023-10-03"", ""headline"": ""Moderna Inc. stock falls Tuesday, still outperforms market"", ""summary"": ""Shares of Moderna Inc. slumped 0.22% to $103.08 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-10-03"", ""headline"": ""Novavax updated COVID vaccine gets FDA approval "", ""summary"": ""Stock jumps 12% on regulatory approval of new shot""}, {""date"": ""2023-10-03"", ""headline"": ""Behind the new malaria vaccine endorsed by the World Health Organization"", ""summary"": ""The Serum Institute of India has received a recommendation from WHO for malaria doses using a Novavax adjuvant.""}, {""date"": ""2023-10-03"", ""headline"": ""Alexandria Real Estate accelerates delivery of Moderna's new R&D center"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-03"", ""headline"": ""Covid-19 vaccine winners suffer reversal of fortunes"", ""summary"": ""At the height of the pandemic, investors clamoured to buy vaccine makers, the closest thing to a sure bet.  Shares in Pfizer, which developed a vaccine and an antiviral drug, have plummeted 46 per cent from their peak in late 2021, while its German vaccine partner BioNTech is down 75 per cent and rival Moderna has plunged 79 per cent.  Less successful vaccine makers have fallen back even more significantly: shares in Novavax, whose Covid shot has sold far fewer than the messenger RNA jabs, have fallen 97 per cent since early 2021.""}, {""date"": ""2023-10-03"", ""headline"": ""Reversal of fortunes for Covid-19 vaccine winners"", ""summary"": ""At the height of the pandemic, investors clamoured to buy vaccine makers, the closest thing to a sure bet.  Shares in Pfizer, which developed a vaccine and an antiviral, have plummeted 46 per cent from their peak in late 2021, while its German vaccine partner BioNTech is down 75 per cent and rival Moderna has plunged 79 per cent.  Less successful vaccine makers have fallen back even more dramatically: shares in Novavax, which has an approved Covid-19 shot that has sold far fewer than the mRNA jabs, has fallen 97 per cent since early 2021.""}, {""date"": ""2023-10-04"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing"", ""summary"": ""In the latest trading session, Moderna (MRNA) closed at $104.26, marking a +1.14% move from the previous day.""}, {""date"": ""2023-10-04"", ""headline"": ""Next-generation mRNA vaccines will be easier to use: Moderna CEO"", ""summary"": ""Moderna CEO St\u00e9phane Bancel says the company is working on a vaccine formula and packaging that will make it easier to use mNRA technology.""}, {""date"": ""2023-10-04"", ""headline"": ""Next-gen mRNA vaccines will be easier to use: Moderna CEO"", ""summary"": ""Moderna CEO St\u00e9phane Bancel says the company is working on a vaccine formula and packaging that will make it easier to use mNRA technology.""}, {""date"": ""2023-10-04"", ""headline"": ""Moderna CEO on combo Covid, flu vaccine moving to next trial phase"", ""summary"": ""A lot of Americans are planning on getting both a flu shot and Covid booster this fall. But Moderna (MRNA) has been working on a combination flu and Covid vaccine, so patients only need to get one shot instead of two. The biotech company announced that the combination vaccine will be moving on to its final trial after positive results from its early-stage trial. The company is hoping to have regulatory approval for the shot in 2025. Moderna CEO St\u00e9phane Bancel tells Yahoo Finance Live that when it comes to it's current Covid vaccine, there has been \""strong demand.\"" Bancel expects to continue to see sales of the Covid vaccine into 2025 and \""re-acceleration of sales\"" when the combination vaccine launches. When it comes to the current updated Covid booster, Bancel thinks that pharmacy chains may have underestimated demand for the shot and how quickly people would want it. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-10-04"", ""headline"": ""Novavax (NVAX) Up 8% on FDA Nod for Updated COVID Booster Jab"", ""summary"": ""Novavax's (NVAX) updated COVID vaccine is authorized under emergency use for individuals aged 12 years and older. It is currently the only non-mRNA COVID vaccine available in the country.""}, {""date"": ""2023-10-04"", ""headline"": ""Moderna\u2019s Combo Vaccine Moves Towards Late-Stage Trial"", ""summary"": ""The combination vaccine has acceptable side effects and could be ready to launch as early as 2025, according to Moderna.""}, {""date"": ""2023-10-04"", ""headline"": ""Alexandria (ARE) Expedites Delivery of Moderna's New HQ"", ""summary"": ""Alexandria (ARE) to hand over the new global headquarters and core R&D operations center to Moderna in November 2023. ARE will benefit from the project's incremental annual net operating income.""}, {""date"": ""2023-10-04"", ""headline"": ""Catalent Remains Overvalued"", ""summary"": ""Catalent trades at over 17x forward EBITDA. Its growth prospects do not justify its valuation. Read more to see a detailed analysis on CTLT stock.""}, {""date"": ""2023-10-04"", ""headline"": ""U.S. stocks rise after ADP data shows fewer-than-expected jobs created in September"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Novavax slips despite FDA nod for updated COVID shot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Mainz Biomed Continues To Transform Early Cancer Detection Across The Globe"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Moderna reports trial success for dual Covid and flu vaccine"", ""summary"": ""Moderna\u2019s combined Covid-19 and influenza vaccine was as effective as separate shots in an early stage trial, giving the US biotech company hope that the more convenient way of protecting against the diseases could be approved by 2025.  Interim data measuring antibody levels from the phase 1/2 trial showed that the combined jab elicited a similar or greater immune response to flu viruses as the currently approved flu vaccines, including Sanofi\u2019s high-dose shots designed for the elderly.  The jab also elicited a similar immune response to Sars-Cov-2 as Moderna\u2019s Covid booster, known as Spikevax.""}, {""date"": ""2023-10-04"", ""headline"": ""Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company's Combination Vaccine Against Influenza and COVID-19"", ""summary"": ""mRNA-1083 showed strong immunogenicity against influenza and COVID-19, with an acceptable reactogenicity and safety profile, compared to licensed standalone vaccinesCompany to begin Phase 3 trial of mRNA-1083 in adults 50 years and aboveCAMBRIDGE, ...""}, {""date"": ""2023-10-04"", ""headline"": ""Moderna combo COVID-19/flu vaccine succeeds in early-stage trial"", ""summary"": ""Moderna on Wednesday said its combination vaccine to protect against both COVID-19 and influenza generated a strong immune response compared to individual shots for the viruses in an early-stage study.""}, {""date"": ""2023-10-04"", ""headline"": ""Dow wavers, Nasdaq rises after ADP data shows fewer-than-expected jobs created in September"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Dow falls 100 points as stocks waver after ADP data shows fewer-than-expected jobs created in September"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""U.S. stocks open higher after ADP data shows fewer-than-expected jobs created in September"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Short Sellers Are Betting Against Novavax (NVAX) Stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Moderna eyes late-stage trial for COVID/flu combo shot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Moderna reports positive results for combination flu and COVID vaccine"", ""summary"": ""Moderna Inc. announced positive interim results from a Phase 1/2 trial of its combination vaccine against COVID-19 and flu on Wednesday.""}, {""date"": ""2023-10-04"", ""headline"": ""What You Missed On Wall Street On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Moderna announces positive phase 1/2 results for flu, Covid-19 vaccine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""U.S. stock futures rise slightly after ADP data shows fewer-than-expected jobs created in September"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""Moderna announces Phase 1/2 data from mRNA-1083"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-04"", ""headline"": ""S&P 500 futures recover early losses after Treasury yields spike"", ""summary"": ""U.S. stock index futures rallied off session lows early Wednesday after Treasurys recovered from a sharp sell-off that took yields to fresh 16-year highs.""}, {""date"": ""2023-10-04"", ""headline"": ""Novavax Stock (NASDAQ:NVAX) Surged After Winning the FDA\u2019s Approval"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""Moderna Inc. stock rises Friday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""Investing In Moderna: A Speculative Buy For Long-Term Gains"", ""summary"": ""Moderna has a large drug pipeline and plans to launch 15 new mRNA-based medicines over the next 5 years. Click here to read why MRNA stock is a Buy.""}, {""date"": ""2023-10-05"", ""headline"": ""Pfizer resolves Promosome patent lawsuit over COVID-19 vaccine"", ""summary"": ""Pfizer, BioNTech and biotech firm Promosome told a federal judge in San Diego, California that they have agreed to end Promosome's lawsuit accusing the COVID-19 vaccine makers of infringing a patent related to messenger RNA technology.  The companies said in a court filing on Wednesday that Promosome would dismiss its case with prejudice, which means it cannot be refiled, and that Promosome had agreed not to bring future claims over the patent against Pfizer and its partner BioNTech.""}, {""date"": ""2023-10-05"", ""headline"": ""Biotech Stock Roundup: NVAX Up on Updates, ALXO Gains on Study Data & More"", ""summary"": ""Regulatory and pipeline updates from Novavax (NVAX) and ALX Oncology Holdings (ALXO) are in focus in the biotech sector.""}, {""date"": ""2023-10-05"", ""headline"": ""Moderna (MRNA) to Advance COVID/Flu Combo Jab to Late-Stage Study"", ""summary"": ""Moderna's (MRNA) intends to start the late-stage study on its COVID-19-influenza combination vaccine candidate before year-end. A commercial launch is expected in 2025.""}, {""date"": ""2023-10-05"", ""headline"": ""November 24th Options Now Available For Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""Thinking Of Buying Alexandria Real Estate Equities? Here Are The Properties And Tenants You'd Add To Your Portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-05"", ""headline"": ""Moderna Files Submission for RSV Vaccine to Health Canada"", ""summary"": ""By Adriano Marchese Moderna has filed a new drug submission to Canadian health regulators for an investigational vaccine aimed at preventing RSV in older...""}, {""date"": ""2023-10-05"", ""headline"": ""Can Moderna Achieve Its Most Ambitious Goal Yet?"", ""summary"": ""Moderna (NASDAQ: MRNA) and ambition seem to go hand and hand.  The company doesn't fear taking on challenges, as it demonstrated during the earliest days of the pandemic when it brought its coronavirus vaccine from the drawing board to market in less than a year.  Investors rewarded the biotech company for its audacity and scientific strengths, driving up the share price by 1,700% in just 1 1/2 years..""}, {""date"": ""2023-10-05"", ""headline"": ""RBC Capital Sticks to Its Buy Rating for Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-06"", ""headline"": ""Rockwell\u2019s Heitkoetter Talks Options Strategies, \u201cWheel Options,\u201d Volatility, & Value Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-06"", ""headline"": ""Goldman Sachs Says These 2 Stocks Could Double Your Money \u2014 Here\u2019s Why They Could Jump"", ""summary"": ""In the ever-evolving world of stocks, the year has seen its share of ups and downs. Currently, the stock market grapples with the headwinds of rising interest rates and the resulting surge in bond yields. At the same time, there is reason for optimism. Based on historical patterns, Q4 is typically the year\u2019s strongest for US stocks, and investment bank Goldman Sachs is sticking resolutely with its earlier year-end price target of 4,500 on the S&P 500. \u201cOur baseline view remains that the index wi""}, {""date"": ""2023-10-06"", ""headline"": ""Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market?"", ""summary"": ""Vaccine leaders Moderna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) are making gains in this competition, as is smaller rival Novavax (NASDAQ: NVAX).  This week, Moderna reported the latest from its phase 1/2 study and said it was ready to start a phase 3 trial.  Did Moderna just jump ahead of its vaccine rivals?""}, {""date"": ""2023-10-06"", ""headline"": ""The Zacks Analyst Blog Highlights Novavax, ALX Oncology, Regeneron Pharmaceuticals, Intellia and Moderna"", ""summary"": ""Novavax, ALX Oncology, Regeneron Pharmaceuticals, Intellia and Moderna are included in this Analyst Blog.""}, {""date"": ""2023-10-07"", ""headline"": ""These 2 Top Stocks Are Screaming Buys Right Now"", ""summary"": ""Today, Moderna (NASDAQ: MRNA) and Doximity (NYSE: DOCS) both fit the bill.  Moderna is known for its coronavirus vaccine, but it may not be a one-product company for long.  Doximity is a platform that helps doctors connect and save time -- and the company has grown by leaps and bounds.""}, {""date"": ""2023-10-07"", ""headline"": ""This Could be Novavax's Big Opportunity"", ""summary"": ""Early on in the pandemic, Moderna and Pfizer beat smaller rival Novavax (NASDAQ: NVAX) to market with their coronavirus vaccines by a year or more in some countries.  This head start offered them the lion's share of the market and revenue, and Novavax couldn't catch up.  As we head into a new vaccination season, Moderna and Pfizer once again reached commercialization first with their updated coronavirus vaccines.""}, {""date"": ""2023-10-08"", ""headline"": ""New COVID shots still hard to find for some Americans"", ""summary"": ""Shot seekers also say they have been surprised by requests for upfront payments of $150 to $200 now that the U.S. government has handed off to private companies including vaccine makers, pharmacies, and insurance plans to handle distribution, administration and payment coverage.  Around 4 million people received the updated Pfizer /BioNTech or Moderna shots in September, and 12 million doses were shipped, according to data from the U.S. Department of Health and Human Services (HHS).  The U.S. government has recommended all Americans ages 6 months and older receive one.""}, {""date"": ""2023-10-08"", ""headline"": ""3 Pharma Stocks to Dump Before the Damage Is Done"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3995, ""bookValue"": 13455, ""cashRatio"": 0.6686431014823261, ""currentRatio"": 2.4627, ""ebitPerShare"": -5.2808, ""eps"": -9.5276, ""ev"": 37112.02, ""fcfPerShareTTM"": -6.9738, ""grossMargin"": -0.2239, ""inventoryTurnoverTTM"": 4.4321, ""netDebtToTotalCapital"": -0.1556, ""netDebtToTotalEquity"": -0.164, ""netMargin"": -1.9825, ""operatingMargin"": -1.0989, ""pb"": 2.9223, ""pretaxMargin"": -1.0694, ""psTTM"": 4.3108, ""ptbv"": 2.9321, ""quickRatio"": 2.2383, ""receivablesTurnoverTTM"": 3.9996, ""roaTTM"": -0.1518, ""roeTTM"": -0.2027, ""roicTTM"": -0.192, ""rotcTTM"": -0.1476, ""salesPerShare"": 4.8058, ""sgaToSale"": 1.2239, ""tangibleBookValue"": 13410, ""totalDebtToEquity"": 0.0539, ""totalDebtToTotalAsset"": 0.0373, ""totalDebtToTotalCapital"": 0.0511, ""totalRatio"": 3.2444, ""period"": ""2023-09-30""}"
39,2023-10-08,103.87999725341797,2023-10-15,98.30000305175781,-0.05371577155559226,D5+,"[{""date"": ""2023-10-08"", ""headline"": ""Moderna Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-08"", ""headline"": ""Moderna management to meet with Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-08"", ""headline"": ""Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-08"", ""headline"": ""New COVID shots still hard to find for some Americans"", ""summary"": ""Shot seekers also say they have been surprised by requests for upfront payments of $150 to $200 now that the U.S. government has handed off to private companies including vaccine makers, pharmacies, and insurance plans to handle distribution, administration and payment coverage.  Around 4 million people received the updated Pfizer /BioNTech or Moderna shots in September, and 12 million doses were shipped, according to data from the U.S. Department of Health and Human Services (HHS).  The U.S. government has recommended all Americans ages 6 months and older receive one.""}, {""date"": ""2023-10-08"", ""headline"": ""3 Pharma Stocks to Dump Before the Damage Is Done"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""Moderna Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""3 Shaky Stocks to Sell in October Before It\u2019s Too Late"", ""summary"": ""Uncertainty abounds in the market right now. Whether driven by fears tied to surging inflation, rising interest rates, or geopolitical turmoil, investors have plenty to consider moving forward. This may mean that investors are focused more on stocks to sell rather than stocks to buy at this point in the economic cycle. Indeed, bearish reasons prevail. If any sort of shock hits the market, I would argue that valuations aren\u2019t positioned to absorb any sort of hit. Thus, the market is priced for ba""}, {""date"": ""2023-10-09"", ""headline"": ""Merck: Right On Time"", ""summary"": ""Merck is slowly executing a pivot into adjacent areas of oncology, immunology, and beyond. Read more to see why MRK stock is a Hold.""}, {""date"": ""2023-10-09"", ""headline"": ""Alnylam sends Arbutus lower after FDA snub for amyloidosis drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""Privatized Vaccine Distribution Sparks Confusion, Payment Challenges"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""Moderna says Noubar Afeya sells 15K shares in the company"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""Intuit, Nordstrom And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-09"", ""headline"": ""14 Best Cancer Stocks To Buy Now"", ""summary"": ""In this article, we discuss 14 best cancer stocks to buy. If you want to skip our detailed discussion on the oncology industry, head directly to 5 Best Cancer Stocks To Buy Now. The global oncology landscape continues to evolve, with ongoing efforts to discover, develop, and provide innovative treatments aimed at improving outcomes for [\u2026]""}, {""date"": ""2023-10-10"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-10"", ""headline"": ""Big Pharma Could Transform Into BioTech Pharma"", ""summary"": ""As the word itself says, biotechnology is simply technology based on biology. It uses the knowledge of cellular and biomolecular processes to develop technologies that improve our lives and overall health of the planet that is only our home. This technology is being developed with the aim to reduce rates of infectious diseases, save lives, lower the odds of life-threatening diseases affecting the world\u2019s population, customize patient treatments to increase the odds of success and lower the odds""}, {""date"": ""2023-10-11"", ""headline"": ""Moderna Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-11"", ""headline"": ""Moderna Unusual Options Activity For October 12"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-11"", ""headline"": ""More than 7M Americans have received updated COVID shots"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-11"", ""headline"": ""Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note"", ""summary"": ""In the closing of the recent trading day, Moderna (MRNA) stood at $102.76, denoting a -1.6% change from the preceding trading day.""}, {""date"": ""2023-10-11"", ""headline"": ""The COVID Vaccine Market Is Changing Dramatically. Do Vaccine Stocks Still Make Good Investments?"", ""summary"": ""Companies rushed to bring a coronavirus vaccine through development and to market, and investors rushed to invest in these potential vaccine makers.  As a result, back in 2020, biotech hopefuls including Moderna (NASDAQ: MRNA), Novavax, and BioNTech (NASDAQ: BNTX) -- and even some smaller players -- saw their shares soar.  In recent times, though, investors have shied away from vaccine makers and potential vaccine makers.""}, {""date"": ""2023-10-12"", ""headline"": ""Moderna Inc. stock falls Friday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-12"", ""headline"": ""2 Top Biotech Stocks to Buy Right Now"", ""summary"": ""The biotech industry is severely lagging the market this year, at least according to the SPDR S&P Biotech ETF, an industry benchmark that is down about 14% so far in 2023.  Vertex Pharmaceuticals is inching closer to a new drug approval.  The company's therapy exa-cel, co-developed with CRISPR Therapeutics, is currently being considered by regulatory authorities in the U.S. and Europe for treating sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT), two blood-related conditions.""}, {""date"": ""2023-10-12"", ""headline"": ""Moderna, Inc. (NASDAQ:MRNA) is favoured by institutional owners who hold 66% of the company"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Moderna's stock price might be vulnerable to their...""}, {""date"": ""2023-10-12"", ""headline"": ""Moderna to Report Third Quarter 2023 Financial Results on Thursday, November 2, 2023"", ""summary"": ""CAMBRIDGE, MA / ACCESSWIRE / October 12, 2023 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 2, 2023 to report its third quarter 2023 financial results, and ...""}, {""date"": ""2023-10-12"", ""headline"": ""Over 7 million Americans have gotten updated COVID vaccines"", ""summary"": ""More than 7 million Americans had rolled up their sleeves for the updated COVID-19 vaccines as of Wednesday, according to the U.S. Department of Health and Human Services, despite reports that some people are still finding it difficult to book vaccination appointments or find the shots at no cost.  The updated vaccines from Moderna or Pfizer and BioNTech are single-target shots aimed at the XBB.1.5 Omicron subvariant of the coronavirus, which was the dominant variant in the U.S. for much of this year but has since been overtaken as the virus continues to evolve.  Millions of doses of another updated COVID vaccine from Novavax have also been made available to Americans this week, according to the company.""}, {""date"": ""2023-10-12"", ""headline"": ""The Fall Vaccination Season Is Here. Is Novavax a Buy?"", ""summary"": ""Novavax (NASDAQ: NVAX) fell behind in the original coronavirus vaccine race as rivals Pfizer and Moderna brought their products to market.  Coronavirus vaccines still are needed, and the market today is making an important shift.  Instead, it's following the flu vaccine market with the idea that people will get an annual vaccine -- and that should lead to recurrent revenue for vaccine makers including Novavax.""}, {""date"": ""2023-10-12"", ""headline"": ""3 Stocks That Are Down Big, But Are Due to Fall Much Further"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-13"", ""headline"": ""Stocks to Watch: Pfizer, Moderna, Lululemon Athletica"", ""summary"": ""By Ben Glickman Pfizer said it would reverse $4.2 billion in revenue after revising its agreement with the U.S. government related to its Covid-19 treatment...""}, {""date"": ""2023-10-13"", ""headline"": ""Top 30 Oncology Companies in the World"", ""summary"": ""In this article, we shall cover the top 30 oncology companies in the world. To skip our detailed analysis of the global oncology industry in 2023, go directly and see Top 10 Oncology Companies in the World. According to a report by McKinsey and Company, the economic outlook for the US healthcare industry in 2023 [\u2026]""}, {""date"": ""2023-10-13"", ""headline"": ""Pfizer's stock sinks after company slashes $9 billion from outlook, foreshadows layoffs"", ""summary"": ""Pfizer and biotech drug maker shares fell after Pfizer slashed its full-year earnings outlook due to a drop in demand for COVID pills and more.""}, {""date"": ""2023-10-13"", ""headline"": ""1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid"", ""summary"": ""Artificial intelligence (AI) could revolutionize the world by automating tedious tasks, reducing errors, and generally increasing efficiency in the workplace and at home.  In most cases, when we think of AI, we think of chipmakers or tech companies that power AI tools.  AI could speed up drug development, produce better products, and improve surgical outcomes.""}, {""date"": ""2023-10-13"", ""headline"": ""Where to Invest $100,000 Right Now"", ""summary"": ""With stocks well off their 2023 highs, bonds down for the year, and investors hanging on the Federal Reserve\u2019s every word, it can be tough to decide where to invest new money.  For this special report, we asked each writer to envision an investor who has a few million dollars in a well-diversified portfolio and then comes upon an extra $100,000 to invest.""}, {""date"": ""2023-10-13"", ""headline"": ""Pfizer cuts outlook after modifying supply deal for COVID products with U.S.; shares fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-13"", ""headline"": ""Pfizer shares fall after cutting FY revenue and earnings outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-14"", ""headline"": ""20 Countries with the Most COVID-19 Cases in the World in 2023"", ""summary"": ""In this article, we will be analyzing the history of COVID-19 and the counteraction against the pandemic, while covering the 20 countries with the most COVID-19 cases in the world in 2023. If you wish to skip our detailed analysis, you can move directly to the 5 Countries with the Most COVID-19 Cases in the [\u2026]""}, {""date"": ""2023-10-15"", ""headline"": ""Don\u2019t Hold On: 7 Stocks to Sell Before 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3995, ""bookValue"": 13455, ""cashRatio"": 0.6686431014823261, ""currentRatio"": 2.4627, ""ebitPerShare"": -5.2808, ""eps"": -9.5276, ""ev"": 37112.02, ""fcfPerShareTTM"": -6.9738, ""grossMargin"": -0.2239, ""inventoryTurnoverTTM"": 4.4321, ""netDebtToTotalCapital"": -0.1556, ""netDebtToTotalEquity"": -0.164, ""netMargin"": -1.9825, ""operatingMargin"": -1.0989, ""pb"": 2.9223, ""pretaxMargin"": -1.0694, ""psTTM"": 4.3108, ""ptbv"": 2.9321, ""quickRatio"": 2.2383, ""receivablesTurnoverTTM"": 3.9996, ""roaTTM"": -0.1518, ""roeTTM"": -0.2027, ""roicTTM"": -0.192, ""rotcTTM"": -0.1476, ""salesPerShare"": 4.8058, ""sgaToSale"": 1.2239, ""tangibleBookValue"": 13410, ""totalDebtToEquity"": 0.0539, ""totalDebtToTotalAsset"": 0.0373, ""totalDebtToTotalCapital"": 0.0511, ""totalRatio"": 3.2444, ""period"": ""2023-09-30""}"
40,2023-10-15,98.30000305175781,2023-10-22,80.4000015258789,-0.18209563550526076,D5+,"[{""date"": ""2023-10-15"", ""headline"": ""Moderna management to meet with Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""Healthcare Portfolio Focus Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""Check Out What Whales Are Doing With MRNA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""Novavax (NASDAQ:NVAX): Europe Delays Vaccine Approval"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""Novavax\u2019s (NASDAQ:NVAX) Updated COVID Shot Approval Gets Delayed in Europe"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""Hennessy Funds is bullish on stocks. These in specific."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""Monday Sector Laggards: Healthcare, Materials"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-15"", ""headline"": ""Don\u2019t Hold On: 7 Stocks to Sell Before 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Lonza Shares Drop After Warning of 2024 Profitability Shortfall"", ""summary"": ""By Adria Calatayud Shares of Lonza Group fell sharply after the company issued new 2024 guidance that fell short of consensus expectations and warned of a...""}, {""date"": ""2023-10-16"", ""headline"": ""IN BRIEF: Lonza raises dividend payout range but takes Moderna hit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""S&P 500 Gains and Losses Today: Index Climbs to Start Week of Key Earnings Reports"", ""summary"": ""The S&P 500 rose 1.1% on Monday, Oct. 16, 2023, posting solid gains as the markets kick off a week of noteworthy earnings reports.""}, {""date"": ""2023-10-16"", ""headline"": ""Moderna Shares Slump Amid Concerns About COVID-19 Vaccine Demand"", ""summary"": ""Moderna shares fell to an almost three-year low after the biotech firm reiterated its full-year guidance but warned it couldn't yet predict COVID-19 vaccine demand.""}, {""date"": ""2023-10-16"", ""headline"": ""These Stocks Moved the Most Today: Pfizer, Moderna, Schwab, Lululemon, Alignment Healthcare, Varonis, and More"", ""summary"": ""Pfizer slashes revenue expectations, Charles Schwab's adjusted earnings beat estimates, and Lululemon will be joining the S&P 500 on Wednesday.""}, {""date"": ""2023-10-16"", ""headline"": ""Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion"", ""summary"": ""Moderna stock and BioNTech stock led a sell-off Monday among Covid vaccine makers after Pfizer slashed its full-year guidance.""}, {""date"": ""2023-10-16"", ""headline"": ""Moderna Sticks With Its Forecast Covid-19 Vaccine Sales; Stock Drops"", ""summary"": ""Moderna is sticking by its forecast range for 2023 Covid-19 vaccine sales, after rival [Pfizer cut the sales outlook for its own shot](https://www.wsj.com/livecoverage/stock-market-today-dow-jones-10-16-2023/card/pfizer-stock-falls-on-guidance-cut-other-covid-19-vaccine-makers-also-drop-SA1rMYsazC5f6xCoBLbo), citing lower-than-expected vaccination rates.  Here\u2019s why:  + The company said \u201cit is still too early in the U.S. vaccination season to accurately project where vaccination rates will land for the full year.\u201d  + Updated Covid-19 shots were introduced by both Moderna and Pfizer in September, for a booster campaign aimed at protecting Americans from the latest strains of the virus in fall and winter.""}, {""date"": ""2023-10-16"", ""headline"": ""Moderna Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Moderna Inc. shed 6.47% to $91.94 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-10-16"", ""headline"": ""NEW YORK MARKET CLOSE: US stocks advance ahead of earnings barrage"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Markets Jump at Midday to Begin a Week of Key Corporate Earnings Reports"", ""summary"": ""U.S. equities gained at midday on Monday, Oct. 16, 2023, to start a busy week with key corporate earnings reports.""}, {""date"": ""2023-10-16"", ""headline"": ""US STOCKS-Wall St jumps 1% to kick-start earnings and data-heavy week, megacaps rise"", ""summary"": ""Wall Street's main indexes jumped more than 1% on Monday as megacaps rose to kick-start a week packed with corporate earnings and economic data, while investors also monitored the Israel-Hamas conflict.  The Dow touched a near four-week high and was on course for its best day in more than two months, while the S&P 500 and the Nasdaq were headed for their best days in nearly two weeks.""}, {""date"": ""2023-10-16"", ""headline"": ""Moderna\u2019s stock slides to three-year low as co-founder sells more shares"", ""summary"": ""Moderna's stock slid toward a fourth straight loss Monday. The company's co-founder and chair, Noubar Afeyan, has sold $3 million worth of shares in October.""}, {""date"": ""2023-10-16"", ""headline"": ""Moderna (NASDAQ:MRNA) Slides as COVID-19 Vaccine Sales Confirmed"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Moderna\u2019s Stock Outlook Dampened by Pfizer\u2019s Reduced COVID-19 Product Demand: A Sell Rating Review"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, LULU"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Video: S&P 500 Movers: MRNA, PFE"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Moderna reaffirms 2023 COVID vaccine sales outlook; shares tumble"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Moderna confirms COVID sales guidance as shares sink on Pfizer news "", ""summary"": ""Company sees full-year COVID sales of $6 billion to $8 billion but says size of U.S. market is still uncertain""}, {""date"": ""2023-10-16"", ""headline"": ""Moderna Backs 2023 Covid Vaccine Sales Outlook, Despite Uptake Uncertainty"", ""summary"": ""By Will Feuer Moderna backed its Covid-19 vaccine sales outlook for the year, saying the guidance already accounts for the uncertainty of U.S. vaccination...""}, {""date"": ""2023-10-16"", ""headline"": ""Moderna confirms COVID sales guidance as shares sink on Pfizer news"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Moderna 'comfortable' with guidance for $6B-$8B in FY23 COVID-19 vaccine sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Pfizer trims expectations for 2023 with sales of COVID-19 vaccine, treatment, weaker than thought"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Analysts\u2019 Top Healthcare Picks: BeiGene (BGNE), Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Moderna price target lowered to $64 from $66 at Leerink"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""S&P 500 Futures Climb in Premarket Trading; Mettler-Toledo, lululemon athletica Lead"", ""summary"": ""With U.S. stock markets set to open in two hours, (MTD) was up 5.9% in pre-market trading, and (LULU) was up 5.5%. (IMO), (CGNX), and (GEN) were all posting...""}, {""date"": ""2023-10-16"", ""headline"": ""BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-16"", ""headline"": ""Pfizer shares fall on guidance cut, weighing on BioNTech and Moderna stocks, and other shares on the move"", ""summary"": ""Shares in Pfizer, BioNTech, Moderna, Manchester United, and Lululemon Atheltica were all active in premarket trading""}, {""date"": ""2023-10-17"", ""headline"": ""China's Quarterly GDP Grew More Than Expected"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""S&P 500 Gains and Losses Today: Chipmaker Shares Drop Amid Tightening Export Rules"", ""summary"": ""The S&P 500 dipped 0.01% on Tuesday, Oct. 17, 2023, as news that retail sales jumped more than expected in September renewed concerns about more Fed rate hikes.""}, {""date"": ""2023-10-17"", ""headline"": ""Moderna Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slid 6.10% to $86.33 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-10-17"", ""headline"": ""Moderna\u2019s stock pummeled to pace the S&P 500\u2019s decliners, as it heads for yet another 5-day losing streak"", ""summary"": ""Shares of Moderna Inc. took a 5.9% beating toward a three-year low in afternoon trading Tuesday, enough to lead the S&P 500\u2019s losers, and to put them on...""}, {""date"": ""2023-10-17"", ""headline"": ""Moderna (MRNA) Down Despite Maintaining COVID Jab Sales View"", ""summary"": ""Though Moderna (MRNA) reiterated its sales guidance for COVID vaccine, it warned investors that it could not predict exact demand yet.""}, {""date"": ""2023-10-17"", ""headline"": ""Moderna Vs. Novavax: Neither Offering Short-Term Value As Fall Vaccine Season Begins"", ""summary"": ""Moderna and Novavax rely on COVID vaccine sales, but the size and scale of the private COVID vaccine market remain uncertain. Read why this presents a risk for both companies.""}, {""date"": ""2023-10-17"", ""headline"": ""Pfizer Looks for a Covid Bottom"", ""summary"": ""During much of the pandemic, shares of vaccine makers  Pfizer  and  Moderna  have generally responded similarly following Covid-19 news.  Pfizer said, in a late Friday release, that it was slashing its 2023 revenue projection by $9 billion due to falling sales of Covid vaccines and the Paxlovid treatment.  What investors especially liked about the announcement was Pfizer\u2019s decision to undertake a $3.5 billion cost-cutting program.""}, {""date"": ""2023-10-17"", ""headline"": ""Nvidia, United Airlines, Moderna, Lucid, Bank Of America: Why These Five Stocks Are On Investors' Horizons Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Heard on the Street Recap: Yielding to Change"", ""summary"": ""Big things are changing in the world. At the top, that starts with the Israel-Hamas war [potentially tilting the global balance of power](https://www.wsj.com/world/how-the-israel-hamas-war-is-tilting-the-global-power-balance-in-favor-of-russia-china-6fe4710a).""}, {""date"": ""2023-10-17"", ""headline"": ""Lonza Warns on 2024 Profitability Hit From Lost Moderna Revenue"", ""summary"": ""Lonza said its core earnings growth for 2023 will be above its previously indicated range, but cautioned its profits next year will take a hit from lost Moderna revenue.""}, {""date"": ""2023-10-17"", ""headline"": ""Moderna price target lowered to $125 from $150 at BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-17"", ""headline"": ""Why did Moderna stock fall today? Investors come to grips with waning COVID-19 sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-18"", ""headline"": ""Moderna (MRNA) Stock Moves -0.37%: What You Should Know"", ""summary"": ""In the latest trading session, Moderna (MRNA) closed at $86.01, marking a -0.37% move from the previous day.""}, {""date"": ""2023-10-18"", ""headline"": ""Moderna Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Moderna Inc. slid 0.37% to $86.01 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-10-18"", ""headline"": ""Heard on the Street Recap: Breaking Bond"", ""summary"": ""Treasury yields are at new multi-year highs?  Bank stocks have previously this year been hit hard by rising market yields, with investors worried about deposit outflows and money-losing bond portfolios.  Overall, it was another strong day for bank stocks, after BofA and Bank of New York Mellon reported solid earnings.""}, {""date"": ""2023-10-18"", ""headline"": ""Moderna (MRNA) Gets a Hold from Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""Why Moderna Stock Is Sinking This Week"", ""summary"": ""Shares of Moderna (NASDAQ: MRNA) were down 16.2% for the week as of the market close on Thursday, according to data provided by S&P Global Market Intelligence.  The reduced outlook was solely due to weaker sales expectations for COVID products Comirnaty and Paxlovid.  Moderna, though, sought to reassure investors.""}, {""date"": ""2023-10-19"", ""headline"": ""3 Stocks That Are Dead in the Water"", ""summary"": ""The stock market appears to be entering choppy waters as the year winds down. Between high inflation, unpredictable interest rates and an increasingly frightful geopolitical landscape, risk factors abound. So here are three stocks to avoid. Given this challenging investment environment, this is not time to be holding onto struggling companies that have seen better days. It\u2019s time to cut these three dead in the water companies loose today. AMC Entertainment (AMC) InvestorPlace - Stock Market News""}, {""date"": ""2023-10-19"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 4.23% to $82.37 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-10-19"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""Baron Health Care Fund Q3 2023 Shareholder Letter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""Moderna to Host Second Digital Investor Event on November 8th, 2023"", ""summary"": ""CAMBRIDGE, MA / ACCESSWIRE / October 19, 2023 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a virtual Digital and AI Investor Event at 8:00 a.m. ET on Wednesday, November 8, 2023.The event will include presentations from management ...""}, {""date"": ""2023-10-19"", ""headline"": ""Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-19"", ""headline"": ""Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point"", ""summary"": ""Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) have been in agreement on a lot since the beginning of the pandemic.  The vaccine leaders also have predicted the coronavirus vaccine market is likely to follow that of the flu market, with many Americans going for an annual jab.""}, {""date"": ""2023-10-19"", ""headline"": ""Pfizer, Moderna to deliver 10M additional COVID shots to Japan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-20"", ""headline"": ""Analyzing 13Fs: ARK Investment Management (Cathie Wood) Q3 2023"", ""summary"": ""ARK has expanded positions in companies like Roblox, Palantir, Archer Aviation, and Teradyne while reducing positions in Tesla, Coinbase Global, Shopify, and Exact Sciences. Read more here.""}, {""date"": ""2023-10-20"", ""headline"": ""Moderna Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 2.39% to $80.40 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-10-20"", ""headline"": ""Moderna Shaves Off $7 Billion in Value After Pfizer Warning"", ""summary"": ""(Bloomberg) -- The pandemic officially ended months ago, allowing a weary public to get back to normal living. That was great news for large swaths of the economy.Most Read from BloombergIsrael Latest: Hamas Says Two US Hostages Held in Gaza ReleasedHere\u2019s What 8% Mortgage Rates Will Do to the Housing MarketBiden\u2019s Influence Turns Israel's Ground War Plans Into \u2018Something Different\u2019Where Does Israel Get Its 220,000 Barrels of Oil Every Day?UAW and General Motors Inch Toward Tentative Deal, Union""}, {""date"": ""2023-10-20"", ""headline"": ""Biotech stocks are in a post-pandemic slump and recovery in 2024 is questionable"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-21"", ""headline"": ""Declining Stock and Decent Financials: Is The Market Wrong About Moderna, Inc. (NASDAQ:MRNA)?"", ""summary"": ""Moderna (NASDAQ:MRNA) has had a rough three months with its share price down 36%. However, the company's fundamentals...""}, {""date"": ""2023-10-21"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Spotify.""}, {""date"": ""2023-10-22"", ""headline"": ""Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks This Year?"", ""summary"": ""Venture beyond the headlines on a journey among 2023's least celebrated S&P 500 stocks. A roadmap to informed investment decisions awaits.""}]",{}
41,2023-10-22,80.4000015258789,2023-10-29,71.91000366210938,-0.10559698635126014,D5+,"[{""date"": ""2023-10-22"", ""headline"": ""Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks This Year?"", ""summary"": ""Venture beyond the headlines on a journey among 2023's least celebrated S&P 500 stocks. A roadmap to informed investment decisions awaits.""}, {""date"": ""2023-10-23"", ""headline"": ""Moderna Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slid 2.19% to $78.64 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-10-23"", ""headline"": ""Moderna\u2019s stock suffering record losing streak as \u2018investor caution remains high\u2019 over COVID vaccine sales"", ""summary"": ""Moderna's stock was in danger of breaking its record for consecutive losses as investors expressed increasing caution over slowing sales of COVID vaccines.""}, {""date"": ""2023-10-23"", ""headline"": ""3 Healthcare Stocks to Invest in for a Big Shot of Gains"", ""summary"": ""With a few exceptions, healthcare stocks have had a rough go of it in 2023. The Standards and Practices (S&P) 500 Healthcare Index is down 5% year to date, versus a 13% increase in the benchmark S&P 500 index. Most healthcare stocks are down across the board. Pharma companies, health insurers and medical device manufacturers have all seen their share prices decline. That said, there are a few stocks that have managed to separate themselves from the pack with new innovations and strong financial""}, {""date"": ""2023-10-23"", ""headline"": ""Moderna Unusual Options Activity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-23"", ""headline"": ""Amid A Crypto Rally, Cathie Wood's Ark Invest Sells Coinbase, Grayscale Bitcoin Trust, Buys Robinhood Shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-23"", ""headline"": ""3 No-Brainer Stocks to Buy Right Now for Less than $100"", ""summary"": ""Biotech players CRISPR Therapeutics (NASDAQ: CRSP), Axsome Therapeutics (NASDAQ: AXSM), and Moderna (NASDAQ: MRNA) are perfect examples.  CRISPR Therapeutics is getting closer and closer to a transformative moment: Regulators at the U.S. Food and Drug Administration soon will decide on what may become the company's first commercialized product.  This could be big for CRISPR Therapeutics for two reasons.""}, {""date"": ""2023-10-23"", ""headline"": ""GLOBAL BROKER RATINGS: Deutsche Bank cuts Nexi to 'hold'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-24"", ""headline"": ""This Tax Strategy Could Hurt, Then Help, These 10 Stock-Market Laggards"", ""summary"": ""Mutual funds selling losing positions could further pummel the S&P 500\u2019s biggest underperforming stocks over the next week.""}, {""date"": ""2023-10-24"", ""headline"": ""Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know"", ""summary"": ""Moderna (MRNA) closed the most recent trading day at $79.76, moving +1.42% from the previous trading session.""}, {""date"": ""2023-10-24"", ""headline"": ""Moderna Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Moderna Inc. rose 1.42% to $79.76 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-10-24"", ""headline"": ""YieldMax Boosts Fund Suite With MRNA Option Income Strategy ETF"", ""summary"": ""In the immortal words of OK Go, here it goes again. YieldMax continues to dole out its single-stock option ETFs one at a time with the launch of the YieldMax MRNA Option Income Strategy ETF (MRNY ). MRNY seeks to generate monthly income via a synthetic covered call strategy on Moderna, Inc. (MRNA).""}, {""date"": ""2023-10-24"", ""headline"": ""First Participant Dosed in Phase 3 Study of Moderna Flu-Covid Combination Vaccine mRNA-1083"", ""summary"": ""By Josh Beckerman Moderna said the first participant has been dosed in a Phase 3 study of mRNA-1083, its combination vaccine candidate against influenza and...""}, {""date"": ""2023-10-24"", ""headline"": ""Moderna Stock Hasn't Been This Cheap Since 2020: Is Now the Time to Buy?"", ""summary"": ""Moderna (NASDAQ: MRNA) has lost more than half of its value this year.  Rival Pfizer has also recently raised concerns about slowing demand for COVID-19 shots as it reduced its guidance for the year.  Has Moderna become an attractive contrarian stock to buy right now, or could the stock be heading even lower?""}, {""date"": ""2023-10-24"", ""headline"": ""Moderna\u2019s stock snaps record losing streak as Cathie Wood\u2019s ETF boosts stake by more than $4 million"", ""summary"": ""Moderna Inc. investors enjoyed a rare rally Tuesday as the shares of the biotechnology company headed for their first gain in two weeks.""}, {""date"": ""2023-10-24"", ""headline"": ""Moderna Announces First Participant Dosed in Phase 3 Study of mRNA-1083, a Combination Vaccine Against Influenza and COVID-19"", ""summary"": ""mRNA-1083 is Moderna's first respiratory combination vaccine candidate to enter a Phase 3 trialPhase 3 initiation follows data from a Phase 1/2 trial where mRNA-1083 showed strong immunogenicity against influenza and COVID-19, with an acceptable reactogenicity ...""}, {""date"": ""2023-10-24"", ""headline"": ""Caris Life Sciences and Moderna Announce Multi-Year Strategic Partnership to Advance mRNA-Based Oncology Therapeutics"", ""summary"": ""Caris Life Sciences\u00ae(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular science and AI, today announced a new agreement with Moderna (NASDAQ:MRNA) in support of Moderna's oncology and novel therapeutics initiatives.""}, {""date"": ""2023-10-24"", ""headline"": ""The Best Stocks to Invest $5,000 In Right Now"", ""summary"": ""Vertex Pharmaceuticals (NASDAQ: VRTX) brings you a solid track record of growth -- plus potential for more ahead.  The company is testing a new CF treatment in phase 3 studies that may even beat Trikafta, paving the way for Vertex to hold onto its leadership at least until the late 2030s.  Meanwhile, Vertex may be about to launch its first potential blockbuster beyond CF.""}, {""date"": ""2023-10-24"", ""headline"": ""These bad YTD performers could bounce after tax loss selling abates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-24"", ""headline"": ""Moderna, Caris Life Team Up to Advance mRNA-Based Oncology Therapeutics"", ""summary"": ""By Stephen Nakrosis Moderna and Caris Life Sciences on Tuesday said they entered a multi-year strategic partnership to work on advancing mRNA-based oncology...""}, {""date"": ""2023-10-24"", ""headline"": ""Moderna doses first participant in Phase 3 study of mRNA-1083"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-24"", ""headline"": ""Moderna announces first participant dosed in Phase 3 flu/COVID combo vax study"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-24"", ""headline"": ""Moderna, Caris enter multi-year oncology and novel therapeutics agreement"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-25"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 3.76% to $76.76 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-10-25"", ""headline"": ""Moderna (MRNA) to Report Q3 Earnings: What's in the Cards?"", ""summary"": ""Investors' focus will likely be on updates on Moderna's (MRNA) pipeline, especially its late-stage pipeline candidates, when it reports third-quarter earnings.""}, {""date"": ""2023-10-25"", ""headline"": ""5 Stocks To Sell Before Tax-Loss Season Begins"", ""summary"": ""Tax-loss selling may occur earlier this year, instead of usual time of selling pressure in late December. Click here to find the 5 stocks to sell before season begins.""}, {""date"": ""2023-10-25"", ""headline"": ""Jim Cramer Says 'I'd Rather Just Own Bitcoin,' Over Investing In BTC Miner Stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-25"", ""headline"": ""Moderna price target lowered to $100 from $125 at TD Cowen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""Catalyst Watch: Apple earnings, Fed policy meeting, jobs report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""Moderna Named a Top Employer by Science for Ninth Consecutive Year"", ""summary"": ""CAMBRIDGE, MA / ACCESSWIRE / October 26, 2023 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as one of the top employers in the global biopharmaceutical industry in Science and Science Careers' 2023 Top Employers Survey for the ninth ...""}, {""date"": ""2023-10-26"", ""headline"": ""Moderna Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Moderna Inc. slipped 1.02% to $75.98 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-10-26"", ""headline"": ""Pfizer Gets Good Results From Covid-Flu Shot. The Race Is on With Moderna."", ""summary"": ""Pfizer and German partner BioNTech said the combo vaccine could lessen the impact of both illnesses with a single injection.""}, {""date"": ""2023-10-26"", ""headline"": ""Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline"", ""summary"": ""Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""2023-10-26"", ""headline"": ""Mixed Day for Vaccine Stocks as Terrible News Emerges"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""Noteworthy Thursday Option Activity: MRNA, AAPL, ENPH"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-26"", ""headline"": ""Concurrent use of COVID and flu shots is linked to stroke risk in older adults"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""What an updated COVID vaccine will mean for Moderna"", ""summary"": ""In an attempt to expand its portfolio, Moderna (MRNA) is developing an updated COVID-19 vaccine that could also provide protection against the seasonal flu. Piper Sandler Managing Director and Senior Biotechnology Analyst Ted Tenthoff joins Yahoo Finance Live to discuss the value this new vaccine presents for Moderna as a company and patients worldwide. \""We're clearly seeing that vaccination rates are low,\"" Tenthoff says. \""So, it could be... our current guidance is they've recently said within the low end of that $6 to $8 [billion] range. That's still positive, bringing in $6 billion a year for a company that before the pandemic was bringing in... a couple hundred million. This is still a meaningful product for Moderna.\"" For more expert insight and the latest market action,\u00a0click here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-10-27"", ""headline"": ""Moderna stock decline: What it will take to get it moving higher again"", ""summary"": ""Moderna's (MRNA) stock has fallen off in the post-pandemic period as demand for its COVID-19 vaccine \u2014 the company's primary commercial product \u2014 decreased significantly. Pfizer (PFE) recently lowered guidance on declining vaccine revenue, which Moderna shares took a hit correlatively. Moderna shares face heavy volatility because its business is tied heavily to the COVID shot, however the vaccine maker is looking to introduce new products to stabilize growth. Yahoo Finance's Health Reporter Anjalee Khemlani discusses the fall of Moderna post-COVID, giving insights on the company's plan to introduce new products moving forward. For more expert insight and the latest market action,\u00a0click here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-10-27"", ""headline"": ""Moderna Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 5.36% to $71.91 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-10-27"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-27"", ""headline"": ""Moderna: Looking Beyond Covid, The Pipeline Is Promising"", ""summary"": ""Investors should consider accumulating Moderna stock due to its promising pipeline and significant upside potential, despite short-term setbacks. Click here to read my analysis.""}, {""date"": ""2023-10-27"", ""headline"": ""Got $2,000? Here Are 2 Beaten-Down Growth Stocks to Buy Right Now"", ""summary"": ""You don't need a pile of cash to invest in some of today's beaten-down growth stocks.  Moderna stock has dropped more than 55% so far this year, leaving it trading at about 8 times forward-earnings estimates -- a bargain for what may be ahead.""}, {""date"": ""2023-10-29"", ""headline"": ""15 Countries with the Highest Number of Heart Diseases"", ""summary"": ""In this article, we will be taking a look at the 15 countries with the highest number of heart diseases. If you are not interested in reading about the heart disease market, head straight to the 5 Countries With The Highest Number Of Heart Diseases. The Profound Economic Impact of Heart Disease Heart disease is [\u2026]""}, {""date"": ""2023-10-29"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-29"", ""headline"": ""Earnings week ahead: Apple, AMD, Pfizer, McDonald's, Starbucks and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
42,2023-10-29,71.91000366210938,2023-11-05,77.52999877929688,0.07815317523268006,U5+,"[{""date"": ""2023-10-29"", ""headline"": ""Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-29"", ""headline"": ""15 Countries with the Highest Number of Heart Diseases"", ""summary"": ""In this article, we will be taking a look at the 15 countries with the highest number of heart diseases. If you are not interested in reading about the heart disease market, head straight to the 5 Countries With The Highest Number Of Heart Diseases. The Profound Economic Impact of Heart Disease Heart disease is [\u2026]""}, {""date"": ""2023-10-29"", ""headline"": ""Pharma, PBMs spar over rising drug costs amid public scrutiny"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-29"", ""headline"": ""Earnings week ahead: Apple, AMD, Pfizer, McDonald's, Starbucks and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. rallied 3.00% to $74.07 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-10-30"", ""headline"": ""Check Out What Whales Are Doing With MRNA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""Moderna to partner with epidemic preparedness group on quick vaccines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""11 Best Immunotherapy Stocks To Buy Now"", ""summary"": ""In this article, we discuss 11 of the best immunotherapy stocks to buy now. If you want to skip our detailed discussion on the cancer and oncology industry, head directly to the 5 Best Immunotherapy Stocks To Buy Now. The global oncology landscape is continually transforming, driven by persistent efforts to explore, create, and deliver [\u2026]""}, {""date"": ""2023-10-30"", ""headline"": ""GLOBAL BROKER RATINGS: Stifel cuts Mercedes and Sanofi to 'hold'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""McCormick, CME Group And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""CEPI and Moderna Harness mRNA Technology to Advance 100 Days Mission"", ""summary"": ""New partnership will harness Moderna's mRNA rapid-response platform, clinically validated during the COVID-19 pandemic, to accelerate epidemic and pandemic vaccine developmentFirst project will enable rapid pre-clinical testing of antigen designs ...""}, {""date"": ""2023-10-30"", ""headline"": ""Moderna, CEPI partner to drive development of mRNA vaccines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-30"", ""headline"": ""Moderna, CEPI enter strategic partnership to advance 100 Days Mission"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-31"", ""headline"": ""Never Mind Covid, Investors Want a Pfizer Obesity Pill"", ""summary"": ""It is little wonder, then, that investors were hoping Pfizer could jump to the winning camp with an obesity pill.  \u201cNot one mention [of danuglipron] in the prepared remarks from Pfizer,\u201d noted  Will Sevush,  a healthcare strategist for Jefferies.  Before today\u2019s earnings,  David Risinger,  a Leerink Partners analyst, had written that Pfizer might even release data from its mid-stage study alongside the earnings results as soon as Tuesday.""}, {""date"": ""2023-10-31"", ""headline"": ""Gilead Sciences (GILD) Earnings Expected to Grow: Should You Buy?"", ""summary"": ""Gilead (GILD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""2023-10-31"", ""headline"": ""Pfizer hits new 52-week low after another revenue miss in Q3 (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-31"", ""headline"": ""\u2018Nobody wants to speak about COVID\u2019: Less than 3% of eligible Americans got a booster shot in September \u2014 does that spell trouble for these 3 big vaccine stocks?"", ""summary"": ""Market performance hangs on U.S. vaccination rates for these three companies.""}, {""date"": ""2023-10-31"", ""headline"": ""Carisma Therapeutics to present efficacy results of Moderna collaboration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-31"", ""headline"": ""Trick or Treat: S&P 500 top and bottom YTD performers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-10-31"", ""headline"": ""Pfizer posts rare topline miss in Q3 amid COVID cliff"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-01"", ""headline"": ""Moderna Inc. stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.32% higher to $76.20 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-11-01"", ""headline"": ""Flagship Pioneering Launches Pioneering Intelligence"", ""summary"": ""Flagship Pioneering today launched Pioneering Intelligence, an initiative of Flagship Pioneering harnessing artificial intelligence (AI) to accelerate innovation in the life sciences and beyond. Flagship marked the official launch of Pioneering Intelligence with an AI Summit that drew tech and life sciences leaders from around the globe for a day long series of talks. Initiated in 2021, Pioneering Intelligence will augment the capabilities of Flagship companies, drive AI and machine learning (ML""}, {""date"": ""2023-11-01"", ""headline"": ""Exploring Analyst Estimates for Moderna (MRNA) Q3 Earnings, Beyond Revenue and EPS"", ""summary"": ""Beyond analysts' top -and-bottom-line estimates for Moderna (MRNA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2023.""}, {""date"": ""2023-11-01"", ""headline"": ""UPDATE 1-Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say"", ""summary"": ""Moderna should hit the lower end of its sales target for this year as it only needs to tap a small portion of the private market with its COVID vaccine to reach that goal, according to industry analysts.  Around 20 million people need to be vaccinated with Moderna's updated COVID-19 vaccine for the company to reach $2 billion in 2023 sales from the private market, a figure four analysts told Reuters was achievable.  Moderna forecast $6 billion to $8 billion for sales of its COVID-19 vaccine in 2023, $2 billion to $4 billion of which is expected to come from the commercial market.""}, {""date"": ""2023-11-01"", ""headline"": ""Unlike Pfizer, Moderna can meet 2023 COVID forecast, analysts say"", ""summary"": ""(Reuters) -Moderna should hit the lower end of its sales target for this year as it only needs to tap a small portion of the private market with its COVID vaccine to reach that goal, according to industry analysts.  Around 20 million people need to be vaccinated with Moderna's updated COVID-19 vaccine for the company to reach $2 billion in 2023 sales from the private market, a figure four analysts told Reuters was achievable.  Moderna forecast $6 billion to $8 billion for sales of its COVID-19 vaccine in 2023, $2 billion to $4 billion of which is expected to come from the commercial market.""}, {""date"": ""2023-11-02"", ""headline"": ""Goldman Sachs Remains a Buy on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna (NASDAQ:MRNA) Rises on HSBC Upgrade"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Biotechs rally with gene editing stocks among notable gainers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Catalyst Watch: Disney earnings, Moderna AI event, Powell IMF speech and Las Vegas strike threat"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Buy/Sell: Wall Street's top 10 stock calls this week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Why Moderna Stock Plummeted by Almost 7% Today"", ""summary"": ""A quarterly bottom line that was deep in the red sent Moderna (NASDAQ: MRNA) shareholders booking for the exits on Thursday.  Its cost of sales should come in at around $5 billion, which includes what the biotech terms as a \""proactive resizing of the company's manufacturing footprint\"" that is anticipated to total $1.6 billion across the third and fourth quarters alone.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna Takes $1.3 Billion Hit From Sluggish Covid Vaccine Uptake"", ""summary"": ""When vaccines go bad, so does your bottom line. Moderna posted a quarterly loss of $3.63 billion on Thursday, half of which was accounted for by...""}, {""date"": ""2023-11-02"", ""headline"": ""S&P 500 Gains and Losses Today: Starbucks Shares Jump Following Profit Record"", ""summary"": ""The S&P 500 added 1.9% on Thursday, Nov. 2, 2023, amid optimism that the Federal Reserve might stop boosting interest rates to bring down inflation.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna Shares Slide After Posting a Loss on Falling COVID-19 Vaccine Sales and Production"", ""summary"": ""Moderna shares tumbled after reporting a steep loss as demand for its COVID-19 vaccine fell and it cut back on production of the shot.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna will break even in 2026: CEO St\u00e9phane Bancel"", ""summary"": ""Moderna reports loss for another quarter as it works to regain momentum after vaccine sales slump.""}, {""date"": ""2023-11-02"", ""headline"": ""Deutsche Bank Downgrades Moderna (MRNA)"", ""summary"": """"}, {""date"": ""2023-11-02"", ""headline"": ""Moderna Tumbles As Light Guidance And Steep Losses Overshadow Sales Beat"", ""summary"": ""Moderna stock tumbled Thursday after the Covid vaccine maker handily beat third-quarter sales forecasts, but issued light guidance.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna Stock Falls After Big Covid Vaccine Writedown"", ""summary"": ""**Moderna** ([MRNA](https://www.wsj.com/market-data/quotes/MRNA)) swung to a loss and posted a steep drop in quarterly sales, weighed down by soft demand for its Covid-19 vaccine. The company also forecast sales of about $4 billion for next year, softer than Wall Street analysts were expecting.""}, {""date"": ""2023-11-02"", ""headline"": ""How Moderna aims to break even by 2026"", ""summary"": ""While boasting a third-quarter revenue beat, biotech firm Moderna (MRNA) reported an overwhelmingly higher-than-expected loss of $9.53 per share. Its shares find themselves under pressure over weakening COVID-19 vaccine demand. Moderna's Chief Financial Officer Jamey Mock joins Yahoo Finance\u2019s Anjalee Khemlani to discuss the company\u2019s forward strategy. Mock notes that the company aims to \""break-even by 2026,\"" acknowledging investors' concerns. Mock\u2019s optimism for the 2026 deadline is based on \""organic growth opportunity\u201d in the late-stage product pipeline with plans to introduce RSV and flu vaccines in the coming years. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-11-02"", ""headline"": ""Markets Jump at Midday Amid Optimism the Fed Could Be Done Raising Interest Rates in 2023"", ""summary"": ""U.S. equities posted strong gains at midday on Thursday, Nov. 2, 2023 amid enthusiasm that the Federal Reserve may not raise interest rates to fight inflation any more this year.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna (MRNA) Q3 2023 Earnings Call Transcript"", ""summary"": ""At this time, I'd like to turn the call over to Lavina Talukdar, head of investor relations at Moderna.  Good morning, everyone, and thank you for joining us on today's call to discuss Moderna's third-quarter 2023 financial results and business updates.  On today's call are St\u00e9phane Bancel, our chief executive officer; Stephen Hoge, our president; Arpa Garay, our chief commercial officer; and Jamey Mock, our chief financial officer.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 6.52% to $71.23 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-11-02"", ""headline"": ""NEW YORK MARKET CLOSE: Dow leaps on hopes interest rates have peaked"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna (MRNA) Beats on Q3 Earnings & Sales, Expects Lower COVID Demand"", ""summary"": ""Moderna (MRNA) beats expectations for earnings and sales. However, the company projects lower-than-expected 2024 guidance, which likely led to a decline in share price after the earnings announcement.""}, {""date"": ""2023-11-02"", ""headline"": ""Starbucks, DoorDash, Roku, Qualcomm rise premarket; Peloton, Moderna fall"", ""summary"": ""Investing.com -- U.S. futures climbed higher Thursday, as investors took confidence in Fed Chair Jerome Powell\u2019s comments, hoping that U.S. interest rates have now peaked.""}, {""date"": ""2023-11-02"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Earnings Recap: Shell, Palantir, Starbucks, Shopify Rise; Moderna Falls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna Inc (MRNA) Reports Q3 2023 Financial Results"", ""summary"": ""Company records $1.8 billion in revenues and a net loss of $3.6 billion""}, {""date"": ""2023-11-02"", ""headline"": ""Trending tickers: Novo Nordisk | Moderna | Apple | Paypal"", ""summary"": ""The latest investor updates on stocks that are trending on Thursday.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna, Inc. (MRNA) Q3 2023 Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna in earnings miss as demand for Covid shots falls"", ""summary"": ""Diluted earnings per share were $9.53, far wider than the $1.79 expected by analysts.  Falling demand for Covid vaccinations in the US meant Moderna now expected full-year sales of at least $6bn, at the lower end of its previous guidance and below the consensus forecast for $6.6bn.  Moderna predicted it would return to growth in 2025, and break even in 2026.""}, {""date"": ""2023-11-02"", ""headline"": ""Deutsche Bank downgrades Moderna as shares tank after massive Q3 loss"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""UPDATE 1-Moderna tempers 2023 COVID vaccine sales forecast"", ""summary"": ""Moderna on Thursday said it expected 2023 revenue of  at least $6 billion, tempering its forecast to reflect weaker demand for COVID-19 vaccines, but added it would return to sales growth in 2025 and break even the following year.  Moderna's COVID-19 vaccine is its lone marketed product.  Some $900 million of its quarterly revenue came from the U.S. and $800 million from international sales.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna tempers 2023 COVID vaccine sales forecast"", ""summary"": ""(Reuters) -Moderna on Thursday said it expected 2023 revenue of  at least $6 billion, tempering its forecast to reflect weaker demand for COVID-19 vaccines, but added it would return to sales growth in 2025 and break even the following year.  Moderna's COVID-19 vaccine is its lone marketed product.  Some $900 million of its quarterly revenue came from the U.S. and $800 million from international sales.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares"", ""summary"": ""Moderna stock could take a hit Thursday after the Covid vaccine maker handily beat third-quarter sales forecasts, but issued light guidance.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna revenue tops expectations, expects to return to sales growth in 2025"", ""summary"": ""Moderna on Thursday said it expected 2023 revenue of  at least $6 billion, a decline reflecting weaker demand for COVID-19 vaccines this year, but that it would return to sales growth in 2025 and break even the following year.  Moderna's COVID-19 vaccine is its lone marketed product.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna Reports Big Quarterly Loss in Post-Pandemic Reset"", ""summary"": ""The company\u2019s net loss for the quarter was $3.6 billion. Analysts had anticipated a net loss of $728 million.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates"", ""summary"": ""Third quarter 2023 revenues of $1.8 billion; Company expects 2023 revenues of at least $6 billionSpikevax U.S. market share to date increased to 45% from 36% in 2022Company anticipates 2024 revenue of approximately $4 billion and return to growth ...""}, {""date"": ""2023-11-02"", ""headline"": ""Cathie Wood's Ark Invest Goes Shopping For Moderna Stock \u2014 Sells DraftKings Shares Amid Quarterly Rise In Revenue, EPS Beat"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, SBUX"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna (MRNA) Receives a Buy from UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Biggest stock movers today: Moderna, Starbucks, Qualcomm, PayPal, Roku, Fastly and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna: Q3 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Roku upgraded, Amazon initiated: Wall Street's top analyst calls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""12 Health Care Stocks Moving In Thursday's Pre-Market Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna, Inc. 2023 Q3 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Moderna, Inc.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna downgraded to Sell at Deutsche Bank after 'another tough update'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""QNST, HOWL and TRKA among pre-market losers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna downgraded to Sell from Hold at Deutsche Bank"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""TOP NEWS: Moderna swings to quarterly loss amid Covid jab write-downs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna posts wider-than-expected loss, reins in full-year outlook\u00a0"", ""summary"": ""COVID vaccine maker unwinds pandemic-era manufacturing capacity as it aims to break even in 2026""}, {""date"": ""2023-11-02"", ""headline"": ""US Stocks On Track For Solid Start Amid Lingering Fed Optimism: Traders Eye Earnings From Market Bellwether Apple"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna swings to loss in Q3 on COVID vaccine related resizing, write-downs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna swings to loss in Q3 on COVID-19 related resizing, write-downs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna sees $4B in sales in 2024, mostly in 2H"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna sees product sales of at least $6B for 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna sees 2023 Spikevax sales of at least $6B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna reports Q3 EPS ($9.53) including items, consensus ($1.98)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna EPS of -$9.53, revenue of $1.83B beats by $450M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna posts wider-than-expected loss, reins in full-year outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""**EMBARGOED DO NOT PUBLISH** Moderna posts wider-than-expected loss, reins in full-year outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""ModernaEPS of -$9.53, revenue of $1.83B beats by $450M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""Moderna\u2019s Financial Performance and Future Outlook: A Hold Rating Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-02"", ""headline"": ""What You Missed On Wall Street On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Moderna (MRNA) Reports Q3 Earnings: What Key Metrics Have to Say"", ""summary"": ""Although the revenue and EPS for Moderna (MRNA) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.""}, {""date"": ""2023-11-03"", ""headline"": ""Unusual Put Option Trade in Moderna (MRNA)  Worth $9,322.50K"", ""summary"": """"}, {""date"": ""2023-11-03"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. rose 8.84% to $77.53 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-11-03"", ""headline"": ""HSBC Upgrades Moderna (MRNA)"", ""summary"": """"}, {""date"": ""2023-11-03"", ""headline"": ""Moderna adjusts to changing outlook for COVID vaccine demand"", ""summary"": ""The company recorded a net loss in the third quarter as it \u201cresizes\u201d its manufacturing footprint, and now expects revenue to come in at low end of its previous guidance.""}, {""date"": ""2023-11-03"", ""headline"": ""These Analysts Cut Their Forecasts On Moderna After Q3 Results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Moderna\u2019s CFO on the $25 billion innovation plan to work past the post-COVID slump"", ""summary"": ""\u201cThere\u2019s a true organic growth opportunity here,\u201d Jamey Mock says.""}, {""date"": ""2023-11-03"", ""headline"": ""What The Fed Will Do After October Jobs Report Weakened"", ""summary"": ""S&P 500 and Nasdaq soar on subdued job growth in October 2023 NFP report. Read for my full review of the impact of the rising unemployment rate and other data.""}, {""date"": ""2023-11-03"", ""headline"": ""Analyst Forecasts Just Became More Bearish On Moderna, Inc. (NASDAQ:MRNA)"", ""summary"": ""The analysts covering Moderna, Inc. ( NASDAQ:MRNA ) delivered a dose of negativity to shareholders today, by making a...""}, {""date"": ""2023-11-03"", ""headline"": ""Biggest stock movers today: Apple, Block, Digital Ocean, Moderna, BILL and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Moderna price target lowered to $125 from $180 at RBC Capital"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Early notable gainers among liquid option names on November 3rd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Moderna upgraded at HSBC; says bearish thesis has played out"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Not Big Tech \u2014 3 S&P 500 Stocks with the Most Upside Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""The 3 S&P 500 Stocks with the Most Upside Potential"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""GLOBAL BROKER RATINGS: HSBC raises Moderna; Investec likes Kering"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Stryker (SYK) and Eli Lilly & Co (LLY)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Cyberark Software To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Moderna (MRNA) Gets a Hold from Oppenheimer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Uber notches upgrade ahead of Q3 earnings: 4 big analyst picks"", ""summary"": ""Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: upgrades at Uber,  Moderna  ,  Zillow  , and Aptiv.  KeyBanc upgraded Uber Technologies (NYSE:UBER) to Overweight from Sector Weight with a price target of $60.00, as reported in real-time on InvestingPro.  Uber's stock climbed over 6% yesterday following an announcement by New York's attorney general that the ride-sharing company will pay a $290 million settlement to conclude a multi-year investigation.""}, {""date"": ""2023-11-03"", ""headline"": ""Moderna price target lowered to $110 from $125 at BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Piper Sandler Keeps Their Buy Rating on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Moderna upgraded to Hold from Reduce at HSBC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-03"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS), Moderna (MRNA) and Regeneron (REGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-04"", ""headline"": ""Moderna, Inc. (NASDAQ:MRNA) Q3 2023 Earnings Call Transcript"", ""summary"": ""Moderna, Inc. (NASDAQ:MRNA) Q3 2023 Earnings Call Transcript November 2, 2023 Moderna, Inc. misses on earnings expectations. Reported EPS is $-9.53 EPS, expectations were $-1.81. Operator: Good morning. My name is Kevin. And welcome to Moderna\u2019s Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. Following the formal remarks, [\u2026]""}, {""date"": ""2023-11-04"", ""headline"": ""Baron Partners Fund Q3 2023 Shareholder Letter"", ""summary"": ""Baron Partners Fund fell 7.17% (Institutional Shares) and trailed both the Russell Midcap Growth Index and the S&P 500 Index during Q3 2023. Click here to read the full fund letter.""}, {""date"": ""2023-11-04"", ""headline"": ""Stocks To Watch: Spotlight On Disney, Rivian Automotive, Moderna, Birkenstock And Stryker"", ""summary"": ""Stay informed with Seeking Alpha's Stocks to Watch newsletter, featuring key events like IPOs, earnings reports, and investor days that are set to make...""}, {""date"": ""2023-11-04"", ""headline"": ""Moderna May Be Facing Its Toughest Moment Ever. Time to Sell?"", ""summary"": ""Moderna still has big ambitions -- beyond the coronavirus vaccine -- that could pay off in a few years.""}, {""date"": ""2023-11-04"", ""headline"": ""\""Moderna (MRNA): A Smart Investment or a Value Trap? An In-Depth Exploration\"""", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-04"", ""headline"": ""The Moderna Inc (MRNA) Company: A Short SWOT Analysis"", ""summary"": ""Unveiling the Strengths and Challenges: A Deep Dive into Moderna Inc (MRNA) SWOT Analysis""}, {""date"": ""2023-11-05"", ""headline"": ""Down 84% From Its Peak. Is It Finally Time to Buy Moderna?"", ""summary"": ""Shares of Moderna (NASDAQ: MRNA) recently did some bouncing around.  This isn't the first time falling sales of its COVID-19 vaccine, Spikevax, led shares of Moderna lower.  By the end of 2024, there's a good chance Spikevax won't be Moderna's only source of recurring revenue.""}, {""date"": ""2023-11-05"", ""headline"": ""Moderna price target lowered to $168 from $210 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
43,2023-11-05,77.52999877929688,2023-11-12,70.05000305175781,-0.09647872881866304,D5+,"[{""date"": ""2023-11-05"", ""headline"": ""Down 84% From Its Peak. Is It Finally Time to Buy Moderna?"", ""summary"": ""Shares of Moderna (NASDAQ: MRNA) recently did some bouncing around.  This isn't the first time falling sales of its COVID-19 vaccine, Spikevax, led shares of Moderna lower.  By the end of 2024, there's a good chance Spikevax won't be Moderna's only source of recurring revenue.""}, {""date"": ""2023-11-05"", ""headline"": ""Moderna price target lowered to $168 from $210 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-06"", ""headline"": ""Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday"", ""summary"": ""Eli Lilly was an S&P 500 top performer Monday, while energy plays were among the day's biggest winners and losers.""}, {""date"": ""2023-11-06"", ""headline"": ""Moderna Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 7.04% to $72.07 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-11-06"", ""headline"": ""Moderna\u2019s Financial Outlook: A Risky Proposition Amidst Declining Sales, High COGS, and Unlikely Profitability \u2013 Analyst Reiterates Sell Rating"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-06"", ""headline"": ""BioNTech Earnings Beat. Pfizer\u2019s Vaccine Partner Battles Covid Downturn."", ""summary"": ""Shares have dropped 36% this year as demand for its coronavirus inoculations has fallen.""}, {""date"": ""2023-11-06"", ""headline"": ""Moderna price target lowered to $143 from $178 at UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-07"", ""headline"": ""High Risk Alert: 7 Vulnerable Stocks to Dump Now"", ""summary"": ""Investors face a complicated picture heading into the holiday season. War, inflation, high interest rates, and a potential recession are among the risk factors on the horizon. Many investors are understandably turning to fixed income and defensive stocks to ride out the current storm. By contrast, this is precisely the wrong time to be taking more speculative bets. These seven vulnerable and risky stocks would be tough to own even in the best of times, and they\u2019re downright toxic for your portfo""}, {""date"": ""2023-11-07"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. rallied 2.21% to $73.66 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-11-07"", ""headline"": ""Moderna Tops BioSpace\u2019s Best Places to Work Ranking for Third Consecutive Year"", ""summary"": ""CAMBRIDGE, MA / ACCESSWIRE / November 7, 2023 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one large employer in BioSpace's 2024 Best Places to Work report for the third consecutive year.\""We are proud to be named the best ...""}, {""date"": ""2023-11-07"", ""headline"": ""Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?"", ""summary"": ""Instead, rising interest rates hit the solar industry hard, significantly raising the cost of such projects for homeowners.  Enphase reported revenue of $551.1 million in the third quarter, down 13% from the quarter a year ago, but profits were essentially flat at $114 million, a sign it's managing the downturn better than SolarEdge.""}, {""date"": ""2023-11-07"", ""headline"": ""Cathie Wood Just Bought This Struggling Stock After Its Billion-Dollar Quarterly Loss. Should You?"", ""summary"": ""Superstar investor Cathie Wood doesn't flinch when she sees a declining stock price.  In recent days, Wood was at it again -- picking up a stock not only as it dropped, but also as the company reported a billion-dollar quarterly loss.  This stock had already been on the decline before the report.""}, {""date"": ""2023-11-07"", ""headline"": ""BioNTech Shifted Its Focus To Innovative Oncology And Mainz Biomed Announced A Showcasing Of Its Revolutionary Colorectal Cancer Detection Test"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""MRNA, NVAX and BNTX are among after hour movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Warning: MRNA is at high risk of performing badly"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Moderna to Present at Upcoming Conferences in November 2023"", ""summary"": ""CAMBRIDGE, MA / ACCESSWIRE / November 8, 2023 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:2023 UBS Global Biopharma Conference on November 9th at 8:00 a.m. ET.2023 Jefferies London ...""}, {""date"": ""2023-11-08"", ""headline"": ""6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%"", ""summary"": ""One knock against Wall Street analysts is they\u2019re too bullish, especially when it comes to Nasdaq 100 stocks. No matter the market conditions, they seem able to find the silver lining. There are very few \u201csell\u201d recommendations, with most stock endorsements being a \u201cbuy\u201d or \u201cstrong buy.\u201d Yet maybe they\u2019re seeing something through those rose-colored glasses they wear. Nasdaq 100 stocks are down 4% from recent highs in July but was technically in a correction toward the end of October. The tech-hea""}, {""date"": ""2023-11-08"", ""headline"": ""Moderna Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 3.15% to $71.34 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-11-08"", ""headline"": ""Moderna Highlights its Digital and AI Strategy and Progress at Second Digital Investor Event"", ""summary"": ""The Company demonstrates how its integrated Artificial Intelligence ecosystem accelerates innovation at scale and creates value across the enterpriseModerna to present case studies on how the organization is building a real-time AI CompanyCAMBRIDGE, ...""}, {""date"": ""2023-11-08"", ""headline"": ""Novavax COVID vaccine in focus ahead of Q3 earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Moderna Unusual Options Activity For November 08"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Moderna highlights digital, AI strategy at second Digital Investor event"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-08"", ""headline"": ""Moderna to unveil AI, digital strategy at second Digital Investor Event"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 2.57% to $69.51 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-11-09"", ""headline"": ""Moderna's Stock Just Tumbled 12%. Here's Why It's Still a Buy."", ""summary"": ""After its dim third-quarter earnings report on Nov. 2, Moderna (NASDAQ: MRNA) saw its shares crash by more than 12% before recovering.  Let's examine how its strategic plans and favorable stock valuation might make it a great performer for those with a little patience.  Most people are familiar with Moderna thanks to its coronavirus vaccines.""}, {""date"": ""2023-11-09"", ""headline"": ""Interesting MRNA Put And Call Options For December 29th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-09"", ""headline"": ""Top 20 Drug Companies in the US by Revenue"", ""summary"": ""In this article, we will be taking a look at the top 20 drug companies in the US by revenue. To skip our detailed analysis, you can go directly to see the Top 5 Drug Companies in the US by Revenue. Following the Covid-19 pandemic, which drastically altered the way of living, the top pharmaceutical [\u2026]""}, {""date"": ""2023-11-10"", ""headline"": ""Moderna Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.78% higher to $70.05 Friday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-11-10"", ""headline"": ""2 Top Biotech Stocks to Buy Right Now"", ""summary"": ""It's been a rough year for the biotech industry, which as a whole has substantially lagged the broader market.  Two worth a closer look today are Amgen (NASDAQ: AMGN) and Moderna (NASDAQ: MRNA) whose prospects really don't look as bad as their year-to-date performances suggest.  At current levels, both Amgen and Moderna are worth investing in now.""}, {""date"": ""2023-11-10"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-10"", ""headline"": ""Why Moderna Stock Was Cratering This Week"", ""summary"": ""Moderna (NASDAQ: MRNA), a star stock during the pandemic era, continues to struggle in a world that seems to be moving past COVID-19.  According to data compiled by S&P Global Market Intelligence, the biotech's shares were down by over 10% week to date as of Thursday night.  Moderna's great disadvantage is that it has only one commercialized product, the go-to coronavirus vaccine Spikevax.""}, {""date"": ""2023-11-11"", ""headline"": ""Moderna, Inc. (MRNA) Second Digital Investor Event Transcript"", ""summary"": ""Moderna, Inc. (NASDAQ:NASDAQ:MRNA) Second Digital Investor Event November 8, 2023 8:00 AM ETCompany ParticipantsLavina Talukdar - Head of IRStephane Bancel...""}, {""date"": ""2023-11-11"", ""headline"": ""Where Will Novavax Be in 3 Years?"", ""summary"": ""A lot can happen in just a few years, and Novavax (NASDAQ: NVAX) is the proof of that.  Three years ago, the company was rushing toward the coronavirus vaccine finish line -- and the shares were soaring.  Novavax brought its vaccine to market, but its late arrival meant it lost out on the biggest revenue opportunity.""}]",{}
44,2023-11-12,70.05000305175781,2023-11-19,76.44000244140625,0.09122054405803603,U5+,"[{""date"": ""2023-11-12"", ""headline"": ""Baillie Gifford Adjusts Portfolio in Q3 2023, NVIDIA Corp Sees Notable Reduction"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-13"", ""headline"": ""3 Cathie Wood Bargain Buys That Should Be on Your List Too"", ""summary"": ""Cathie Wood favors companies that innovate and have what it takes to become tomorrow's winners. But she won't buy them at just any price. The superstar investor will only pick up shares of these players if the price is reasonable -- and even better if it's an absolute steal.""}, {""date"": ""2023-11-14"", ""headline"": ""Coatue Management trims stakes in five Magnificent 7 members, adds Palantir, Shopify"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-14"", ""headline"": ""Moderna Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Moderna Inc. advanced 5.54% to $74.10 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-11-14"", ""headline"": ""Moderna to Host Second Environmental, Social and Governance (ESG) Investor Event on December 7th, 2023"", ""summary"": ""CAMBRIDGE, MA / ACCESSWIRE / November 14, 2023 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host its second virtual ESG investor event at 8:00 a.m. ET on Thursday, December 7, 2023.Moderna's ESG Investor Event will include presentations ...""}, {""date"": ""2023-11-14"", ""headline"": ""Moderna (MRNA)'s Market Value: A Comprehensive Valuation Analysis"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-15"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. advanced 3.04% to $76.35 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-11-15"", ""headline"": ""Tracking Baillie Gifford's 13F Portfolio - Q3 2023 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-15"", ""headline"": ""Catalent trades higher after quarterly beat"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-15"", ""headline"": ""Moderna to Host Second Environmental, Social and Governance Investor Event on December 7th, 2023"", ""summary"": ""CAMBRIDGE - Moderna, Inc. , today announced that it will host its second virtual ESG investor event at 8:00 a.m. ET on Thursday, December 7, 2023.Moderna s ESG Investor Event will include...""}, {""date"": ""2023-11-15"", ""headline"": ""Peering Into Moderna's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-15"", ""headline"": ""Lone Pine exited Nvidia during Q3, bought Meta and made top holding"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-16"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. inched 0.26% higher to $76.55 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-11-16"", ""headline"": ""Moderna, Inc. (MRNA) 2023 Jefferies London Healthcare Conference Transcript"", ""summary"": ""Moderna, Inc. (NASDAQ:NASDAQ:MRNA) 2023 Jefferies London Healthcare Conference November 16, 2023 3:30 AM ETCompany ParticipantsLavina Talukdar - Senior Vice...""}, {""date"": ""2023-11-17"", ""headline"": ""Moderna Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 0.14% to $76.44 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-11-17"", ""headline"": ""Moderna: Bad News Is Still Bad News"", ""summary"": ""Moderna, Inc. reported weak Covid vaccine sales and cut revenue targets for 2023 and 2024. Read more about MRNA stock here.""}, {""date"": ""2023-11-17"", ""headline"": ""Big Players' Recent Trades in MRNA Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-19"", ""headline"": ""Investing In Moderna: A Calculated Risk Worth Taking For Patient Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-19"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
45,2023-11-19,76.44000244140625,2023-11-26,78.5199966430664,0.02721080762987338,U3,"[{""date"": ""2023-11-19"", ""headline"": """", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-19"", ""headline"": ""Moderna Nears Key Technical Level With Indications Of Reversal (Rating Upgrade)"", ""summary"": ""Moderna experienced a significant decline in Q3 2023 revenue, primarily due to a slump in COVID-19 vaccine sales. See why I upgrade MRNA stock to a buy.""}, {""date"": ""2023-11-19"", ""headline"": ""Investing In Moderna: A Calculated Risk Worth Taking For Patient Investors"", ""summary"": ""Moderna reported $1.8 billion in revenue, beating estimates, but recorded a massive GAAP EPS loss. Learn why I rate MRNA stock a buy.""}, {""date"": ""2023-11-19"", ""headline"": ""M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades: survey"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""Half Of S&P 500 Stocks Still Below 200-Day Average, Ignoring Covid-Like Rally: 10 Bargain Plays For Latecomer Bulls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""Half Of S&P 500 Stocks Still Below 200-Day Average: 10 Bargain Plays For Latecomer Bulls"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""Pfizer (NYSE:PFE) Sued Re:Low-Quality ADHD Drug for Kids"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-20"", ""headline"": ""Don\u2019t Let the Q3 Earnings Miss Keep You From These 3 Stocks!"", ""summary"": ""Most of the earnings reports are in for the third quarter. But a contrarian play based on the results to date could actually be investment opportunities. According to FactSet, of the 94% of the S&P 500 companies that had reported earnings as of Nov. 17, 82% delivered a positive earnings per share surprise, while 62% had a positive revenue surprise in the quarter. If my math is correct, of the 470 companies that had reported by Nov. 17, 385 delivered an EPS surprise. That leaves me with 85 compan""}, {""date"": ""2023-11-20"", ""headline"": ""Happy Anniversary"", ""summary"": ""It\u00e2\u0080\u0099s been the worst of times and the best of times for the Nasdaq 100, which marked the two-year anniversary of its record high from 11/19/21 over the weekend.""}, {""date"": ""2023-11-20"", ""headline"": ""Moderna Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Moderna Inc. rallied 3.30% to $78.96 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-11-21"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 2.30% to $77.14 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-11-21"", ""headline"": ""UPDATE 1-European Patent Office declares Moderna mRNA patent invalid"", ""summary"": ""The European Patent Office declared a contested mRNA patent owned by Moderna invalid on Tuesday, the office said, handing a win to BioNTech and its partner Pfizer in a patent dispute between the two coronavirus vaccine makers.  Moderna said in a statement that it disagreed with the office's decision and would lodge an appeal.  Shares in Moderna were down 2.3% in premarket trading on Wall Street after the decision was announced by BioNTech earlier on Tuesday.""}, {""date"": ""2023-11-21"", ""headline"": ""Pfizer (NYSE:PFE) Sued for Low-Quality ADHD Drug for Kids"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""10 large-cap stocks that are the furthest below the 200-day MA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""QQQ ETF Update, 11/22/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics"", ""summary"": ""Flagship Pioneering, the bioplatform innovation company, today unveiled Quotient Therapeutics, a company pioneering somatic genomics, the study of genetic variation at the cellular level, to discover therapeutics informed by new links between genes and disease. Flagship has made an initial commitment of $50 million to advance development of the company's platform following two years of development at Flagship Labs and pursue a pipeline of medicines across a wide range of therapeutic areas and mo""}, {""date"": ""2023-11-21"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""BioNTech says European Patent Office has declared Moderna patent invalid"", ""summary"": ""COVID-19 vaccine maker BioNTech said on Tuesday the European Patent Office has declared as invalid an mRNA patent that has been invoked by Moderna in litigation about alleged an patent violation by BioNTech and its partner Pfizer.  \""We understand and welcome the European Patent Office\u2019s decision to revoke Moderna\u2019s European Patent 3 718 565 B1,\"" the German biotech firm said in a statement.  \""The European Patent Office\u2019s decision is an important one as we believe that this and others of Moderna\u2019s patents do not meet the requirements for grant and should never have been granted,\"" it added.""}, {""date"": ""2023-11-21"", ""headline"": ""Moderna tells Reuters will appeal European Patent Office decision"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""Biggest stock movers today: Agilent, Medtronic, MorphoSys, Moderna and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""European Patent Office declares Moderna mRNA patent invalid"", ""summary"": ""The European Patent Officedeclared a contested mRNA patent owned by Modernainvalid on Tuesday, the office said, handing a win to BioNTechand its partner Pfizer in a patent disputebetween the two...""}, {""date"": ""2023-11-21"", ""headline"": ""BioNTech says Moderna patent declared invalid by EPO, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""Madrigal Pharmaceuticals appoints Ronald Filippo as CIO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-21"", ""headline"": ""A Golden Age of Vaccines Is Here. What It Means for You."", ""summary"": ""Pharmaceutical companies are currently developing vaccines for a range of purposes, from preventing disease to treating cancers.""}, {""date"": ""2023-11-21"", ""headline"": ""Moderna slips as BioNTech scores EU patent win over COVID vaccine tech"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-22"", ""headline"": ""SPY ETF Update, 11/23/2023\ufffd\ufffd\ufffd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-22"", ""headline"": ""Analyzing ARKG's Trading Activity In Q3"", ""summary"": ""ARK Genomic Revolution ETF applies genomic innovation to sectors like healthcare, IT, and energy, through significant buying and selling. Read more on ARKG here.""}, {""date"": ""2023-11-22"", ""headline"": ""Moderna Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Moderna Inc. advanced 1.34% to $78.17 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-11-22"", ""headline"": ""Big Players' Recent Trades in MRNA Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-22"", ""headline"": ""3 Biotech Stocks That Could Be Millionaire Makers"", ""summary"": ""In my view, these three players, held as part of a diversified portfolio, could be millionaire makers.  CRISPR Therapeutics (NASDAQ: CRSP) just reached a huge moment in its story as a company.  Along with partner Vertex Pharmaceuticals, it earned the world's first authorization for a gene-editing treatment that uses the \""CRISPR technique.\""""}, {""date"": ""2023-11-22"", ""headline"": ""Why Investors Are Wrong About Pfizer?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-22"", ""headline"": ""BioNTech Vs. Moderna: Navigating The mRNA Landscape"", ""summary"": ""Moderna (MRNA) and BioNTech (BNTX) are pioneering companies in mRNA technology, known for their fast development of highly effective COVID-19 vaccines. Learn which one is best.""}, {""date"": ""2023-11-23"", ""headline"": ""SPY ETF Update, 11/24/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-23"", ""headline"": ""QQQ ETF Update, 11/24/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-23"", ""headline"": ""South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-24"", ""headline"": ""Moderna Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.45% higher to $78.52 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...""}, {""date"": ""2023-11-24"", ""headline"": ""Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-24"", ""headline"": ""Pneumonia outbreak in China is no reason for alarm: WHO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-24"", ""headline"": ""Early notable gainers among liquid option names on November 24th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-24"", ""headline"": ""$100 Invested In Moderna 5 Years Ago Would Be Worth This Much Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
46,2023-11-26,78.5199966430664,2023-12-03,79.83000183105469,0.016683714263810545,U2,"[{""date"": ""2023-11-27"", ""headline"": ""SPY ETF Update, 11/28/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-27"", ""headline"": ""Moderna begins work on China mRNA manufacturing site"", ""summary"": ""U.S. vaccine maker Moderna began construction of its first facility in China this month to manufacture mRNA medicines, the company said on Tuesday.  Moderna's COVID-19 vaccine has yet to be approved in China, but the company said in July it had signed a deal with the city government of China's financial hub Shanghai to work towards opportunities for it to research, develop and manufacture mRNA medicines in the country.  The facility in Shanghai would manufacture medicines for the domestic population, the world's second largest after India, a spokesperson for Moderna told Reuters.""}, {""date"": ""2023-11-27"", ""headline"": ""Moderna initiated with a Hold at Canaccord"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-27"", ""headline"": ""Arcturus, CSL win approval for world\u2019s first self-amplifying mRNA vaccine in Japan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-27"", ""headline"": ""Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-27"", ""headline"": ""Moderna Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 1.02% to $77.72 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-11-27"", ""headline"": ""11 Best Upside Stocks To Buy Right Now"", ""summary"": ""In this piece, we will take a look at the 11 best upside stocks to buy right now. If you want to skip our overview of share valuation, then take a look at the 5 Best Upside Stocks To Buy Now. The art of buying shares on the market has always gone hand in hand [\u2026]""}, {""date"": ""2023-11-27"", ""headline"": ""Feeling Lucky? 5 \u2018Jackpot\u2019 Stocks to Buy for 2024."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""Canaccord starts Moderna at Hold on 'still-healthy valuation'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""Canaccord starts Moderna at hold, says valuation properly reflects risk/reward"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""What You Missed On Wall Street for Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""AWS expands big pharma partnerships in manufacturing, AI, and R&D"", ""summary"": ""Pfizer and Amazon Web Services are just another example of how artificial intelligence is working in the background in healthcare.""}, {""date"": ""2023-11-28"", ""headline"": ""YieldMax Launches Option Income Strategy ETF on C3.ai"", ""summary"": ""YieldMax announced the launch of the YieldMax AI Option Income Strategy ETF AIYY on the New York Stock Exchange. AIYY seeks to generate monthly income via a synthetic covered call strategy on C3.ai Inc. (AI).""}, {""date"": ""2023-11-28"", ""headline"": ""QQQ ETF Update, 11/28/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""Singapore says Nuvaxovid COVID vaccine won't be available under NVP as of Jan. 1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""Moderna (MRNA): A Fair Valuation in Today's Market?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""Moderna starts building mRNA plant in China"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-28"", ""headline"": ""Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-29"", ""headline"": ""SPY ETF Update, 11/30/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-29"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. advanced 1.06% to $79.01 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-11-29"", ""headline"": ""Airbnb downgraded, Moderna initiated: Wall Street's top analyst calls"", ""summary"": ""Airbnb downgraded, Moderna initiated: Wall Street's top analyst calls""}, {""date"": ""2023-11-29"", ""headline"": ""Canaccord Genuity Initiates Coverage of Moderna (MRNA) with Hold Recommendation"", ""summary"": """"}, {""date"": ""2023-11-29"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-29"", ""headline"": ""Generation Bio to cut 40% of staff in business reorganization"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-29"", ""headline"": ""GLOBAL BROKER RATINGS: JPMorgan cuts Volkswagen but raises BMW"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-29"", ""headline"": ""Analyst Expectations for Moderna's Future"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-29"", ""headline"": ""Generation Bio announces strategic reorganization"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""Catalyst Watch: McDonald's event, Lululemon earnings and GameStop volatility redux"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-11-30"", ""headline"": ""CureVac: Failing To Live Up To Its Initial Hype"", ""summary"": ""CureVac has a partnership with GSK plc to develop vaccines for Covid-19 and the flu. Read more to see an overview and analysis of CVAC stock.""}, {""date"": ""2023-11-30"", ""headline"": ""Moderna Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 1.66% to $77.70 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-11-30"", ""headline"": ""Moderna, Inc. (MRNA) Presents at 35th Annual Piper Sandler Healthcare Conference (Transcript)"", ""summary"": ""Moderna, Inc. (NASDAQ:NASDAQ:MRNA) 35th Annual Piper Sandler Healthcare Conference November 30, 2023 12:30 PM ETCompany ParticipantsJamey Mock -...""}, {""date"": ""2023-11-30"", ""headline"": ""Moderna Stock Looks Sick; Here's How To Take Advantage With Options"", ""summary"": ""Moderna stock has bounced off its 52-week low but still looks incredibly weak and that could provide an opportunity for a bearish option play.  A bear call spread involves selling an out-of-the-money call and buying a further out-of-the-money call.  A January-expiry bear call spread on MRNA stock using the 90-95 strike prices can be sold for around $0.95.""}, {""date"": ""2023-11-30"", ""headline"": ""Moderna, Inc.'s (NASDAQ:MRNA) Intrinsic Value Is Potentially 92% Above Its Share Price"", ""summary"": ""Key Insights The projected fair value for Moderna is US$151 based on 2 Stage Free Cash Flow to Equity Current share...""}, {""date"": ""2023-11-30"", ""headline"": ""Texas Sues Pfizer For \""Misrepresenting COVID-19 Vaccine Efficacy\"" And \""Conspiring To Censor Public Discourse\"""", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-01"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. advanced 2.74% to $79.83 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-12-01"", ""headline"": ""GLOBAL BROKER RATINGS: Goldman likes UBS, but cuts SocGen to 'sell'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-01"", ""headline"": ""Analysts\u2019 Opinions Are Mixed on These Healthcare Stocks: CytomX Therapeutics (CTMX), BiomX (PHGE) and Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-01"", ""headline"": ""Moderna price target lowered to $90 from $93 at JPMorgan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-03"", ""headline"": ""Biotechs post record gains in November amid improving outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
47,2023-12-03,79.83000183105469,2023-12-10,80.31999969482422,0.006138016441569416,U1,"[{""date"": ""2023-12-03"", ""headline"": ""SPY ETF Update, 12/4/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-03"", ""headline"": ""Noteworthy Monday Option Activity: MRNA, AAPL, GOOGL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-03"", ""headline"": ""Biotechs post record gains in November amid improving outlook"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""QQQ ETF Update, 12/6/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""Moderna Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.05% higher to $79.87 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-12-04"", ""headline"": ""SPY ETF Update, 4/12/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-04"", ""headline"": ""3 Dirt Cheap Stocks You'll Regret Not Buying Before the New Year"", ""summary"": ""Carnival (NYSE: CCL) (NYSE: CUK) shares have climbed 95% this year, but they're still trading way below their pre-pandemic levels.  Things weren't easy for Carnival at the start of the health crisis since it was forced to halt sailings -- and debt ballooned so the company could stay afloat.  Carnival's latest earnings reports offer us reason to be optimistic.""}, {""date"": ""2023-12-05"", ""headline"": ""Moderna Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 1.99% to $78.28 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-12-05"", ""headline"": ""Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy"", ""summary"": ""Absci (ABSI) announces a collaboration agreement with AstraZeneca to develop an AI-designed antibody for an undisclosed oncology target. The stock rises 13%.""}, {""date"": ""2023-12-06"", ""headline"": ""CRISPR Therapeutics AG (CRSP) Up 20.5% Since Last Earnings Report: Can It Continue?"", ""summary"": ""CRISPR Therapeutics AG (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""2023-12-06"", ""headline"": ""30 Stocks shunned by hedge and mutual funds - GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""Top 30 stocks with highest hedge fund + mutual fund short positions \u2013 GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""Top stocks with highest hedge fund + mutual fund positions, according to GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""Odyssey Therapeutics Announces $101 Million Series C Financing"", ""summary"": ""BOSTON - Odyssey Therapeutics, Inc., a biotechnology company pioneering next-generation precision immunomodulators and oncology medicines, today announced the closing of a $101 million Series C...""}, {""date"": ""2023-12-06"", ""headline"": ""2023 laggards that could bounce in 1Q24' by differentiated bullish views \u2013 GS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""2024's Potential Stock Surprises: Goldman Sachs Unveils S&P 500 Laggards For Major Gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-06"", ""headline"": ""Wall Street Analysts Are Bullish on Top Healthcare Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Moderna Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slid 0.81% to $79.95 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-12-07"", ""headline"": ""Why Is Iovance Biotherapeutics (IOVA) Up 53% Since Last Earnings Report?"", ""summary"": ""Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""2023-12-07"", ""headline"": ""Moderna, Inc. (MRNA) 2023 ESG Day Conference (Transcript)"", ""summary"": ""Moderna, Inc. (NASDAQ:NASDAQ:MRNA) 2023 ESG Day Conference Call December 7, 2023 8:00 AM ETCompany ParticipantsLavina Talukdar - Head of Investor...""}, {""date"": ""2023-12-07"", ""headline"": ""White House Plan to Cut Drug Prices Gets Shrugs From Investors"", ""summary"": ""The Biden administration unveiled a plan to force drugmakers to license generic versions of patented drugs. Stocks barely budged.""}, {""date"": ""2023-12-07"", ""headline"": ""S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""US sets policy to seize patents of government-funded drugs if price deemed too high"", ""summary"": ""The Biden Administration on Thursdayannounced it is setting new policy that will allow it to seizepatents for medicines developed with government funding if itbelieves their prices are too high. ...""}, {""date"": ""2023-12-07"", ""headline"": ""Recent uptick might appease Moderna, Inc. (NASDAQ:MRNA) institutional owners after losing 55% over the past year"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Moderna's stock price might be vulnerable to their...""}, {""date"": ""2023-12-07"", ""headline"": ""Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event"", ""summary"": ""The Company's ESG strategy demonstrates its efforts to advance global health and environmental sustainability, as well as its commitments to employees and communitiesCAMBRIDGE, MA / ACCESSWIRE / December 7, 2023 / Moderna, Inc. (NASDAQ:MRNA) today ...""}, {""date"": ""2023-12-07"", ""headline"": ""Moderna : updated ESG strategy"", ""summary"": ""Moderna announces an update to its environmental, social and governance strategy on the occasion of its second ESG investor event. Following on from its first ESG Day held in November 2022, the...""}, {""date"": ""2023-12-07"", ""headline"": ""QQQ ETF Update, 12/8/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, GOOG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Video: S&P 500 Movers: MRNA, GOOG"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-07"", ""headline"": ""Moderna, Inc."", ""summary"": ""Moderna Reviews its Environmental, Social and Governance Progress and Ambitions at Second ESG Investor EventThe Company's ESG strategy demonstrates its efforts to advance global health and...""}, {""date"": ""2023-12-07"", ""headline"": ""The EU Protects Its Companies From Big Pharma. South Africa Needs to Do the Same"", ""summary"": ""Critical work being done by local scientists is at riskCritical work done by South African scientists on mRNA vaccines for several diseases is at risk from patent claims from the pharmaceutical giant...""}, {""date"": ""2023-12-08"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. inched 0.46% higher to $80.32 Friday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-12-08"", ""headline"": ""Moderna's Options Frenzy: What You Need to Know"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-08"", ""headline"": ""Moderna Reviews its Environmental, Social and Governance Progress and Ambitions at Second ESG Investor Event"", ""summary"": ""CAMBRIDGE - Moderna, Inc. today will provide an update on its Environmental, Social and Governance strategy at its second ESG Investor Event.Building off its inaugural ESG Day in November 2022,...""}, {""date"": ""2023-12-08"", ""headline"": ""7 F-Rated Stocks to Sell in December"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-10"", ""headline"": ""Generative AI could upend every sector. Oppenheimer has 10 predictions for how it plays out."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
48,2023-12-10,80.31999969482422,2023-12-17,86.01000213623047,0.07084166413129256,U5+,"[{""date"": ""2023-12-10"", ""headline"": ""Generative AI could upend every sector. Oppenheimer has 10 predictions for how it plays out."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""The Forgotten Man of mRNA Research"", ""summary"": ""Jason Schrum\u2019s work helped lay the foundation for Moderna\u2019s mRNA Covid vaccine, but he hasn\u2019t won any prizes or royalties and left the company after disagreements.""}, {""date"": ""2023-12-11"", ""headline"": ""Moderna Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Moderna Inc. advanced 2.09% to $82.00 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-12-11"", ""headline"": ""Merck reports mixed updates for cancer treatment, Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""UPDATE 1-Moderna, Merck begin late-stage study for mRNA cancer therapy"", ""summary"": ""Moderna and Merck & Co said on Monday they have started a late-stage trial of their experimental personalized mRNA cancer treatment in combination with blockbuster drug Keytruda for patients with a type of lung cancer.  Moderna and Merck started a late-stage study in July testing the combination therapy in patients with melanoma, the most deadly form of skin cancer.""}, {""date"": ""2023-12-11"", ""headline"": ""Merck and Moderna Initiate INTerpath-002, a Phase 3 Study Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA\u00ae (pembrolizumab) for Adjuvant Treatment of Patients with Certain Types of Resected Non-Small Cell Lung Cancer"", ""summary"": ""RAHWAY, N.J. & CAMBRIDGE, Mass., December 11, 2023--Merck and Moderna Initiate INTerpath-002 Evaluating V940 (mRNA-4157) in Combination with KEYTRUDA for Certain Types of Resected NSCLC""}, {""date"": ""2023-12-11"", ""headline"": ""Moderna (NASDAQ:MRNA) shareholders have earned a 36% CAGR over the last five years"", ""summary"": ""It hasn't been the best quarter for Moderna, Inc. ( NASDAQ:MRNA ) shareholders, since the share price has fallen 24% in...""}, {""date"": ""2023-12-11"", ""headline"": ""Moderna : to evaluate mRNA in lung cancer"", ""summary"": ""Merck and Moderna announced on Monday the launch of their Phase III clinical trial to evaluate the combination of immunotherapy and messenger RNA technology in the treatment of lung cancer.The two...""}, {""date"": ""2023-12-11"", ""headline"": ""These 2 Stocks Are All-Stars in the Making"", ""summary"": ""What are stock market all-stars? The companies that wow us year after year with earnings growth, a healthy financial situation, and share performance over time. They also are industry leaders, maintaining dominance in their field.""}, {""date"": ""2023-12-11"", ""headline"": ""Moderna, Merck begin late-stage study for mRNA cancer therapy"", ""summary"": ""Moderna and Merck & Cosaid on Monday they have started a late-stage trial oftheir experimental personalized mRNA cancer treatment incombination with blockbuster drug Keytruda for patients with...""}, {""date"": ""2023-12-11"", ""headline"": ""Merck, Moderna begin new Phase 3 trial for mRNA-based cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-11"", ""headline"": ""Merck, Moderna initiat INTerpath-002 phase 3 study of V940"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Cava, Moderna, Airbnb: Trending tickers"", ""summary"": ""Cava (CAVA) stock climbed Tuesday as the IPO lockup expiration allows insiders to sell shares. The Mediterranean food chain notes there are currently no Wall Street \""Sell\"" ratings on the stock. Moderna (MRNA) has announced Chief Commercial Officer Arpa Garay will step down, after joining the company in April 2022. CEO Stephane Bancel will assume Garay's responsibilities. Barclays downgraded Airbnb (ABNB) to \""Underweight\"" from \""Equal Weight\"" on concerns that \""pent-up travel demand will get exhausted.\"" The firm cited a weakening travel outlook for 2024 and increased pressure from hotels as other reasons for the downgrade. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-12-12"", ""headline"": ""30 Largest Pharmaceutical Companies in the World"", ""summary"": ""In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world. To skip our detailed analysis, you can go directly to see the 10 Largest Pharmaceutical Companies in the World. The world\u2019s leading pharmaceutical companies became the center of attention for people all over the world as a [\u2026]""}, {""date"": ""2023-12-12"", ""headline"": ""Moderna's Immunity to Lower Prices Appears to Be Waning"", ""summary"": ""Despite the promise of mRNA medicines, it looks like shares of Moderna are going to remain in a downward path until an important low is made. Let's take a jab at the charts and indicators. In this daily bar chart of MRNA, below, I can see that prices have failed at the underside of the declining 50-day moving average line going back to February.""}, {""date"": ""2023-12-12"", ""headline"": ""Moderna (MRNA), Merck Start 2nd Late-Study on Cancer Therapy"", ""summary"": ""The second late-stage study will evaluate Moderna (MRNA)/Merck's investigational cancer combination therapy in certain lung cancer patients. A late-stage study in melanoma indication is ongoing.""}, {""date"": ""2023-12-12"", ""headline"": ""Moderna Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 4.83% to $78.04 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2023-12-12"", ""headline"": ""IN BRIEF: Moderna reorganises ahead of 2024 and 2025 product launches"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Moderna commercial officer steps down, CEO to look over vaccine sales"", ""summary"": ""Her exit from the role comes at a time when the company, which is looking to break even in 2026, is ramping up spending on research and development as weak sales of COVID vaccine weigh on stock performance.  In contrast, Pfizer expects annual sales from COVID shot to be about $11.5 billion.  CEO Bancel will now directly oversee the company's efforts to drive sales of the COVID shot and its preparation to roll out the vaccine against respiratory syncytial virus (RSV) next year.""}, {""date"": ""2023-12-12"", ""headline"": ""QQQ ETF Update, 12/12/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Moderna (NASDAQ:MRNA) Sinks after Launching Reorganization"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Moderna (NASDAQ:MRNA) Sinks After Launching Reorg"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Moderna : departure of sales director in sight"", ""summary"": ""Moderna announces the departure of its commercial director Arpa Garay over the next few months , as part of changes to the group's operating model in order to focus on its commercial objectives.The...""}, {""date"": ""2023-12-12"", ""headline"": ""Biggest stock movers today: Oracle, Workhorse Group, Icosavax and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Biggest stock movers today: Oracle, Hasbro, Icosavax and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Moderna chief commercial officer steps down"", ""summary"": ""U.S. drugmaker Moderna saidon Tuesday Chief Commercial Officer Arpa Garay has steppeddown more than a year after she took on the role. Effective Dec. 8, Garay is no longer the CCO,...""}, {""date"": ""2023-12-12"", ""headline"": ""Moderna reorganizes to sharpen focus on vaccine sales, chief commercial officer to leave company"", ""summary"": ""Moderna Inc. on Tuesday announced a reorganization designed to sharpen the company\u2019s focus on driving sales of COVID vaccine Spikevax and on the expected...""}, {""date"": ""2023-12-12"", ""headline"": ""Moderna reports commercial organization changes to prepare for product launches"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Moderna CEO to lead sales and marketing as commercial chief departs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Moderna announces operating model changes, CCO to leave company"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-12"", ""headline"": ""Moderna price target lowered by $23 at Morgan Stanley, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""These Stocks Are Moving the Most Today: Moderna, Rivian, SolarEdge, Adobe, Opendoor, Illumina, Foot Locker, and More"", ""summary"": ""Moderna reports more promising data on its personalized cancer treatment, AT&T will be buying Rivian vehicles in a pilot program, SolarEdge and other solar...""}, {""date"": ""2023-12-13"", ""headline"": ""MRNA Stock Surges as Moderna Teams Up With Merck to Fight Cancer"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""What You Missed On Wall Street On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Stock market today: Asian markets churn upward after the Dow ticks to another record high"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Stock market today: Wall Street rises again as the Dow ticks to another record"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Moderna CEO Highlights Promising Cancer Vaccine Data: 'Think About The Number Of Lives That Can Be Impacted'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""QQQ ETF Update, 14/12/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Dow hits pause on record-setting rally, S&P 500 and Nasdaq struggle for direction"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Nasdaq Turns Lower; US Retail Sales Top Estimates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""US Stocks Eye 7-Day Winning Streak As Mortgage Rates Fall Below 7%, Yields Tumble: What's Driving Markets Thursday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Tracking Philippe Laffont's Coatue Management Portfolio - Q3 2023 Update"", ""summary"": ""Coatue Management's 13F portfolio value dropped in Q3 2023. Key holdings are Nvidia, Meta, Amazon, AMD, and Microsoft. Read the article for more details.""}, {""date"": ""2023-12-13"", ""headline"": ""Moderna Inc. stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.72% higher to $78.60 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...""}, {""date"": ""2023-12-13"", ""headline"": ""Big Pharma: Why the drug industry faces a 3-front battle with the FTC, Medicare, and the White House"", ""summary"": ""The Biden administration is increasingly focused on finding ways to lower drug prices, putting the drug industry in a three-way battle to defend its ecosystem.""}, {""date"": ""2023-12-13"", ""headline"": ""Bottom U.S. Triple Momentum stocks - BofA Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""SPY ETF Update, 12/13/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Stocks Hold Steady, Yields Decline As Fed Meeting Looms: What's Driving Markets Wednesday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Column: A new initiative by Biden that might finally bring drug prices down"", ""summary"": ""The feds have never used the 50-year-old 'march-in' rights that have given them power over drug prices. Biden has signaled that he may do so""}, {""date"": ""2023-12-13"", ""headline"": ""Pfizer hits 52-week low, drags COVID vaccine peers on weak guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Pfizer Issues FY24 Forecast, Joins Target Hospitality, Southwest Airlines And Other Big Stocks Moving Lower On Wednesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""3 Dirt-Cheap Stocks to Buy Hand Over Fist Before the End of the Year"", ""summary"": ""These players could lift your portfolio when they rebound and over the long term.""}, {""date"": ""2023-12-13"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, VRTX"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-13"", ""headline"": ""Moderna Announces Changes to Commercial Organization to Prepare for Multiple Product Launches in 2024 and 2025"", ""summary"": ""CAMBRIDGE - Moderna, Inc. today announced changes to its operating model to bring focus to its short and long-term business goals.The Company is focused on driving continued sales of its COVID-19...""}, {""date"": ""2023-12-13"", ""headline"": ""Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer"", ""summary"": ""By Will Feuer Shares of Moderna and other makers of Covid-19 vaccines were dragged lower after rival Pfizer warned that it expects revenue from its Covid-19...""}, {""date"": ""2023-12-13"", ""headline"": ""Pfizer Stock Falls After Company Slashes Guidance. Why Wall Street Is Disappointed."", ""summary"": ""The pharmaceutical company said it expects adjusted earnings per share in the range of $2.05 to $2.25 for 2024. Wall Street was looking for $3.16.""}, {""date"": ""2023-12-13"", ""headline"": ""Moderna Patent On MRNA Vaccine Against COVID-19 Revoked"", ""summary"": ""On Tuesday 21 November 2023, an Opposition Division of the European Patent Office declared Moderna's patent EP 3 718 565 B1 invalid. Moderna, however, indicated to be willing to file an Appeal to...""}, {""date"": ""2023-12-14"", ""headline"": ""FDA flagged quality control issues at Moderna vaccine plant: Reuters"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""FDA report flagged quality control issues at Moderna vaccine plant: Reuters"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Merck gets US FDA nod for Welireg, as trial with Moderna bears fruit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna Inc. stock rises Friday, still underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""FDA found control lapses at Moderna plant, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Leerink Partners Reaffirms Their Sell Rating on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Fear & Greed Index Remains In 'Greed' Zone Following Economic Reports; Dow Records New High"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna stock sees boost over skin cancer treatment trials"", ""summary"": ""Moderna (MRNA) shares have jumped by over 9% on Thursday in relation to positive trial results in Moderna and Merck's (MRK) collaborative skin cancer treatment that utilizes both a vaccine and the drug Keytruda. Additionally, Pfizer (PFE) disappointed investors this week over the pharmaceutical company's 2024 guidance. Yahoo Finance Health Reporter Anjalee Khemlani details the top stories and biggest drivers behind pharmaceutical stocks Thursday. For more expert insight and the latest market action, click\u00a0here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-12-14"", ""headline"": ""Rebel's Edge - December 14: $W, $RDFN, $MRNA, and QB Injuries"", ""summary"": ""Jon and Pete Najarian join forces to discuss and debate their favorite topics, including the hottest stock-specific news and sports!""}, {""date"": ""2023-12-14"", ""headline"": ""UPDATE 2-US CDC says there's urgent need to increase respiratory vaccine coverage"", ""summary"": ""The U.S. Centers for Disease Control and Prevention (CDC) on Thursday issued an alert urging healthcare providers to increase immunization coverage for influenza, COVID-19 and respiratory syncytial virus (RSV).  The health regulator said that low vaccination rates, coupled with ongoing increases in respiratory disease activity, could lead to more severe disease and increased healthcare capacity strain in the coming weeks.  Healthcare providers should recommend antiviral medications for influenza and COVID-19 for all eligible patients, especially older adults and people with certain underlying medical condition, the CDC said.""}, {""date"": ""2023-12-14"", ""headline"": ""Stock Market Erases Gains As Indexes Stumble; Solar Stocks Shine"", ""summary"": ""The Dow Jones index reached another high but the market weakened in afternoon trading. CAT stock jumped.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna-Merck Vaccine for Skin Cancer Shows Positive Results; Moderna Stock Jumps"", ""summary"": ""A vaccine made by Moderna and Merck showed promise in preventing recurrence and death for patients afflicted by skin cancer.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna CEO talks skin cancer vaccine"", ""summary"": ""Moderna (MRNA) shares surged Thursday following positive results from a mid-stage trial for its experimental cancer vaccine. The trial found the vaccine, when used in combination with Merck's (MRK) immunotherapy Keytruda, significantly reduced the risk of death or relapse for patients with advanced melanoma skin cancer. \""We are so happy for patients,\"" Moderna CEO St\u00e9phane Bancel told Yahoo Finance Live, noting the trial showed a roughly 50% survival rate, meaning one in two treated patients were able to live without a relapse. Bancel also highlighted other vaccines in Moderna's pipeline, including its treatment for Respiratory Syncytial Virus (RSV). For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna: Stock soars on cancer vaccine data; CEO Bancel takes on commercial role."", ""summary"": ""Shares of Moderna (MRNA) soared around 14% on Thursday on the news that a personalized cancer vaccine, in partnership with Merck (MRK), reduced the risk of late-stage melanoma by 49%""}, {""date"": ""2023-12-14"", ""headline"": ""US STOCKS-Wall St rises on Fed's rate-cut signal; Apple scales record high"", ""summary"": ""Wall Street's main indexes rose on Thursday, with tech giant Apple notching up a record high, a day after the Federal Reserve hinted an end to its aggressive rate-hike campaign and signaled that borrowing costs would be lower next year.  The Fed left interest rates unchanged on Wednesday, as expected, with Chair Jerome Powell saying the historic tightening of monetary policy was likely over, as inflation falls faster than expected, and discussions on cuts in borrowing costs were coming \""into view\"".  The Fed has raised its policy rate by a market-punishing 525 basis points since March 2022 in an effort to curb decades-high inflation.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna, Rivian rise; Apellis, Adobe fall, Thursday, 12/14/2023"", ""summary"": ""NEW YORK \u2014 Stocks that traded heavily or had substantial price changes on Thursday: Moderna Inc., up $7.27 to $85.87. The vaccine maker gave investors an encouraging update on a potential...""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna Stock Soars On 'Transformational' Potential Of Its Merck-Tied Cancer Vaccine"", ""summary"": ""Moderna's Merck-partnered cancer vaccine reduced the risk of relapse or death by 49% in melanoma patients. Moderna stock soared.""}, {""date"": ""2023-12-14"", ""headline"": ""Trending : Moderna Shares Rise on Favorable Skin Cancer Study Results"", ""summary"": ""14:55 ET -- Moderna is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. Shares were up 8% to $84.96 after Moderna and partner...""}, {""date"": ""2023-12-14"", ""headline"": ""US STOCKS-Wall St advances after Fed hints at rate cuts; Apple scales record high"", ""summary"": ""Wall Street's main indexes rose on Thursday, with tech giant Apple notching a record high, a day after the Federal Reserve hinted an end to its aggressive rate hike campaign and signaled that borrowing costs would be lower next year.  The Fed left interest rates unchanged on Wednesday, as expected, with Chair Jerome Powell saying the historic tightening of monetary policy was likely over, as inflation falls faster than expected, and discussions on cuts in borrowing costs were coming \""into view\"".  The Fed has raised its policy rate by a market-punishing 525 basis points since March 2022 in an effort to curb decades-high inflation.""}, {""date"": ""2023-12-14"", ""headline"": ""Merck-Moderna Vaccine Cuts Return of Skin Cancer by Half"", ""summary"": ""(Bloomberg) -- A personalized vaccine developed by Merck & Co. and Moderna Inc. helped prevent the recurrence of severe skin cancer for three years in promising new results from a study.Most Read from BloombergCitigroup Offers Partial Early Bonuses to Encourage Staff DeparturesWall Street Traders Go All-In on Great Monetary Pivot of 2024Elon Musk Is Planning a New University in AustinOwner of the Philippines\u2019 Largest Malls Says China Feud May Hurt BusinessesJPMorgan Is in a Fight Over Its Client""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna Stock Surges After Positive Trial Results"", ""summary"": ""Moderna shares rose more than 15% after the company and partner Merck [disclosed positive trial results](https://www.merck.com/news/moderna-and-merck-announce-mrna-4157-v940-an-investigational-personalized-mrna-cancer-vaccine-in-combination-with-keytruda-pembrolizumab-met-primary-efficacy-endpoint-in-phase-2b-keynote-94/) for an experimental mRNA-based treatment for skin cancer.""}, {""date"": ""2023-12-14"", ""headline"": ""Stocks to Watch Thursday: Adobe, Opendoor, Lennar"", ""summary"": ""[**Adobe (ADBE)**](https://www.wsj.com/market-data/quotes/ADBE): Shares in the software provider fell 6% [after it issued revenue projections](https://www.wsj.com/livecoverage/fed-meeting-fomc-interest-rate-december-2023/card/adobe-stock-slides-after-company-reports-weak-outlook-lRnIBTKFL49pAJkOBtp9) for next year that undershot analysts\u2019 forecasts.""}, {""date"": ""2023-12-14"", ""headline"": ""2 Big Stocks Making Big Moves Thursday"", ""summary"": ""One is rising while the other's on the decline. Here's why.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna Reports More Promising Data on Its Cancer Treatment. The Stock Jumps."", ""summary"": ""Moderna\u2019s personalized cancer vaccine is being used with a Merck immunotherapy drug to fight melanoma cancer.""}, {""date"": ""2023-12-14"", ""headline"": ""US STOCKS-Wall St set for higher open after Fed hints at rate cuts"", ""summary"": ""Wall Street's main indexes were on course to open higher on Thursday, a day after the Federal Reserve hinted an end to its recent aggressive rate hikes and signaled that borrowing costs would be lower next year.  The Fed left interest rates unchanged on Wednesday, as expected, with Chair Jerome Powell saying the historic tightening of monetary policy was likely over, as inflation falls faster than expected, and discussions on cuts in borrowing costs were coming \""into view\"".  The Fed has raised its policy rate by a market-punishing 525 basis points since March 2022 in an effort to curb decades-high inflation.""}, {""date"": ""2023-12-14"", ""headline"": ""UPDATE 2-Benefits of Moderna and Merck melanoma vaccine plus Keytruda extend to three years"", ""summary"": ""An experimental messenger RNA cancer vaccine developed by Moderna and Merck & Co paired with Merck's Keytruda cut the chance of recurrence or death from melanoma by half after three years, showing that benefits demonstrated a year ago have held up over time.  Moderna shares rose 11.1% to $87.20 premarket, while Merck shares were up marginally at $106.70 before the bell.  The combination of the personalized cancer vaccine and Merck's blockbuster immunotherapy cut the risk of recurrence or death of the most deadly skin cancer by 49% compared with Keytruda alone in the midstage trial, the companies said.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna surges on positive skin-cancer-vaccine trial data"", ""summary"": ""Moderna  shares surged Thursday after the biotech and Merck  reported encouraging results from an experimental skin cancer vaccine.  Shares of Merck, Kenilworth, N.J., were little changed near $107.  The companies said that the experimental vaccine, when used in combination with Merck's blockbuster therapy Keytruda, reduced the risk of death or recurrence of melanoma by 49% in patients in later stages of the disease compared with those who received Keytruda alone after three years.""}, {""date"": ""2023-12-14"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""US STOCKS-Futures rise after Fed signals rate cuts are on the horizon"", ""summary"": ""U.S. stock index futures gained on Thursday, a day after the Federal Reserve hinted an end to its recent aggressive rate hikes and signaled that borrowing costs would be lower next year.  The Fed left interest rates unchanged on Wednesday, as expected, with Chair Jerome Powell saying the historic tightening of monetary policy was likely over, as inflation falls faster than expected, and discussions on cuts in borrowing costs were coming \""into view\"".""}, {""date"": ""2023-12-14"", ""headline"": ""Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration"", ""summary"": ""Carisma Therapeutics Inc. (Nasdaq: CARM) (\""Carisma\"" or the \""Company\""), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced the nomination of its first lead candidate under the collaboration with Moderna, Inc. (Nasdaq: MRNA). This first lead candidate will target an antigen present on a solid tumor with significant unmet medical need. This strategic collaboration brings together Carisma's chimeric antigen receptor macrophage""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna And Merck Announce mRNA-4157 (V940) In Combination with Keytruda(R) (Pembrolizumab) Demonstrated Continued Improvement in Recurrence-Free Survival and Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Complete Resection Versus Keytruda at Three Years"", ""summary"": ""At a median planned follow-up of approximately three years, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% (HR=0.510 [95% CI, 0.288-0.906]; one-sided nominal p=0.0095) and the risk of distant metastasis ...""}, {""date"": ""2023-12-14"", ""headline"": ""Benefits of Moderna and Merck melanoma vaccine plus Keytruda extend to three years"", ""summary"": ""An experimental messenger RNA cancer vaccine developed by Moderna and Merck & Co paired with Merck's Keytruda cut the chance of recurrence or death from melanoma by half after three years, showing that benefits demonstrated a year ago have held up over time.  The combination of the personalized cancer vaccine and Merck's blockbuster immunotherapy cut the risk of recurrence or death of the most deadly skin cancer by 49% compared with Keytruda alone in the midstage trial, the companies said.""}, {""date"": ""2023-12-14"", ""headline"": ""Leerink skeptical on sustainability of Moderna rally given eroding fundamentals"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Biggest detractors to the S&P 500 from the past 2 years - UBS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Why Are Bank Stocks Up Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Biggest stock movers today: Moderna, Foot Locker, Adobe, Ocular Therapeutix and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna\u2019s stock boosted by positive data from trial of melanoma treatment combined with Merck\u2019s Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Jabil Posts Upbeat Earnings, Joins Moderna, Rivian Automotive And Other Big Stocks Moving Higher On Thursday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Why Is SOFI Stock Up Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna call volume above normal and directionally bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Opendoor (OPEN) Stock Jumps on Analyst Upgrade"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Early notable gainers among liquid option names on December 14th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Dow climbs to fresh record as Fed rate-cut forecasts spur global markets rally"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Unusually active option classes on open December 14th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Costco, Pfizer, Moderna, Lennar Corp, Tesla: Why These 5 Stocks Are On Investors' Radars Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Why Is Moderna (MRNA) Stock Up 11% Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""5 stocks to watch on Thursday: Moderna, Costco, Live Nation and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna : positive follow-up data in melanoma"", ""summary"": ""Moderna and Merck announce positive follow-up data from a Phase 2b study, evaluating mRNA-4157 in combination with Keytruda, in patients with stage III/IV melanoma at high risk of recurrence after...""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna\u2019s (NASDAQ:MRNA) Positive Melanoma Trial Data Sparks Stock Surge"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna\u2019s stock rallies after announcement of positive data from trial of melanoma treatment combined with Merck\u2019s Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna's stock buoyed by positive data in trial of melanoma treatment"", ""summary"": ""Moderna's stock was on track for its biggest one-day gain in more than a year.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna CEO Bancel says melanoma vaccine could be available by 2025"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna, Merck post three-year data for mRNA-based skin cancer therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna Reports More Promising Data on Cancer Treatment. The Stock Jumps."", ""summary"": ""The personalized cancer vaccine is being used with a Merck immunotherapy drug to fight melanoma cancer.""}, {""date"": ""2023-12-14"", ""headline"": ""Carisma Therapeutics nominates first lead candidate in Moderna collaboration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna\u2019s stock rallies 7.9% after announcing positive data in trial of melanoma treatment combined with Merck\u2019s Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-14"", ""headline"": ""Moderna, Merck announc e follow-up data on V940 with Keytruda"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-15"", ""headline"": ""Contaminated Vaccines: FDA Reportedly Finds Cleaning And Expiry Lapses At Moderna's Massachusetts Facility"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-15"", ""headline"": ""Moderna: good news on skin cancer vaccine is welcome distraction from Covid-19 shot sales woes"", ""summary"": ""US biotech company\u2019s stock worth nearly $500 at its peak in August 2021, currently trades at less than $87""}, {""date"": ""2023-12-15"", ""headline"": ""FDA Expands Merck's (MRK) Welireg Label in Renal Cell Carcinoma"", ""summary"": ""Per Merck (MRK), the latest FDA approval to Welireg marks the first time a new treatment has been approved in a novel therapeutic class in advanced renal cell carcinoma since 2015.""}, {""date"": ""2023-12-15"", ""headline"": ""Moderna (MRNA) Soars on Upbeat Data From Cancer Therapy Study"", ""summary"": ""Three-year follow up data from a mid-stage study shows that treatment with Moderna (MRNA)/Merck's cancer combination therapy reduces recurrence/death risk in certain melanoma patients by half.""}, {""date"": ""2023-12-15"", ""headline"": ""US FDA finds control lapses at Moderna manufacturing plant"", ""summary"": ""U.S. drug regulators in Septemberfound quality control lapses at Moderna\u2019s main factoryincluding with equipment used to manufacture drug substance forits COVID-19 vaccine, according to the report...""}, {""date"": ""2023-12-15"", ""headline"": ""11 Most Promising Biotech Stocks to Buy According to Analysts"", ""summary"": ""In this article, we will take a look at the 11 most promising biotech stocks to buy according to analysts. To skip our analysis of the recent trends, and market activity, you can go directly to see the 5 Most Promising Biotech Stocks to Buy According to Analysts. The biotech industry is making a resurgence [\u2026]""}, {""date"": ""2023-12-15"", ""headline"": ""Pfizer\u2019s Bleak Forecast Dims Hope for Rebound After 2023 Rout"", ""summary"": ""(Bloomberg) -- Pfizer Inc. shares are set to enter the new year trading near the lowest level in a decade, yet Wall Street is increasingly hesitant to bet on a recovery after the drugmaker issued a disappointing 2024 outlook this week. Most Read from BloombergMike Johnson May Be the Next House Speaker to Lose His JobCiti Shuts Muni Business That Once Was Envy of RivalsShipping Giants Pause Red Sea Route as Houthi Attacks IntensifyChina\u2019s iPhone Ban Accelerates Across Government and State FirmsTh""}, {""date"": ""2023-12-15"", ""headline"": ""Pharma Stock Roundup: PFE Issues Weak 2024 View, AZN to Buy Icosavax & More"", ""summary"": ""Pfizer (PFE) issues a disappointing outlook for 2024. AstraZeneca (AZN) announces that it is buying vaccine company, Icosavax.""}, {""date"": ""2023-12-15"", ""headline"": ""Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data For MRNA-1345, The Company\u2019s Investigational Respiratory Syncytial Virus (RSV) Vaccine"", ""summary"": ""Moderna has submitted marketing authorizations globally for mRNA-1345 and continues to prepare for an expected 2024 marketing launchCAMBRIDGE, MA / ACCESSWIRE / December 15, 2023 / Moderna, Inc. (Nasdaq:MRNA) today announced the publication of positive ...""}, {""date"": ""2023-12-15"", ""headline"": ""Trending tickers: Costco | Moderna | Rivian | H&M"", ""summary"": ""The latest investor updates on stocks that are trending on Friday.""}, {""date"": ""2023-12-15"", ""headline"": ""3 No-Brainer Healthcare Stocks to Buy Right Now"", ""summary"": ""These players have what it takes to boost your portfolio over time.""}, {""date"": ""2023-12-15"", ""headline"": ""Moderna : positive results for RSV vaccine candidate"", ""summary"": ""Moderna today announced the publication of positive results from a Phase 3 clinical trial evaluating its respiratory syncytial virus vaccine candidate, mRNA-1345, in the New England Journal of...""}, {""date"": ""2023-12-15"", ""headline"": ""Moderna RSV vaccine more than 80% effective, study shows"", ""summary"": ""Moderna Inc.\u2019s investigational vaccine for respiratory syncytial virus is 84% effective against the lower respiratory tract illness linked with the virus,...""}, {""date"": ""2023-12-15"", ""headline"": ""Moderna and Merck Announce mRNA-4157 in Combination with Keytruda Demonstrated Continued Improvement in Recurrence-Free Survival and Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma"", ""summary"": ""CAMBRIDGE - Moderna, Inc. and Merck , known as MSD outside of the United States and Canada, today announced follow-up data from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study, a clinical...""}, {""date"": ""2023-12-15"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Regeneron (REGN) and Teva Pharmaceutical (TEVA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-15"", ""headline"": ""Balancing Promise and Prudence: Hold Rating on Moderna Amidst Cancer Vaccine Developments"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-15"", ""headline"": ""Moderna announces publication of Phase 3 study results evaluating mRNA-1345"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-15"", ""headline"": ""Moderna announces publication of Phase 3 study results on mRNA-1345"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-15"", ""headline"": ""Positive results for mRNA vaccine in melanoma patients"", ""summary"": ""Moderna and MSD have announced follow-up data from the Phase IIb clinical trial evaluating cancer vaccine mRNA-4157 in combination with MSD's Keytruda in patients with resected high-risk...""}, {""date"": ""2023-12-16"", ""headline"": ""Moderna Entering Weekly Bluebox Support Area"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-16"", ""headline"": ""3 S&P 500 Stocks That Are About to Get Absolutely Crushed"", ""summary"": ""The bulls look to be firmly in control of the stock market now. The U.S. Federal Reserve has pivoted away from its monetary tightening regime and signaled three interest rate cuts in 2024. However, while the Santa Claus rally now appears in full swing, not every stock is celebrating as we close the year. Some stocks continue to trade sideways or are falling based on poor fundamentals, sector problems, or a lack of investor interest. With the market rally broadening, investors should shun these p""}, {""date"": ""2023-12-16"", ""headline"": ""Moderna: MRNA-4157 Cancer Vaccine Data Points To A Future Beyond Spikevax"", ""summary"": ""Moderna and Merck reported data regarding a cutting-edge mRNA-based skin cancer regimen that includes the former\u00e2\u0080\u0099s cancer vaccine, MRNA-4157. Read more here.""}]",{}
49,2023-12-17,86.01000213623047,2023-12-24,94.88999938964844,0.10324377436188192,U5+,"[{""date"": ""2023-12-16"", ""headline"": ""Moderna Entering Weekly Bluebox Support Area"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-17"", ""headline"": ""Moderna: FDA Finds Quality Control Lapses"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-17"", ""headline"": ""On This Day: House impeaches President Trump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-17"", ""headline"": ""QQQ ETF Update, 12/18/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""Picking Through the Rubble of This Year's Hardest-Hit Stocks"", ""summary"": ""A look at the worst-performing stocks""}, {""date"": ""2023-12-18"", ""headline"": ""Moderna Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Moderna Inc. dropped 0.69% to $85.42 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-12-18"", ""headline"": ""Why Investors Shouldn't Be Surprised By Moderna, Inc.'s (NASDAQ:MRNA) Low P/S"", ""summary"": ""You may think that with a price-to-sales (or \""P/S\"") ratio of 3.6x Moderna, Inc. ( NASDAQ:MRNA ) is definitely a stock...""}, {""date"": ""2023-12-18"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024"", ""summary"": ""Analysts think these beaten-down stocks could rebound strongly in the new year.""}, {""date"": ""2023-12-18"", ""headline"": ""$100 Invested In This Stock 5 Years Ago Would Be Worth $500 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-18"", ""headline"": ""Moderna Just Took a Step Closer to Its Product Launch Goal. Is the Stock a Buy?"", ""summary"": ""Moderna's personalized cancer vaccine candidate just delivered excellent clinical trial results.""}, {""date"": ""2023-12-18"", ""headline"": ""Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for MRNA-1345, The Company's Investigational Respiratory Syncytial Virus Vaccine"", ""summary"": ""CAMBRIDGE - Moderna, Inc. today announced the publication of positive Phase 3 clinical study results evaluating mRNA-1345, its vaccine candidate for respiratory syncytial virus , in The New England...""}, {""date"": ""2023-12-19"", ""headline"": ""QQQ And QQQM ETFs Top Gainers And Laggards Of 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""Don\u2019t Waste Another Minute: Dump These 3 F-Rated Stocks Now"", ""summary"": ""Investors need to understand and be able to steer clear of companies that have a poor future outlook. Whether from reduced financial guidance, overall financial instability, management issues, or relevancy surrounding their product and or services. Some companies struggle with the changing times, and investors don\u2019t want to be aboard a sinking ship. These are the F-Rated stocks you want to kick out of your portfolio. These are a few different companies that investors should be aware of, and it\u2019s""}, {""date"": ""2023-12-19"", ""headline"": ""Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""SPY ETF Update, 12/19/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-19"", ""headline"": ""CureVac price target lowered to $6.40 from $8 at BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""This Is What Whales Are Betting On Moderna"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""Thursday Sector Leaders: Healthcare, Technology & Communications"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""Moderna to Present at the 42nd Annual J.P. Morgan Healthcare Conference"", ""summary"": ""CAMBRIDGE, MA / ACCESSWIRE / December 20, 2023 / Moderna, Inc. (Nasdaq:MRNA), today announced that Jamey Mock, Chief Financial Officer, will present at the 42nd annual J.P. Morgan Healthcare Conference on Monday, January 8th at 6:45 p.m. ET / 3:45 ...""}, {""date"": ""2023-12-20"", ""headline"": ""12 Most Promising Gene Editing Stocks According to Hedge Funds"", ""summary"": ""In this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds. If you want to skip our take on how the gene editing industry sits right at the top of the global innovation food chain, then you can take a look at the 5 Most Promising [\u2026]""}, {""date"": ""2023-12-20"", ""headline"": ""Moderna Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slipped 3.26% to $86.19 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-12-20"", ""headline"": ""6 Cheap Healthcare Stock Picks With Room to Grow in 2024"", ""summary"": ""After an abysmal year for healthcare stocks, Wall Street is upbeat on Cigna, Humana, Bristol Myers, and three others.""}, {""date"": ""2023-12-20"", ""headline"": ""Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks This Year?"", ""summary"": ""One retail chain may have the clearest path to market-beating upside from here.""}, {""date"": ""2023-12-20"", ""headline"": ""Pfizer Is Not Cheap, And The 5.7% Yield Is Not As Safe As You Might Think"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""QQQ ETF Update, 12/20/2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""2024 - Liquidia, Burford, And Roivant"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""Long-Term, Organic Revenue Growth Is A Key To Investment Success"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-20"", ""headline"": ""Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barriers to Outperformance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-21"", ""headline"": ""What to Know About the New Fast-Spreading Covid-19 Strain"", ""summary"": ""The alert about the new variant, called JN.1, comes as hospitalizations of patients with Covid-19 are climbing in the U.S., amid a seasonal increase in respiratory virus hospitalizations.""}, {""date"": ""2023-12-21"", ""headline"": ""Biotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More"", ""summary"": ""Compugen (CGEN) and Moderna (MRNA) are in the news on collaboration and study updates, respectively.""}, {""date"": ""2023-12-22"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. advanced 4.09% to $94.89 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-12-22"", ""headline"": ""HBM Gets Health Boost From Drug Licensing Deals"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-22"", ""headline"": ""S&P 500, Nasdaq 100 Aim For 8th Week Of Gains As Fed's Inflation Gauge Cools: What's Driving Markets Friday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-22"", ""headline"": ""SPGP: Not Very Reasonable"", ""summary"": ""The Invesco S&P 500 GARP ETF has successfully utilized a growth at a reasonable price (GARP) strategy, but currently has an expensive valuation. Read more here.""}, {""date"": ""2023-12-22"", ""headline"": ""Moderna call volume above normal and directionally bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-22"", ""headline"": ""Early notable gainers among liquid option names on December 22nd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-23"", ""headline"": ""20 Best Countries for Doctors to Immigrate to"", ""summary"": ""In this article, we will list and explore the 20 best countries for doctors to immigrate to. You can skip our detailed analysis and go directly to our list of 5 Best Countries for Doctors to Immigrate to. For many medical professionals, the United States has historically been an attractive destination due to its renowned healthcare [\u2026]""}, {""date"": ""2023-12-23"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Spotify.""}]",{}
50,2023-12-24,94.88999938964844,2023-12-31,99.44999694824219,0.048055617956840324,U5,"[{""date"": ""2023-12-25"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-25"", ""headline"": ""Should You Buy This Year's Worst-Performing S&P 500 Stocks for 2024?"", ""summary"": ""Some of this year's underperformers could have brighter futures.""}, {""date"": ""2023-12-25"", ""headline"": ""Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barriers to Outperformance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-25"", ""headline"": ""Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A Comprehensive Guide"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-26"", ""headline"": ""Best and worst performing big names of 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-26"", ""headline"": ""Why Is RayzeBio (RYZB) Stock Up 100% Today?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-26"", ""headline"": ""JN.1 Omicron strain becomes dominant COVID variant in U.S."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-27"", ""headline"": ""Tracking Lone Pine Capital Portfolio - Q3 2023 Update"", ""summary"": ""Lone Pine Capital's portfolio value declined in Q3 2023, with top holdings in META, AMZN, and MA stocks constituting 21% of the assets. Explore more here.""}, {""date"": ""2023-12-27"", ""headline"": ""The Winners and Losers: 2023 Stock Market Performance Review"", ""summary"": ""A 2023 stock market recap is a tale of highs and lows. We entered the year after a Fed tightening cycle proved restrictive but seemingly unsuccessful as inflation continued while rates rose. Those factors began squeezing consumers and commercial segments to apparent breaking points. But a rapid reversal transpired in mid-fall, with inflation falling and calls for a soft landing seeming more viable. That uptick accelerated in December amid rumors of imminent rate cuts, and markets climbed back to""}, {""date"": ""2023-12-27"", ""headline"": ""Moderna and Pfizer Stock Tumbled in 2023. Wall Street Sees a Rebound."", ""summary"": ""Covid-19-vaccine makers Moderna and Pfizer saw shares drop in 2023, but analysts expect double-digit-percentage gains next year.""}, {""date"": ""2023-12-27"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Moderna Inc. advanced 3.49% to $100.73 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2023-12-27"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-28"", ""headline"": ""Can Moderna shares rebound in 2024?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-28"", ""headline"": ""The Biggest Losers in S&P 500 This Year: Dollar General, Moderna, and More"", ""summary"": ""The five worst performers in the market benchmark so far this year could be set for brighter futures.""}, {""date"": ""2023-12-28"", ""headline"": ""Moderna Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 1.93% to $98.79 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""2023-12-28"", ""headline"": ""Walgreens, Nike, Moderna: Bargain hunting stocks"", ""summary"": ""The most recent bull market run has been widely described as \""weird,\"" with several household stocks underperforming during the bull run on S&P 500 (^GSPC) components. Yahoo Finance Reporter Madison Mills showcases three of these companies \u2014 Moderna (MRNA), Walgreens (WBA), and Nike (NKE) \u2014 where investors may find the most value for a bargain price on the stocks. For more expert insight and the latest market action, click\u00a0here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-12-28"", ""headline"": ""Gilead in 2024: What to expect?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-28"", ""headline"": ""S&P 500 Is Nearing a Record High. This Could Derail It in 2024."", ""summary"": ""Microsoft and OpenAI are sued by the New York Times for copyright infringement, Amazon plans to launch adverts on Prime Video next month, and other news to start your day.""}, {""date"": ""2023-12-28"", ""headline"": ""Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-28"", ""headline"": ""Moderna exec sells $4.5M in common stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-28"", ""headline"": ""Thoughts For Thursday: With War Clouds As A Backdrop The Market Is Set To End The Year On A High"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-29"", ""headline"": ""Why the Market Dipped But Moderna (MRNA) Gained Today"", ""summary"": ""In the latest trading session, Moderna (MRNA) closed at $99.45, marking a +0.67% move from the previous day.""}, {""date"": ""2023-12-29"", ""headline"": ""2023 Will Go Down As The Year Pharma Showed Its Determination To Beat Cancer"", ""summary"": ""During the last week of 2023, AstraZeneca PLC (NASDAQ: AZN) agreed to acquire Chinese cancer therapy developer Gracell Biotechnologies Inc. as it continues its efforts to tap pharma innovations from China\u2019s biotech industry. Although this year, Covid-19 stars, namely Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA), were left in the dust with their shares tumbling, Wall Street is expecting a rebound as both are making efforts to enhance their cancer treatment businesses. AstraZeneca\u2019s Newes""}, {""date"": ""2023-12-29"", ""headline"": ""Moderna Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.67% higher to $99.45 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...""}, {""date"": ""2023-12-29"", ""headline"": ""Whatever happened to the pandemic darling stocks?"", ""summary"": ""The COVID-19 pandemic propelled a variety of stocks to new heights, including companies that enabled work-from-home setups like Zoom (ZM) or Peloton (PTON). Yahoo Finance's Jared Blikre observes how these \""pandemic darlings\"" have held up since slowly coming out of the pandemic these past two years, highlighting the losses seen over that period despite significant year-to-date gains in 2023. Some of these stocks include Carvana (CVNA), Coinbase (COIN), and several other companies that have seen major turnarounds this past year. For more expert insight and the latest market action, click\u00a0here\u00a0to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2023-12-29"", ""headline"": ""NEW YORK MARKET CLOSE: Top tech names dominate bumper year for stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-29"", ""headline"": ""Moderna Stock Is Climbing Thanks to Merck, But Is It Still a Buy?"", ""summary"": ""The pair's collaboration is making waves, and there's more to come.""}, {""date"": ""2023-12-29"", ""headline"": ""Early notable gainers among liquid option names on December 29th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2023-12-30"", ""headline"": ""Year-End Portfolio Review: 9 Stocks, 5% Above The S&P, And 3 Resolutions"", ""summary"": ""Learn how my portfolio outperformed the S&P 500 in 2023, analyze my sell decisions, and discover my investment strategy for 2024.""}, {""date"": ""2023-12-30"", ""headline"": ""Wall Street Breakfast: Survey In Review"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Spotify.""}, {""date"": ""2023-12-31"", ""headline"": ""QQQ ETF Update, 1/1/2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
51,2023-12-31,99.44999694824219,2024-01-07,111.12000274658203,0.11734546160331605,U5+,"[{""date"": ""2023-12-31"", ""headline"": ""QQQ ETF Update, 1/1/2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-01"", ""headline"": ""U.S. stocks lower to start 2024,  amid Apple downgrade and looming jobs report "", ""summary"": ""U.S. stocks opened lower Tuesday, with Wall Street starting the new trading year on a negative note after a 2023 rally that left the S&P 500 just shy of a...""}, {""date"": ""2024-01-01"", ""headline"": ""These Stocks Are Moving the Most Today: Tesla, BYD, Li Auto, Apple, ASML, Coinbase, and More"", ""summary"": ""Tesla is expected by analysts on Tuesday to report fourth-quarter deliveries of between 475,000 and 480,000 units, while China\u2019s BYD tops that number with...""}, {""date"": ""2024-01-01"", ""headline"": ""Stock market today: Asian markets track Wall Street's decline, eroding last year's gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-01"", ""headline"": ""Stock market today: Wall Street slumps to start 2024 and gives back some of last year's big gains"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-01"", ""headline"": ""Moderna Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-01"", ""headline"": ""Dow ekes out new record close, Nasdaq ends lower to start 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-01"", ""headline"": ""Dow edges lower to start 2024, with jobs report ahead this week"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-01"", ""headline"": ""Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barriers to Outperformance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-01"", ""headline"": ""Covid-vaccine makers top laggard list, LLY and WST top gainers list"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""2023's Biggest Losers In The Russell 1000"", ""summary"": ""While broad swathes of the equity market rose in 2023, that is not to say there were not areas of weakness.""}, {""date"": ""2024-01-02"", ""headline"": ""Shanghai govt official visits China's Stemirna amid financing woes"", ""summary"": ""A senior Shanghai governmentofficial has visited Chinese COVID-19 vaccine developer StemirnaTherapeutics, the company said in a social media post onWednesday, as it grapples with tight...""}, {""date"": ""2024-01-02"", ""headline"": ""Oppenheimer analyst explains why he upgraded Moderna's stock"", ""summary"": ""Oppenheimer & Co Analyst, Hartaj Singh, recently upgraded Moderna (MRNA) shares to \""Outperform,\"" with a price target of $142 per share. News of the upgrade has caused shares of the stock to trade over 13% higher on Tuesday. Hartaj Singh joins the Live show to discuss why he upgraded the stock and take a deeper dive into Moderna's performance going forward. Singh explains that with he expects Covid-19 demand to be bottoming, adding that \""if you believe that Covid-19 vaccine sales have... hit a bottom going forward, that essentially funds their pipeline and that pipeline is very important... there are some material catalysts that are coming.\"" Click here to watch the full interview on the Yahoo Finance YouTube page or you can watch this full episode of Yahoo Finance Live here.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna shares soar on upgrade, best day since 2022"", ""summary"": ""Moderna (MRNA) shares surged Tuesday after Oppenheimer upgraded the stock to 'Outperform' and raised its price target to $142 per share, implying a more than 40% gain from Friday's closing price.\u00a0 Analysts led by Hartaj Singh listed a number of potential catalysts, including the approval of additional commercial products by 2026 and a rebound in COVID-19 vaccine sales in 2025.\u00a0 Yahoo Finance\u2019s Seana Smith and Madison Mills break down the upgrade. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna surges after CEO says sales growth expected in 2025"", ""summary"": ""\""With the expected launch of our RSV vaccine candidate in 2024, and potential launch of our flu/COVID combination vaccine as early as 2025, we believe Moderna will experience sales growth in 2025,\"" said Bancel.  Moderna had said in November it would only hit the low end of its sales forecast of $6 billion to $8 billion for 2023, reflecting weaker demand for COVID-19 vaccines.""}, {""date"": ""2024-01-02"", ""headline"": ""Stocks to Watch Tuesday: ASML, Apple, Baidu"", ""summary"": ""**\u2198\ufe0f** [**ASML Holding (ASML)**](https://www.wsj.com/market-data/quotes/ASML/research-ratings), [**(NL:ASML)**](https://www.wsj.com/market-data/quotes/NL/XAMS/ASML): The semiconductor-equipment giant said the Netherlands had [blocked exports](https://www.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna Stock Is Top Performer in S&P 500 Tuesday After Miserable 2023. Why This Year Could Be Better."", ""summary"": ""The vaccine maker's shares tumbled 45% over the past 12 months, but Oppenheimer analysts can see a turning point.""}, {""date"": ""2024-01-02"", ""headline"": ""Apple downgraded, Booking upgraded: Wall Street's top analyst calls"", ""summary"": ""Apple downgraded, Booking upgraded: Wall Street's top analyst calls""}, {""date"": ""2024-01-02"", ""headline"": ""Dow edges higher, Nasdaq falls to start 2024 with jobs report ahead"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""2 Major Reasons Why Moderna (MRNA) Stock Is Up Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna jumps on Oppenheimer upgrade, 2025 sales growth goal"", ""summary"": ""Moderna shares gained nearly14% on Tuesday as brokerage Oppenheimer upgraded the stock tooutperform and the vaccine maker's CEO reiterated thecompany's goal of achieving sales growth in 2025. ...""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna : CEO optimistic for 2024, share price soars"", ""summary"": ""In a letter to shareholders, Moderna CEO St\u00e9phane Bancel believes that the most optimistic five-year scenario set out in 2018 is coming true. As we reflect on the past year, our commitment to...""}, {""date"": ""2024-01-02"", ""headline"": ""Video: Tuesday's ETF Movers: ARKG, ARKF"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Bank of America more favorable on SMID-cap biotechs into 2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Tech Stalls As Rising Bond Yields Spook Investors"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna Breaks Above 200-Day Moving Average - Bullish for MRNA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna's stock soars after Oppenheimer upgrades to buy"", ""summary"": ""Moderna's stock started the year with a bang thanks to an analyst upgrade.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna upgraded at Oppenheimer on commercial prospects"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna Analyst Projects Transformation Into 'Five-Product Commercial Company' By 2026"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna\u2019s stock soars 10% to lead S&P 500 gainers as Oppenheimer upgrades to buy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna call volume above normal and directionally bullish"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Early notable gainers among liquid option names on January 2nd"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna Stock Is Top Performer in S&P 500 After Miserable 2023. Why This Year Could Be Better."", ""summary"": ""The vaccine maker's shares tumbled 45% over the past 12 months, but Oppenheimer analysts can see a turning point.""}, {""date"": ""2024-01-02"", ""headline"": ""COVID Vaccine Leader Moderna (NASDAQ:MRNA) Eyes 2025 Growth with Vaccine Launches"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Apple, Longboard Pharmaceuticals, Coinbase, Moderna, Tesla: Why These 5 Stocks Are On Investors' Radars Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna expands U.S. market share for COVID vaccines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Moderna : 2023 Shareholder Letter"", ""summary"": ""View All News Moderna 2023 Shareholder Letter January 2, 2024 Moderna has added its 2023 Shareholder Letter from CEO...""}, {""date"": ""2024-01-02"", ""headline"": ""Oppenheimer upgrades Moderna on increasing vaccine visibility"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""Oppenheimer gets more bullish on Moderna, upgrades shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-02"", ""headline"": ""2023's Biggest Losers In The Russell 1,000"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Why Moderna (MRNA) Stock Price Was Up 13% on Tuesday"", ""summary"": ""Moderna (MRNA) surges after analysts at Oppenheimer upgraded its rating in anticipation of the company marketing five products by 2026.""}, {""date"": ""2024-01-03"", ""headline"": ""Stocks to Watch Wednesday: Tesla, Xerox, Moderna"", ""summary"": ""[**Tesla (TSLA)**](https://www.wsj.com/market-data/quotes/TSLA): The company's shares slipped more than 4%. Data Tuesday from Tesla [showed](https://www.wsj.com/business/autos/tesla-delivered-1-81-million-cars-globally-in-2023-hitting-full-year-target-2bcc396b) that China's BYD had overtaken it as the largest seller of electric vehicles on a quarterly basis.""}, {""date"": ""2024-01-03"", ""headline"": ""Verizon Stock Jumps on an Upgrade. Why Wall Street Is Optimistic."", ""summary"": ""It\u2019s been a busy start year on Wall Street with a deluge of stock upgrades and downgrades, most notably for Apple and Moderna.""}, {""date"": ""2024-01-03"", ""headline"": ""Moderna (MRNA) Moves 13.1% Higher: Will This Strength Last?"", ""summary"": ""Moderna (MRNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.""}, {""date"": ""2024-01-03"", ""headline"": ""Company News for Jan 3, 2024"", ""summary"": ""Companies in The News Are: MRNA, RCL, NVDA, MRK""}, {""date"": ""2024-01-03"", ""headline"": ""Moderna (NASDAQ:MRNA): Analysts Bullish on Sales Growth Prospects"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""S&P 500 and Nasdaq extend selloff ahead of Fed minutes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Trending tickers: Apple | Rivian | Moderna | GSK"", ""summary"": ""The latest investor updates on stocks that are trending on Wednesday.""}, {""date"": ""2024-01-03"", ""headline"": ""The biopharmaceuticals stocks to own in 2024, according to BofA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Tech Sell-Off Triggers Market Reset: Value Stocks Reach 7-Month High Versus Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Florida surgeon general calls for halt to use of mRNA Covid-19 vaccines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""4 stocks to watch on Wednesday: Apple, Moderna and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""4 Red-Hot Stocks Top Wednesday\u2019s Biggest Wall Street Upgrades and Downgrades"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Moderna\u2019s stock soars 13% to lead S&P 500 gainers as Oppenheimer upgrades to buy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Biotech Bonanza: 2024 Biotech Outlook As The Fed Turns Dovish"", ""summary"": ""Biotechnology is well-positioned to outperform the broader indexes in 2024, provided the 10-year yield remains below 4%, with potential gains of 20%-25% and likely higher. Read more here.""}, {""date"": ""2024-01-03"", ""headline"": ""US Stocks Set To Open Weaker As Traders Eye Key Main Street Events: Analyst Sees Buying Opportunity On 'Stunning' Earnings Expectations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-03"", ""headline"": ""Moderna price target raised by $10 at BofA, here's why"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""Strides Toward Lower Drug Costs: Florida Becomes First To Receive Nod To Import Prescription Drugs from Canada"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""Catalyst Watch: CES lights up tech, retail's ICR conference and bank earnings blitz"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""Moderna (MRNA) Ascends While Market Falls: Some Facts to Note"", ""summary"": ""Moderna (MRNA) closed the most recent trading day at $108.66, moving +0.07% from the previous trading session.""}, {""date"": ""2024-01-04"", ""headline"": ""2 Healthcare Stocks That Turned $1,000 Into $2,400 (or More)"", ""summary"": ""These innovative biotechs likely aren't done rewarding their shareholders.""}, {""date"": ""2024-01-04"", ""headline"": ""Time to Buy Moderna-Heavy ETFs on Vaccine Optimism?"", ""summary"": ""Shares of Moderna witnessed a significant increase of more than 13% on Jan 2, 2024, driven by Oppenheimer's decision to upgrade the stock to \""outperform,\"" as quoted on CNBC.""}, {""date"": ""2024-01-04"", ""headline"": ""Masking returns to some U.S. hospitals amid rising COVID, flu cases"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-04"", ""headline"": ""Market Whales and Their Recent Bets on MRNA Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Moderna, Bayer-backed startup Metagenomi files for US IPO"", ""summary"": ""Growing expectations that the Federal Reserve could guide the economy to a soft landing is boosting confidence after a dismal spell late last year.  Earlier this week, KKR-backed BrightSpring Health Services also submitted paperwork for a Nasdaq listing.  Metagenomi is developing therapies for genetic diseases.""}, {""date"": ""2024-01-05"", ""headline"": ""11 Stocks Are Taking Off Already \u2014 And The Year Just Started"", ""summary"": ""The calendar just flipped to 2024 \u2014 and investors already have their favorite S&P 500 stocks. And none of them are the Big Tech giants that dominated.""}, {""date"": ""2024-01-05"", ""headline"": ""Healthcare Champions Kick Off 2024"", ""summary"": ""Surprisingly, it is not Big Tech that kicked off 2024 but healtchare champions. Moderna Inc (NASDAQ: MRNA) shares rose after Oppenheimer upgraded the stock due to the Covid-19 vaccine star possibly marketing as many as five products by 2026. Merck & CO Inc (NYSE: MRK) shares also rose 7.3% this year so far with the pharma giant announcing it is kicking off its phase 3 trial for four of its investigational candidates from its diverse and promising hematology and oncology pipeline. 2023 Was A Dism""}, {""date"": ""2024-01-05"", ""headline"": ""Moderna-backed genetic drugs firm Metagenomi files for US IPO"", ""summary"": ""Metagenomi Technologies, a geneticmedicines company backed by Bayer Healthcare and Moderna, filed for an initial public offering in the UnitedStates on Friday.(Reporting by Niket Nishant in...""}, {""date"": ""2024-01-05"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. advanced 2.26% to $111.12 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2024-01-05"", ""headline"": ""2023 in Review: Key Stock Trends and Sector Shifts Unveiled"", ""summary"": ""The year 2023 was a great one for the stock market. The Dow Jones Industrial Average rose 14% to finish the year at a record high. The benchmark S&P 500 index gained 25% and came within a whisker of a record close. And the technology-focused Nasdaq index increased 43% to register its best year since the internet rally of 1999. So, what can we expect in 2024? How will the markets perform in the year ahead? It\u2019s still very early days, but already we are seeing some trends and shifts take hold in t""}, {""date"": ""2024-01-05"", ""headline"": ""7 Stocks Are Taking Off Already \u2014 And The Year Just Started"", ""summary"": ""The calendar just flipped to 2024 \u2014 and investors already have their favorite S&P 500 stocks. And none of them are the Big Tech giants that dominated.""}, {""date"": ""2024-01-05"", ""headline"": ""Dry January Investing: Trading Pints For Portfolio Growth"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Biotech Alert: Searches spiking for these stocks today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Florida wins FDA nod for mass drug imports from Canada (update)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Early notable gainers among liquid option names on January 5th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Short Sellers' Nightmare: $195B Evaporates In 2023's Market Surge"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""Florida to become first state to win FDA nod for mass drug imports from Canada: NYT"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-05"", ""headline"": ""CureVac stock gains as COVID vaccine candidates show promise"", ""summary"": ""CureVac N.V. shares gained 3% premarket on Friday as the company released new data from a trial of its mRNA COVID-19 vaccine candidates, which it is...""}, {""date"": ""2024-01-05"", ""headline"": ""RBC Capital Sticks to Their Buy Rating for Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-06"", ""headline"": ""Great week for Moderna, Inc. (NASDAQ:MRNA) institutional investors after losing 38% over the previous year"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Moderna's stock price might be vulnerable to their...""}, {""date"": ""2024-01-06"", ""headline"": ""Wall Street Breakfast: What Moved Markets"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available this morning on Seeking Alpha, iTunes, Spotify.""}, {""date"": ""2024-01-07"", ""headline"": ""J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-07"", ""headline"": ""Moderna's Flu/COVID Vaccine Prospects Are Undervalued By The Market"", ""summary"": ""Moderna's mRNA-1083 vaccine, targeting COVID-19 and flu, in Phase 3, reflects innovation in combination vaccinations. Read more about MRNA stock here.""}]",{}
52,2024-01-07,111.12000274658203,2024-01-14,105.94999694824219,-0.04652632892864894,D5,"[{""date"": ""2024-01-07"", ""headline"": ""J.P. Morgan event in spotlight as biotech M&A, obesity frenzy, AI pick up"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-07"", ""headline"": ""Moderna's Flu/COVID Vaccine Prospects Are Undervalued By The Market"", ""summary"": ""Moderna's mRNA-1083 vaccine, targeting COVID-19 and flu, in Phase 3, reflects innovation in combination vaccinations. Read more about MRNA stock here.""}, {""date"": ""2024-01-08"", ""headline"": ""Maintaining Hold: Weighing Moderna\u2019s Product Prospects Against Financial Uncertainties"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna, Inc. (MRNA) Presents at J.P. Morgan 42nd Annual Healthcare Conference Transcript"", ""summary"": ""Moderna, Inc. (NASDAQ:NASDAQ:MRNA) J.P.""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Moderna Inc. rallied 3.89% to $115.44 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna Stock Is Rising. Sales Fell a Bit Less Than Expected in 2023."", ""summary"": ""Covid-19 vaccine maker Moderna said 2023 product sales hit $6.7 billion, above the company\u2019s guidance, but down more than 60% from 2022.""}, {""date"": ""2024-01-08"", ""headline"": ""UPDATE 2-Moderna says it hit its 2023 COVID vaccine sales goal"", ""summary"": ""Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.  Weak overall sales of the vaccine have weighed on the stock's performance, dragging it down over 40% in the last year.  Moderna had said then that it would only hit the lower end of its previous forecast range of $6 billion to $8 billion.""}, {""date"": ""2024-01-08"", ""headline"": ""Boeing, Alaska Air, Spirit AeroSystems fall premarket; Nvidia, Moderna rise"", ""summary"": ""Investing.com -- U.S. futures retreated Monday, with investors cautious ahead of the release of the key monthly inflation data later in the week, which could determine risk appetite going forward.""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna says it hit its 2023 COVID vaccine sales goal"", ""summary"": ""(Reuters) -Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.  Weak overall sales of the vaccine have weighed on the stock's performance, dragging it down over 40% in the last year.  Moderna had said then that it would only hit the lower end of its previous forecast range of $6 billion to $8 billion.""}, {""date"": ""2024-01-08"", ""headline"": ""Baillie Gifford Trims Position in Codexis Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna's 2023 prelim COVID vaccine sales meet target"", ""summary"": ""Moderna on Monday reported preliminary 2023 sales of $6.7 billion for its COVID vaccine, surpassing the lower end of its full-year forecast, while reiterating its goal of returning to sales growth in 2025.  The $6.7 billion prelim sales figure includes about $600 million of deferred revenue related to Moderna's efforts with the global vaccine alliance GAVI.  Demand for COVID vaccines has fallen sharply since 2021, when the shots first became available.""}, {""date"": ""2024-01-08"", ""headline"": ""Is It Time to Buy the S&P 500's 4 Worst-Performing Stocks of 2023?"", ""summary"": ""These four names span different sectors, but all underperformed in 2023. Is it time to be a contrarian and pick up bargains on the discount aisle?""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna (NASDAQ:MRNA) Forecasts $4B in Sales during FY24"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna (NASDAQ:MRNA) Forecasts Sales of $4B in FY24"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Baillie Gifford Adjusts Stake in Chegg Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Baillie Gifford Bolsters Stake in YETI Holdings Inc"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barriers to Outperformance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Healthcare Outlook 2024"", ""summary"": ""The healthcare sector was flat in 2023 year as a result of some unique issues. Check out the healthcare outlook for 2024.""}, {""date"": ""2024-01-08"", ""headline"": ""Morning Brew: Apple Unveils Vision Pro Amid Mixed Market Signals"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna (NASDAQ:MRNA) Forecasts $4 Billion Sales in FY24"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna posts $6.7B COVID-19 vaccine sales for 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna : increased Covid market share in the USA"", ""summary"": ""At the JPMorgan Healthcare Conference, Moderna reports that it will have sold around $6.7 billion worth of products in 2023 and increased its Covid-19 market share in the USA from 37% in 2022 to 48%...""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna anounces upcoming pipeline milestones"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna reports 2023 COVID-19 vaccine sales $6.7B"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Moderna\u2019s stock rises on 2023 product sales of $6.7B"", ""summary"": ""Moderna Inc.\u2019s stock was up by 1.2% after the drug maker said it sold $6.7 billion of products in 2023. Analyst expected the company to sell $6.35 billion in...""}, {""date"": ""2024-01-08"", ""headline"": ""Arbutus Biopharma lays out 2024 objectives, sees cash runway into Q1 of 2026"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""Flagship Pioneering Debuts Enabling Technologies Initiative"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-08"", ""headline"": ""5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""Your Path to Wealth: 3 Stocks Predicted to Double Your Investment by 2025"", ""summary"": ""Today, identifying investments with promising growth potential is a quest every investor undertakes. Within the loud noises of the stock market, three standout companies are making waves. Their strategies and innovations forecast substantial gains, promising a 2X capital level by 2025. The first one on the list is a pioneer in digital payments, emphasizing enhanced security measures and seamless platform integrations. The second is a pharmaceutical giant. It focuses on an ambitious lineup of new""}, {""date"": ""2024-01-09"", ""headline"": ""Eli Lilly Could Be the Next Apple Stock. It Still Looks Cheap."", ""summary"": ""The drugmaker\u2019s obesity treatment and other medications could be revolutionary\u2014and a smart way to bet on them is through options.""}, {""date"": ""2024-01-09"", ""headline"": ""2024 Marks a New Era Of Pharmaceutical Innovation"", ""summary"": ""With Covid-19 finally fading into history, the Covid-19 heroes, namely Moderna Inc (NASDAQ: MRNA) and Pfizer Inc (NYSE: PFE) were forced to redefine their business focus last year, and so, they turned to fighting cancer, the one battle that pharma never seems to win. Moderna ended 2023 by delivering good news regarding its cancer vaccine and Pfizer received approval to buy the cancer drug maker Seagan and execute its plan of creating a new oncology division that will battle cancer at the speed o""}, {""date"": ""2024-01-09"", ""headline"": ""Moderna (MRNA) Issues 2023 Preliminary Results, Stock Up 4%"", ""summary"": ""Moderna (MRNA) reports unaudited product sales of around $6.7 billion for 2023, meeting its previously issued guidance. Share price rises following the announcement.""}, {""date"": ""2024-01-09"", ""headline"": ""7 S&P 500 Stocks to Buy to Keep the Bull Market Running"", ""summary"": ""The S&P 500 is within striking distance of entering official bull market territory. To qualify, the index would need to rise more than 20% from its previous low and hit a new all-time high. The popular benchmark crossed the first threshold and needs to close above 4,796.56 to achieve the second. It\u2019s within about 75 points of making it and there\u2019s good reason to think it could happen soon. Bear markets are relatively short-term events lasting about 15 months on average. Bull markets, on the othe""}, {""date"": ""2024-01-09"", ""headline"": ""Moderna Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 4.56% to $110.18 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2024-01-09"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""Moderna's Post-Covid Hangover Might Persist For A Few More Years"", ""summary"": ""Moderna's revenue is expected to decline after COVID-19 vaccine sales peak, but it aims to achieve positive cash flow by 2026. Find out why MRNA stock is a Sell.""}, {""date"": ""2024-01-09"", ""headline"": ""Chris DeMuth Sure Likes Uranium And SHF Holdings + 3 Litigation Ideas"", ""summary"": ""Chris DeMuth Jr. is still really bullish on the commodity uranium and cannabis fintech SHF Holdings. He also shares 3 new litigation ideas for investors.""}, {""date"": ""2024-01-09"", ""headline"": ""DEAN BANKS APPOINTED CEO OF INDIGO AG AND CEO-PARTNER OF FLAGSHIP PIONEERING"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,700 Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-09"", ""headline"": ""Moderna Provides Business and Pipeline Updates at 42nd Annual J.P. Morgan Healthcare Conference"", ""summary"": ""CAMBRIDGE - Moderna, Inc. today announced business updates and progress on the Company's pipeline of transformative mRNA medicines.Moderna enters 2024 with 45 therapeutic and vaccine programs, nine...""}, {""date"": ""2024-01-09"", ""headline"": ""Piper Sandler Keeps Their Buy Rating on Moderna (MRNA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-10"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Moderna (MRNA) and Inspire Medical Systems (INSP)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-10"", ""headline"": ""Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note"", ""summary"": ""The latest trading day saw Moderna (MRNA) settling at $109.46, representing a -0.65% change from its previous close.""}, {""date"": ""2024-01-10"", ""headline"": ""Moderna Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. dropped 0.65% to $109.46 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ...""}, {""date"": ""2024-01-10"", ""headline"": ""Investors in Moderna (NASDAQ:MRNA) have seen enviable returns of 578% over the past five years"", ""summary"": ""Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...""}, {""date"": ""2024-01-10"", ""headline"": ""QQQ ETF Update, 1/11/2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-10"", ""headline"": ""10 Health Care Stocks With Whale Alerts In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-10"", ""headline"": ""Smart Money Is Betting Big In MRNA Options"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-10"", ""headline"": ""Sana Biotechnology hits 52-week high amid rising volumes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2023 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2023 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2022 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2022 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2022 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2022 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2021 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2021 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2021 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2021 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2020 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2020 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2020 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2020 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2019 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2019 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q2 2019 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q1 2019 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q4 2018 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Q3 2023 Moderna Inc Earnings Call Transcript"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""WHO sees 'incredibly low' COVID, flu vaccination rates as cases surge"", ""summary"": ""Low vaccination ratesagainst the latest versions of COVID-19 and influenza areputting pressure on healthcare systems this winter, leadingpublic health officials told Reuters. In the...""}, {""date"": ""2024-01-11"", ""headline"": ""3 Megatrend Stocks that Will Revolutionize Your Portfolio"", ""summary"": ""Owning powerhouse stocks can add significant value to your portfolio. Megatrends are those that are shaping or will shape society in significant ways. Think AI, EVs, renewable energy, biotech, and more. Megatrend stocks are often large, established companies that are capable of sequestering a large market share for its own ends. Often, these stocks are also leaders in their fields with enough resources to ride out the trend to its eventual completion or evolution. Investors can hold these compan""}, {""date"": ""2024-01-11"", ""headline"": ""Moderna Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 2.43% to $106.80 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ...""}, {""date"": ""2024-01-11"", ""headline"": ""Biotech Stock Roundup: REGN Down on Eylea Update, MRNA Gains on Preliminary Results"", ""summary"": ""Preliminary Q4 and 2023 results from Regeneron (REGN) and Moderna (MRNA) were key highlights this week in the biotech sector.""}, {""date"": ""2024-01-11"", ""headline"": ""Health stocks to watch this earnings season as sector poised for resurgence"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Health stocks to watch this earning season as sector poised for resurgence"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Sana Biotechnology cools after record-breaking rally"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-11"", ""headline"": ""Oxford University Kicks off Human Study for AstraZeneca's COVID-19 Vaccine Technology in Nipah Virus Defense"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Moderna Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Moderna Inc. sank 0.79% to $105.95 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite...""}, {""date"": ""2024-01-12"", ""headline"": ""Why Investors Need to Take Advantage of These 2 Medical Stocks Now"", ""summary"": ""The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.""}, {""date"": ""2024-01-12"", ""headline"": ""Critical Insights From Moderna Analyst Ratings: What You Need To Know"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-12"", ""headline"": ""Analysts Are Bullish on These Healthcare Stocks: Genmab (GMAB), SOPHiA GENETICS (SOPH)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-14"", ""headline"": ""Moderna: Fade 2025 Outlook"", ""summary"": ""Moderna faces tough comps in 2024 with declining Covid vaccine sales and questions about RSV vaccine sales. Read why it is an opportunity to dump MRNA stock.""}, {""date"": ""2024-01-14"", ""headline"": ""7 Healthcare Stocks Taking Medicine to the Next Level"", ""summary"": ""While the technology sector \u2013 especially regarding artificial intelligence \u2013 may have captured the spotlight, investors ought to consider adding healthcare stocks to their portfolio. If I had to boil it down to one phrase, it would be permanent relevance. A bold claim but I believe there\u2019s much validity to it. First and foremost, advanced medicine stocks help improve the human condition. Nobody in their last moments wished they had spent more time in the office. Instead, they regret that they di""}]",{}
53,2024-01-14,105.94999694824219,2024-01-21,100.3499984741211,-0.05285510746033106,D5+,"[{""date"": ""2024-01-14"", ""headline"": ""Moderna: Fade 2025 Outlook"", ""summary"": ""Moderna faces tough comps in 2024 with declining Covid vaccine sales and questions about RSV vaccine sales. Read why it is an opportunity to dump MRNA stock.""}, {""date"": ""2024-01-14"", ""headline"": ""7 Healthcare Stocks Taking Medicine to the Next Level"", ""summary"": ""While the technology sector \u2013 especially regarding artificial intelligence \u2013 may have captured the spotlight, investors ought to consider adding healthcare stocks to their portfolio. If I had to boil it down to one phrase, it would be permanent relevance. A bold claim but I believe there\u2019s much validity to it. First and foremost, advanced medicine stocks help improve the human condition. Nobody in their last moments wished they had spent more time in the office. Instead, they regret that they di""}, {""date"": ""2024-01-16"", ""headline"": ""Moderna president Hoge sells 15,000 common shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-16"", ""headline"": ""10 Stocks That Show Why Healthcare Stocks Are Hot in 2024"", ""summary"": ""The sector has seen one of the best starts to the year in decades, Goldman says.""}, {""date"": ""2024-01-16"", ""headline"": ""10 Stocks That Show Why Healthcare Is Hot in 2024"", ""summary"": ""The sector has seen one of the best starts to the year in decades, Goldman says.""}, {""date"": ""2024-01-16"", ""headline"": ""Peering Into Moderna's Recent Short Interest"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-16"", ""headline"": ""Moderna Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. shed 3.58% to $102.16 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ...""}, {""date"": ""2024-01-16"", ""headline"": ""Omega Therapeutics: The Next Weight Loss Drug Runner"", ""summary"": ""Omega Therapeutics may be a speculative investment opportunity in the weight loss drug market as it entered into a collaboration with Novo Nordisk. Learn more on OMGA stock here.""}, {""date"": ""2024-01-16"", ""headline"": ""Goldman says these stocks with weak pricing power can outperform"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-16"", ""headline"": ""Top And Bottom S&P 500 Stocks To Consider In 2024"", ""summary"": ""Investors keep a close eye on the S&P 500 as it retreats at the start of the year. Check out the top and bottom S&P 500 stocks to consider in 2024.""}, {""date"": ""2024-01-16"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, AMD"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-16"", ""headline"": ""Video: S&P 500 Movers: MRNA, AMD"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-17"", ""headline"": ""Moderna continues losing streak for seven straight sessions"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-17"", ""headline"": ""Notable Thursday Option Activity: MRNA, TGT, EPAM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-17"", ""headline"": ""UK is \""on the up and open for business\"" - Hunt to tell Davos summit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-17"", ""headline"": ""Moderna (MRNA) Falls More Steeply Than Broader Market: What Investors Need to Know"", ""summary"": ""Moderna (MRNA) closed at $100.35 in the latest trading session, marking a -1.77% move from the prior day.""}, {""date"": ""2024-01-17"", ""headline"": ""7 Mighty Healthcare Stocks Changing the Game of Medicine"", ""summary"": ""With so many question marks facing the viability of the equities sector, concerned investors may want to turn their attention to compelling healthcare stocks. Primarily, the sector benefits from permanent relevance. It\u2019s in a nation\u2019s best interest to keep its citizenry healthy and productive, meaning that there will always be funds directed toward the broader health and wellness space. Another factor that could bolster healthcare stocks is its relative insulation from the economy. Now, don\u2019t ge""}, {""date"": ""2024-01-17"", ""headline"": ""Moderna Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Moderna Inc. slid 1.77% to $100.35 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ...""}, {""date"": ""2024-01-17"", ""headline"": ""3 Struggling Businesses Investors Shouldn't Gamble on This Year"", ""summary"": ""These stocks all crashed heavily in 2023, and there is no reason to expect things will get a whole lot better this year.""}, {""date"": ""2024-01-17"", ""headline"": ""Jim Cramer Says Hold Onto This Biotech Stock: 'I Don't Understand Why It's So Inexpensive'"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-18"", ""headline"": ""3 Stocks Poised to Bounce Back After a Brutal 2023"", ""summary"": ""While 2023 was a good year overall for the stock market, not every company shared in the gains. The S&P 500 index rose 24% last year, but most of that growth came from a handful of mega-cap technology stocks known as the Magnificent 7, many of which are closely associated with the red-hot field of artificial intelligence (AI). Numerous stocks continued to decline in 2023 and their shareholders only saw red during the year. Reasons for the decline include poor financial results, difficult economi""}, {""date"": ""2024-01-18"", ""headline"": ""Moderna Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Moderna Inc. slipped 1.28% to $99.07 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ...""}, {""date"": ""2024-01-18"", ""headline"": ""Moderna CEO: There's 'so much noise' around vaccine facts"", ""summary"": ""It has been almost four years since the COVID-19 pandemic overtook the United States and there is still so much misinformation surrounding vaccines. Moderna (MRNA) CEO St\u00e9phane Bancel joins Yahoo Finance's Julie Hyman and Brian Sozzi from the World Economic Forum in Davos, Switzerland to discuss the politicized environment for vaccinations. \""What I think is difficult is that there's so much noise that for most people to understand whatever facts versus fiction is really, really difficult,\"" Bancel states, emphasizing the importance of vaccines to protect the elderly and infants. \""That's the other thing we want to make sure is that we educate new moms, new parents so that they are able to have the facts \u2014 Do I prefer to have my kid... go to the hospital, and the child stays in the hospital, hospitalized... or do I want the vaccine that has a lot of safety data...\"" Bancel also comments on whether the 2024 US election will influence bias around science \u2014 \""Do not forget it's the Trump administration who set up... and actually... created and developed the vaccine...\"" \u2014 while discussing Moderna's future product pipeline. It's all part of\u00a0Yahoo Finance's exclusive coverage\u00a0from the World Economic Forum in Davos, Switzerland, where our team will speak to top decision-makers as well as preeminent leaders in business, finance, and politics about the world\u2019s most pressing issues and priorities for the coming year. Watch this full episode of Yahoo Finance Live\u00a0here. Editor's note: This article was written by Luke Carberry Mogan.""}, {""date"": ""2024-01-18"", ""headline"": ""QQQ ETF Update, 1/18/2024"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-18"", ""headline"": ""Moderna set for seventh straight session of losses"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-18"", ""headline"": ""Behind the Scenes of Moderna's Latest Options Trends"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-18"", ""headline"": ""Moderna set for seventh straight sessions of losses"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-18"", ""headline"": ""3 Things That Could Help 2023 Loser-Stock Moderna Roar Higher in 2024"", ""summary"": ""Moderna may be heading for a new era of growth.""}, {""date"": ""2024-01-18"", ""headline"": ""Video: Nasdaq 100 Movers: MRNA, FAST"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-18"", ""headline"": ""Alphabet, Electronic Arts And 2 Other Stocks Insiders Are Selling"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-19"", ""headline"": ""Moderna Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Moderna Inc. inched 0.64% higher to $99.70 Friday, on what proved to be an all-around favorable trading session for the stock market, with the...""}, {""date"": ""2024-01-19"", ""headline"": ""Senate panel to consider subpoenas for J&J and Merck CEOs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""2024-01-20"", ""headline"": ""Better Bull Market Buy: Pfizer vs. Moderna"", ""summary"": ""There could be a light at the end of the COVID-19 tunnel for both of these beaten-down stocks.""}, {""date"": ""2024-01-20"", ""headline"": ""NZS Capital Growth Equity Strategy Q4 2023 Investment Commentary"", ""summary"": ""NZS Capital's flagship strategy was up 16% (net) vs. 11% for its benchmark index. Click here to read the full fund letter.""}, {""date"": ""2024-01-21"", ""headline"": ""If You Invested $10,000 in Moderna at the End of 2019, This Is How Much You Would Have Today"", ""summary"": ""Has the stock wiped out its gains since the pandemic?""}, {""date"": ""2024-01-21"", ""headline"": ""1 Stock Down 43% to Buy and Hold for 10 Years"", ""summary"": ""This biotech isn't just a pandemic stock.""}]",{}
